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Abstract 
 
Synthetic biology practitioners look through an engineer's lens at the incredibly 
complex, sensitive and seemingly endless resource of living reproductive material 
and contemplate turning biology into a substrate – composed of modular, well-
characterised parts – that can be used to design and build new functional devices 
and systems. It is often explained that this vision for engineering biology may 
deliver future forms of efficient drug production, renewable sources of biofuel, 
methods to sense and remediate toxins and numerous other applications. Yet, 
synthetic biology remains a field in its infancy, facing a barrage of interconnected 
challenges across technical, social, ethical, legal and political realms. This 
multifaceted dynamic makes it a timely and important locus for socio-
philosophical investigation. 
 
This thesis provides a highly empirical ethnographic account of two research 
groups as they were challenged to design and build a microbiological machine for 
the International Genetically Engineered Machine competition (iGEM) in 2009. 
The work examines forms of knowledge and material production in synthetic 
biology and, in focusing on iGEM, argues that this field is not only a feat of 
technical engineering, but also one of social engineering as it educates and 
indoctrinates a next generation of researchers through this unique contest. In this 
narrative, one discovers a microsocial sphere in which new ideas and biological 
entities at the intersection of natural and synthetic kingdoms of life are being 
constructed. Forms of teaching, tools, practices and processes that make 
imagining, designing and building new living systems possible are illustrated. The 
reader is also introduced to some international stakeholders and dynamics at play. 
With gathering media interest, attention from art and design perspectives, as well 
as publications across social, philosophical, political and legal studies of this 
‘new’ biotechnology, there is a great need for the kind of detailed, insider view 
that this thesis provides – it contributes to an informed space through which 
constructive questions may be asked as the debate around engineering synthetic 
life continues to unfold. As such, this work helps to enable a reflection on the 
kinds of intervention possible in the process of dreaming up ideas of potential 
future living machines. Involved collaborators, as well as the resistance of life 
itself, will ultimately govern the limits of synthetic biology. 
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Key terms and abbreviations 
 
BBF: “The BioBricks Foundation (BBF) is a not-for-profit organization founded by engineers and 
scientists from MIT, Harvard, and UCSF with significant experience in both non-profit and 
commercial biotechnology research. BBF encourages the development and responsible use of 
technologies based on BioBrick™ standard DNA parts that encode basic biological functions....”2 
BioBrick™3:  A BioBrick™ standard biological part is a standard biological part that meets the 
technical and legal standards set forth by the BioBricks Foundation (BBF). Each distinct 
BioBrick™ standard biological part is a nucleic acid-encoded molecular biological function (e.g., 
turn on/off gene expression), along with the associated information defining and describing the 
part.4 
BioBricks™ come in various forms5: 
• At the most basic level, they are “parts” (e.g. RNA, DNA, regulatory region, protein 
coding region); 
• A level of sophistication higher, they are “devices” (e.g. with functions such as 
signaling or inversion); 
• And, one step higher, they are “systems” (e.g. that measure). 
• Other kinds of parts include chassis, vectors and flags.  
BioBricks (in ideal form) have standard methods of assembly and characterisation.6  
BIOFAB: “The BIOFAB: International Open Facility Advancing Biotechnology (BIOFAB) was 
founded in December 2009 as the world's first biological design-build facility. This professionally 
staffed public-benefit facility was initiated by a grant from the National Science Foundation (NSF) 
and is led by bioengineers from UC Berkeley and Stanford University…  
BioFab projects will be designed to produce broadly useful collections of standard biological parts 
that can be made freely available to both academic and commercial users, while also enabling the 
rapid design and prototyping of genetic constructs needed to support specific needs of partner 
efforts such as SynBERC Testbeds. The BioFab will thus also represent the first significant 
focused investment in the development of open technology platforms underlying and supporting 
the next generation of biotechnology. Once fully operational the BioFab facility will be capable of 
producing tens of thousands of professionally engineered, high quality standard biological parts 
each year.”7 
Chassis: Refers to the microorganism or cell-free system that acts as the framework or shell in 
which synthetic biology constructs are operated (e.g. E. coli and yeast). 
CSAIL: Computer Science and Artificial Intelligence Laboratory at MIT (Massachusetts Institute 
of Technology), Cambridge, MA, US.8  
CSynBI: The Centre for Synthetic Biology and Innovation (CSynBI) at Imperial College London 
and in association with London School of Economics and Political Science seeks to develop 
foundational tools for synthetic biology and generate applications for research, healthcare and 
industry. Alongside the technical research, CSynBI’s partnership with BIOS Centre researchers 
                                                
2 http://bbf.openwetware.org/.  
3 BioBrick(s)™ is an officially trademarked term, under the BioBricks™ Public Agreement 
(BPA). In the body of this thesis, the use of the term appears without the ™ symbol, with 
recognition of its official form given here. For proposed legal agreement on sharing BioBricks, 
see: http://bbf.openwetware.org/BPA.html.  
4 http://biobricks.org/faq/.  
5 http://partsregistry.org/Part_Types.  
6 http://partsregistry.org/Help:BioBrick_Assembly; 
http://openwetware.org/wiki/The_BioBricks_Foundation:Standards/Technical/Exchange/Old_Disc
ussion#Biobrick_Characterization.  
7 http://www.biofab.org/about.  
8 http://www.csail.mit.edu/.  
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from The LSE integrates science with emerging ethical, legal and societal issues in an attempt to 
mature this biotechnology responsibly.9  
Design Interactions: A niche of speculative and critical design that explores roles, contexts and 
approaches in relation to (possible) social, cultural and ethical impacts of existing and emerging 
technologies.10 Two of the field’s most eminent pioneers are Professor Anthony Dune and 
Professor Fiona Raby of the Royal College of Art, where they run a masters program in this 
subject (both Daisy and James hold this MA). Interaction designers such as Daisy and James tend 
to work closely with practitioners of biotechnology to inform their work (expressed in prototypes, 
simulations, video and photography) that inspires reflection on potential future implications – 
positive and negative – of humans living in an increasingly technological world. 
DIYbio: Do-it-yourself biology (DIYbio) is a sub-culture and organisation within the synthetic 
biology community that is “dedicated to making biology an pursuit for citizen scientists, amateur 
biologists and biological engineers who value openness and safety”.11  
Dry lab / work: refers to work on computers (e.g. modelling, Wiki edits), or on paper (e.g. 
mathematics, mind mapping). 
iGEM: The International Genetically Engineered Machines Competition. 
JCVI: J. Craig Venter Institute.12 
Plasmid: a small, autonomously replicating, circular piece of DNA that exists in bacteria. 
Promoter: a region of DNA that regulates the transcription of functional genetic units. 
The Registry: Also known as The Registry of Standard Biological Parts,  
Wet lab / work: refers to work on biological materials, with the researcher typically gloved and in 
a lab coat.  
 
 
 
 
 
 
 
 
 
 
 
 
Note 1: Some quotations have been smoothed over to make them more comprehensible. 
Note 2: The photos throughout this work are attributed to the author, Caitlin Cockerton, unless 
otherwise attributed in captions or footnotes. Photos are also aligned as best as possible given their 
size and other textual constraints in the formatting of this thesis. 
Note 3: There are several website references throughout this work. For consistency and clarity in 
text, websites are referenced as footnotes in the body of this work. A full reference that includes 
holder of website and date accessed is provided in the Internet Reference list. 
                                                
9 http://www3.imperial.ac.uk/syntheticbiology; 
http://www2.lse.ac.uk/BIOS/research/synbio/synbio.aspx. 
10 http://www.di09.rca.ac.uk/information.  
11 http://diybio.org/.  
12 http://www.jcvi.org/.  
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INTRODUCTION: GOING SYNTHETIC 
 
In October 2007 at the LSE, a panel of eminent scientists and humanities scholars 
came together to discuss the social implications of an emerging biotechnology in 
an event entitled, ‘Beyond the Genome: The Challenge of Synthetic Biology’ 
(Debate 2008). At that time, the J. C. Venter Institute was attempting to construct 
a well-defined “minimal operating system for life” in a redesigned microorganism 
called Mycoplasma genitalium. The audience of lawyers, regulators, economists, 
ethicists, social scientists and members of the public had a number of concerns:   
What in fact is synthetic biology? And what impacts will it have? Are 
the projected possibilities of synthetic biology part of a fantastical 
future, or will these new technologies indeed transform our lives? 
(Debate 2008, 3) 
Two and a half years later, in May 2010, Venter’s group succeeded in 
constructing the first fully synthetic chromosome and operating it in a bacterial 
cell (Gibson et al. 2010). With that development Craig Venter received major 
media attention for himself and the broader field (Adams 2010; BBC News 2010; 
Cookson 2010; Economist 2010; Sample 2010; Wade 2010). Researchers at the J. 
C. Venter Institute have since focused on developing a synthetic organism that 
they hope may enable the production of a variety of biological products and 
renewable fuels. 
 
The story of my motivation to examine this nascent biotechnology began at that 
LSE debate almost four years ago. As Sarah Franklin declared that evening, “We 
can never have a science that’s outside the social” (Debate 2008, 10); furthermore, 
in the UK and other developed countries a secular, scientifically driven agenda is 
at the core of modern society. Franklin went on to celebrate and encourage a 
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continuation of the dialogue between scientists, sociologists and other interested 
parties – one that was not laden with hype and fear-mongering statements, but 
rather a conversation that afforded “room to think”, with genuine empirical 
consideration of what it means to engineer synthetic life in the 21st Century (ibid, 
13). Following that initial point of inspiration, I went on to write two related MSc 
dissertations: one which looked into early UK and EU policy discourses in 
comparison to the positions of UK pioneers in synthetic biology; and, the other, 
which examined the open source biotechnology movement. These explorations 
led to this doctoral work. However, before introducing my thesis’ particular 
concerns, I would like to provide an overview of synthetic biology and some 
critical context.  
 
Imagine considering biology from the perspective of an engineer who is seeking 
to mine its incredibly complex, sensitive, reproducing and vast resources in order 
to design and build new living machines – this is the ambition driving synthetic 
biology. More precisely, practitioners of this field aim to make products and 
applications (such as sensor and remediator devices, medicines and biofuels13) 
that solve real world problems by sourcing, manipulating and piecing together 
functional components from microorganisms, plants and animals. Pioneers of this 
vision for engineering biology believe that we now know enough about genetic 
material so it can be used as building blocks – so called BioBricks14 – for 
                                                
13 For further on synthetic biology applications, few of which have been realised but many held as 
future promises, see McDaniel and Weiss 2005; Adrianantoandro et al. 2006; Ro et al. 2006; 
Khalil and Collins 2010.  
14 “A BioBrick™ standard biological part is a standard biological part that meets the technical and 
legal standards set forth by the BioBricks Foundation (BBF). Each distinct BioBrick™ standard 
biological part is a nucleic acid-encoded molecular biological function (e.g., turn on/off gene 
expression), along with the associated information defining and describing the part” 
(http://biobricks.org/faq/).  
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systematically constructing well-characterised, discretely purposeful biological 
parts, devices and systems.15 Interestingly, projects that subscribe to this school of 
thought require expertise from life sciences, engineering and other disciplines. 
Exciting as the philosophy of synthetic biology may be – with its reconfiguration 
of life as the 21st Century building material that might solve pressing global 
problems – the field’s grand ideas are far from the present reality.  
 
Figure I: The New Tree of Life 
 
With this image, designer Daisy Ginsberg proposes adding an extra branch to the Tree of Life in 
order to categorise new living material emerging from synthetic biology:  
“The Synthetic Kingdom is part of our new nature”.16  
 
                                                
15 Definitions of synthetic biology are various and contested as different approaches to biological 
engineering (e.g. bottom-up, top-down and proto-cell construction) employ this brand (O’Malley 
et al. 2008; Rabinow and Bennett 2008). This branding, being part of the ‘cutting edge’, is an 
important funding strategy. This thesis focuses on the so-called ‘parts, devices, systems’ or 
‘engineering approach’ (Endy 2005; Canton, Labno and Endy 2008; Purnick and Weiss 2009). 
16 http://www.daisyginsberg.com/projects/synthetickingdom.html. 
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Synthetic biology faces a number of significant and interlinking challenges, 
making it a fascinating site for social study. These challenges are inherent in the 
biology that it seeks to engineer, present in the institutions where this research is 
practiced, embedded in the wider political and economic contexts and in the 
socio-cultural spheres in which techno-science always exists. This is a locus 
where claims about a burgeoning biotech revolution are constantly made and 
disputed; a site where big egos, brilliant minds, academic laboratories and private 
institutions compete for funding; where a ‘new breed’ of idealistic and socially 
mindful young scientists and engineers are trying to drive this technology through 
an open source framework for sharing DNA parts, rather than clamping down on 
research innovations by concealing and patenting; this is a world where scientists 
in their garage believe they are pioneering a kind of radical movement to ‘bring 
science to the people’ through ‘Do It Yourself Biology’ (DIYbio)17. At this point, 
we cannot know whether synthetic biology will lead to the construction of 
completely synthetic organisms that function as generic production machines 
where, with the swapping of a few components, the output could be a medicine, a 
material or a biofuel; neither can we know whether the current research into 
cancer-eating bacteria will be effective; nor can we anticipate that biology will 
eventually get so easy to engineer that it becomes part of childhood play (the 
‘Lego™ of the future’ as some speculate). In what are still early days, synthetic 
biology’s definitions, principles, practices and culture are in-the-making.  
 
I’ll begin with technical difficulties in engineering biology. Living systems and 
their component parts have incredible molecular complexity, stochastic behaviour 
                                                
17 See http://diybio.org/about/. A selection of media references support these claims: Jan 2006; 
Pollack 2006; Morelle 2007; Ahuja 2009; Economist 2009; Harmon 2009; Henderson 2009; 
McFadden 2009; Specter 2009; Whalen 2009; Mooalem 2010.  
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patterns, and a capactity to evolve and generate emergent properties – these 
characteristics pose a number of challenges to synthetic biologists as they struggle 
to work with building materials that are far from the reliable, robust, predictable 
ideal. Even though described and visualised as BioBricks that ‘snap together, like 
Lego™’, biology is simply not a material of engineering like the bricks and 
mortar of buildings or bridges (see Figure II). Similarly, biology is not analogous 
to the build-up of electronic circuitry where resistors, capacitors and transistors 
can be constructed in a standard way to produce computers and networks (Figure 
III). Nonetheless, many synthetic biologists like to think in such parallels and 
there is an abundance of supportive imagery that is flashed up in presentations and 
in the media.  
 
 
Figure II: BioBricks associated imagery18 
   
                                                
18 From top left, three images are sourced from: Spector 2009; 
http://partsregistry.org/Assembly_standard_23; http://partsregistry.org/Catalog. 
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Figure III: Biology as parallel to electronics engineering19 
 
 
Most recently, the technical challenges to synthetic biology have been 
summarised in “five hard truths”, namely that (1) biological parts are difficult to 
                                                
19 Image sourced from: http://nextbigfuture.com/2006_05_28_archive.html.  
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define and characterize; (2) biological circuitry is unpredictable; (3) complexity in 
living systems is unwieldy; (4) biological parts that are human-made constructs 
often don’t fit well together; and (5) variablity in living systems tends to crash the 
desired circuit construction (Kwok 2010). Other biologists present convincing 
arguments that confront synthetic biology’s reductionism in celebrating biology as 
a study of complex, evolving organic material (Woese 2004; Mazzocchi 2008); 
such papers condemn the notion that biology can be understood in simple, 
mechanical terms and advocate that those points of view miss the idea of what is 
most special about the living world. Biology (in Woese’s view) is the most 
wonderous and elusive of sciences – our representations of the living world will 
only ever be partial. Moreover, for Woese, biologists ought to be utterly 
fascinated, and humbled, by the incredible phenomena they seek to understand, 
and ought not to think it possible to engineer life (at least, not on the scale 
synthetic biology sometimes proposes). Far more dated views coming from 
vitalist20 traditions pose similar challenges to synthetic biology’s philosophy. 
Canguilhem (2009) reminds us that life resists mechanisation and that organisms 
must be considered with respect to survival in a milieu. For Canguilhem (2009), 
the prevalence of vitalism throughout history lends proof-worthy quality to the 
idea that living organisms are more than the sum of their parts. The non-
mechanical, special nature of biology – its messiness that “gets in the way of the 
engineering” (Kwok 2010, 288) – are important themes that will be revisited 
throughout this thesis. 
 
                                                
20 In very basic terms, vitalism says that biological systems are not reducible to purely physical 
and chemical mechanics. 
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Leaving  technical difficulties, let us acknowledge that some elements of biology 
can be thought of from a reductionist and mechanistic perspective to allow the 
rational design and building of novel synthetic living systems, albeit relatively 
simple ones at present.21 However basic intentionally engineered biological 
clocks, switches, oscillators and feedback loops may sound, proponents of 
synthetic biology often argue that there is great potential for the field to eventually 
develop into a full-fledged industry, even constitute a “third industrial revolution” 
(Royal Society of Chemistry Science and Technology 2009). Such advocates 
would add that the path of creating an industry based on building with biological 
parts may be thought of as analogous to trajectories witnessed in the synthetic 
chemistry or electronics industries – these highly economically valuable fields, 
they point out, started with characterising basic parts (elements and compounds, 
or resistors and transistors). Of course, promissory parallels – for instance, 
synthetic biology parts will eventually lead to a great number of industry 
applications (e.g. from biofuels to bioremediators), just as synthetic chemistry 
research eventually led to a vast range of materials and products (e.g. from 
rubber to pharmaceuticals) – are called upon with the emergence of any research 
field that needs to trade promises of future financial gain for present funding.  
 
As it stands, the state of functioning synthetic biology applications is limited – 
though several parts or systems are claimed to be on their way to…, in my view, 
the number of systems that feasibly look like they might turn into a ‘consumable’ 
within the next five years are probably counted on one hand. What has been called 
the poster child work of synthetic biology has been carried out in Jay Keasling’s 
                                                
21 A number of synthetic biology articles explain functional success of engineered biological 
clocks, oscillators, switches and feedback loops (e.g. McDaniel and Weiss 2005; Tyson et al. 
2008; Purnick and Weiss 2009; Tigges et al. 2009; Danino et al. 2010; Fussenegger 2010).  
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laboratory at UC Berkeley; there, scientists and engineers have been working for 
almost ten years to make microbes that produce the antimalarial drug 
artemisinin.22 This has been one of the most extensive, expensive and successful 
research and development efforts in the field (though still in the pipeline with its 
projected commercial distribution in 2012). The Keasling laboratory has followed 
the artemisinin project in taking up the challenge to engineer microbes that 
produce biofuel. We await the outcome of this endeavour.   
 
With at least one very exciting, tangible application to point to, synthetic biology 
advocates have, over the last few years, been actively promoting the vast potential 
“biovalue” that this field could generate. There are hyperbolic arguments along 
the lines of, ‘just look at what Keasling has done – completely re-engineered and 
refined a biological pathway in order to treat malaria…. The ways that biology 
can be re-designed and re-engineered to solve major world problems are endless!’ 
Biovalue, however, is a term that has been used often in social studies of techno-
science; in this tradition, one appreciates the kinds of complex socio-political 
networks within which biovalue operates. This useful concept began with 
Waldby’s (2002) definition: 
Biovalue refers to the yield of vitality by the biotechnical 
reformulation of living processes. Biotechnology tries to gain traction 
in living processes, to induce them to increase or change their 
productivity along specified lines.... This intensification of leveraging 
of living processes typically takes place not at the level of the body as 
a macro-anatomical system but at the level of the cellular or molecular 
fragment, the mRNA, the bacterium, the oocyte, the stem cell. (309-
10) 
Scholarship around this topic after Waldby’s introduction (e.g. Franklin 2003; 
Hilgartner 2007; Rose 2007), shows that the concept of biovalue can be enlarged, 
                                                
22 Keasling (2009); http://keaslinglab.lbl.gov/wiki/index.php/Main_Page. 
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mapped out at multiple sites and intertwined with a range of dynamic factors: 
investor confidence, consumer hopes and fears, promissory visions and hyped up 
claims, credibility in science, trust in government, public understanding of 
science, cultural values and beliefs. Without going into detail here, I state rather 
plainly that with synthetic biology’s trading on biovalue, inevitably there exists a 
political complex that ties into national economic agendas, various structures of 
governance, private and public monies, popular opinion, a code of ethics and so 
on. I am trying to convey a sense of the complexities and challenges that shadow 
synthetic biology’s emergence; so, I ask for the reader’s patience, knowing these 
generalisations will gain substance in later chapters. 
 
As this work focuses largely on a UK context, I briefly indicate the high levels of 
political and economic interest in synthetic biology in this country. Consider the 
following extract from a recent policy document that demonstrates a political 
priority to stake a place for the UK as an international leader in this 
biotechnology: 
We found good indications that the UK is learning from past 
experiences in bioengineering when handling new emerging 
technologies, such as synthetic biology. The Government and 
Research Councils have recognised the value of synthetic biology 
early, and are providing funding. There is good activity in public 
engagement on synthetic biology. However we are concerned that 
while research is well funded there is not enough forethought about 
synthetic biology translation, for example developing DNA synthesis 
capability, which would provide the UK with an excellent opportunity 
to get ahead internationally. If this is not addressed, synthetic biology 
runs the risk of becoming yet another story of the UK failing to 
capitalise on a strong research base and falling behind internationally. 
(House of Commons Science and Technology Committee 2010, 3) 
Looking at the growing number of UK synthetic biology networks and 
laboratories reinforces the message that researchers are becoming aware of the 
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substantial political and economic force invested.23 Most notable, perhaps, is the 
recent establishment of the Centre for Synthetic Biology and Innovation (CSynBI) 
that partners Imperial College London researchers to social scientists from BIOS 
at the LSE; CSynBI was funded (around £5M) by an Engineering and Physical 
Sciences Research Council (EPSRC) Science and Innovation award that 
specifically aims to support new “areas of national strategic importance” and, 
indeed, the Centre is hoping to develop into a leading synthetic biology facility. 
Other significant research efforts have been underway for a few years at 
University of Cambridge, University of Edinburgh and University of Sheffield, 
with the list growing (footnote 23). Furthermore, a sample list of funding bodies 
that support UK synthetic biology research includes the Wellcome Trust, 
Biotechnology and Biosciences Research Council (BBSRC), Engineering and 
Physical Sciences Research Council (EPSRC), Royal Society, Royal Academy of 
Engineering, Royal Society of Chemistry, Medical Research Council (MRC), 
New and Emerging Science and Technology (NEST) group, Economic and Social 
Research Council (ESRC), Arts and Humanities Research Council (AHRC). Since 
the time I started researching synthetic biology in 2007, I have witnessed the 
funding opportunities grow rapidly in the UK; this growth comes with 
increasingly competitive stakes and a stronger push to form ‘new and improved’ 
alliances between science and engineering communities, social scientists, policy 
bodies and those in the field of interaction design.  
 
                                                
23 An incomplete sample list of UK synthetic biology laboratories, research centres and networks: 
http://www.synbiostandards.co.uk/index.php; 
http://sysos.eng.ox.ac.uk/control/RoSBNet/index.php/Main_Page; 
http://www2.lse.ac.uk/BIOS/research/synbio/synbio.aspx; 
http://www3.imperial.ac.uk/syntheticbiology; www.biochem.ucl.ac.uk/synbion/; 
www.bris.ac.uk/scn/; www.sheffield.ac.uk/synbio/home.html; www.synbiont.org/.  
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UK synthetic biology practitioners know that in order to be competitive in grant 
applications, there ought to be consideration of ‘social and ethical implications’ in 
most proposals. In part, this upstream inclusion of social and ethical issues, is tied 
to the notion of learning from the past (as quoted above, from the House of 
Commons); it is commonly held among UK synthetic biology stakeholders that, in 
order for the field to enjoy future mainstream success, the research community 
ought to do all it can to ‘avoid another GM’.24 Hence, it has become 
commonplace that most UK synthetic biology networks and research centres seek 
out an affiliation with social scientists (that is, with scientists and engineers 
inviting social scientists in), hoping that this may be a way to help consider social 
implications and lead to forms of governance that somehow lessen the risk of 
public backlash. This invitation to join a synthetic biology team has put a number 
of UK social scientists in a tricky position – on the one hand, they are often 
delighted to be granted open access to an interesting field of study; on the other, 
they feel uneasy about the extent to which they can do proper social science 
research, given their funding sources and implicit pressure from some synthetic 
biologists to legitimise their work, rather than seek genuine forms of 
collaboration. The complex relations that are developing across such disciplinary 
boundaries is an issue that cannot be substantively addressed here; however, they 
have been explored in recent publications (Calvert and Martin 2009; Macilwain 
2009; Schuurbiers and Fisher 2009) and will also be explored to some extent 
throughout this thesis.  
 
                                                
24 Referring to the ‘GM crisis’ where public rejection of genetically modified foods was seen 
across the UK and Europe in the late 1990s and early 2000s (Gaskell et al. 2003). 
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Before turning more to this work’s particular focus, it is important to note some of 
the content of the social and ethical issues. However, I must add a caveat: the 
meanings of these commonly cited issues are far more complex than I reveal here 
and there are many developing social dynamics that I cannot address in this brief 
overview. From 2007 and into 2009, the key social and ethical challenges in 
synthetic biology (mainly referring to UK and European contexts) generally 
consisted in a list of five or so standard topics. Not wishing to dwell on this overly 
rehearsed list, I provide the following summary chart and references:  
 
Figure IV: Commonly cited social and ethical challeges in synthetic biology 
 Commonly cited concerns References 
Biosafety 
 
Accidental or intentional release of 
microorganisms into the environment 
could have unexpected consequences as 
synthetic organisms interact with 
surroundings and possibly evolve 
unpredictably.  
NEST 2005; HSE 2007; 
Balmer and Martin 2008; 
POSTnote 2008; Schmidt 
et al. 2008; IRGC 2009; 
Lentzos 2009; Nuffield 
Report 2009; Schmidt et 
al. 2009 
Biosecurity / 
Bioterrorism 
 
The ability to construct new, modified or 
already existing microorganisms to use 
for malicious purposes is a threat. The 
increasing capacity to design and order 
DNA online from synthesis companies, in 
combination with a growing community 
of ‘do-it-yourself biologists’ practicing 
‘garage biotechnology’ are a significant 
worry and difficult to regulate. A 
biosecurity threat is conceivable at both 
state- and individual- levels. 
NEST 2005; HSE 2007; 
Kelle 2007; Balmer and 
Martin 2008; POSTnote 
2008; Schmidt et al. 
2008; IRGC 2009; 
Lentzos 2009; Nuffield 
Report 2009; Schmidt et 
al. 2009 
 
Patenting;  
Commercial vs 
Public Good  
 
The commercial potential of synthetic 
biology applications has led to concern 
that patents and monopolies could inhibit 
basic research and progress in the field. 
An ‘open source’ movement has 
responded to worries over burdensome 
patent thickets; for instance, the 
BioBricks Foundation (BBF) is a 
significant initiative working to facilitate 
an open research commons. Experts 
suggest both patent and open source 
frameworks are needed, but no uniform 
resolution yet exists. 
NEST 2005; Balmer and 
Martin 2008; POSTnote 
2008; Schmidt et al. 
2008; Lentzos 2009; 
Nuffield Report 2009; 
Schmidt et al. 2009 
 
 
Trade and Global With the development of synthetic NEST 2005; Balmer and 
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Justice 
 
chemicals to replace cumbersome 
isolation and manufacture of naturally 
exisitng compounds (e.g. from plants), 
critics argue that synthetic biology could 
destroy local production in developing 
countries, thus maintaining the gap of 
health and wealth between rich and poor 
countries. 
Martin 2008; POSTnote 
2008; Schmidt et al. 
2008; Lentzos 2009; 
Nuffield Report 2009; 
Schmidt et al. 2009 
‘Playing God’ 
 
The promise that synthetic biology might 
create ‘artificial life’ or is about the 
‘design and construction of synthetic life 
forms’ has evoked fears that practitioners 
of synthetic biology might be ‘playing 
God’.  
NEST 2005; Balmer and 
Martin 2008; POSTnote 
2008; Schmidt et al. 
2008; Lentzos 2009; 
Nuffield Report 2009; 
Schmidt et al. 2009 
I have found that by 2011, discussions around such social, political, moral matters 
and beyond have become far more sophistocated than they were previously.25 
Despite glossing over this list, UK synthetic biology leaders deserve recognition 
for their initiatives in opening up several arenas for questioning and debate. 
 
With that introduction and brief context around synthetic biology, it is clear that 
there are many avenues that might be investigated sociologically and I have had to 
make some choices as to the focus of the present study. This thesis does not take 
place at a macrosocial scale – it is not concerned with, for instance, how 
governments might regulate synthetic biology or how various publics perceive 
this technology (though these are certainly pertinent matters). This thesis is also 
not historical, in the sense of looking back and tracking when and how synthetic 
biology came into existence (an interesting topic with deep historical, 
philosophical and literary roots that merit contestations about the field’s 
‘newnness’).26 Further, while I draw on participation, observation and interview 
                                                
25 An LSE event in November 2009 (‘Creating the organisms that evolution forgot - An 'Any 
Questions?' debate on synthetic biology’), meetings at the Royal Society and a set of gatherings 
among a network of UK social scientists examining synthetic biology have all encouraged a more 
informed and rich debate than I observed upon first studying this field.  
26 Points of debate on this issue can be found in referring to Leduc (1911), Loeb (1912), Szybalski 
(1974) and Serrano (2007).  
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data, this thesis is not a laboratory ethnography that prsues an argument for the  
construction (or the ‘social construction’) of scientific ‘facts’.27 
 
This thesis is, however, situated within the broad field of sociology (and 
philosophy) of scientific knowledge. I therefore discuss some key aspects from 
this extensive body of work in Chapter 1, focusing in particular on those that are 
relevant to the argument that will be made in this thesis – that is to say, those 
which I draw upon, and those which I depart from in significant ways. Above all, 
this work is empirical in its focus as I was a participant and an observer in the 
work of two small, but influential, groups of scientists and engineers as they 
helped to lay the groundwork for developing synthetic biology in the UK. In my 
account of this journey, the reader is invited into an exploration of how synthetic 
biology practitioners actively construct new forms of knowledge and life. I detail 
the practices and processes of going synthetic that is considering living materials 
not only as something to decode, understand, mutate and utilize for human ends, 
but also something to design, assemble from scratch and engineer into precise 
machines. 
 
Gradually coming to the exact research questions addressed, I must first explain 
another layer of the empirical site that I have found most fascinating – the 
International Genetically Engineered Machines competition (iGEM)28. Having 
already given a flavour of several complexities ranging from those inherent in the 
biology to those in socio-political realms, it is apparent that the development and 
flourishing of a prosperous synthetic biology industry is far from certain. 
                                                
27 As in Latour and Woolgar (1986) or Knorr Cetina (1981), discussed further in Chapter 1. 
28 http://2009.igem.org/About. 
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However, many eminent synthetic biologists believe that iGEM is a locus of 
particular importance for the field’s future as it is designed to inspire and teach a 
next generation of synthetic biologists. iGEM began in 2003 when its creators29 
decided to challenge a small group of MIT undergraduates, over the course of a 
month-long Independent Activities Period, to make improvements to a biological 
oscillator, a microbiological machine that acts like a time-keeping device and 
appears as blinking cells.30 From this mini design course grew a summer 
competition of five American teams in 2004, 13 (international) teams in 2005, 32 
teams in 2006, 54 teams in 2007 and 84 teams in 2008. In 2009 – the year in 
which I conducted my fieldwork – iGEM had over 1200 participants in 112 teams 
from five continents and the competition had almost out-grown the space 
limitations of residing in parallel sessions in MIT’s six largest auditoriums. 
Interestingly, by 2009 iGEM had also collected a substantial list of supporting 
corporate biotech companies as well as other sources of national and institutional 
funding – including financial backing from the FBI.31 Not surprisingly, the media 
attention around iGEM – with its reputation as a source of budding biotech ideas 
and practitioners – was also a significant feature (Bland 2009; Ginsberg 2009; 
NPR 2009; Smolke 2009; Mooallem 2010).  
 
                                                
29 Tom Knight and Randy Rettberg of MIT’s Computer Science and Artificial Intelligence 
Laboratory (CSAIL), and Drew Endy from (at that time) MIT’s Biological Engineering Division. 
(Endy is now Assistant Professor of Biological Engineering at Stanford University.) Importantly, 
this group of very successful computer scientists and engineers rather like to be thought of as ‘big 
kids’ who like to ‘build stuff’. 
30 Interestingly, the inspiration for the iGEM competition can be traced back to a course on 
electronic circuit design taught at MIT by Lynn Conway that started in 1978 (Carlson 2010, 82). 
Owing to a rigorous abstraction hierarchy and decoupling of design and fabrication that was easy 
to adopt, this course led to the international dissemination of very large systems integration 
(VELSI) circuit design (ibid). The success of this model strongly influenced developers of iGEM. 
31 iGEM 2009 partners: The MathWorks, GENEART, SynBERC/National Science Foundation; 
sponsors: Invitrogen LIFE Technologies, Federal Bureau of Investigation; affiliates: MIT, 
BioBricks Foundation, Institute of Biological Engineering (http://2009.igem.org/Sponsors). 
Additionally, 2009 iGEM teams were sponsored by other biotech companies and corporate 
sponsors – too many to name here. For example, see Cambridge iGEM team Wiki. 
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Every year this competition challenges university teams of approximately six to 
ten top-performing undergraduates from across life science and engineering 
disciplines32 – supervised by a few eager PhD students and faculty – to craft a 
genetic machine using a database of BioBricks.33 Teams typically design and 
build their bio-machine over a period of three or four summer months before 
competing at the iGEM Jamboree held at MIT in November. The clever business-
like aspect of iGEM is a requirement that teams not only use a particular standard 
of part-assembly and characterisation, but also contribute back to The Registry of 
Standard Biological Parts, thereby continually growing the library of BioBricks 
and supporting synthetic biology’s greater development. In brief, this competition 
works to (i) inspire and specifically train a possible next generation of synthetic 
biology practitioners; (ii) encourage the growth of knowledge as well as a central 
database of biological parts that significantly helps the field’s advancement; (iii) 
seed the development of several academic synthetic biology laboratories and even 
some start-up biotech companies; and (iv) symbolise a number of fundamental 
principles and ideologies of this field, both technically and socially.  
 
Finally, then, this work aims to (i) illustrate a process of knowledge and material 
production, situated in the practices and processes of developing scientists and 
engineers as they undertake the iGEM challenge, and (ii) assess the significance 
                                                
32 Typically, students undergo a selection process to ‘make the team’ – CV’s, lab skills, maths 
ability, computer skills and general social demeanour are evaluated (see Chapter 3). 
33 BioBricks come from The Registry of Standard Biological Parts. Noting the description on the 
website: “The Registry is a continuously growing collection of genetic parts that can be mixed and 
matched to build synthetic biology devices and systems. Founded in 2003 at MIT, The Registry is 
part of the Synthetic Biology community's efforts to make biology easier to engineer. It provides a 
resource of available genetic parts to iGEM teams and academic labs” 
(http://partsregistry.org/Main_Page). 
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of iGEM as an interesting social ‘tool’ that is striving to support synthetic 
biology’s future flourishing. I address the following research questions: 
• How do teams of scientists and engineers imagine, design and build 
new living systems? What tools for thinking and doing do they 
employ in this process? 
• In this process of knowledge and material production in synthetic 
biology, how do young researchers transition and rationalise the gaps 
between the imagined, the designed and the real microbiological 
machines that they craft? 
• How does an undergraduate competition at the heart of synthetic 
biology seek to ensure the future flourishing of this emerging 
biotechnology? 
The empirical study conducted took place mainly in laboratories at the University 
of Cambridge and Imperial College London, but also at MIT, where participants 
embarked on the iGEM challenge. (Note that the thesis questions, aims, literature 
and methodology are fleshed out in greater detail in the next two chapters.)  
 
The ways in which curious, eager students dream up ideas of living machines and 
turn them into material realities, as well as their resultant beliefs about this 
biotechnology after their iGEM experiences, reveals a great deal about the 
technical, social and cultural dynamics of this field-in-making. In investigating a 
microsocial sphere that is developing synthetic biology’s tools, materials, values 
and practitioners of the future, this thesis opens an informed space through which 
one may begin to think about how, over the coming years and decades, new 
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engineering perspectives of biology and the living might percolate into society 
and culture more generally.  
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CHAPTER SYNOPSES 
 
Chapter 1: An inspired inquiry 
The research questions, aims and influential literature are discussed. Four main 
bodies of literature are explored: (i) Sociology of scientific knowledge, laboratory 
studies, selected STS concepts; (ii) Intervening science and ‘taking a look’; (iii) 
Synthetic biology-specific literature; (iv) Bachelard and Canguilhem. 
 
Chapter 2: Following knowledge and material production in iGEM 
This chapter concerns research methodology. Relevant background about entry 
into the field and an outline of the narrative’s substantive text are given. I explain 
how my role as an embedded social scientist developed as relations with 
participants in the field changed over time. Finally, I discuss modes of analysis 
employed in working with field-notes, interview data and visual material.    
 
Chapter 3: Dreaming up ideas 
Beginning the substantive chapters that take place in the ‘home laboratories’ of 
the University of Cambridge and Imperial College London groups, this chapter 
explores how each team came to dream up ideas for an iGEM project. I discuss 
the teaching of synthetic biology and illustrate practices and processes in the 
teams’ brainstorming until they reached an idea that they could work with.  
 
Chapter 4: Evolving ideas 
This chapter details how disciplinary contestations, advisors’ judgements, idea re-
evaluations, experimental complications and trouble-shooting of problems all 
shaped the course of the two groups’ biological machine projects. The ideas and 
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their representations that are discussed in Chapter 3 are shown to have evolved as 
laboratory work and computer modelling became the teams’ central focus in the 
middle period of their projects. The exploration revolves around how thoughts 
were transformed, under the influence of intellectual technologies, applied tools, 
techniques and experiments.  
 
Chapter 5: Making real 
This chapter explores what happened as the teams began to make tangible re- 
engineered biological entities. How shall we understand these forms of glowing or 
pigment producing bacteria? Taking Hacking’s (1983) position as a ‘realist about 
entities and an anti-realist about theories’, I describe the reality of these new 
forms of living material and articulate why my conceptual analysis departs from 
social constructionist views.  
 
Chapter 6: Selling ideas 
This chapter takes place mostly at the iGEM Jamboree, when thousands of 
competition participants descended upon MIT to showcase their synthetic biology 
creations to an international community. I explain how students demonstrated an 
ability to ‘sell’ their ideas, fitting their technical accomplishments into a particular 
set of social and political rules of the field.  
 
Chapter 7: To join the club, or not 
Empirically, this chapter draws on interviews and informal conversations with 
students and leaders of the synthetic biology community in which they reflected 
upon the competition’s impact. I explore iGEM’s success as a tool to educate and 
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indoctrinate a next generation of synthetic biologists to develop the field. Follow-
up stories illustrate where some of this study’s participants went after a little time 
and distance from the 2009 competition.  
 
Chapter 8 / Conclusion: Emerging waves in synthetic biology and 
beyond? 
The key arguments are summarised, outlining an informed space through which 
readers may better participate in current and future debates on engineering living 
forms. New questions arising in synthetic biology are opened up, inviting the 
reader to further levels of reflection.  
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1.   AN INSPIRED INQUIRY 
 
Nikolas Rose (2007) calls for scholars across social studies of life sciences to join 
forces in mapping a “modest cartography of the present” as a complex network of 
“molecular biopolitics” takes shape across several areas of biomedicine and 
biotechnology, interconnected with political, economic and social issues; 
operations in these networks bring us to question how 21st Century philosophies 
of life and the living are being shaped (5, 12). This inquiry takes part in that 
challenge, examining the operations of a microsocial sphere of scientists and 
engineers seeking to design and build living machines in 2009. This work is 
largely based upon empirical findings but I begin by describing my research 
questions and aims, as well as introducing the body of literature that originally 
inspired this investigation. 
 
1.1   Research questions and thesis aims 
Core research questions:  
• How do teams of scientists and engineers imagine, design and build 
new living systems? What tools for thinking and doing do they 
employ in this process? 
• In this process of knowledge and material production in synthetic 
biology, how do young researchers transition and rationalise the gaps 
between the imagined, the designed and the real microbiological 
machines that they craft? 
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• How does an undergraduate competition at the heart of synthetic 
biology seek to ensure the future flourishing of this emerging 
biotechnology? 
 
I shall now elaborate each question, outline the courses that their answers follow 
and say a little about how they intertwine. The first set of questions are examined 
in Chapters 3 through 5, where I provide an empirical account of how teams went 
about imagining, designing and experimentally building synthetic biological 
machines. This content is social, material and practical. The social involves how 
synthetic biology is taught; how team dynamics evolve (e.g. with respect to 
leadership roles and organisational behaviour) and operate within hierarchical 
chains of affirmation; and how boundaries operate across disciplinary perspectives 
(e.g. dividing engineers and life scientists). For the material content of imagining, 
designing and constructing, I use photographic data to illustrate ‘intellectual 
technologies’ (Miller and Rose 1990) in operation – that is, the notion that 
dreaming up ideas is not just a matter of thought, but has a materiality in the use 
of ‘tools for thinking’ such as drawing diagrams, making lists, using computer 
programs and presenting. Many ideas that will be discussed began their material 
journey on paper as mind maps or online in brainstorming forums (Chapter 3); a 
select few ideas were then translated into laboratory experiments and processed 
further in computer modelling (Chapter 4); finally, some ideas evolved into real 
biological systems, ones with a functionality that could be visualised and / or 
measured (Chapter 5). Finally, the practical content of engineering a 
microbiological machine is explained in relatively non-technical terms and 
concerns how practices and protocols were carried out in experiments and 
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computer modelling. All three of these aspects – social, material and practical – 
are, of course, interwoven. 
 
The second area of questioning – on transitioning and rationalising the gaps 
between the imagined, the designed and the real microbiological construction – is 
answered, in part, because these teams were on a forced timeline that would result 
in the final competition Jamboree (at the end of October, after about three to six 
months of intensive work). Although the direction of knowledge and material 
formation in synthetic biology projects is not linear – the three stages overlap and 
there is a re-circuiting (re-imagining, re-designing and re-building), as problems 
and troubleshooting feature in all biological laboratories – the forced conclusion 
of the competition meant that iGEM teams adhered to beginning-, middle- and 
end-stages, even though they do not necessarily flow smoothly. There are gaps 
and leaps to make in order to move from ideas, to experiments, to results, to 
bringing a competitive project to the iGEM finale. These are evident in Chapters 3 
to 6.  
 
The final research question is investigated with findings at, and after, the 
Jamboree when I realised how iGEM inspires students to really sell their ideas, 
while they are simultaneously being sold several ideologies of the wider synthetic 
biology community; for some, this ‘selling’ extends beyond the competition and 
links up to joining the ‘synthetic biology club’ (Chapters 6-7). In considering 
iGEM’s role in synthetic biology’s future, I point to examples where ideas from 
the competition have been plucked and pursued at key laboratories. There are 
many cases of iGEMers going on to further study in this field, in masters and PhD 
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programmes. Others, such as team advisors, are inspired by their iGEM journeys; 
one major trend has been advisors going back to their universities after the 
Jamboree and developing synthetic biology courses and some fully-fledged 
research centres. There are also several instances where teams are built first by 
keen students who then approach a member of their university faculty to ask for 
supervision; hence, sometimes iGEM students even teach themselves and faculty 
about synthetic biology. Often, successful teams return home and receive attention 
from their university and local press, and place another point on the international 
synthetic biology map. Overall, iGEM is the point of origin for many lines of 
development: development for individual students, some of whom may turn into 
future leaders of synthetic biology; development for institutions that do further 
work in this field; and, development for synthetic biology as an up-and-coming, 
global biotechnology.   
 
1.2   Literature review 
In this thesis I examine a process of knowledge and material production as I was 
an embedded participant/observer of the practices and processes of scientists and 
engineers as they undertook the iGEM challenge; I also explore the significance 
of iGEM as a ‘tool’ for social and cultural engineering that is striving to support 
synthetic biology’s future flourishing. There is now a very large literature 
spanning over half a century of sociological and anthropological investigations of 
the activities of scientists as they go about their work. In this review of the 
literature, I have therefore been selective, and focussed on those contributions that 
– in their modes of questioning, conceptual and analytical frameworks – relate to 
this thesis. My aim is not to provide a comprehensive overview, but to consider 
 38 
the works that have helped me to reflect critically on where and how this study fits 
in a landscape of sociology and philosophy of science scholarship. In the core 
chapters, I focus on providing new empirical richness (and also conceptual 
frameworks to fit that data), so it is here that I take the opportunity to highlight 
where some of this work’s themes hold affinities with earlier works.  
 
Sociology of scientific knowledge, laboratory studies, selected STS concepts 
One of this work’s core aims – to give an empirical account of knowledge and 
material production in a local site of biotechnological development – sits in a 
tradition of sociology of scientific knowledge (SSK).34 I will focus here on those 
contributions that have relevance to, and made a contribution to, the way that I 
have approached this study. 
 
Much contemporary sociology of scientific knowledge takes issue with the 
arguments made by one of the earliest sociologists to consider science – Robert 
Merton35. Merton, whose position is usually described as ‘structural-
functionalist’, assumes that a well-functioning society is made up of unified, 
overarching institutions – religion, science, government, etc. “The institutional 
goal of science”, according to Merton, “is the extension of certified knowledge” 
(1973, 270). Further, Merton argued that appropriate institutional conduct is 
guided by certain norms, whereby followers are rewarded and violators punished. 
                                                
34 This field of work has been rather controversial. For instance it is common to refer to ‘the 
science wars’ to describe about a decade of intense intellectual debate between scientific realists 
and postmodern critics (from STS, cultural studies, feminist studies and other disciplines) about 
the nature of scientific knowledge – one side believing it to have a real, objective nature, the other 
critiquing this notion of scientific objectivity from several angles (Brown 2001; Parsons 2003). 
35 Merton is considered a major predecessor of ‘new’ SSK, which largely reacted against the ideals 
he set out. ‘New’ SSK is generally considered to have emerged in the early 1970s with the 
Edinburgh strong programme (mostly identified with David Bloor, Barry Barnes and some of their 
colleagues). The Bath school (identified with Harry Collins) is also closely affiliated with the 
strong programme.  
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In the case of science, he identified four norms: universalism, communism (or 
communalism, as later renamed), disinterestedness and organized scepticism.   
• Universalism requires that a claim made in science cannot depend on 
the identity of the person making the claim (their race, class, gender, 
nationality, etc.); science is impersonal and its tenets either true or 
false, regardless of whomever is behind the statements. 
• Communism declares that scientific knowledge is commonly owned, 
where theories, proofs, discoveries, etc. are disseminated openly and 
freely to the science community. Rewards in science therefore come to 
those who rapidly publish, thereby promoting the overall goal of 
science by encouraging collective furtherance of knowledge.  
• Disinterestedness demands that scientists keep their interests 
disengaged from the practices and judgements made in science. This 
norm is enforced in the social institution of science to avoid fraudulent 
behaviour (e.g. reporting false data), which, according to Merton is 
relatively rare in science. 
• Organized scepticism is the notion that new scientific ideas are subject 
to rigorous, methodical communal scrutiny.  
These Mertonian norms of science are “moral” and “social” in nature and 
although he considered that there were “cognitive” rules of science (regarding 
evidence, theory structure, etc.), he distinguished between social and technical 
domains of science, and chose not to treat the latter as a subject for substantial 
sociological inquiry (Merton 1973; Sismondo 2010).   
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Karl Mannheim, whose work is closely related to Merton’s, also made important 
contributions to the early development of this field.  His “relationist” view aimed 
to counter relativism,36 and claim that knowledge can be created in a community, 
at a give time and in a given place (both subject to change), without being 
arbitrary. For Mannheim, even though certain things are true only in a space-time 
context, this does not make them any less true. Most important to the ‘new’ SSK 
movements that took off in the 1970s, Mannheim drew a distinction between 
scientific, social scientific and ordinary systems of knowledge (Lynch 1993). 
Mannheim claimed that some forms of knowledge in mathematics and the exact 
sciences were nonrelational, not bearing the mark of history (e.g. statements such 
as 2 X 2 = 4); knowledge in the social sciences, on the other hand, was always 
historical and social, though this did not inherently take away from its value or 
comprehensiveness; finally, ideologies of a religious, moral and political nature 
are grounded in community beliefs and practices, with both content and criteria 
for validity being “essentially situated” (ibid, 45-6). In part, the idea that 
mathematics and the exact sciences might be excluded from the scrutiny of 
sociology of knowledge helped to spur on what became known as ‘the strong 
programme’ in SSK. 
 
Before turning to consider this ‘strong programme’, it is important to 
acknowledge the contributions that were made to this field of study by Thomas 
Kuhn, notably through his (1996 [1962]) Structure of Scientific Revolutions. His 
arguments, in outline at least, have become very well known, and though I will 
not examine them in detail here, a few points ought to be highlighted. Kuhn 
                                                
36 Crudely, relativism implies that points of view cannot have any inherent truth or validity, always 
only relative to a subjective set of perceptions. 
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argued that science does not proceed as a form of rational, steady progress, but 
rather shows periods of normal science disrupted by paradigm shifts. During 
normal science practitioners share a paradigm – a set of beliefs, theories, methods, 
exemplars etc. In these periods of normal science, scientists engage in puzzle 
solving in a regimented and mostly cumulative fashion, without questioning the 
basic parameters of the paradigm in which they work. However, anomalies and 
problems tend to accumulate until a crisis point is reached. At this stage, an 
alternative paradigm comes to the fore, often led by younger scientists, and a 
revolution and paradigm shift might follow. If that revolution succeeds and 
becomes the new accepted view, normal science and puzzle solving can resume. 
Importantly, in Kuhn’s work, science communities are based on ideas and 
practices, not idealistic norms (e.g. like Merton’s) and they are organized locally, 
from bottom-up, not striving towards a broad, sweeping goal. Kuhn’s Structure of 
Scientific Revolutions helped in opening the door for arguments that social factors 
relating to the organization of scientific activity and thought itself are essential in 
shaping the nature of scientific activity, its forms of thought and practice, and its 
periods of stability and change. 
 
In the 1970s this way of examining science was given a radical twist, as a number 
of sociologists, historians and philosophers developed the strong programme in 
the sociology of knowledge. This programme explicitly challenged the divisions 
between technical and social domains of science (with only the latter as a matter 
for sociological inquiry), seeking to not only understand the organisation of 
scientific knowledge but also its content (Bloor 1991 [1976]; Barnes and Bloor 
1982). David Bloor outlines this school’s “four tenets” as follows: 
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1) It would be causal, that is, concerned with the conditions which bring 
about belief or states of knowledge. Naturally there will be other types 
of causes apart from social ones which will cooperate in bringing 
about belief. 
2) It would be impartial with respect to truth and falsity, rationality or 
irrationality, success or failure. Both sides of these dichotemies will 
require explanation. 
3) It would be symmetrical in its style of explanation. The same types of 
cause would explain, say, true or false beliefs. 
4) It would be reflexive. In principle its patterns of explanation would 
have to be applicable to sociology itself. Like the requirement of 
symmetry this is a response to the need to seek for general 
explanations. It is an obvious requirement of principle because 
otherwise sociology would be a standing refutation of its own 
theories. (Bloor 1991 [1976], 5) 
The mission of this new form of SSK is stated explicitly from the outset of 
Bloor’s (1991 [1976]) book: 
Can the sociology of knowledge investigate and explain the very 
content and nature of scientific knowledge? Many sociologists believe 
that it cannot. They say that knowledge as such, as distinct from the 
circumstances surrounding its production, is beyond their grasp. They 
voluntarily limit the scope of their own enquiries, I shall argue that 
this is a betrayal of their disciplinary standpoint. All knowledge, 
whether it be in the empirical sciences or even in mathematics, should 
be treated, through and through, as material for investigation. … 
There are no limitations which lie in the absolute or transcendent 
character of scientific knowledge itself, or in the special nature of 
rationality, validity, truth or objectivity. (Bloor 1991 [1976], 1) 
 
With that powerful calling, a new territory was opened for sociological study.37 
Key to this approach was methodological symmetry. In earlier work on the social 
history of science, the tendency was to explain ‘false’ beliefs in terms of external 
or social factors, while ‘true’ beliefs were explained in internal and rational terms.  
However, the strong programme’s methodological symmetry demands an agnostic 
                                                
37 By way of key case study referencing in this genre, socio-historical works such as Pickering’s 
(1984) examination of differing interpretations of high energy particle physics experiments and 
Shapin and Schaffer’s (1985) investigation of competing interpretations of vacuum pump 
experiments both offer exemplary strong programme interpretations of controversial scientific 
knowledge production. 
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view that considers both ‘true’ and ‘false’ beliefs in science to be equally open to 
sociological explanation (Sismondo 2010). This has been an important premise 
for SSK scholarship, enabling researchers to analyse scientific knowledge 
production without considering the present state of knowledge as in some way 
more truthful, factual or rational than that which has gone before. The strong 
programme’s early days were especially marked by attempts to connect broad 
social structure and social interests to internal scientific judgements, contents and 
controversies. This usually entailed a macro-social conflict or theme being 
connected to positions taken within a smaller-scale scientific debate.38 This 
approach became controversial within SSK itself, with a number of scholars, 
notably Latour and Woolgar, arguing that it was invalid to regard social factors as 
the unproblematic external determinants of scientific thought and practice.39 
 
Laboratory Life became the exemplar for a whole series of later laboratory 
studies, but these took several different forms.40 For the present purposes, I will 
focus on selected themes from some key studies that are relevant to my own work.  
                                                
38 An example of such a case study is MacKenzie (1978), in which differing social interests in 
Britain on the subject of eugenics are linked to an examination of controversy around how to best 
measure statistical association between 1900 and 1914. 
39 Note in this transition between discussing SSK’s strong programme and laboratory studies that a 
number of progeny intellectual pursuits broke off from this school of thought. Lynch (1993) 
amusingly describes the programme’s descendants as a “loose and extended” family whose “lines 
of ancestry are far from “pure””, marked by several episodes of heated “sibling rivalries” and 
“intermarriage[s] of themes and research initiatives” (82-3). This lineage is not comprehensively 
described within the limits of the present literature review; however, a more thorough overview of 
spin out SSK scholarship can be found in Lynch (1983, 82-102) and Sismondo (2010). Shapin’s 
(1982) article is also of interest in its defence of SSK coming under attack by many philosophers 
and historians as he highlights the value of several SSK empirical studies. 
40 Beyond the laboratory studies discussed in the body of this section, I have sourced inspiration in 
style and form from multi-sited ethnographies such as Franklin and Roberts’ (2006) insightful 
examination of pre-implantation genetic diagnosis and Lock’s (2001) cross-cultural portraits of 
organ transplantation and criteria for death in Japan and North America. Traweek’s (1988) 
ethnography of Japanese and North American particle physics communities that documents the 
construction of scientific truth, the role of women and differences in experimentalists and 
theorists; Knorr Cetina’s (1999) comparative work that highlights the differences in epistemic 
cultures between a molecular biology laboratory and a high energy physics laboratory; and 
Helmreich’s (1998) ethnography that brings the reader into the world of Artificial Intelligence 
have also been influential in developing my appreciation for the craft of this kind of research. 
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First, Laboratory Life (Latour and Woolgar (1986 [1979]), which follows a 
process of ‘fact construction’ in Nobel Prize winning Roger Guillemin’s 
neuroendocrinology laboratory at the Salk Institute. Second, Karen Knorr Cetina’s 
(1981) The Manufacture of Knowledge, in which she follows the day-to-day 
workings of a plant science laboratory at UC Berkeley. Third, Joan Fujimura’s 
(1996) Crafting Science, which details the collective production of accepted 
knowledge in the field of proto-oncogene research. Each of these three studies 
adopts an ethnographic approach to observing and detailing the day-to-day 
practical actions, tools, contextual complexities and social life at particular 
laboratories – a task that this thesis shares. Each also has relevance for questions 
of (social) constructivism, as in different ways, each argues that scientific facts 
and artefacts are actively created in the practices and cultures of the laboratory, 
and can be studied as such, even in their most ‘technical’ forms. No part of 
scientific practice is ‘asocial’. For reasons that I will discuss shortly, however, the 
debate about social construction is not central to my argument in this thesis.  
 
Latour and Woolgar’s (1986 [1979]) pioneering anthropological treatment of 
laboratory scientists as an alien tribe traces the journey of how a scientific “fact” 
(namely that “TRF is Pyro-Glu-His-Pro_NH2”41) came to stabilize and count as 
reliable knowledge in the context of everyday laboratory practices. In this work, 
the anthropological probe “brackets” out any previous knowledge of scientific 
practice, naïvely asking questions to gradually work out his observations. Latour 
                                                
41 TRF refers to “Thyrotopin Releasing Factor”, a tri-peptide chemical produced in the 
hypothalamus, essential in human metabolism. Latour followed the production of that “fact” as an 
anthropological probe (and also lab tech assistant, ergo participant) based in the laboratory that 
‘discovered’ TRF’s structure not through analysis, but rather through synthesis. These discovery 
methods were considered extremely innovative at the time and the consequences of great 
importance to research on human metabolism (with medical implications, etc.); for this, in 1977 
Roger Guillemin and Andrew Scally were jointly awarded the Nobel Prize in medicine.  
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and Woolgar (ibid) famously use the concept of literary inscriptions to describe 
the laboratory’s obsession with various forms of writing – writing on blackboards; 
preparing slides for presentation; constructing graphs, diagrams and charts; 
constantly “coding, marking, altering” (49). They also extend this concept, 
describing laboratory equipment (such as mass spectrometers and bioassays) as 
“inscription devices” that “transform pieces of matter into written documents” 
(ibid, 51). Inscriptions then, for Latour and Woolgar (ibid), are observed to 
become pieces of evidence for scientists, something durable, transportable, readily 
shared and consumed by colleagues. In later works, Latour (1986; 1987) develops 
the concept of a specialized inscription, which he calls an “immutable mobile” – 
objects which are mobile, immutable, presentable, readable and combinable 
(1986, 7). While this conception clearly relates to the processes that I observe in 
my own study, it is significant to point out that the inscriptions that I examine are 
not so immutable, and indeed change as they travel across time and space.   
 
In this work, I encounter mind maps, written protocols and practices involving a 
range of equipment and technologies; however, I do not use either the concept of 
inscriptions or that of immutable mobiles to characterise them. Certainly, the idea 
that scientific knowledge production essentially involves progressive inscription 
practices (e.g. from blackboard scribblings, to experimental protocols, to the 
making of tables and graphs, to the production of scientific papers and text 
books), each layering upon one another in a process of materialization or 
reification (Latour and Woolgar 1986), resonates with my own observations. 
However, I find it less helpful to unify all of these stages under the heading of 
‘inscriptions’. Further, the notion of immutable mobiles doesn’t quite fit in 
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analysing the field of synthetic biology where inscriptions and descriptions of 
existing entities and practices, new hypotheses, new entities are all understood as 
essentially mutable. The very core of synthetic biology’s proposal is that all 
biological entities, and our ideas of what we can create with their micro-
components, are open to change; open to disassembly and reassembly that is only 
bound (hypothetically) by the imaginations of those who perform this kind of 
biological engineering. For these reasons, I have chosen a different approach, 
taking the vast amounts of visual, audio and written data gathered in my study and 
developing appropriate concepts for their analysis. That is to say, I chose to 
immerse myself in the data, and develop the concepts and draw out themes that I 
felt most relevant to this specific study. My methodological choices are further 
elaborated and substantiated in Chapter 2.  
 
Let me now turn to Knorr Cetina’s study (1981). She points out how “truth”, 
“nature” and “theories” (what may commonly come to mind in thinking about 
scientific knowledge) are actually quite difficult to find in everyday laboratory 
existence. The laboratory is a localised place, notoriously contingent and 
circumstantial, where practitioners artfully modify situated scientific practices in 
the quest for “success” (not “truth” or “fact”).  
The scientists’ vocabulary of how things work, of why they do or do 
not work, of steps to take to make them work, does not reflect some 
form of naïve verificationism, but is in fact a discourse appropriate to 
the instrumental manufacture of knowledge in the workshop called a 
“lab”. Success in making things work is a much more mundane 
pursuit than that of truth, and one which is constantly turned into 
credits in scientific everyday life via publication. Thus, it is a success 
in making things work which is reinforced as a concrete and feasible 
goal of scientific action, and not the distant ideal of truth which is 
never quite attained.” (Ibid, 4) 
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Knorr Cetina (ibid) uses tinkering42 and making things work as concepts that more 
accurately describe what scientists must do in their construction of scientific 
knowledge.  
It is the scientists’ knowledge of what is a problem and what counts as 
a solution, educated guesses about where to look and what to ignore, 
and highly selective, expectation-based tinkering with the material 
that guides them toward an “innovative” result. (Ibid, 12) 
Fujimura’s (1996) study, Crafting Science, also demonstrates the ways in which 
scientists focus, not so much on questions of truth and falsity, but on creating and 
solving problems and making things work.  She describes how scientists articulate 
“doable” problems – “the process of solving a problem from beginning to end” 
(Fujimura 1996, 10) – using a case study in which researchers in a private 
laboratory construct a problem involving antibodies that seemed to counteract the 
effects of oncogenes (ibid, Chapter 7). Fujimura shows how a research program 
was laid out; how keeping sponsors and funders happy, as well as incorporating 
marketing strategies, played into the process; how the experiments succeed and 
failed at different times; and how a division of labour was carried out. My own 
analysis, in Chapters 3 through 5, though framed in different terms, demonstrates 
a similar process, showing how “doable” problems are constructed and worked 
through in the iGEM context. 
 
A second relevant aspect of Fujimura’s (1996) study is her focus on 
standardization of theory and methods, which she argues runs alongside the 
growth of proto-oncogene research. Fujimura observes how previous conceptions 
of objects and theories such as genes, cancer, tumours, normal and abnormal 
                                                
42 Knorr Cetina’s use of tinkering is much like Latour and Woolger’s (1986 [1979]) use of the term 
bricolage, both relating to the sense in which the unruly materials and results of scientific practice 
are arranged, rearranged, negotiated and made to fit into the scientist’s expected or desired view of 
things.  
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growth, which had been used variably across different fields, get reformulated in a 
collective fashion (though not without conflict). Moreover, she shows how the 
technical standardization of tools, technologies and practices (e.g. the use of the 
transgenic OncoMouse, recombinant DNA technologies, cloning procedures, etc.) 
is essential in the co-construction of a robust theory of oncogenes – the scientists’ 
own shifting framing of research in this area as well as the very tools that they use 
are involved in a collective creation. She also notes how pioneers of oncogene 
research had to strike “a productive balance between novelty and standardization” 
(Fujimura 1996, 9). My own study demonstrates that, in the case of synthetic 
biology and the practices of iGEM teams, very similar issues of standardization 
prove to be central to the success, or otherwise, of the process. 
 
Each of the laboratory studies I have described also considers the end products of 
scientific knowledge production. Latour and Woolgar (1986 [1979]) refer to an 
inversion happening at the end of the scientific research process. After early 
stages of doubts, contingencies, disagreements, changes in hypotheses and 
method, re-experiment, etc. – all evidently under the agency of scientists – when 
all is said and done, reality and solidity get attributed to the fact(s) and agency in 
making the fact is denied. Nature (as science’s subject) and engineered products 
(as possible fruits of scientific research) are ‘orderly’ and that order must be 
restored at the end of a messy process – hence, the necessity of inversion (ibid). 
The reader will find in this thesis that a similar re-ordering of messy experimental 
processes and incomplete results takes place when iGEM students present their 
achievements on an international, competitive stage to conclude their work. 
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Both Laboratory Life and The Manufacture of Knowledge explore the importance 
of publishing scientific papers and attaining peer validation, credit and acceptance 
as ends of scientific knowledge production – a highly political and social activity 
at that. Knorr Cetina (1981) argues that scientific practices are re-crafted into 
research papers – a process that disconnects the active makings of science and 
presents the objectivist, ideal and tidy vision of a scientific achievement. 
Publication, marketing strategies and details of how a local scientific investigation 
fits into a wider, competitive economic funding structure are also explored in 
Knorr Cetina’s (ibid) work, helping her build towards the challenging argument 
that there should be no distinction between social and natural sciences. While I do 
not follow this general line of argument in the analysis conducted for the present 
study, we will see, more specifically, that similar processes of marketing and 
presentation play a crucial role in stabilizing and objectifying the results of the 
work of the iGEM teams that I follow. 
 
A further relevant aspect of Fujimura’s (1996) study is her description of the 
creation of what she terms the oncogene research ‘bandwagon’. This bandwagon 
is a configuration held together primarily by the standardization of experimental 
systems, tools and packages that enabled practices and theories to be shared and 
passed between participants across several social and disciplinary spheres.  
The proto-oncogene bandwagon represents a particular configuration 
of events, actions, and situations through which cancer and cancer 
research worlds have been reconstructed. The multitude of 
commitments to oncogene research does not establish the fact that 
proto-oncogenes play significant roles in causing human cancers. 
Excitement and enthusiasm over a particular research program do not 
necessarily mean that theory is accepted… However, the sustained 
commitments and the continued momentum of oncogene research 
long past its initial emergence is one sign of the stabilization of the 
oncogene theory. (Fujimura 1996, 226) 
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The reader will see parallels between the processes described in the present study 
and Fujimura’s account of the role of laboratory practices and activities that 
helped unite commitments under the prevailing oncogene bandwagon. I similarly 
detail lab practices and standards that enable a kind of synthetic biology 
bandwagon; additionally, in Chapters 6 and 7 of this study, one observes a kind of 
social and political rallying that is crucial to the processes of ‘selling ideas’ and 
choosing to ‘join the club, or not’. 
 
One of the abiding issues that have been debated in STS concerns ‘social 
constructionism’ – the claim that this or that fact, theory, piece of evidence or 
whatever has been ‘socially constructed’. There are many different versions of 
these arguments concerning ‘the social construction of x’43, and those who argue 
in this way make different theoretical and explanatory claims for this approach. 
Let us consider social constructionism as it has been applied in laboratory 
ethnographies that demonstrate the crafting of facts and artefacts in science and 
technology. Knorr-Cetina (1983) writes that “the constructivist interpretation 
considers the products of science as first and foremost the result of (reflexive) 
fabrication” (119) – a fabrication that is contingent upon particular people, a 
particular space, time, institutional culture, set of norms, etc. She explains that 
many (‘first wave’) laboratory ethnographic studies that take a constructivist 
stance on scientific knowledge (led especially by Latour and Woolgar (1986 
[1979])) have seen it as their task to (i) reject the ‘correspondence theory’ (the 
idea that scientific facts and law statements correspond to independent realities) 
and (ii) elaborate the complex and manifold social processes of constructing facts 
                                                
43 Hacking (1999) in The Social Construction of What? presents a long alphabetical list that 
includes, for instance, x as brotherhood, danger, homosexual culture, literacy, nature, technological 
systems, vital statistics and Zulu nationalism (1). 
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and artefacts in laboratories. The idea that the products of science exist ‘out there’ 
as an independent reality is problematic – ‘facts’ and artefacts only become what 
they are, in a way accessible to us, through processes of inscription, being made 
visible, being made measurable, becoming subjects for wider community 
discussion as well as objects for experimentation. As Sismondo (2010) succinctly 
summarizes, constructivism offers three important reminders about the nature of 
science and technology: they are social, active and not themselves natural. 
 
Some take the social constructionist view of laboratory activities to be somehow 
‘anti-science’.  However, it is important to clarify that this view does not require 
an anti-realist position, or one that denies inherent reality of scientific facts and 
artefacts – it simply necessitates that ‘technical’ and ‘scientific’ activities be 
treated as social phenomena. In his celebratory review of Laboratory Life, 
Hacking (1988) argues that although Latour and Woolgar’s work is strongly anti-
realist in some sense, upon closer inspection, it is a certain kind of irrealism and 
one that actually does afford some realism. Latour and Woolgar’s (1986 [1979]) 
work is consistent with a belief in the existence of facts about the world and the 
reality of unobservable theoretical entities. The claims of Latour and Woolgar 
require only that such entities do not exist until they are constructed. Latour and 
Woolgar (1986 [1979]) offer “quite [a] different doctrine from that of the anti-
realists who say that theories are only instruments to be used but not believed, or 
those who say that the aim of science is empirical adequacy, not truth” (Hacking 
1988, 281). Hacking (ibid) continues,  
Latour and Woolgar report a world full of facts, but those facts are the 
historical product of 'microsociological processes.' There is a 
substance, TRH, secreted in minute amounts by the hypothalamus, 
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and whose structure is that of a tripeptide, a string of three amino 
acids. That is a fact. But it became a fact. (281) 
Above all, Hacking believes that what is most important about Laboratory Life is 
that its conclusions are arrived at through a detailed attention to the processes of 
scientific experiment, a site too often ignored by philosophers of science who are 
caught up in an ungrounded realist / anti-realist debate about scientific theories 
and entities. 
 
Turning briefly to other developments on the constructionist argument in SSK, we 
can notice that the nature of the claims being made have been clarified, perhaps in 
an attempt to spare a continuation of some heated debates. The work of Bruno 
Latour and Michel Callon has been very significant here. Publications such as 
Latour (1983) and Callon and Latour (1992) move away from stronger social 
constructionist positions that seem to undermine the privileging of techno-
scientific ‘facts’ and practices by revealing their many socially contingent factors. 
In their second (1986) edition of Laboratory Life: The Construction of Scientific 
Facts, Latour and Woolgar notably removed the word ‘social’ from the title of the 
1979 original, Laboratory Life: the Social Construction of Scientific Facts. They 
argued that, in the aftermath of their original publication, a slew of social studies 
of science commentary that demonstrated the pervasiveness of “social” 
construction effectively “rendered “social” devoid of any meaning” (1986, 281). 
Hence they chose to delete the term altogether to avoid the impression that they 
were allocating causal powers to this ‘social’ domain. Further, Callon and Latour 
(1992) argue that a one-dimensional “tug-of-war” between an extreme “natural 
realist” position, at one end, and an extreme “social realist” position, at the other, 
cannot suffice. 
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As the field of SSK has grown, studies have presented a more intricate analysis of 
scientific knowledge production along multiple axes – mapping out complex 
relations between things, people and concepts in a performative, heterogeneous 
network, with all elements considered in the same terms (“generalized 
symmetry”). This approach was developed into the influential Actor-Network-
Theory (ANT), a theory about how things, concepts and people come together, 
relate, perform and fall apart in a heterogeneous actor-network, whereby all 
elements (‘things’ included) have agency (Law and Hassard 1999; Latour 2005). 
A key contributor here was Pickering’s (1993) focus on ‘the mangle of practice’: 
where ‘things’ (machines, instruments, etc.) have a material agency and that they, 
along with scientific knowledge, practices and human beings, exist in a constantly 
shifting “mangled” set of relationships, all under various cultural and local 
influences. While my own study does not take an ‘actor network’ approach, it 
certainly demonstrates that ‘things’ have ‘agency’ – or rather, as I prefer to think 
of it, that it is hard to produce results and artefacts in the laboratory, not least 
because the components that synthetic biologists try to create and bring into 
alignment often ‘say no’ to the attempts to make them work in particular ways. 
 
In light of this discussion, it is now possible to outline the position on social 
constructionism that I will take in the remainder of the thesis. I believe, as 
Hacking does, that identifying instances of ‘social construction’, is not 
particularly important or intriguing. It is true that certain entities, facts, people, 
conditions, etc. are made up in a complex social matrix, but this neither exhausts 
the process, nor amounts to an explanation, far less a critique. More importantly, 
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one ought to ask, “what’s the point of social constructionism” (Hacking 1999, 5)? 
Hacking writes, “what unites many of the claims [in arguments that take the form 
X is not inevitable; X is socially constructed] is an underlying aim to raise 
consciousness” (ibid, 6). Certainly, the ideas and biological entities that are 
discussed in the coming chapters are partly social constructs. However, I am not 
driven to ‘raise consciousness’ about this in the present work. My focus, rather, 
remains on providing a rich empirical story of knowledge and material production 
in a relatively new field, and conceptually framing that data in a way that remains 
close to the details. While it might be possible to describe this as a process of 
‘construction’, I believe this would add little intelligibility to the richness of the 
empirical account.  
 
There is one other important line of argument in recent STS work that has 
relevance to this thesis – the generation of hope and hype that comes hand-in-hand 
with the emergence of any ‘new’ biotechnology. I have already said that synthetic 
biology is associated with promises of eventually producing biofuels, cheap drugs, 
applications for bioremediation and more; equally prevalent are worrisome 
possible future scenarios around bioterrorism and accidental release of genetically 
engineered machines into nature. There is extensive STS literature (e.g. in Brown, 
Rappert and Webster’s (2000) collection, Contested Futures) that focuses on how 
various actors in budding areas of techno-science use resources, political power 
and rhetoric (hopeful and frightening) to create a ‘direction’ or convince an 
audience (e.g. funding bodies or a potentially sceptical public audience) of ‘what 
the future will bring’ (ibid, 4). Those who write about the construction of 
predictive futures (e.g. Brown 2003; Hedgecoe 2004; Nightingale and Martin 
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2004) often argue for the need to question and destabilise the assemblages of 
metaphors, expectations, agendas and promises made by spokespeople of nascent 
technologies, because so often the prophecies of these narratives turn out 
unfulfilled, leaving great disappointment as well as wasted money, time and 
energy after hope and hype deflates. Moreover, they have suggested that 
contesting the construction of futures in the present is essential in making wise 
policy decisions, concerning choices about resource allocation and managing 
more realistic expectations. Calling for more agency, accountability and 
responsibility in the political economy of biotechnological expectations is 
essential; however, the cycle of creating hope, energy and promise around an 
emerging biotechnology in need of substantial funding is inevitable, as is, to some 
degree, disappointment when a technology does not deliver on its hoped for 
applications. In the closing chapters of this study (6 and 7), I briefly attend to the 
matter of how a promising, yet also risky, future vision is being constructed and 
managed in the present as synthetic biology emerges. Other studies are under way 
that examine ‘future scenarios’ of synthetic biology that share a number of 
similarities with parallel fields of biotechnological promise and risk – in an early 
and to some extent speculative technology such as synthetic biology, such 
possible futures are in flux, evolving through a number of challenges and selective 
pressures. At this point, one of the most valuable resources that can aid in 
constructing good governance structures for synthetic biology’s future is to have a 
highly informed view of the present. This thesis, with its empirical grounding in 
observing the contemporary practices of key actors in the UK, aims to contribute 
to such a view.  
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Intervening science and ‘taking a look’ 
As already discussed, Ian Hacking’s view on social constructivism has had a 
significant impact on the position I take in this thesis. Let me turn to consider a 
few more of Hacking’s concepts and arguments that have been particularly 
helpful. In Representing and Intervening, Hacking (1983) describes his position as 
a ‘realist about entities and an anti-realist about theories’. This broadly describes 
the view I take towards the material I examine in this study. To appreciate the 
significance of this position, one needs to realise that one of Hacking’s major 
complaints about contemporary philosophy of science lies in its tendency to get 
caught in idealist thinking, trapped in out-dated questions of epistemology that 
view scientific knowledge as a representation of nature. Such conceptions, he 
claims, are simply out of touch with the realities of practising science. Hacking 
(1983) argues that scholars must get away from thinking about the “reality of 
representation” and move towards “what affects us and what we can affect”, 
found in attending to what goes on in scientific experimentation, interaction and 
creation (146). When one examines the practices of contemporary science – as 
laboratory ethnographies do – the researcher can comment on the epistemological 
and ontological questions embedded in experimental work. Hacking finds too that 
these sorts of investigation can sometimes offer resolution to long-standing realist 
/ anti-realist debates in philosophy of science. In brief, Hacking (1983) argues: 
• Science’s two aims are theory (representation) and experiment 
(intervention) where theories aim to describe “how the world is” and 
experiment and technology “change the world” (31). Representation 
and intervention are obviously connected, each informing the other.  
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• Contemporary debates around scientific realism deal with theory, 
representation and truth. Hacking claims that these discussions are 
“illuminating but not decisive” and are “infected with intractable 
metaphysics”; he asserts that “there can be no final argument for or 
against realism at the level of representation” (31). However, in 
attending to intervention – such as spraying niobium balls with 
positrons – then anti-realism seems less plausible. 
• “We shall count as real what we can use to intervene in the world to 
affect something else, or what the world can use to affect us” (146). 
 
Why is this argument relevant here? Synthetic biology remains theoretical in 
many of its premises – for example, the notion that you can black box the details 
of biological parts, devices and systems, and work at each level in a separable, 
modular fashion. For now, there is good experimental reason to doubt such a 
claim. To the extent that my work is critical of synthetic biology, then, this often 
relates to its poorly supported theories – representations that often do not reflect 
the realities of intervention. Occasionally, however, building BioBrick-by-
BioBrick yields something that intervenes and affects something real. In Chapter 
5, the reader will see how the Cambridge team built biological systems that 
produced a range of colour pigments, systems that could be hooked up to other 
parts and systems, adding a colour output. In other words, the theory enabled them 
to produce something that ‘worked’, though whether this demonstrated the truth 
of the theory is open to question. Nonetheless, biological entities that intervene in 
the world are produced. This is why the position Hacking describes as ‘realist 
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about entities and anti-realist about theories’ position fits most closely the attitude 
I have taken in this study. 
 
This thesis also links to Hacking’s (2002) view of historical ontology. Historical 
ontology is about “the ways in which the possibilities for choice, and for being, 
arise in history”; it is “not to be practiced in terms of grand abstractions, but in 
terms of explicit formations in which we can constitute ourselves, formations 
whose trajectories can be plotted [closely], … or, at one remove, that can be 
traced more obscurely by larger organizing concepts such as objectivity or even 
facts themselves” (ibid, 23). When Hacking explains that laboratory ethnographies 
are part of historical ontology, he comments on the difficulty of labelling this type 
of study – part history (of the present), part anthropology, part sociology, part 
microsociology, part philosophy, part paraphilosophy, but none completely fitting 
as an accurate descriptor of what good laboratory ethnographies and historical 
ontology actually do; Hacking prefers to call this approach “taking a look” (ibid, 
64).  
 
I find it particularly appealing to brand this thesis as ‘taking a look’, or belonging 
to the larger field of ‘historical ontology’ because, as Hacking frames these 
approaches, they are at once broad and inclusive of many kinds of problems and 
methodologies, but at the same time, also situated in detailed investigations of 
how objects, ideas and ourselves are constituted. This work ‘takes a look’ in 
asking socio-philosophical questions in terms of the epistemology and ontology of 
synthetic biology (e.g. exploring how ideas and entities are made), while 
employing socio-anthropological methods. Specifically, this work aims to:  
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(i) Explore the conditions that make a new field of knowledge and living 
material production possible (at the levels of what goes on in 
laboratories, as well as at wider community and cultural levels of 
synthetic biology).  
(ii) Attend to (i) not in ‘grand abstraction’, but through research that 
occurred in a discrete period of time, in which I was situated with the 
scientists, engineers, entities and organizations under study.  
(iii) Ultimately serve as a point of departure: from close 
microsociological research, one might later ask questions of social and 
political significance in a more informed way. How might synthetic 
biology’s forms of ‘engineering life’ affect larger societal 
understandings of biology and ‘the living’? 
 
Synthetic biology-specific literature44 
Let us turn to a growing body of literature that focuses more specifically on 
synthetic biology, exploring social, ethical, regulatory and legal issues. Loosely 
categorised as concerning social and ethical matters, some works consider 
contested definitions of synthetic biology (O’Malley et al. 2008; Rabinow and 
Bennett 2008; Fox Keller 2009); others provide an overview of debates in the UK 
context (Balmer and Martin 2008; Lentzos 2009); still others address the role of 
social scientists in collaborating with synthetic biologists (Calvert and Martin 
2009; Macilwain 2009; Schuurbiers and Fisher 2009); Molyneux-Hodgson and 
Meyer’s (2009) article addresses the formation of communities in the EU and UK; 
other publications provide transcripts that recount lectures and conversations in 
                                                
44 This section covers recent literature that comments on social, ethical, regulatory and legal issues 
as they have broadly been categorized in relation to synthetic biology.   
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the field  (Debate 2008; Lentzos et al. 2008). Interestingly, there have also been a 
number of articles on social and ethical aspects of synthetic biology coming out of 
Nature, Science and other notable scientific journals; these articles have been 
authored by writers specific to these journals, as well as social scientists, ethicists, 
natural scientists and engineers, and largely target a readership of biotechnology 
experts (e.g. Ferber 2004; Check 2005a; Church 2005; Tepfer 2005; Bugl 2007; 
Editorial 2007; Serano 2007; Parens, Johnston and Moses 2008; Alper 2009; 
Bennett et al. 2009; Cameron and Caplan 2009; Editorial 2009; Kaebnick 2009; 
Pauwels 2009; Schmidt et al. 2009; Yearley 2009). This growing body of work 
indicates the significant extent to which a discourse on social and ethical issues is 
embedded in relations among synthetic biologists, policy makers and humanities 
academics alike. Most of these works, however, seek to open questions for debate 
and are often not rooted in substantial fieldwork. 
 
What appears to be the most ambitious social science collaboration with synthetic 
biologists so far has been underway since 2006 as part of the well-funded 
Synthetic Biology Engineering Research Centre, or SynBERC.45 Breaking down 
the SynBERC initiative, it is oriented around four thrusts: Parts, Devices, Chassis 
and Human Practices, each with its own set of specific goals. Paul Rabinow used 
to lead the Human Practices category (though has since been replaced by Drew 
                                                
45 SynBERC brings together engineers, life scientists and humanities scholars from UC Berkeley, 
MIT, Harvard and UC San Francisco and is funded by the US National Science Foundation. 
SynBERC is one of the most significant institutions of this kind, claiming its “vision is to develop 
the foundational understanding and technologies to build biological components and assemble 
them into integrated systems to accomplish many particular tasks; to train a new cadre of engineers 
who will specialize in synthetic biology; and to educate the public about the benefits and potential 
risks of synthetic biology. In essence, we want to make biology easier to engineer” 
(www.synberc.org).  
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Endy, a popular figure in synthetic biology)46 and points out that the particular 
naming of this “thrust” was coined in order to “differentiate the goals and 
strategies of this component from previous attempts to bring “science and society” 
together into one frame so as to anticipate and ameliorate science’s “social 
consequences” – this is a ‘post-ELSI’47 project” (Rabinow 2009, 303-4). Rabinow 
continues, “[t]he task of Human Practices is to pose and repose the question of the 
ways in which synthetic biology is contributing or failing to contribute to the 
promised near future through its eventual input into medicine, security, energy, 
and the environment” (ibid, 304). Rabinow’s team seeks to engage in “critical 
examination” and “genuine collaboration” with synthetic biology practitioners 
with whom they are partnered, in “a relationship designed to facilitate a 
remediation of the currently existing relations between knowledge and care in 
terms of mutual flourishing” (ibid, 304-5). These goals, according to Rabinow’s 
research group, are to be met through “improved pedagogy” in collaboration, 
where pedagogy refers not merely to training, but is a reflective process of 
developing a “disposition to learn how one’s practices and experiences form or 
deform one’s existence and how the sciences, understood in the broadest terms, 
enrich or impoverish those dispositions” (ibid, 305). Without belabouring further, 
the reader likely appreciates that this version of human practices is a highly 
theoretical endeavour, with rather lofty goals – aiming to foster collaborations that 
                                                
46 No formal publications report a reason for this replacement but it has been remarked informally 
that some relationships between SynBERS’s Human Practices scholars and those in the technical 
areas have had a difficult start. Certainly, the reality of developing non-hierarchical collaboration 
has been extremely challenging (if not unsuccessful, according to some points of view).    
47 Post-ELSI refers to a paradigm that distinguishes itself from the ‘Ethical, Legal, and Social 
Issues’ (ELSI) model associated with the Human Genome Project when such considerations 
generally occurred downstream of scientific developments; in post-ELSI projects, the evaluation 
of socio-ethical matters occurs in parallel with scientific practice, helping to shape its 
development.  
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affect the deep-seated moral character of those involved to work towards mutual 
flourishing and the betterment of humanity.  
 
To have such aspirations, Rabinow’s team rationalised that they would need to 
invent a new form of equipment – “a practice situated between the traditional 
terms of method and technology” – in order to explore the benefit of trying to 
form collaborative relations (305-6). According to Rabinow and Bennett (2008) in 
their most comprehensive publication that outlines “Designs for Human Practice”, 
“[e]quipmental platforms are characterized by constantly available generality. 
Platforms are designed to function effectively in the reconstruction of specific 
problems, while being plausibly applicable to a range of analogous problems” 
(22-3). Rabinow and Bennett (2008) lay out extensive tables, categories, modules, 
connections, modes, methods and purposes in the elaborate equipmental platforms 
system that they employ; these reportedly problematic platforms, however, are not 
useful in this thesis.48 Its overly complex and top-down theoretical structure, rife 
with ironic use of technical terminology and potentially idealised accounts of 
synthetic biology, aspects of this human practices agenda have already come 
under strong critique (Caudill 2009; Edmond and Mercer 2009; eliciting Rabinow, 
Bennett and Stravrianakis (2009) in response). My reasoning behind not making 
use of the Rabinow group’s approach differs from previous critiques, but can be 
summarised as follows: (i) this research project began with relatively open and 
exploratory questions about what it means to design and build forms of synthetic 
life; (ii) the confines of an elaborately plotted theoretical system were therefore 
                                                
48 Rabinow and other members of the Human Practices thrust are open about several problems 
they’ve encountered in this collaborative venture, often arising from power differentials between 
those practising synthetic biology and social scientists (Rabinow and Bennett 2008; Rabinow 
2009; also noted in discussions I’ve had with members of this research group).  
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not particularly useful in this kind of an investigation; and (iii) I have the freedom 
to pursue scholarly interest without the same level of commitment to high 
‘impact’ outcomes (as in Rabinow’s group). Moreover, the Human Practices 
endeavour explains that its task, influenced by Weber (1949, 68), is to explore not 
the “actual interconnections of things”, but rather, “the conceptual 
interconnections of problems”, hoping to “open up significant new points of 
view” in a general sense (Rabinow 2009, 307). This work, however, seeks to do 
more of the opposite: I map out the ‘actual interconnections of things’ – the 
practices, processes, ideologies, teachings and beliefs – in a segment of the 
synthetic biology community. Though there is conceptual and theoretical analysis 
of the empirical work, this thesis does not seek to do the sort of meta-level, 
general, platform-creating work of Rabinow group’s.  
 
A few additional policy documents and academic publications specific to 
synthetic biology ought to be mentioned. Concerning regulatory and governance 
matters, a number of references point to open questions and, on occasion, give a 
few recommendations: NEST 2005; Garfinkel et al. 2007; HSE 2007; POSTnote 
2008; Schmidt 2008; Balmer and Martin 2008; Nuffield Report 2009; Royal 
Academy of Engineering 2009a, 2009b; Presidential Commission for the Study of 
Bioethical Issues 2010. The problem I find – and this is partly why I sweep over 
such documents and reference them in chart form (Figure IV) – is that, at this 
point, they are largely repetitive (naming the same major concerns and questions), 
quite general and don’t provide much valuable insight for this work’s purpose.  
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The work that explores how synthetic biology might navigate a potentially tricky 
intellectual property landscape, Kumar and Rai (2007), for instance, discusses 
what a bioscience patent culture might mean for this field; for at least the last five 
years, this topic has received significant attention, though little resolution. By way 
of background to the patenting issues in synthetic biology, the reader should know 
that there are already several broad patents held in synthetic biology, some by 
universities and governments, others by private firms (ibid). When broad patents 
cover foundational technologies, there is a real prospect of inhibiting innovation49 
(Kumar and Rai 2007; Rai and Boyle 2007). Perhaps equally important, narrower 
patents that protect individual biological parts might also cover foundational 
elements that could inhibit researchers from accessing basic building blocks for 
their work. Rai and Boyle (2007) outline major questions in developing IP 
frameworks for synthetic biology parts, devices and systems; furthermore, they 
warn that the history of proprietary issues in related fields (such as genetics and 
software) might come together in a “perfect storm” that could significantly 
impede the potential of this new technology (389).  
 
Given this worry that synthetic biologists may find their line of work caught in a  
“patent thicket”50, alternatives in “open source biology” have been popular, 
particularly among those involved in iGEM. The BioBricks Foundation (BBF), 
The Registry of Standard Biological Parts (The Registry) and iGEM are all linked; 
for the curious reader, a brief exploration of these organisations’ websites 
illustrates how attempts have been made to balance a certain altruistic sharing of 
                                                
49 In synthetic biology, foundational patents exist that cover, for instance, use of cellular 
machinery for information processing tasks, mechanisms that modulate cellular pathways and 
methods to select optimal DNA-binding proteins. 
50 A tangle of intellectual property rights that hamper research progress (Shapiro 2001). 
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biological parts with IP frameworks that might also afford commercial 
development of products and applications (also see Endy and Grewal 2010). 
Additionally, it should be noted that the open source culture in synthetic biology 
is, to some extent, competing with private and highly patented (‘closed’) ventures 
such as those in a different school of synthetic biology, the J. Craig Venter 
Institute’s approach of synthetic genomics.51 A lengthy discussion of legal 
dilemmas and proposed frameworks in synthetic biology is certainly possible52, 
though that would occupy another extensive project entirely; I shall not go into 
further detail. What will be important later in this thesis is not any particular 
resolution or IP framework, but rather the influence that discourses about both 
open source sharing and desires to patent and commercialise have on the iGEM 
culture.  
 
Bachelard and Canguilhem  
I now turn to some works of Gaston Bachelard and Georges Canguilhem that may 
seem remote to this emerging field of synthetic biology. Yet, concepts in 
Bachelard’s and Canguilhem’s works, in a French tradition of historical 
epistemology, have been particularly illuminating and have significantly shaped 
my thinking for this thesis. In their approaches to history and philosophy of 
science, these scholars provide a critique of reason through illustrating important 
episodes in science; they believe that the history of science is not a continuous 
development of reason, but a series of discontinuous breaks; and, there is a shared 
                                                
51 Scientists working at the J. C Venter Institute (JCVI) are well known for their tendencies to 
conceal information and patent innovations related to synthetic biology – this is referenced in 
several reports (listed in Figure IV). JCVI’s website: http://www.jcvi.org/. It is worth noting that 
although Craig Venter is often portrayed as a ‘bad guy’, not sharing with the rest of the community 
(Marshall 2009), several other synthetic biologists wish to patent and profit from their innovations.  
52 A brief list of publications that have arisen regarding patenting in synthetic biology: Rai and 
Boyle 2007; Kumar and Rai 2007; Calvert 2008; Hope 2008; Henkel and Maurer 2009; Rai 2010.  
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emphasis on rejecting grand theories and normative claims in philosophy of 
science, in favour of attending to scientific rationality on regional terms (that is, 
trying to understand rationality in a way that is informed by real details in science, 
as opposed to enforcing philosophical norms onto science) (Gutting 1989).  
 
In fact, and not surprisingly, some of the early laboratory ethnographies that I 
have described made reference to these approaches. In particular, Latour and 
Woolgar (1986 [1979]) draw on Bachelard’s notion of ‘phenomenotechnique’ in 
their argument that “the artificial reality, which participants describe in terms of 
an objective entity, has in fact been constructed by the use of inscription devices” 
(64). As Hacking (1988) points out, much of Latour and Woolgar’s (ibid) usage 
hangs on how terms like ‘artificial reality’ and ‘constructed’ are interpreted, and 
there is an ambiguity as to whether there is a relationship between ‘being 
artificial’ and ‘being an objective entity’. I follow Hacking (ibid) here when he 
argues that,  
“Virtually none of the phenomena by which we elaborate, articulate 
and test theories exists, in a pure state, in nature, before we create 
them. I find this not merely consistent with scientific realism (about 
entities and phenomena as opposed to theories) but positively an 
argument for it.” (285).  
Importantly, Rheinberger (2005) points out, Bachelard himself seldom uses the 
term ‘construction’ preferring the alternative English translation as ‘realization’ – 
that is to say, making real. Scientific entities are not immediately given, but rather, 
they take shape and are made real gradually, in a complex socio-technical process. 
This is the way in which I follow Bachelard’s concept of phenomenotechnique.   
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Furthermore, the Bachelardian notion of phenomenotechnique (also written as 
‘phenomenotechnology’ or ‘phenomeno-technology’ in English translations) is a 
conception of how scientific thinking works. With a broader aim to challenge 
philosophers of science to re-evaluate their views in light of dramatic shifts in the 
physics and mathematics of his day (late 1920s to the 1950s), when quantum 
theory, non-Euclidian geometry and Einstein’s theory of relativity were all 
examples of ‘epistemological breaks’ and genuinely novel thinking, Bachelard 
(1984) writes: 
A truly scientific phenomenology is therefore essentially a 
phenomeno-technology. … It takes its instruction from construction. 
Wonderworking reason designs its own miracles. Science conjures up 
a world, by means not of magic immanent in reality but of rational 
impulse immanent in mind. The first achievement of the scientific 
spirit was to create reason in the image of the world; modern science 
has moved on to the project of constructing a world in the image of 
reason. Scientific work makes rational entities real, in the full sense of 
the word. (13)53 
 
According to Rheinberger (2005), phenomenotechnique is emphasized as the idea 
that technology is at the heart of scientific thinking and practice. Rheinberger 
quotes a passage from Bachelard on the subject of microphysics, describing how, 
through the phenomenotechnique, “new phenomena are not simply found, but 
invented, that is, thoroughly constructed”54 (Bachelard [1931-32] 1970, 18-19, as 
                                                
53 At the time Bachelard was writing, philosophical debates about realism and rationality in 
science were, according to him, mostly constructed falsely by philosophers pre-occupied with 
projecting their ideologies onto science – whether it be a positivist view of science as a continually 
progressive effort or about scientific discovery as an endeavour that first finds natural truths and 
then comes to a theoretical position. For Bachelard, such views neglect what has actually gone on 
(and what still goes on) in markedly different developments of science and mathematics. For 
Bachelard to say that scientific thought firstly involved ‘conjuring up a world’ in mind, before 
anything could be made material or proven real, was quite unusual for his time.  
54 Where “construction” means something like “realization” and “instruction”, whereby scientific 
objects are engaged agents in the knowledge production process (Rheinberger 2005, 320-1).  
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quoted in Rheinberger 2005, 315). Later in the paper, Rheinberger (2005) 
elaborates: 
[A]pplicability is built right into the core of modern sciences’ concept 
formation. … Applied rationalism is thus technically implemented 
materialism. It is not the idea of science in search of application, but 
of a science that is taken and accepted as science because it moves in 
and has always existed in the realm of the applicable, because its very 
epistemological constitution has a technical dimension, because 
application is built into the very meaning of concepts and into the 
rules of concept formation, because the technical is built into the 
experimental phenomena…” (324) 
To summarise, then, scientific work has invention, construction and technical 
applicability built-in at all stages – from ‘dreaming up ideas’ through to 
experiment and making real applications. In this work, I make use of this concept 
of phenomenotechnique particularly in describing the early stages of synthetic 
biology research, when specific projects are being ‘conjured up in mind’ before 
they are tried in wet laboratory practices. Using this concept in such a way serves 
as a reminder that technology and application do not merely come ‘downstream’ 
of scientific thinking – technology and application are active when the scientific 
imagination, the dreaming up of ideas, is just beginning. Chapter 3 articulates 
phenomenotechnique in operation in describing how groups of students ‘conjure 
up’ projects that exist firstly in the mind before teams can even conceive of 
experiments or making something real. 
 
Under a general framework of writing a history of biological concepts that rejects 
the notion that science consists in discovering phenomena in a continually 
progressive way, Canguilhem explores the conceptual and historical value of 
vitalism – where I focus in considering his work. In very basic terms, the doctrine 
of vitalism says that biological systems are not reducible to the purely physical 
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and chemical (the mechanics); mechanism is vitalism’s relative opposite. 
Canguilhem (2009) explains that when one considers vitalism in the history of 
science, three things are notable: (i) the ‘vitality of vitalism’ – that is, despite the 
many divisions and oscillations of biological theories throughout history, vitalism 
has been returned to time after time; (ii) the ‘fecundity of vitalism’ – that is, an 
ability to reproduce or measure the fitness of vitalism; and (iii) the ‘character of 
honesty in vitalism’. According to Canguilhem, the rebirths of vitalism translate 
“life’s permanent distrust of the mechanization of life” – this historian of biology 
continually finds “life seeking to put mechanism back into its place within life” 
(Canguilhem 2009, 73). Canguilhem’s fascination with vitalism is helpful to 
consider as an opposing movement to synthetic biology’s vision that often appears 
to be the epitome of a reductionist view of living systems, wanting to remake life 
into ‘engineerable’, mechanical forms.  
 
There are three additional concepts in Canguilhem’s (2009) work that I find useful 
in thinking about how to challenge the synthetic biologists’ view of the systems 
they are constructing: (i) the relation between machine and organism, (ii) the 
complexity of an organisms’ survival in a milieu, and (iii) the idea that only life is 
capable of generating monstrosity. Though I do not intend to discuss details of 
historical examples that Canguilhem explores, for me, his work tends to highlight 
important themes through which I can question and analyse empirical findings of 
the synthetic biology world. For instance, I question to what extent the materials 
that synthetic biologists work with can be thought of as machine or as organism – 
this changes at different stages in a research project and with different challenges 
or accomplishments. The concept of a milieu (though not used explicitly) relates 
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to my discussions of biological complexity and, at a larger scale, can be thought 
of as a concept to describe the cultural intricacies in which this field is practiced. 
Finally, notions of monstrosity and the monstrous remind us why, for some, it is 
unsettling that synthetic biology seeks to design and construct new forms of life. 
 
Conclusion 
This chapter begun with a brief roadmap, indicating where in the thesis the reader 
will find answers to the particular research questions at hand. For the most part, 
however, I have provided a review of a wide range of important literature for this 
study. I have discussed themes from sociology of scientific knowledge, from 
selected laboratory studies and from the social constructivist school of thought; I 
have described various influences I’ve found in reading Ian Hacking, including 
my particular satisfaction if this work is thought of as ‘taking a look’; I then 
explored a range of quite recent scholarship that centres on various social, ethical, 
regulatory and legal issues pertinent to synthetic biology; finally, I examined 
some helpful concepts from French philosophers Gaston Bachelard and Georges 
Canguilhem. While, in the body of the thesis, I have not made explicit reference to 
many of the authors discussed here, their arguments and their empirical analyses 
have informed the approach that I have taken, and as I have indicated in this 
Chapter, there are many resonances between my findings and those of previous 
studies. The main influences on the approach I have adopted in this study have 
been Hacking’s (1983) ‘realism about entities and anti-realism about theories’, 
Bachelard’s (1984) notion of ‘phenomenotechnique’ and Canguilhem’s (2009) 
reflections on vitalism. In the core empirical chapters of this study, I have 
focussed directly on the analysis of the very large amount of empirical data 
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collected during my research. Rather than referring back to previous work, I 
decided to concentrate on providing a detailed account of a specific set of 
practitioners, places, activities and social dynamics arising in a fascinating field. 
Given the mounting academic, governmental and media interest in synthetic 
biology, I hope that such an empirical approach provides basic research (co-
opting the typically scientific sense of the term) that may be applied in further 
questioning and different forms of scholarship from the social sciences.  
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2.     FOLLOWING KNOWLEDGE AND MATERIAL  
PRODUCTION IN iGEM 
 
Given that this thesis aims to unravel questions surrounding knowledge and 
material production in synthetic biology, as well as to investigate beliefs, hopes, 
practices, ideologies and tools of the field, I have taken a qualitative 
methodological approach. This chapter explains my entry into the field and how I 
used ethnographic techniques to follow a particular narrative. I also discuss how 
evolving relations with participants shaped the course of this study. Finally, I 
describe the kinds of data gathered and how I developed a methodology for a 
suitable analysis.  
 
2.1   How to follow the narrative  
In 2007, while working on my master’s dissertations and starting to examine this 
field, there were only three or four UK laboratories doing what might be 
considered synthetic biology; however, I had a critical advantage in the form of a 
previous contact, Dr. Thomas Wiseman (pseudonym), a lecturer at University of 
Edinburgh who had taught me microbiology as an undergraduate. I contacted 
Thomas to ask whether he knew anything about synthetic biology and, as it 
happened, he was amongst the first of UK leaders in the field. From that initial 
key informer, a contact list grew as I sent emails, telephoned and networked at 
any synthetic biology event or conference I could attend; eventually, I had a good 
dozen or so relevant people to interview for my MSc research.  
 
While at the University of Cambridge in 2008 interviewing two distinguished 
practitioners of synthetic biology, I had the opportunity to meet and talk with that 
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year’s iGEM group. Though the iGEM perspective and competition was not a 
concentration in my MSc research, I was struck by how excited this group was to 
be part of ‘the synthetic biology movement’ and I began to think about the 
significance of inspiring and educating these students. Having had some 
experience speaking to established academics and equipped with a general 
knowledge of the workings in the community already, when it came to deciding 
my PhD focus, I knew that investigating the iGEM competition would be a rich 
site for social study. Furthermore, iGEM was a place of inquiry that – in early 
2009 – was neglected by the steadily growing group of social scientists, ethicists, 
NGOs and policy makers that were examining and writing about the emergence of 
this potentially controversial biotechnology. Finally, I suspected that as a young 
researcher with an undergraduate background in biomedical sciences, I might 
have somewhat privileged access to be able to understand the science and be 
accepted by a group of undergraduate iGEMers.  
 
And so begins the story of staking a place at two prestigious universities as the 
resident social scientist in groups of life scientists, engineers, physicists and 
computer scientists. Having made good contact with a few of the UK’s main 
synthetic biology practitioners, access to the chosen field sites was relatively easy 
to acquire.55 I had been informed well in advance that I was welcome to follow 
and participate in the Cambridge iGEM team; however, when I met with three 
leaders for the iGEM group in early May to discuss my research and formally 
obtain signatures on consent forms, a few conditions were placed on my proposal 
                                                
55 An institutional alliance between BIOS and Imperial College’s synthetic biology group – in the 
form of the Centre for Synthetic Biology and Innovation (CSynBI) – also factored into rather 
straightforward access. Notably, however, I had already met and interviewed the key contacts at 
Imperial College prior to the formation of CSynBI, during my MSc research. 
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(see Appendix I). One of the head advisors – naturally with the interests of iGEM 
students in mind – was concerned about the extent to which I might reveal 
personal rifts within the team or faculty; he explained that he would not be happy 
if my work ‘spiced it up’ and strayed too far from ‘what goes on in the science’. 
As delicately as possible, I talked further about my research interests and we laid 
out a few more agreements: for example, all students would have to consent 
individually and advisors could request to see my work to ensure its content did 
not sacrifice the professional or personal integrity of participants. I modified the 
agreements that were eventually signed by the involved faculty at Cambridge and 
later paid great attention to explaining the nature of my research to iGEMers, 
obtaining signed consent from each of them. At Imperial College, the case was 
more straightforward as I had been attending the synthetic biology undergraduate 
course since January, building rapport. Upon asking for access, a meeting was 
arranged and I outlined my research, then all the advisors signed consent forms, 
with the only minor added condition that I would ‘not reveal the scientific content 
of the project until after the Jamboree’.56 Again, I explained my research and had 
consent forms signed by all the students. With participant consent, a commitment 
to being open to questions, maintaining respectful relations among the actors in 
the study and using pseudonyms (where agreed) throughout this thesis, I have 
done my best to pursue this work in an ethically responsible manner.57 
 
The coming chapters proceed with the backdrop of a chronological narrative, 
involving a set of characters whose roles, personalities, gender, goals, hierarchical 
                                                
56 This was ‘due to IP reasons’. It is amusing that at one institution, the concern was about me 
straying from the science; while at the other, it was that I might reveal too much science and 
compromise the group’s intellectual property.  
57 I don’t claim that participants are fully anonymised as websites are given and it was agreed that 
institutional and disciplinary affiliations would be disclosed. 
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positions and institutional affiliations are relevant. A useful reference list of this 
work’s main characters (with a description indicating participants’ status and 
disciplinary affiliation) is provided prior to the Introduction (p. 8-9). Chapters 3 
through 5 follow a trajectory of practices and processes in the two home 
laboratories as the teams brainstormed, decided on a project to pursue, navigated 
the challenges of engineering biology and eventually made a synthetic biological 
system (or part thereof) from late June to October 2009. For the sake of clarity, as 
well as for the integrity of what occurred in two quite different groups, these 
chapters are divided into two main sections, delineating the Cambridge and 
Imperial College teams. In Chapter 3, I briefly discuss how synthetic biology was 
taught at the respective institutions, as it was through participating in 
undergraduate courses that I (and most of the iGEMers) had the first technical 
point of entry into the field. At Cambridge, I participated in a two-week intensive 
crash course that took place directly before iGEM time began; it was the first year 
that this course was formally run and, in addition to all the iGEM students being 
present, there were a few other Cambridge undergraduates taking the course, four 
interested designers and me. At Imperial College, the synthetic biology course 
was a great deal more formal, running the full length of a term and getting 
stronger in its second year with a class of about twenty-five undergraduate 
engineers and life scientists. Attending both courses was useful in several ways: it 
provided a technical introduction to synthetic biology; it was a way for me to 
demonstrate ‘seriousness’ or ‘commitment to the science’ to the groups I was 
trying to work with; it showed me how synthetic biology was being taught, 
especially marked by enthusiasm and rhetoric that aimed to get students involved 
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in the discipline’s development; and, it was a way to build relationships and trust 
that would afford me better participatory opportunities.  
 
To give a sense of how I went about conducting my fieldwork, I will outline a few 
practicalities of my schedule. At first, I planned to spend full and alternating 
working weeks at each site, staying in a Cambridge college room so I could 
participate in evening activities. Obviously, access to the Imperial team and 
activities in London was an easy tube ride away. My alternating weeks between 
the sites worked out fine for a couple weeks and there were occasions for evening 
drinks and dinners as team members got to know one another; however, as time 
went on, the evening get-togethers faded out in Cambridge and that team 
developed a work pattern that generally consisted of weekday laboratory hours 
from 9 / 10am to 5 / 6pm (with occasional weekend workdays), where, for the 
most part, individuals’ would return to their personal lives in the evenings. To 
save money and not spend lonely evenings writing field-notes and reading in a 
Cambridge dorm room, I decided that I would commute for the remainder of my 
research time. This actually became more advantageous when I realised that 
alternating between groups on a weekly basis left me quite out of the loop, 
missing five workdays in a row at a given site. So, when I began commuting to 
Cambridge, I also alternated between teams more frequently; typically, I spent 
three days a week at one site and two at the other, switching the balance weekly. 
My dozens of train journeys were devoted to writing field-notes or reading Wiki 
entries and other recommendations from participants. When both teams settled 
into a routine towards the end of July, I realised the need to allot myself an 
occasional full day of reflection and writing, necessary as it was to occasionally 
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re-focus when I felt ‘lost’ as a researcher in the field – not knowing what I was 
looking for exactly or how I would use all the data I was collecting. Alongside a 
group of iGEMers learning what it meant to become synthetic biologists, I too 
was learning what it meant to conduct ethnographic research.  
 
Although Chapters 3 through 5 take place in the teams’ UK laboratories and 
involve thick description in chronological time (answering how these groups 
imagined, designed and built synthetic biological machines), each chapter has a 
core analytic theme, influenced by literature discussed in Chapter 1. In Chapters 6 
through 8, the narrative departs from the home laboratories and expands to 
describe what happened at the iGEM Jamboree’s international stage; how iGEM 
is a tool for developing synthetic biology on a global scale; and finally, the reader 
arrives at a new space through which to consider synthetic biology’s social and 
philosophical impacts in light of a real story that’s been told.  
 
2.2   Evolving relations in the field 
According to Hammersley and Atkinson (1995), the two most important 
requirements of social research are fidelity to the subject under study and 
reflexivity as a researcher – it is essential that a good ethnographer has self-
conscious awareness of what is learned in a given study, how it is learned and 
through what social relations. This work is embedded in the context of its 
production: as a young, female researcher coming from what was often seen by 
senior participants in the field as a ‘soft discipline’ (the social sciences as opposed 
to the real sciences), I was trying to penetrate a world where those at the top of the 
hierarchy were mostly well-established, male academic scientists and engineers. 
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One can appreciate that my role in elite synthetic biology circles would 
occasionally involve unfortunate dynamics – my age, gender, methodology and 
subject of study were all, at some times and by certain participants, viewed as 
points to undermine my purpose where I did not ‘naturally’ belong. Such 
undermining was thankfully rare and did not pose a significant threat to my work; 
aside from two or three people who were not particularly supportive of my 
research and occasionally made this known (or at least felt), I largely had good 
working relationships. I believe the fruitful interactions I developed are partly 
owed to two important features of the synthetic biology culture: (i) many ideals 
are based on embracing interdisciplinary views and tools (not only in science and 
engineering, but also extending to humanities and design) and (ii) the younger 
iGEM generation tends to be particularly excited by the alternative and diverse 
disciplinary associations of this field. It was nonetheless essential to this study’s 
success that I continually reflect upon my role in the field, thinking about how I 
could open opportunities, forge good impressions and develop as a researcher. 
This section provides preliminary insight into how my interactions with 
participants developed over time. 
 
At Cambridge 
Cambridge and Imperial College have unique institutional cultures where different 
values and goals are relevant; hence, I consider examples from each site in turn 
and am careful about when to, and when to not, meld analyses.  
 
I met Andy at a conference in early 2008, and he was my first point of contact 
with the Cambridge circle. Over the course of my master’s and doctoral research, 
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Andy became the most important contact for me in both the UK and international 
synthetic biology communities, as he proved to be one of the most extraordinarily 
outgoing networkers and enthusiasts in the field. Andy was also a frequent source 
of insider gossip so long as I kept it off the record; though I do not disclose such 
sensitive information and cannot be sure of its accuracy anyway, learning insider 
politics over the odd informal coffee certainly added texture to my knowledge and 
directed some lines of inquiry. With good contacts in place (having met Samuel, 
Geoffrey, Frederick and Andy on several occasions) and relative assurance that 
I’d be welcome to participate in the crash course and summer iGEM programme, 
the real journey of evolving relations began. 
 
After spending only a few intensive days in Cambridge, it was clear that a non-
hierarchical and convivial atmosphere was being fostered in the group – a number 
of pleasant discussions (inclusive of students, supervisors, visiting designers and 
me) over tea breaks, lunches or the odd drink in a pub helped set this tone. Having 
sandwiches in large group circles with the sun beaming down on the immaculately 
groomed lawns of Downing or Emmanuel College became a very fond memory of 
the first two weeks when, in many ways, I was participating as other iGEM 
students were: taking in a mass of synthetic biology information, doing laboratory 
experiments and getting to know everyone. I was of course also an outsider,58 ‘the 
social scientist from LSE’, often misperceived as the ‘expert’ on the whole range 
of ‘social, ethical, political and legal challenges in synthetic biology’. This was an 
obviously overstated label to carry, and something I would occasionally try to 
shake by explaining to participants my interests in ‘scientific epistemology’ and 
                                                
58 Notably, in a somewhat similar way, the four visiting designers taking the course were also 
outsiders – non-Cambridge students and not scientists or engineers. Being part of a group of 
outsiders softened feelings of difference that a lone ethnographer typically feels. 
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‘ontology’. However, it seemed clear that, at least initially, to perceive me as the 
person examining ‘social and ethical stuff’ was far more convenient. I accepted 
this perceived view on occasion, even using it to describe myself in the early days 
of fieldwork, as I felt (inevitably) uncertain about how my research might turn 
out. At some stage, I simply told myself to stop worrying about the label and carry 
on with the work at hand.  
 
When the course was over and only the core group of iGEMers, advisors and 
myself remained,59 a routine began to settle. Students were generally in the 
laboratory on normal workday schedules and I would arrive on my Cambridge 
days to observe and participate from about 10am to 5pm (and, when possible, 
would stay along for evening activities). On a typical day during the middle-
period of the project (Chapters 4-5), students gathered in the morning to brief each 
other on who was doing what and gave updates; then, they would set to work, 
some in the wet laboratory, others working on computers to model reaction 
dynamics, research or add to their team Wiki. I would arrive at the laboratory, 
promptly set up my computer, notebook and camera, then get myself into rotation, 
jumping between individuals or small groups working on particular tasks: I 
learned about and carried out laboratory experiments; learned about computer 
modelling (though avoided actually doing this so as not to reveal great 
mathematical and computer deficiencies); took copious numbers of photographs; 
and talked with advisors. One of the running jokes in the group was that my role 
was to go around asking, ‘what are you up to?’ I was careful not to probe to the 
extent of annoyance and for the most part, I think I struck a good balance between 
                                                
59 The handful of non-iGEM undergraduates and the designers left after the two-week course.  
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asking questions and getting involved and also sitting back to observe, letting the 
scene unfold and giving everyone space. During particularly stressful times – 
often the result of failed experiments or a need to re-evaluate a given goal – I 
would sometimes sit with my laptop and take field-notes. For this kind of periodic 
retreat, I was eventually teased by one of the students: “Aren’t ethnographers 
supposed to scribble down their notes in the bathroom or something?” At which 
point, it was also suggested that I should “do something”, helping in an 
experiment. I was always happy to jump to those calls and became aware of my 
increasing integration as time went on. 
 
To convey the developing friendly atmosphere in context, I’ll share a memorable 
anecdote. In making their Wiki site, the Cambridge group added a ‘Friends’ of the 
team page, where one finds a blurb about the visiting designers and I.60 The 
caption that the team endearingly wrote for me reads:  
Caitlin Cockerton: Caitlin is from the London School of Economics 
and is interested in the ethical implications of Synthetic Biology. She 
is also following the Imperial 2009 iGEM team, who she likes, but not 
as much as us.  
This blurb entry and my continual back-and-forth between institutions led to a 
short flurry of Twitter exchanges between the Imperial and Cambridge teams, 
which bantered jokingly about who had more ‘Caitlin time’: 
Cambridge (11am, 29 July): Stop stealing Caitlin from us, she’s 
ours!! ;D 
Imperial (2:11pm, 30 July): We found Caitlin crying after only 4 
days in Cambridge. 
Caitlin (2:23pm, 30 July): Wonderful iGEMers… Please stop this 
sibling rivalry… I love you all equally. 
                                                
60 http://2009.igem.org/Team:Cambridge/Team.  
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Silly though these exchanges may be, they nonetheless signal that I was receiving 
informal embrace by the students. As the summer progressed, running jokes 
developed across all members of the very humorous Cambridge team, as students 
and advisors got to know each other; another tease I periodically received would 
occur in the midst of a laboratory mistake of some sort61 or a dispute, when 
someone would typically say with a chuckle, ‘Caitlin – you got this one on 
record?!’ 
 
My closeness with the team grew as we spent countless tea breaks and lunches 
together, witnessed each other’s laboratory successes and failures and all 
developed as researchers. As time went on, students also took greater care in 
explaining to me what they were doing; they knew I was genuinely interested in 
the concepts, tools and techniques that they were using and would not dumb down 
their explanations for the social scientist (though having an undergraduate degree 
in biomedical sciences also came in handy). Admittedly, this sometimes meant I 
was the recipient of more technically detailed accounts than I could hope to 
understand, but those moments lost in translation were nonetheless enjoyable and 
valuable. I also spent a good deal of time chatting informally with all of the 
advisors as they dropped in daily to check on the students and give guidance. 
Without the stress of term-time teaching and given the advisors’ keen support of 
iGEM in general as well as this particular group and project, I usually had a 
handful of quality conversations with these experts each week. We talked about 
the team’s progress, the development of synthetic biology, dangers or fears 
circulating the field, notable laboratories and scientists as well as institutional 
                                                
61 For example, one student poured acetone into a £20K piece of equipment, nearly ruining it 
(luckily, it was rescued). Another student melted together a bunch of plastic plates by accidentally 
putting them under heat treatment.   
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politics. Further anecdotes in later chapters add colour to this outline; but, with 
brevity in mind, I provide only a few additional highlights to illustrate my 
experience of evolving dynamics with this team. 
 
After introducing their work during the crash course, Daisy and James returned to 
Cambridge, running two additional workshops, and later, they attended the 
Jamboree. The importance of these workshops and general influence from these 
designers in engaging the students’ imaginations, opening up discussion and 
shaking up the usual laboratory atmosphere, cannot be underestimated. In part, 
Chapters 5 and 6 explore the impact that design had with this group; but for now, 
suffice it to say that the design perspectives and workshop activities encouraged 
the team to think about possible futures that not only demanded they reflect on the 
utility and aesthetic aspects of possible synthetic biology applications, but also 
pushed the students to think about their work in a complex societal network. 
These workshops were also very fun – usually ending at a pub or with a group 
dinner – adding significance as real team bonding occasions.  
 
Skipping forward to the iGEM Jamboree, the relationships I had with participants 
continued to get stronger; in fact, the significance of those four non-stop, 
incredibly demanding, exciting and emotional days cannot be underestimated 
(Chapter 6). In the lead-up to the Cambridge team’s scheduled presentation, I 
spent a great deal of time with them, sat in packed and buzzy MIT auditoriums, 
listening to dozens of impressive teams show off their projects; I also tagged 
along to tour MIT and Boston / Cambridge, led by the well-connected Andy, who 
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had lived and worked there62. Finally, being in the same hotel as the Cambridge 
team, I shared moments of defusing: watching mindless television one evening, 
going to dinner, chatting over drinks and even going out dancing over the course 
of the weekend. I also had profound talks with advisors – conversations that 
reflected on the summer experience and looked forward to what would happen at 
the Jamboree and in the more distant future for the iGEMers. Then, when it came 
to the team’s presentation day, I was with them as they put together last-minute 
preparations and managed their nerves and excitement; I sat in the full-house 
audience with the beamingly proud advisors and watched the group give a 
fabulous presentation. On the closing day of the Jamboree, I spent most of my 
time with the Cambridge group as one exhilarating moment followed another: 
they were announced as one of the six finalists; they presented their work again 
(as all finalists did); they won the Best Environmental Project prize; they won the 
entire competition (receiving the Grand Prize BioBrick Trophy, shaped like a 
giant Lego™ block); finally, when the competition ended, there was a flurry of 
congratulations to the team. Photographic opportunities and media attention 
ensued (including an interview with a journalist from The New York Times 
Magazine). These whirlwind four days were extremely important to the team and 
to my research. I suppose the last thing to mention here – in reflecting on evolving 
relations in the field – is that, by the time I flew back to London with the students, 
I felt I had truly become a friend of the Cambridge 2009 iGEM team. 
 
A couple weeks following the Jamboree – after the dust settled – I conducted 
follow-up interviews with students and advisors, and was struck by how a number 
                                                
62 With the team, I saw The Registry, talked with iGEM founders and toured the important ‘MIT 
syn bio crew hang-out spots’ (the coffee shop, AI laboratory, roof garden, favourite pub, etc.). 
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of clips reflect participants’ views of my role in the field. A small selection of 
such comments included:  
• One student said of having me around all summer: “I think it was 
awesome – I mean anything that is going to integrate science and 
society is going to be really good. Otherwise, we can get kind of 
‘locked up’ in the science bit! … It sort of made me feel more useful 
also… I felt that even if this whole iGEM thing failed and the project 
didn’t work, it would have been useful for Caitlin’s PhD!”   
• Another student, jokingly: “At the beginning, you were like, ‘I’m a 
social scientists and I’m going to be studying you and can you sign 
these release forms?’ That was a bit weird! But then, once you’d been 
around a while, we chatted and we realized that you’re fine!” 
• Towards the end of an interview with Frederick, he commented: “I 
suppose going further into the future, you’re actually in a rather good 
position now because you’re one of the relatively few people who 
both considers the social side of things and actually knows a fair 
amount about the way iGEM, and the whole field of synthetic biology, 
works. I don’t know where you see yourself going but presumably 
there ought to be plenty of job opportunities for you.” 
• In conducting an interview I remarked that I at least felt that my 
presence with the students generated a “vague awareness” and 
interest in how synthetic biology fits into wider social contexts and 
research. Geoffrey replied: “I don’t agree that it’s a ‘vague 
awareness’, because I think what people should be taking more on 
board is that although there are traditional ways of learning, those 
probably don’t work in these contexts [in iGEM]. You can give a 
lecture on ethics, but basically the kids are just going to yawn, OK, 
and they won’t learn anything. But when you talk about it in the 
context of what they’re doing and you’re asking them questions – it’s 
insidious in a certain way – but actually that’s the best way to learn 
and the best way to understand how the process works, by 
participating in it, not by being lectured at.”  
 
The relationships with participants at Cambridge grew stronger over time, and the 
perceptions of my work also changed – eventually, some participants took an 
interest in what I was doing, and the quality of exchanges I had with students and 
advisors about our respective research and future goals is something I am very 
grateful for. The informal conversations I had were invaluable, not least in 
developing a rich understanding of this field, and in particular of how iGEM 
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operates as a special tool to support the development of synthetic biology. My last 
proud moment took place in November – while helping to make a short film about 
the Cambridge iGEM project63 – when Andy described my work to the film-
maker as being about ‘knowledge production in synthetic biology’, not merely 
captured in a token phrase about ‘social and ethical issues’. By the time I finished 
all the interviews and concluded my official time in the field, everyone at 
Cambridge expressed their best wishes to me, extended invites to return and 
requested updates and future works to read. I am deeply thankful for the learning 
experience I had with the Cambridge team and for the warmth that they extended 
to me. 
 
At Imperial College 
My start at Imperial College was fairly smooth, partly due to participating in the 
undergraduate course. However, only half of the iGEMers took the synthetic 
biology module and so my integration at that stage had more to do with gaining 
rapport with senior figures – lecturers such as Roger, Bernard and John, who were 
also iGEM advisors. As this was a formal course taught from January to April, 
there wasn’t the intensity of full days with lunch breaks, extended tea time and 
post-work drinks as I had experienced at Cambridge; I simply showed up, took 
my place in the margins of the classroom or at the laboratory bench and tried to 
learn as much as I could. I talked with students and lecturers when possible, 
before and after class or in the occasional quick coffee break, but on the whole, 
the classroom group was quite serious and stuck to their social cliques (those in 
the Bioengineering faculty sat in one part of the classroom and those in Life 
                                                
63 http://vimeo.com/19759432.  
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Sciences sat in another). The students on this course were focused on getting good 
grades and, understandably, the academically rigorous atmosphere didn’t afford 
me an opportunity to get close to anyone. Still, laying contact and knowledge 
foundations during the course led to a smooth transition to working with the 
iGEM group, which began in February with a series of iGEM try out meetings. 
 
These try outs occurred after a pitch-style meeting organised by the advisors when 
they spoke to over 50 keen engineering and life science undergraduates about the 
wonders of synthetic biology and iGEM. This period is discussed in the next 
chapter, but it is important to mention how my role in the field began to take 
shape at that stage. During the try out meetings, I did not participate with the 
iGEM candidates (who were busy rehearsing their knowledge and presentation 
skills) and instead took mostly an observer view of the students, while also trying 
to participate in side conversations with advisors as they judged the group. A few 
advisors welcomed me with interest in the research – asking me questions, touring 
me around laboratories, meeting for coffee and generally helping to facilitate my 
early days at Imperial College. Most were rather neutral to my presence; however, 
there was one advisor who was initially forthright about his distaste for social 
studies of scientific communities, evidenced by his occasional laughter and snide 
comments.64    
 
As the lead-up to selecting the iGEM team and planning the summer continued, I 
was almost always invited to the meetings, including ones that were only for the 
advisors; and yet, I had a distinct feeling that my presence at Imperial College 
                                                
64 I later discovered that Pierre had a certain cynicism about many topics, including research in his 
own field.  
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received mixed reception. I was also not alone in receiving a mixed welcome. A 
designer from the Royal College of Art was interested in working with the 
Imperial College iGEM team and proposed to run a workshop similar to the 
sessions that Daisy and James did at Cambridge. There was one meeting between 
three advisors, the designer and I, as well as a number of informal conversations, 
that revealed to me scepticism – oddly combined with interest and excitement – of 
interdisciplinary interactions with the humanities and design communities.  
 
I proceeded to work at Imperial College without substantial difficulty; however, 
there was an occasional feeling of being the token sociologist65, which contrasted 
with the more integrated culture at Cambridge. Moving forward in the trajectory 
of developing interactions, things changed significantly once the team was chosen 
and a routine was established. I ‘hung out’ with the iGEM students far more than 
with the advisors. When students and advisors met (especially when it was with 
senior advisors), my presence received little notice – all eyes were on the 
iGEMers while they worked to justify their ideas or experimental progress under 
the pressures and standards of their superiors. In Chapters 3 and 4, the reader will 
find that the Imperial College team struggled to pin down a solid project plan, but 
worked tirelessly in researching ideas well into July as stressful interactions 
between students and advisors ensued. During this period, I did a lot of sitting 
back, observing and not interfering. I always had lunch with students and shared 
coffee breaks in which my relationships with them became more relaxed and 
friendly; at the same time, my relationships with advisors was more remote. 
                                                
65 Although my entry into Imperial College’s synthetic biology group was not officially organised 
through the alliance linking BIOS to CSynBI, because of what was then a recent joining of these 
institutions, I sometimes felt that my presence was merely viewed as the ‘token’ gesture of inviting 
social scientists into the laboratory as part of the institutional set-up.  
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One of the fascinating things that happened was that I became a confidante to a 
few members of the team while they were increasingly pushed and critiqued by 
advisors for having not made the progress that was expected of them (until finally, 
at the Jamboree, when the team did extremely well and were heavily praised). Part 
of the routine at Imperial College was for students to meet daily with at least one 
of the advisors (more often, the junior ones, Pierre, Max and Olivia) to give an 
update on progress and planned work, and to also meet weekly with a larger panel 
of the advisors (including at least some of the senior faculty, Roger, Bernard and 
John) for a presentation and feedback session. I was present for a number of these 
sessions and documented a few that were highly critical of the students’ work; 
however, I was not always present (as I’d been in Cambridge), and would tend to 
get filled in on events I’d missed by the iGEMers. It was in such catching up on 
missed information over coffee breaks that I realised I was becoming closer with 
the group as students confided in me about perceived harsh critiques and tensions 
that they were experiencing with advisors.  
 
I gradually grew a little closer to Pierre and Max as well – two junior advisors 
who spent a good deal of time with the team, responsible for keeping an eye on 
the students and reporting back to the senior figures. We talked about synthetic 
biology, the team’s progress and various institutional politics. Interestingly, 
although Pierre had at first showed distaste for my work, over time, I established 
enough credibility with him to be worth talking to while he watched over the 
team. By the time students entered into their wet laboratory work in August, I felt 
that despite a few struggles, I had solid and friendly working relationships to 
 90 
participate with the Imperial College team in a meaningful way. As with the other 
group, I tended to rotate among students who were either doing computer and 
research-based work or conducting laboratory experiments, asking routine 
questions: What are you up to? How does that work? Can you explain this to me? 
Naturally, a few students were more eager to talk than others and I tended to 
spend a little more time with them, some of whom would make excellent teachers.  
 
Probably the most significant point of participation – and of impact in terms of 
my evolving interactions with the team – was my role in helping with a human 
practices side project. Quite early on, I introduced the idea that if the team wished 
to do something for what has been labelled as the human practices stream in 
iGEM, I would be happy to help with such work. I offered this help, in part 
because I thought it would be valuable for the students, but also as a gesture of 
thanks for having received access to Imperial College synthetic biology research 
for a number of months. I knew too that a human practices component was a 
recent addition to iGEM judging criteria.66 I thought that helping students with an 
undertaking in this stream would be a win-win situation and although it did turn 
out that way eventually, difficulties were experienced along the way. These 
tensions play out in Chapters 4 through 6. At this point, it is only important to 
note that a good deal of change took place – in team members’ views, my own 
approaches and in collective interactions – through the challenges of collaboration 
beyond the technicalities of building a biological machine.  
 
                                                
66 On the competition’s website, it notes that Grand Prize winners are evaluated for, among many 
other important factors, a consideration of Human Practice issues such as safety, security, ethics, 
ownership, sharing and innovation; also, there is a special award given for ‘Best Human Practices 
Advance’ (http://2009.igem.org/Judging/Judging_Criteria). 
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2.3   Data at the desk 
I have shown that it was through numerous informal conversations and having a 
lasting and close presence that I was able to build good working relationships, 
confidence and trust necessary to gain a place in the field as not only an observer, 
but also as a participant. The openness and extent of this study equipped me with 
data for thick description of the ways in which the teams brainstormed ideas, 
settled disagreements, carried out laboratory activities, dealt with hierarchical 
politics and learned about the workings of synthetic biology as an emerging 
technology with interesting socio-political dynamics. The final methodological 
issue I’d like to discuss concerns how I came to generate and interpret data from 
my multi-sited ethnographic research. Having completed almost a year of 
fieldwork in December 2009, by the time I had re-organised, printed photos and 
transcribed hours of interviews, I had a dozen rather large binders of field-notes, 
printed photographs, interview transcripts and media resources. These stacks of 
data felt rewarding but even more so, daunting.  
 
I shall begin by outlining what I have done with the most straightforward data 
source: the interviews. At Cambridge and Imperial College, I conducted two sets 
of interviews with students, one during the middle of the projects and one after the 
Jamboree; I interviewed all the advisors at least once (except two at Imperial 
College, one who did not respond to repeated requests and the other who 
declined); I also conducted interviews with keynote synthetic biology figures from 
the US, as well as informally interviewed a handful of iGEM teams from around 
the world while at the Jamboree. Having to suit participants’ busy schedules and 
meeting in sometimes less-than-ideal contexts, the interviews took on a variety 
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forms: they were conducted in quiet rooms, busy cafés, offices, hotel lobbies and 
foyers at MIT; they were sometimes conducted with just an individual interviewee 
and other times in small groups; they ranged from 30 minutes to two hours. These 
semi-structured interviews were recorded and transcribed, with a couple of minor 
exceptions67. To analyse the transcripts and develop core concepts in this work’s 
substantive chapters, I use a number of established techniques: coding, writing 
memos, re-writing selected clips in categories and linking ideas through 
diagrammatic mapping. These techniques are written about extensively in 
qualitative research methods literature (Bulmer 1984; Strauss and Corbin 1998; 
Kvale 1996; Charmaz 2002; Flick 2002; Bryman 2004; Silverman 2005).  
 
More complex, and deserving further description than the interview transcripts, 
are my field-notes. These became an amalgamation of three materials: (i) lecture 
slides and notes taken from attending synthetic biology courses; (ii) notes, 
presentations, protocols, diagrams and check-lists that were written by students 
and often posted on their work-in-progress Wiki’s68; and (iii) the (more 
traditional) ethnographic field-notes where I wrote about daily observations and 
activities, described characters, settings and procedures, articulated how 
relationships were developing, as well as reported anecdotes. Materials of types (i) 
and (ii) were straightforward for me to access and use; however, writing and 
analysing ethnographic field-notes has (as expected) taken a great deal of time and 
energy.  
 
                                                
67 In one exception, an advisor at Imperial did not wish to be recorded in interview but I was 
permitted to take notes. Some interviews were selectively transcribed. 
68 http://2009.igem.org/Team:Cambridge; http://2009.igem.org/Team:Imperial_College_London; 
http://openwetware.org/wiki/IGEM:IMPERIAL/2009. 
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Sometimes there were independent research hours for students or repetition in 
laboratory practices. When this was the case, I would have some time during the 
workday to take jottings, if not more extensive field-notes, as well as participate 
and observe. There were, however, very full days too – packed with meetings, 
presentations and experiments while at the home laboratories, and then a non-stop 
pace at the Jamboree. There were several forms of field-notes from the empirical 
study – some entries are multiple pages of written prose, others are point-form 
notes, there are power-point presentations with additional notes and still others are 
audio-recordings (some loosely transcribed). Part of me wishes I was able to 
construct a more consistent set of data that could easily be read and understood by 
an outsider, but the results of this study inevitably reflect not only realities in the 
field, but also indicate my particular interests and choices to follow certain 
activities, agents, discussions, subject matters and dynamics more closely. 
According to many well-practiced ethnographers, though it is important for a 
researcher to strive for neutrality and elucidate a given subject matter in (as much 
as possible) its natural form, it is also essential that she demonstrate reflexivity 
and recognise that such research is always a somewhat personal affair 
(Hammersley and Atkinson 1995; Atkinson et al. 2001).  
 
With the data at my desk, this work continued to be personal, as the more time I 
spent organising and analysing, I made connections and gained greater 
appreciation for where the most relevant material was located. Similar to the 
analysis of interview transcripts, when examining field-notes I used the above-
mentioned popular techniques of qualitative research. I worked with my material 
as hard copies in ring-bound binders and did not use qualitative analysis software 
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packages; this meant that my piles of data were decorated in a personal style, with 
different colours of highlighting and various stickies representing themes or 
codes. I also coded in the margins with words or short phrases, such as ‘blue sky’, 
‘critique’ or ‘problem’; eventually, I categorised according to larger themes such 
as ‘dreaming up ideas’ or ‘making real’ (hence, data to be used in given chapters) 
and re-grouped excerpts from field-notes and interviews into new documents. 
Although I began coding and drawing out themes in the field-notes during my 
fieldwork, the coding, re-reading, writing and analysing continued throughout 
write-up stages – it has been a labour of building my thinking and analysis, layer 
upon layer, gradually coming to theorise more broadly about the detail. I have also 
benefited greatly from conversations with my supervisors that helped me 
strategically find ways into a rather large stack of data for a given section of 
writing; their expertise and comprehensive viewpoints alerted me to the need to 
step back when I felt ‘too close’ to the research material (as I often found myself 
thinking ‘there’s just so much to say!’).  
 
Finally, I turn to the visual data – the unexpected yet extremely valuable resource 
of over a thousand photos that show practices, thought processes and events 
during the two teams’ journeys. The matter of visualization in science has been 
addressed by many in STS – for example, Latour (1990), with his concept of 
‘immutable mobiles’69 and Suchman and Trigg (1993), in their examination of AI 
scientists working together on a whiteboard. I take a somewhat different approach, 
one that is a more pragmatic and particular one.  
                                                
69 That is, the argument that through the use of numbers, diagrams, charts and so forth, scientific 
practices create ‘inscriptions’ that bring together diverse elements in a two dimensional, stable and 
mobile ‘immutable’ artifact, that is ‘mobile’ in the sense that it can be moved from place to place, 
compared and amalgamated with other artifacts and made the object of scientific analysis in a 
‘centre of calculation’  (Latour 1990). 
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I worked with this data in hard copy and electronically. I’ve taken inspiration 
from literature that may be classified under the umbrella of ‘visual culture’ (for 
example, Hall 1997; Evans and Hall 1999; Rose 2001), but have found that in 
developing a methodology to think about and use these photos, the most effective 
activity for me has been to talk with colleagues, my supervisors and participants 
from the field. I employed two broad categories for my visuals: (i) photographic 
field-notes and (ii) photos of ‘mind maps’ (or close variations thereof). In the first 
type, images generally capture a scene (e.g. in the laboratory, during a workshop 
or at the competition); images of the second type show how students represented 
thoughts on paper or on white boards (notes, diagrams, mind maps, doodles, etc.), 
on computer programmes and in presentations. Some images fall under both 
categories, but nonetheless this division was a helpful starting point of 
organisation.  
 
With two major categories of photos, I began thinking about the sorts of questions 
I could ask of each kind. From the photographic field-notes, I stimulated my 
memory, supplemented and crosschecked with written field-notes and found 
answers to questions of this sort: Who is present in a given scene? When was the 
image taken? Where was the image taken? What were the details of a scene’s 
appearance? What artefacts are present – tools, biological entities, lab coats, 
machines, suitcases, etc.? What do people’s expressions convey? What is the 
nature of the activities that people were carrying out (precise, crude, silly, mind-
numbingly repetitive, nerve-wracking)? Does the image capture something iconic 
in synthetic biology (as a few images in Chapter 6 do)? If an image is particularly 
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symbolic, how is it so? On the other hand, in images that portray ways of thinking 
(Chapters 3 and 4), such as mind maps, I ask questions like: What does the 
image’s content capture (e.g. To Do list, protocol, goal, idea, collection of ideas)? 
Is the image largely diagrammatic or does it have a written explanation? How 
simple or complex is the mind map? How is the image’s content used (in 
teaching, presentation, thinking through a problem, organisation), and by whom 
(for an individual or for many)? Who authored a given mind map and what does it 
say about how he or she was thinking (e.g. does it reflect their leadership role or 
disciplinary viewpoint)? These questions give flavour to the richness I found in 
the visuals – data that is highly relevant to this thesis, bringing the reader closer to 
the story than can be offered by description alone.  
 
After days spent organising the electronic photo library, asking myself about what 
each picture revealed, writing notes and coding (attaching themes and stickies), I 
selected favourites that could potentially go into specific chapters. I began by 
considering 20 to 40 photos for each of Chapters 3 through 6. These favourites 
were sometimes supplemented with recorded discussions that I had with 
participants to clarify and discuss the contents and meanings in these photos. 
Finally, this personalised, step-wise method led me to limit the use of photos in a 
given chapter to only what is most helpful in illuminating important points.   
 
 
Conclusion 
This chapter has explained my entry into, and suitability to, this particular field 
study. I have also outlined the trajectory that the narrative follows and addressed 
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ethics of research (noting that, to the degree possible in this particular study, I 
have tried to anonymise most participants with pseudonyms; copies of the 
information sheet, consent form and further agreement for participants are also 
provided in Appendix I). I discussed the reflexivity demanded for this work and 
illustrated how I was integrated into this project, with my particular viewpoint, 
interests and experience of evolving relations with participants. Finally, I have 
outlined my methodological practices in generating and analysing data and 
discussed some challenges faced.  
 
For an ethnographic study to address judgement for its validity, reliability and 
relevance, a researcher’s best defence is to provide strong evidence of “data-
source triangulation” in comparing different data sources that relate to the same 
phenomenon (Hammersley and Atkinson 1995, 230). In the coming chapters, the 
reader finds empirically dense work that draws its illustrations from field-notes, 
interview clips and photographs – my triangulation technique is clear. Although I 
have found sorting through this information pool a “messy affair” (Strauss and 
Corbin 1990, 31), it has equipped me with material to richly answer this work’s 
core research questions.  
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3.   DREAMING UP IDEAS 
 
The Bachelardian (1984) notion of phenomenotechnique is at this chapter’s core – 
the idea that, especially in generating breakthroughs, the scientific spirit must first 
creatively ‘conjure up a world’ in the mind before there is a chance of ideas being 
made material or proven real. This concept also emphasises that applicability and 
technology are built into all stages of scientific thinking and practice – even from 
the very beginning. Highly imaginative and application-driven brainstorming was 
the first major challenge faced by students in this competition and is the subject of 
this chapter. I show how students are encouraged to ‘think outside the box’ and 
come up with a range of useful (at least hypothetically) synthetic biological 
systems. (It is, however, important to keep in mind too another mode of science 
on-the-ground, one where much of everyday thinking and practice consists in a 
routine following of protocols and checking for results that are often elusive. This 
‘everyday’ mode of scientific practice, I believe, can sometimes look as though it 
has forgotten the plot of phenomenotechnique. Interesting as this aside may be, it 
remains tangential to the driving point of this chapter.)  
 
How do pioneers in synthetic biology come up with their ideas for the kinds of 
living machines they want to construct? This has been a curiosity of mine since I 
began learning about some of the popular work in the field. Well respected 
laboratories housing keen iGEMers have engineered bacteria to smell like 
wintergreen and bananas; they have made plates of bacteria act like photographic 
films; they have made cells ‘blink’; they have also worked on cell-free systems to 
detect pathogens living on catheters, which often causes urinary tract infections; 
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they have engineered bacteria to produce haemoglobin that could theoretically 
replace red blood cells in transfusions; they have attempted to pump out biofuel 
from redesigned microorganisms; and they have worked on the development of 
biosensors that detect arsenic in drinking water. I wondered before starting this 
project, who had been dreaming up such ideas – sometimes wacky and playful, 
sometimes with a ‘save the world’ aspiration – and how were they inspired?  
 
This chapter demonstrates how iGEMers were taught and encouraged to think 
along synthetic biology lines – for most of them, a new and different intellectual 
exercise. I then illustrate the kinds of projects that were dreamed up by each team 
until they decided upon their sticking idea and show how this was an activity not 
just of abstract thinking, but one that involved the use of ‘intellectual 
technologies’ (Miller and Rose 1990). That is to say, each team used certain tools 
for thinking – mind mapping, drawing pictures, making lists, setting up online 
discussion forums, presenting in certain patterns, etc. – that helped make, shape 
and develop ideas.  
 
3.1   Dreaming up ideas at Cambridge 
A crash course in synthetic biology  
Scientists discover the world that exists; engineers create the world 
that never was.  
– Theodore von Karman, engineer and physicist 
This quote appears on the first slide in the introductory lecture of a two-week 
intensive synthetic biology crash course at Cambridge70 and it immediately 
relayed an exciting message: by learning to engineer biology, students can help 
                                                
70 This course taught 12 undergraduates (plus four designers and me) synthetic biology basics; five 
out of 12 attended to receive course credit and they left after two-weeks, while seven students 
carried on after the course to pursue the full iGEM project. I only follow the iGEMers in detail.  
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create a new world. The reader will soon appreciate that the dreaming up of new 
ideas in synthetic biology is actually quite a challenge; however, many (not all) 
instructors believe that students of synthetic biology must firstly be inspired by the 
creative potential of the field, before they execute the difficult and patience-trying 
work of actually constructing (or, attempting to construct) a functioning 
microbiological system. Stirring creativity and intrigue about seemingly vast 
possibilities in ‘building with biology’ is at the heart of the Cambridge group’s 
approach to teaching this subject. When Geoffrey was faced with introducing a 
class of science and engineering undergraduates to synthetic biology, all cramped 
into a poorly lit classroom on a sunny summer’s day, his lecture was full of 
motivating highlights. A few details from this crash course (before focusing on 
the dreaming up of ideas by the iGEMers) will allow the reader insight into what 
these students’ first taste of synthetic biology was like and also give background 
to some of the technical material that arises throughout this thesis.  
 
The second slide in Geoffrey’s lecture posed the iGEM questions: “Can simple 
biological systems be built from standard interchangeable parts and operated in 
living cells? Or, is biology so complex that each case is unique?” A working 
definition was then shown: synthetic biology is “the design and construction of 
new biological parts, devices and systems; [and] the re-design of existing, natural 
biological systems for useful purposes”.71 Another slide was divided into two 
pictures with the heading “Construction through Standard Interchangeable Parts”: 
one picture had individual Lego™ pieces categorised under structural, motor, 
sensor, controller and internal logic groupings; the other picture showed a couple 
                                                
71 http://syntheticbiology.org/. 
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of assembled Lego™ robots, apparently in action. The following slide read, 
“Microorganisms as Genetic Machines”, and it labelled parts of a bacterial cell as 
having environmental sensors, protein and chemical synthesis machinery, internal 
logic, communication mechanisms and motility. The desirable – though mostly 
fallacious – analogy that biology can be thought of as discrete parts that snap 
together like Lego™ to build a functional system was made clear in the first 
minute of the lecture. 
 
This lesson continued to demonstrate ideologies and principles in synthetic 
biology. Another oft-cited timeline was illustrated, comparing the development of 
the electronics industry to the development of DNA technologies. The suggestion 
was that with accumulating discoveries and inventions over the last few decades72 
– plus the improving capacities in DNA sequencing and synthesis, and computer 
modelling of biological systems for ‘in silico’ design – synthetic biology looks to 
be primed for a path of exciting industry-scale development. Problems aside, I 
include this detail to show that these comparative histories are used to persuade 
students (and others) of a (possibly) prosperous future for those who get on the 
synthetic biology bandwagon. However, the Cambridge advisors in particular, 
among the accounts I have heard, are generally far more careful in making such 
comparisons and trying not to perpetuate future visions of the field in too 
hyperbolic a way. Indeed, Geoffrey qualified that doing a comparative history can 
only indicate a hopeful line of development for synthetic biology: “Are the 
supporting technologies sufficiently mature that we can move biological 
                                                
72 Citing Watson, Crick and Franklin’s discovery of the structure of the DNA helix in 1953; Cohen 
and Boyer’s invention of recombinant DNA technology (cutting and pasting sequences of DNA) in 
1972; Sanger’s sequencing of the first genome (phage 174) in 1975; Mullis’ invention of the 
revolutionary PCR machine (used to amplify sequences of DNA) in 1983. 
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engineering from a simple bespoke process to a true engineering discipline? Well, 
the jury is still out.”  
 
Geoffrey continued elaborating a transition between what he called “First 
Generation Biotech”, based on technologies such as PCR and recombinant DNA, 
and “Second Generation Biotech”, of which synthetic biology is a part. In the first 
generation paradigm, he claimed, ‘the majority of biological research focused on 
the study and analysis of naturally evolved systems’ and there has also been ‘ad-
hoc construction of genetically engineered solutions’, such as insulin production 
in bacteria and creating pesticide-resistance in crops. In the second generation, 
however, not only do practitioners in this line of work use first generation 
technologies, they also use far more DNA sequencing and synthesis, 
computational modelling and design.73 Furthermore, it is the application of 
“engineering principles” that Geoffrey believes is key to rational design and 
construction of synthetic biology systems that can be made repeatedly, reliably 
and ultimately on a large-scale: 
• Modularity: Genetic sequences for use in synthetic biology are 
broken down into separate, well-characterised modules such that they 
are easily inter-changeable. 
• Standardisation: The application of uniform standards in synthetic 
biology will mean that the community of researchers can work with 
off-the-shelf standardised components, enabling predictable 
performance of parts, devices and systems under construction. 
                                                
73 Through informal conversations with synthetic biologists, I’ve observed that the meaning of 
design in synthetic biology remains contested, meaning different things to different people.  
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• Abstraction: The ability to insulate only relevant characteristics at a 
given abstraction level from the overwhelming detail of other levels 
(lower in the hierarchy) in a biological system will enable synthetic 
biologists to black box components and afford ease of use and 
construction. The abstraction hierarchy in synthetic biology is as 
follows: 
 Applications (e.g. biosensor, biofuel, biomaterial) 
 Systems (e.g. input – sensor – processor – output)  
 Devices (e.g. input, logic gate, output) 
 Parts (e.g. BioBricks of a particular type such as a promoter, a 
ribosome binding site (RBS), a coding region, a terminator) 
 DNA (the underlying genetic code – ATGCTTACCG…) 
• Decoupling: Rules that insulate the design process from the details of 
fabrication will enable teams of parts designers, device designers and 
system designers to work together without having to know the details 
of each other’s work.  
 
Geoffrey continued, ‘in order to develop an industry, an engineering discipline 
based on parts must develop catalogues and suppliers of those parts’. Again, there 
is a desirable analogy: for iGEM-involved and other academic synthetic 
biologists, they would like The Registry of Standard Biological Parts to model 
itself upon The TTL (transistor-transistor logic) Data Book. The TTL Data Book, 
I’m told, is the manual for design and construction of TTL digital circuits – for 
professionals and hobbyists alike. On The Registry website, one not only finds a 
catalogue of thousands of parts, there are also protocols such as Standard 
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Assembly of BioBricks, with its seemingly easy (though deceptively so) 
instructions for ‘sticking parts together’ via commonly used microbiology 
laboratory practices.74 Supporting the large annual intake of iGEM teams by 
sending off BioBrick kits freely and receiving new BioBricks constructed, The 
Registry is continually growing in size and trying its best to maintain uniform 
standards (though this remains next to impossible in practice).75  
 
The purpose here is to sketch the introduction to synthetic biology the iGEMers 
were given before they were challenged to think up their own ideas, so, I will not 
go through the 20-odd lectures; however, it is still worthwhile to provide a list of 
the other major topics covered (before discussing the laboratory practical 
sessions):  
• Working with Genetically Modified Organisms (GMOs): risks and 
ethics76;  
• Visualising gene expression and cellular architecture; 
• Use of fluorescence microscopy and 3-D imaging techniques;  
• Metabolic functions in various strains of bacteria;  
• Bacteria understood as machines that act as biosensors, biocatalytic 
systems, bioremediators, inhibitors and producers of materials and 
chemicals;  
                                                
74 http://partsregistry.org/Assembly:Standard_assembly. 
75 In 2004, iGEM teams submitted about 50 BioBricks to The Registry; in 2005, this number 
increased to about 125 parts; in 2006, it was about 724; in 2007, it was about 800; in 2008, it was 
1387 parts; in 2009, it was 1348 parts (http://2010.igem.org/Previous_iGEM_Competitions). As 
one might imagine, it is very challenging for an open source registry used by undergraduates 
worldwide to keep track of the contents, ensuring that BioBricks adhere to standards and actually 
function as documented.  
76 The emphasis on safety, a key concern around synthetic biology in general, was evident. Topics 
covered included: dual-use dilemma; insufficient detection, analysis and response of potential 
biohazards; limited control of information databases and DNA synthesis companies; regulations at 
institutional, national and international levels; professional training in biosafety; and different 
classes of biological research / facilities (biosafety levels 1 to 4). 
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• How cell-level and population-level communication systems work;  
• DNA sequencing and synthesis technology;  
• How essential microbiology equipment works (e.g. PCR machine, 
plate reader, ‘the robot’);  
• Mathematical modelling of biological systems; 
• Computational modelling of biological systems and an introduction to 
programming languages for use in synthetic biology77; 
• Experimental design, organisational practices and using internet sites 
to document and share work (e.g. Wiki’s and OpenWetWare);  
• Synthetic biology applications and the makings of industrial-scale 
technologies (laden with analogies78). 
Finally, the laboratory sessions that took up at least a few hours each afternoon 
were very important to the teaching style at Cambridge – it was in these practicals 
that students worked together and, for some, had their first hands-on experience of 
microbiology experiments. Many practicals were designed to showcase the toy-
like systems that have been constructed, a few of them taken directly from old 
iGEM projects. The MIT iGEM project from 2006, ‘Eau d’coli’, was 
demonstrated by one of the instructors and everyone in class did ‘the smell test’, 
deciding whether a number of blind samples smelt like bananas, wintergreen or 
simply the normal foul bacteria smell; it turned out that our noses matched the 
                                                
77 Given by an expert from Microsoft who collaborates with Samuel and Andy, this interactive 
lecture taught the basics of a programming language that can be used to do ‘in silico’ modelling of 
biological reaction kinetics, ‘predator-prey’ systems, the catalysis of DNA and the workings of 
logic gates that operate inside cells. Working ‘in silico’ is meant to improve design of ‘wet 
laboratory’ experiments.  
78 The lecture given by Geoffrey and Samuel entitled, “The Industrial Revolution: based on 
innovations in coal, iron, steam and mechanical engineering,” was full of comparisons about other 
industry successes that have been based on standard, interchangeable parts that allowed continuous 
production methods. Standards on nuts and bolts, as well as standards on mechanical and electrical 
interfaces were discussed. The emphasis on the importance of engineering standards cannot be 
underestimated.    
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correct genetic logic 60 to 90 per cent of the time. The class also carried out 
experiments that used colourful purple bacteria, photographic biofilms and 
imaging technology from Samuel’s laboratory to visualise fluorescing microbes.  
 
In addition to the microbiology experiments, there were a few unconventional 
sessions, designed to get students to work together and think about design, 
modularity, time-management, presentation and pitching. For example, the first 
day’s practical was a team building exercise in which the class was divided into 
groups of three or four and challenged to construct a weight-bearing tower as high 
and as strong as possible in 30 minutes from plastic straws, tape, rubber bands and 
two plastic cups.79 The class also had an afternoon to play with Arduino kits.80 
Basic Arduino kits can receive input from a variety of sensors as well as interact 
with computer software; depending on how one plays with Arduino, one can 
make a light show, construct circuits, play sound, operate robots and even hook it 
up to living cells. Finally, on the last day of the course, everything was wrapped 
up in a future-oriented Dragons’ Den81 competition where small teams had to 
think of a synthetic biology application and business plan to pitch to a board of 
external heavy-weight figures from across University of Cambridge as well as 
someone from a biotech start-up company. Students came up with a variety of 
imaginative ideas and found the exercise challenging and fun. The importance of 
building these alternative sessions into the programme, complementing an already 
                                                
79 This exercise was meant to get groups to first thoughtfully design what they would build, then to 
delegate tasks appropriately. Some teams built tall and architecturally sound towers, able to hold 
an impressive weight. My team didn’t really grasp the idea of planning a good design ahead of 
time; our design ‘evolved’ after too much time wasting and unsurprisingly, during the weight-
bearing tests, our tower crumbled. We decided that what we had built resembled a dead fish. 
80 “Arduino is an open-source electronics prototyping platform based on flexible, easy-to-use 
hardware and software. It's intended for artists, designers, hobbyists, and anyone interested in 
creating interactive objects or environments” (http://www.arduino.cc/). 
81 Modelled on the popular BBC television show (http://www.bbc.co.uk/dragonsden/about/). 
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‘cool’ set of microbiology experiments (compared to what one does in 
conventional biology courses), cannot be underestimated. Speaking to advisors 
about how they designed the course, Andy remarked: 
With the practicals, we tried not just to show off the systems but also 
leave a little bit of flexibility for the enquiring minds, a bit of 
inspiration and a bit of creativity, and I hope you noticed that a lot of 
the practicals weren’t just ‘do this set of instructions’… It was more 
about, ‘here’s a pallet, here’s a tool, here’s some fun, go do it, go 
think for yourself and come up with something you could do!’ 
Similarly, Samuel commented: 
In most university biology courses, we teach by exposition, except 
now it’s PowerPoint slides and practicals following recipes. Then of 
course iGEM is the antidote to that because it’s the opposite – it is 
exploration…  
It is team-based, so we don’t try to isolate anyone but rather show that 
the students can draw on other people’s expertise… And you’ve got 
things like the Arduino stuff that we did… which was demonstrating 
the idea of putting something together from modular components…  
 
Returning to the quote that opened this section – “Scientists discover the world 
that exists; Engineers create the world that never was” – it was clear to me that 
the crash course not only equipped iGEMers with the basic synthetic biology 
knowledge they would need for the tasks at hand, more importantly, it provoked 
excitement and creativity. Tobey, a first-year engineer, told me later about how 
the crash course inspired him: 
I only heard about iGEM and synthetic biology just a month before 
starting all this. What appealed to me was that it is a whole new field 
of engineering and I think that is the most interesting thing about 
engineering – the big breakthrough’s, the start-up companies… I don’t 
want to go into anything too established – the appeal is about new 
frontiers… 
I’ve been in some group projects before but this is really original. 
Within the small team, you have the biologists that are really different 
in the way they think than to the engineers. And, without one or the 
other, we wouldn’t have got anywhere near as far – and that includes 
physicists. And having you guys [the designers and me] from all 
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different places and with all different interests – it was really exciting 
– especially in that two-week intro course because it was like we 
really were right on the forefront of this new field and we were all 
investigating it for different reasons…  
Filled with a palpable sense of wonder after the crash course, the seven iGEMers 
returned to the laboratory the following Monday morning and faced one of the 
most challenging stages of their summer – they faced a blank page and had to 
come up with a great idea.  
 
From blank slate to an idea that sticks 
On the team’s official first day, the iGEMers, their advisors and I all gathered for 
a quick morning briefing. The students were reminded of resources at hand – 
computers (to survey literature and previous iGEM projects), the library, a binder 
‘bible’ of key synthetic biology publications, the staff’s expertise and, perhaps 
most importantly, markers, stacks of large sheets of paper and a white board – and 
then the group was set to the task of coming up with some feasible, yet exciting, 
project pitches to present to the faculty in a few days time. After the briefing, 
aside from periodic visits from advisors to monitor progress and answer questions, 
the students were left largely to their own devices. The group promptly set to 
work and agreed that the best strategy would be for everyone to break off 
individually and research areas of interest, each with the goal of bringing at least 
one idea to discuss at tea break. Stationed along the laboratory benches – but with 
nothing ‘wet’82 in sight – the students began their “thought shower” (as Eleonore 
called it).  
 
                                                
82 See Key terms, ‘wet lab’ and ‘dry lab’, p. 11. 
 109 
The first mind map (Figure 3.1) to discuss was drawn throughout that day – 
before and after the all-important tea time discussion– and was done by Tobey, an 
extremely curious engineering student who later commented: 
 My favourite part of the whole thing was the brainstorming. Even 
though everything gets rejected right at the beginning, it is the most 
exciting part because you are thinking of all the things that could 
really be done… It is most creative at the beginning and, after that, 
there is still creative work, but it is sort of more routine – pipetting 
and stuff…  
In Tobey’s particular thought experiment, his diagram shows the large range of 
possible areas for consideration in generating a project idea – this was the group’s 
major overview mind map. Notice that the diagram originated from the team’s not 
yet existent project idea sitting in a cloud in the middle of the mind map, reading 
“iGEM 09 CAMBRIDGE”, sandwiched between “Real Applications” and 
“Existing Biobricks”. 
 
Figure 3.1: Day 1 mind map 
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What stems from the “real applications” arm on the diagram’s left, a number of 
branches illustrate biases towards what was learned in the crash course as well as 
Tobey’s engineering background. Given (key advisor) Samuel’s expertise in plant 
biotechnology, some students pushed their brainstorming in that direction too. 
Looking at the diagram, one can see an indication of this: the “agricultural” arm 
branches out to two linked thoughts, “plant growth control” and “controlled soil”; 
one of two major “type of problem” ideas is “environmental”; the branch off “art” 
is “plants”; “food”, “sensing” and “cellulose producing bacteria” branches may all 
point to an agro-biotechnology bias too. By contrast, the branch for “medicine” 
only includes three ideas, none of which are elaborated – kidney dialysis, tamiflu 
and gene therapy – presumably a less developed area as the advisors had 
emphasised that medical applications are likely too far reaching for an iGEM 
project.83 Other branches appear to have been influenced by the crash course, 
including those in the “uses of bacteria” grouping in which Tobey wrote “sense”, 
“breakdown”, “secrete”, “memory” and “movement”, each in its own strand that 
is also further branched out (recalling an emphasis on microbial metabolism). 
Other thoughts appear to have been inspired by practical sessions, including the 
“repressilator” and “predator / prey” systems off the “modelling” branch; the 
“black and white bacterial biofilm” off the “uses of bacteria” grouping; and the 
“taking + displaying pictures” arm. Reflecting Tobey’s engineering perspective, 
the groupings in “modelling / computer logic”, for instance, are far more 
                                                
83 Occasionally, this was said of synthetic biology in general. Multiple discussions with Cambridge 
advisors revealed their feeling that the field was at a very early stage and better directed towards 
applications in synthetic chemical production, environmental areas (biosensors, biodegradation, 
agriculture, etc.), art and design as opposed to medical applications. They claimed that the field 
was still too immature to reliably make products for direct human consumption. One exception, 
however, is the overwhelming support for the Keasling laboratory’s anti-malarial application.  
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developed than arms such as “art” or “medicine”; Tobey was also considering 
ideas such as “EPROM”84, “Turing machine” and “computer interface”. Notably, 
Tobey had been influenced by the Dragon’s Den session on biotech business as he 
considered “branding it well” to be an important part of crafting a good project.  
 
Moving to the right half of this map, one can see some of the “existing BioBricks” 
that were considered as potentially useful in building a new biological machine, as 
well as some of the existing systems that have been built in previous iGEM years. 
Drawing attention to specific branches, Tobey considered that the available DNA 
library of parts offered up different types of “chassis” (yeast and E. coli); “odour 
production” (e.g. banana and wintergreen smell generators); “cellulose producing 
bacteria”; biological “battery” functions; movement functions (referring to the 
branches “magnetotaxis”, “galvanotaxis” and “geotaxis”); “biosensors”; and the 
“taking + displaying pictures” system. I learned from the advisors that as the 
competition continues, ideas increasingly get recycled – projects on battery 
systems, electronics or biosensors consistently feature at the Jamboree. 
Unsurprisingly, the electronics-leaning ideas tend to appeal to physics and 
engineering iGEMers – far more familiar territory than diving into the daunting 
complexities of the real biological world. Without detailing this mind map further, 
what I find most important is that it illustrates – in a rather nice constellation – the 
wide range of possible ingredients that might go into a good project idea. 
Furthermore, it reflects the great influence that pioneering teachers of synthetic 
biology have in shaping future ideas in this field and reveals some bias towards an 
engineering perspective that is faced with the task of building with biology. 
                                                
84 EPROM is a type of memory chip (http://en.wikipedia.org/wiki/EPROM). 
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Finally, it should be noted that in the first few days, this particular map became a 
reference point for the whole team to evaluate specific ideas against – this was a 
tool for individual and group thinking.  
 
After an hour or two of brainstorming, the students and I went downstairs to the 
departmental tearoom and talked through the group’s initial thoughts. On this, and 
countless other occasions, the ritual tea time was invaluable for the team’s 
developing of ideas and troubleshooting challenges; I also learned a great deal 
about group dynamics, watching how different points of view would clash or 
come together. In this particular session, a number of interesting points were 
raised: 
• Some students agreed that the idea should originate from a real-world 
application; 
• Some students thought the idea should be simple, yet clever, with 
emphasis on good design and building a solid, well-characterised 
system; 
• Another student emphasised that the project shouldn’t be about 
solving a ‘grand’ problem; after all, in a short summer project, ‘are we 
going to fix anything really?’  
• A biologist asked an engineer whether he could model something 
‘cool’. He replied, ‘engineers model – if you tell us anything about 
why and how something works, we’ll be able to model it’;  
• Some thoughts-in-progress were shared:   
o ‘What if we could make self-camouflaging bacteria? You could 
maybe have a red-light sensor that in turn makes the bacteria emit 
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or secrete red.’ Another student interjected: ‘that would mean 
you’d need a bacteria that could sense different frequencies of 
light; and where would you find a gene for that?’ 
o ‘Is there something to do with light sensing, photographic bacteria 
or bacterial tie-dye worth pursuing?’ 
o ‘Apparently there is a strain of helobacteria that are attracted to 
green and repulsed by blue light sources for some reason…’ 
o ‘Maybe we could get bacteria to secrete cellulose for scaffolding or 
creating cartilage?’ 
o ‘Could we use directed evolution to find an antibiotic that bacteria 
won’t be resistant to somehow?’ 
• A biologist reminded everyone of complexities that make many of 
these ideas unfeasible: 
o ‘Bacteria are unstable.’ 
o ‘We need to think about what bacteria do well: sense, breakdown 
compounds, secrete, change colour.’ 
o ‘No project idea is possible if we cannot find the ‘gene for’ the 
function that you want to engineer into the system – this is about 
genetic engineering!’ 
o ‘Using mammalian cells or genes is too complicated and 
unrealistic.’  
o ‘Biochemical pathways have a horrible tendency to turn to 
equilibrium as opposed to pumping out something in excess.’  
Only a couple hours into the project, tensions were apparent between those 
dreaming up big ideas and those with a more grounded sense of the difficulties in 
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working with biological material; the sobering voice usually came from a 
biologist. After tea and discussion, students moved back to their individual 
research stations and carried on brainstorming.  
 
Turning to other diagrams that illustrate specific ideas, Figure 3.2 is about making 
a biological “counterfeit bill detector”. The idea originated from a biology 
students’ knowledge that counterfeit US Dollar bills are made of starch, while 
genuine bills are made of cellulose. It was thought that if one could engineer a 
system that had two types of bacteria in it – one that was programmed to 
constantly produce amylase (the enzyme that breaks down starch into glucose) 
and another that was programmed as a glucose-sensitive sensor that would turn on 
green fluorescent protein (GFP) production – then one could make a biological 
machine that would fluoresce green upon its interaction with a counterfeit bill. 
Without going into much technical detail, what one of the students did after 
thinking about this basic plan was to search scientific literature in order to find a 
gene that triggers the production of amylase. The student found that the desired 
enzyme (amylase) does not naturally exist in the intended chassis (E. coli); 
however, the student also found online the sequence for the amylase-producing 
gene that exists in B. fragilis (a gut bacteria). The student wondered whether it 
might be possible to get the gene from B. fragilis and put it into an E. coli system 
to achieve the desired constant production of amylase.85 However, soon thereafter 
                                                
85 Generally, iGEM teams acquire genes from the following sources: (i) the Registry, (ii) their own 
institution or other academic laboratories willing to share DNA, (iii) DNA synthesis companies, 
through which genetic sequences can be ordered, tailored and delivered via post (e.g. DNA2.0: 
https://www.dna20.com/; and Blue Heron: http://www.blueheronbio.com/). This is a vast library of 
possible material as scientists have been decoding genomes for over 30 years; thousands of DNA 
sequences are online (e.g. in GenBank: http://www.ncbi.nlm.nih.gov/Genbank/), ready to ‘copy 
and paste’ into a synthesis company’s order form. 
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the student constructed a “drawbacks” list and this seemingly simple plan no 
longer looked so straightforward (note bottom right, Figure 3.2).  
 
Figure 3.2: Counterfeit bill detector system 
  
  
 
Figure 3.3 illustrates an idea for a light-sensitive sensor that would produce a 
pigment output to be used in a photographic system. Again, without the 
technicalities, the picture shows a hypothetical reaction relay, where the logic 
could go something like this: if you have a plate of bacteria with this envisioned 
light sensor - inverter - pigment system programmed into its genetic circuitry, 
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then when light shines onto the lawn of bacteria in a particular pattern, the light 
that is sensed will trigger an inverter logic gate and then the production of 
pigment in whatever pattern would be projected in the light. I should emphasise 
that the details are not what matter for the purpose of showing what dreaming up 
ideas for iGEM means. Again, I’d like to draw attention to the lists of “problems” 
and “challenges”. When the students would later present the initial ideas to 
advisors, this potential project was rejected on the basis of being too complex and 
also too similar to work that was being pursued in another well-respected 
laboratory; however, the idea of pigment production was plucked out of this 
system and highlighted as both interesting and feasible to consider further.   
 
Figure 3.3: Light to pigment system 
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Let me clarify a few points of analysis, before further illustrations and the team 
getting to their ‘light bulb’ moment. The drawing and writing out of thoughts on 
paper was, in my view, the most interesting tool for thinking used by the 
Cambridge team.86 These diagrams illustrate a point of origin in ideas – they have 
materiality to them, a certain ontological status. Mind map ideas have had no 
inherent reality ‘out there in the world’; yet, they start a process as they are drawn, 
connected, explained to peers and developed with the incorporation of feedback 
and new lines of research. Students used this exercise to bring together what they 
had learned in the course, while also breaking out to uncharted territory in playful 
and creative ways; they mapped in order to understand and organise their thoughts 
when the array of possible fields for brainstorming seemed endless. Mind 
mapping made certain things thinkable while allowing realisations that most ideas 
must terminate – too many “drawbacks”, “problems”, “challenges” (usually owing 
to biological complexity and time constraints). These figures also show how 
disciplinary leanings shaped certain individuals’ thinking. Engineers often 
illustrated in streamlined, simple ways, using graphs and circuit diagrams where 
possible; biologists tended towards writing out ideas and using illustrations of bio-
chemical pathways.   
 
It has been a great challenge to select only enough photographs to illustrate what 
it means to creatively construct project ideas for this iGEM group as they had, 
over the course of only two intensive brainstorming days, generated over twenty 
ideas that had been researched and drawn out in some depth. Appendix IV has 
additional photos but, as a teaser, here are some titles of other ideas generated at 
                                                
86 Though I choose this focus, it was not this group’s only tool for thinking. The team also worked 
on their Wiki, presented to each other, researched online, read and summarised papers and 
bounced ideas casually off each other and advisors. 
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this early stage: “obedient bacteria”; “incorporating a parasite into a predator-prey 
model”; “wave pulse bacteria”; a “bioclock”; a “glucose-to-cellulose slimming 
treatment”; “self-destructive plasmids”; a “heavy metal sequestration system”; a 
“land-mine detector”; a “project based on game theory”; a “3-D biological 
printer”. One can perhaps appreciate from such a list of dreamt up biological 
machines just how creative this early phase was, as students worked with a huge 
range of real-world or fun inspiration, combined with their knowledge base and 
research. 
 
On the third day, after intensive brainstorming and only two short meetings with 
the supervisors – who, at that point, provided encouragement, suggestions of 
references and subtle steering towards more realistic projects – the team produced 
a list of contending projects. It was then time for the advisors to step in, act as 
gatekeepers and tell the team which ideas were feasible or not. Commenting on 
the advisory role at this stage, Frederick said: 
It is important to give the students some space at first. Then, in actual 
fact, it’s important for the faculty – once the students have had a 
brainstorm – to provide a bit of pruning and reality checking. 
 
Although each short-listed idea was pitched to the advisors, the resounding 
message of the meeting – taken on board by all students, except one, who wanted 
to go for a rather lofty and ambitious project – was that choosing an idea came 
down to feasibility. The advisors were the ones with expertise and experience in 
making such a judgement. Senni told me: 
In the first week of brainstorming, we realised that what we lacked 
was not the ideas… but, the thing is, how exactly feasible are those 
ideas? At that time, most of us did not have lab experience and we did 
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not realise how difficult it is to come up with a working system. So, 
after that, two advisors mentioned that one of the common themes in 
the systems we were brainstorming was colour. So, we zoomed in on 
colours. It was do-able so we did a colours project. 
Tobey also commented on feasibility:   
At the beginning, without the knowledge of the biologists we would 
have gotten nowhere because you need someone to say what won’t 
work… The engineers and physicists could think up ideas but it was 
really down to the biologists to say whether it was feasible or not.  
The decision to pursue a project based around pigment generation made sense for 
a number of reasons: the faculty thought the concept was biologically feasible (in 
theory) and there were already bacteria with pigment genes in Douglas’ laboratory 
that students could use. There was something playful about making colourful 
bacteria, which would appeal to an iGEM audience and there are a number of 
useful applications that pigment production could potentially link to (an output for 
biosensors being one). The Cambridge team had arrived at their ‘sticking point’.  
 
Figure 3.4 shows the white board only three and four days into the team’s work. 
By this point, the group had a list of possible colours to research further and they 
started to think about what kind of larger system a pigment generator might be 
built into. For some, it was a great relief to be started on a more specific path 
(though, as Chapter 4 shows, there was still plenty of evolution in the project): 
At the beginning, I wasn’t good at thinking up the ideas for the 
project. I was good when I had something to do and then I went ahead 
and did it. – Eleonore 
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Figure 3.4: Colour pigments stick 
  
 
Before discussing the Imperial College team’s dreaming up ideas, a few more 
illustrations from the Cambridge team foreshadow things to come, as ideas 
continued to evolve and the group set up experimental processes. By the end of 
week one, the group was coordinating regular To Do lists, delegating tasks among 
team members. The students decided to start working on making at least two 
pigments – violet and brown – and they looked into acquiring strains of 
pseudomonas bacteria that might allow them to build a red-to-green colour 
system. Students continued to think creatively and in illustrations. For instance, 
they hypothesized about how the mixing of different primary and autochrome 
spectrums might help them construct different combinations of three colour 
producing systems to generate a variety of pigments (Figure 3.5 top right).87 The 
bottom left of Figure 3.5 shows how students defined three components in their 
imagined system – input, enzyme and colour – and developed a list of questions to 
tackle about each of these parts. The final picture in the figure below illustrates an 
                                                
87 It was suggested that perhaps the group could try expressing colour combinations in the same 
cell or they could try mixing three different cell types on the same Petri dish. 
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enzyme pathway for violet production, used by one of the team’s biologists to 
start designing experiments. List-making and drawing diagrams to develop 
conceptual ideas as well as laboratory protocols remained a key feature in the 
thought processes of this team as their project progressed; several other practices, 
processes and ‘tools for thinking’ evolved later.  
 
Figure 3.5: Beginning to evolve ideas on colours 
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3.2   Dreaming up ideas at Imperial College 
Introducing synthetic biology in iGEM try outs 
2009 was the second year a full undergraduate course in synthetic biology was 
offered at Imperial College; unlike at Cambridge, however, taking the course was 
not a requirement for all iGEM participants (only half of the final team had been 
in this class). Having already discussed key concepts in synthetic biology in the 
section on Cambridge’s crash course, I address another kind of teaching and 
learning that occurred during the Imperial College iGEM try outs.  
 
Recruiting for the team began in February (well before the official start in July), 
with advisors endorsing the excitement of iGEM and synthetic biology to a group 
of over 50 top science and engineering undergraduates. After that initial pitch, 
students returned for a series of four try out meetings in gradually smaller 
numbers (a self-selectioning occurred, with many deciding for themselves that 
they were not right for the team). These meetings took on a similar pattern: 
students worked in small groups, brainstorming for about an hour (as advisors 
circulated the room, listening in, asking questions and giving advice), before they 
presented and faced critique from superiors and peers. Dozens of interesting, some 
far-fetched, ideas surfaced. Along with the imagining of blue sky synthetic 
biology possibilities, ideas came under scrutiny and were moulded by the 
advisors’ comments. Eager candidates flexed their creativity, group work and 
presentation skills in ways that most of them never had; these meetings, therefore, 
also provided advisors a basis from which to select the final team of eight (from 
about 15 who remained by the time selection occurred). 
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Before describing some dreamed up ideas that arose during try outs and showing 
how the possibilities of thoughts were shaped, I shall first note the kinds of 
intellectual technologies that were most pronounced in this group. Though 
students occasionally drew out mind maps, they did not do so on nearly the same 
scale as the Cambridge team. Discussion in small groups, presenting and using 
online forums were far more important tools for thinking among Imperial College 
students. The first forum (using Google Documents) was set up after the second 
meeting (mid-February). Online, candidates shared research, organised and 
coordinated meetings, posted recommended readings and websites, taught each 
other, made comments on and expanded ideas. The extensive online presence 
(with forums often populated by keen students working in the middle of the night, 
on top of their normal study routines) meant that the group could get right down 
to business at try out meetings.  
 
Turning to an idea that began at that second meeting – and one that gets partly 
translated into the final team’s project – the iGEM candidates imagined a system 
of “Bacteria for Long Term Drug Release”. Online, students contributed to a 
proposal that envisioned a symbiotic relationship between human beings and drug 
releasing bacteria and that would cure ailments. Realising that consumers might 
dislike the idea of ever-proliferating bacteria inside them, the students thought 
about how to engineer a “programmable time of living” for these microbiological 
machines in which they would “release a certain chemical to tackle a certain 
disease”. The goal then, as the team initially conceived, would be to make bacteria 
that survive in humans only to complete their curative job (saving people from the 
inconvenience of taking a pill or undergoing cumbersome or ineffective 
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treatments), to then die, be digested and exit the body via defecation. The team 
claimed that this project vision was so appealing in terms of its modularity and 
extensive application interchangeability – perhaps their bacteria could eventually 
be used to produce any compound to cure any disease. There were, of course, 
challenges: (i) how does one create a programmable lifetime for bacteria; and (ii) 
how does one find bacteria that can withstand the low pH of the human gut? Only 
a couple of meetings in, the aspiring iGEMers had clearly recognised that grand 
project pitches, an engineering approach and an addressing of possible challenges 
were all crucial to receiving positive feedback from advisors on their ideation 
process.  
 
As meetings continued from February through May, students developed a huge 
number of ideas – far too many to describe here, from complete non-sense to the 
fun and frivolous, to the impossible to complete, to ‘save the world’ scenarios. 
Highlights are provided in Figure 3.6.  
 
 
Figure 3.6: Further examples of dreamed up ideas from iGEM try outs 
Project idea 
/ title 
Basic description 
Bio-radio Using bio-electricity (produced in mice and fish), the idea was to create a 
biological radio that somehow used wireless communication and cell 
communication. A student claimed during a pitch, ‘if neurons can send and 
receive wireless signals, we might be able to monitor biological systems 
wirelessly, even communicate with each other without speaking’. 
Living 
battery 
A student proposed to design a ‘self-recharge or regeneration mechanism’. 
Borane-
based fuels 
With the knowledge that a ‘potential and promising hydrogen store is in 
ammonia borane, which can release hydrogen with the aid of Nickel and 
Ruthenium based catalysts’, a student wondered if a biological machine 
could be created to create fuels by co-opting this pathway somehow.  
Biological 
oscillator 
Build an oscillator device that could be used in timed drug release. 
 125 
Bioimaging Make a biological machine that uses bioluminescence to serve as a display / 
imaging system. This kind of machine might be used either in diagnostics or 
in a novelty / commercial scenario (e.g. bio-digital-photo frames, 
holograms, ‘psychedelic mice’ aka ‘animal display systems’). 
Biofuels + 
waste 
management 
A system to make biofuels but not just tackling the energy problem, the 
proposal included addressing the question of waste management. In a 
nutshell, the goal was to find a pathway that could be used to convert 
rubbish into hydrocarbon fuels. 
Biofuels + 
self-directed 
evolution  
The aim of this project would be to improve the production of cellulosic 
ethanol in the following way: (i) identify one or more genes to improve the 
production of ethanol and (ii) construct a system to improve (i) over time 
(aka directed evolution).  
Bactoshave The idea here involves engineering a skin bacterium to degrade hair and 
possibly to generate sunless tanning molecules. 
 
 
With these sorts of examples in mind, what is perhaps more interesting to consider 
is the influence that critiques of pitches had in teaching students what ingredients 
were needed for good project ideas. Repeatedly, the advice from top-tier 
authorities88 – Roger, Bernard and John – was that a good iGEM project had to 
keep in mind the following essentials: 
• New ground must be found and broken – ‘judges won’t want to see 
the same old biosensor’;  
• There needs to be wow factor – incremental steps are simply not 
enough to do well at the Jamboree; 
• The project ideas must be grounded in proteins, genes and DNA that 
is possible for you to get hold of and work with; 
• The project must be about engineering – there’s got to be data and 
results. 
                                                
88 The hierarchical ranking amongst advisors became evident – Bernard and Roger at the top, John 
right below, and Olivia, Max and Pierre below. Olivia, Max and Pierre spent time with iGEMers 
daily; meetings with ‘the Profs’ were more occasional (usually weekly) and took a serious tone. 
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Noting a few specific criticisms of ideas in the chart, advisors reminded students 
that an idea like ‘bactoshave’ was completely ridiculous – why, when there are 
cheap and good products for shaving and tanning readily available, would anyone 
seek to develop a synthetic biology application to replace what already exists? 
Similarly, the bio-radio idea was rejected outright – it was completely implausible 
and people in the room barely contained their laughter as one student tried to 
make the suggestion that remote communication between humans might be 
possible by taking advantage of bio-electricity properties in a rare fish species. 
Certain biases of advisors also came through during the try outs – hints were often 
dropped that ideas around medical or biofuel applications might be particularly 
suiting to Imperial College’s industrial-driven ethos. Comments from superiors – 
sometimes in the form of subtle steering, other times in the form of strong 
criticism or emphatic statements about the radical potential of engineering biology 
– shaped the ways in which students further mapped out potential projects.  
 
By the time students experienced a couple rounds of brainstorming, presenting 
and critique, the online forum showed features in thought organisation that ran 
through most entries: there would be a short pitch (usually problem - solution), 
background information, some ideas on methodology and challenges, a summary 
or mission statement, applications listed, tables, diagrams (e.g. of chemical or bio-
molecular pathways) and points of contact. Students also became conscious of 
presenting their ideas through the engineering cycle (as advised by Bernard) and 
demonstrating principles of modularity and abstraction. Thoughts became more 
organised, tried to tick essential boxes and were pitched in an increasingly 
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competitive fashion as try outs proceeded. Students wanted to sell their ideas and 
themselves as worthy candidates for the final team cut. 
 
Before moving to explore the official team’s starting days, where they continued 
and enhanced this dreaming up of ideas, it was clear that certain roles began to 
take shape during this initial phase; this was evident not only in-person, but also 
on the forum. For instance, the following posting clearly illustrates how one 
student, Zach, made early efforts to stake a leadership position:  
Firstly, thanks for your emails; it’s good to hear that so many of you 
are up for making this work. The first tranche of research has been 
divided up as follows: [sign-up list]… As you identify genes of 
interest, please add your info to the gene table below. [Extensive 
tables and diagrams follow.] … Moving forward: At the end of last 
year, I wrote a dissertation on the prospects of cellulosic ethanol so I 
would be more than happy to run a crash course on the subject… If 
you are interested in meeting up to discuss an iGEM project relating to 
biofuels, just sign your name and I’ll email everyone to work out a 
suitable time.  
Character traits were taken into consideration in the selection process. Advisors 
told me that it was very important to have a team with the right balance, not only 
of disciplinary expertise, but also of personality. They needed some leadership, 
but not so much that strong characters would collide too often, and they wanted 
that balanced with students who just tended to get to work. 
 
The advisors too began to reveal their biases and personalities during try outs. 
Roger and John had words of wisdom on biology, as did Max and Olivia. These 
teachers continually reminded students of biological complexities that would 
make most of the proposed ideas impossible in experiment. Bernard and Pierre, on 
the other hand, held a strict engineering view. They wanted to know about data, 
results and applications that an idea might lead to. Bernard and Roger – two 
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eminent Professors – emphasised repeatedly that ‘This is a competition and, here 
at Imperial, we are a pretty competitive bunch!’  
 
In the early brainstorming sessions, I have described how a competitive spirit and 
clear ambition to solve rather grand-scale problems is at the heart of the Imperial 
College iGEM team tradition. Certain thought patterns were taught and taken up 
by students over the course of recycling through brainstorming work, 
presentations and critiques. The Imperial College way to think about and present 
synthetic biology was to emphasize a systematic, rigorous and competitive 
approach. Online discussion forums were a key intellectual technology utilised by 
the group; indeed, this continued to be the case for the official team. Finally, I’ve 
indicated how some roles began to take shape, even in the first few meetings.  
 
From blank slate to an idea that sticks 
After about three months of try outs, the final team of eight were selected; they 
continued to meet periodically to brainstorm, even during their exams (an early 
sign of deep commitment). But, let’s skip forward to the start of the official iGEM 
project time. On day one, the first order of business was for students and advisors 
to have a quick briefing at ‘base camp’ (Figure 3.7) – the desks got positioned into 
a team circle and the meeting began with introductory remarks from advisors. 
Roger started out saying ‘Congratulations – you’ve made it’, quickly followed by 
the counsel that ‘this will be an intense time’. The first couple weeks of iGEM are 
typically very hard as ‘nailing down a project is challenging, frustrating and time-
consuming’. He continued:  
You must have faith in the process – one that is tremendously 
interesting and creative… At Imperial, we have a tradition of starting 
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from scratch – today, you’ve got a blank page. The goal here is that 
from a blank page, you make something novel, new and exciting that 
actually works in the lab. We eventually need something that delivers 
results and has data… It is a competition! 
Other advisors who described iGEM’s uniqueness in its high level of free-
thinking echoed similar comments of motivation and guidance; it was also 
emphasised that competitive projects had deliverables (“hard experimental data”) 
and “sparkle”. Finally, one advisor counselled, “You must be prepared to deal 
with critique from leaders, as well as failure – your ideas may simply not turn into 
reality”. 
 
 
Figure 3.7: Imperial College team’s ‘base camp’ 
 
 
After the somewhat emotive speeches, students tightened up the circle, advisors 
left and the group proceeded with timetabling and research. The team oriented 
themselves around suggestions in a two-page document, given by advisors, 
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entitled ‘Getting Started’. Recommendations included setting up a journal club, 
conducting student-led presentations and tutorials and investigating old iGEM 
Wiki’s, The Registry and synthetic biology literature. The group delegated who 
would look into specific areas, lead journal club discussions and also decided to 
use social media to track their project (Twitter and YouTube accounts ensued). 
Then, it was off to the computer room – this familiar scene is illustrated in Figure 
3.8. It was a solid two weeks that students spent much of their time in front of 
computer screens as they researched, communicated and imagined ideas for their 
biological machine.  
 
Figure 3.8: Researching in computer room 
 
 
As the dreaming up phase continued, the group focused on developing their online 
forum89 and presenting to each other. In brainstorming, the four engineers or 
                                                
89 At that early point and up until late in their project, students worked on 
http://openwetware.org/wiki/IGEM:IMPERIAL/2009. The team could have used their official 
iGEM Wiki site early on but were warned by Bernard that, to protect their ideas from being 
copied, the lesser-visited OpenWetWare site should be used to start. 
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computer scientists often paired up with the four biologists of the group. Through 
this, students gained an appreciation for the partiality of any given individual’s 
perspective and understood that they would need each other’s different expertise 
in order to build a project that satisfied the requirements as they had been laid out. 
Having not all taken a synthetic biology course, the team also formalised peer-led 
tutorials in order to bring everyone up to speed on crucial basics: an introduction 
to synthetic biology (a 30-minute whirl-wind overview, given by a student who 
had taken the formal course); a lesson on the Central Dogma; a tutorial on 
laboratory techniques; and a workshop on computer modelling. Notable synthetic 
biology papers were also evaluated in journal club sessions during the first two 
weeks. For instance, the work on engineering yeast that produce the anti-malarial 
compound artemisinin (Ro et al. 2006) was held up as a favourite example. 
 
Thoughts for a project proposal continued to develop from selected good ideas 
(validated by advisors) that came up in try outs, as well as broke into new 
directions. The team tirelessly researched useful genes, enzymes and missing links 
around ideas such as hydrogen-production from bio-mass, auto-encapsulating 
pills, making a ‘bacto-camera’, ‘bacterial sun cream’, biological batteries and 
many more. Students developed criteria lists and ways of scoring ideas so that 
when pairs came to present to the rest of the group, there was a systematic routine 
for feedback. Students voted on scores (0 being useless, 5 being average and 10 
being excellent) for each other’s project pitches that were evaluated for 
originality, feasibility, usefulness, “showing the union of engineering and 
biology” and market appeal. In my observation, the systematisation, organisation 
and scrutiny to which students subjected their work were remarkable. Between 
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lessons, online research, journal clubs, brainstorming sessions and presentations, 
the team was working long days and yet students still arrived every morning with 
more work that they had done on their own in the evenings. I was thoroughly 
impressed by the effort to find that sparkling project. 
 
However, the team had great difficulty in getting to the sticking point idea, in no 
small part owing to high standards set by advisors. Leading up to the project 
idea’s finalisation, there were several meetings in which students faced critique 
and re-evaluation of their progress – the interrogation from Max and Pierre was 
daily and, at least every couple of days, their ideas were evaluated by Bernard, 
Roger or John (sometimes all three), for the real authoritative opinions. In the face 
of a great deal of time and effort in dreaming up ideas, upon presenting to their 
superiors in the first two weeks, students were continually reminded of ingredients 
that any particular idea failed to factor in to a satisfactory level (a redundant-
sounding list): 
• Where’s the application? What is the big thinking? 
• That is too trivial – what you want is a ‘save the world’ idea! 
• There needs to be more emphasis on the engineering cycle. 
• What are the desired genes and proteins you’d use in experiment? Can 
you get hold of them? 
• Have you accounted for the biological complexity involved (e.g. 
referring to host-chassis relationships or the diverse, unpredictable and 
noisy natures of bacterial systems)? 
The bottom line for an ideal iGEM project in light of the Imperial College 
competitive spirit was that it must be both grandiose in it’s pitch (something that 
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could, in theory, solve pressing global problems) but also have some doable 
experiments that would give the team data and results to bring to the Jamboree. 
These two factors are particularly at odds when, upon taking the next step to turn 
an idea into designing experiments, a seemingly endless set of biological 
complexities comes into the picture.  
 
Despite what was an uphill battle at times – as the mood often swung from 
incredible excitement at light bulb moments to real depression following some 
harsh critiques – after two weeks of solid work, the iGEMers arrived at their 
project’s core concept. They would engineer an auto-encapsulation property into 
bacteria that produce a compound, X, in order to solve a problem, Y, in the gut. 
This idea was based on two interesting engineerable functions (self-coating and 
drug-producing bacteria); it could be pitched as a generic drug production 
platform (in theory), showing a good manufacturing potential; it was modular, 
making it amenable to an engineering approach. By week three, there were 
occasional approving comments from senior advisors: the team was told, ‘you’ve 
got the bare bones of a good project here’. However, there was a great deal more 
work to do and pressure remained high. By the next meeting, students were 
instructed to show that they had “really drilled down into the different modules” – 
advisors gave the students two days to get full specifications for each module, 
“knowing everything about the genes and enzymes [they] would want to use”. 
Furthermore, the team was expected to have outlines of proposed experiments 
and, perhaps most importantly, an application “with a compelling and emotional 
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message” nailed to the project.90 The project continued to evolve and overlap with 
experimental stages and so the reader will find the ideas development theme 
continuing into Chapter 4. There is one other important point of discussion about 
this early stage. 
 
I’d like to draw attention to some social dynamics and character traits that were 
revealed during this intense beginning. Starting with the iGEMers, all of whom 
proved to be incredibly well accomplished and ambitious – many were on 
prestigious scholarships; all had some ideas about where they’d like to pursue 
graduate studies. Andrew and Zach took turns being the head evangelists of 
synthetic biology and leaders of the team, both having described their dreams to 
venture into biotech start-up companies. The first few days resonated with 
optimism – for instance, as Zach joked that the team “should be preparing the 
acceptance speech for the Jamboree” – but students still worked hard. Then, when 
more difficult times set in after the occasional disappointing meeting, students 
tried to pick up each other’s spirits. A sense of comradery was built over casual 
lunches on the Imperial College quad lawn and in the occasional evening of team 
salsa dancing. In field-notes, I noted also being quite impressed that even two or 
three quieter students found their voices quite quickly and were recognised as 
having an important role. The team knew that they needed each other’s 
perspectives in the work and, at least at the beginning, the group got on as new 
friends.  
 
                                                
90 The emphasis on having a sentimental message was over-the-top, particularly as advised by 
Bernard. He once said, “working on solving AIDS in Africa or curing cancer – this is the stuff that 
wins!” Some students were suspect of such comments but overall, the team felt obliged to play 
into the Professor’s advice.  
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Of the advisors, Pierre quickly became know for his tough love feedback, 
displaying impatience as he sat at the back of the room, arms crossed, leaning 
back in his chair, one foot perched on the other knee, often fiddling with a pen. As 
he worked largely on the computer too, Pierre had the role of primary oversight in 
the first couple weeks and gave a great deal of help to the students. Max 
emphasised biological complexity; however, as a previous iGEMer, his 
suggestions usually rang with positivity and empathy and were much appreciated 
by the team. Olivia took a more neutral stance – constructively critical in her 
feedback and without attitude. As an expert in the laboratory, Olivia repeated one 
major point to the student: “keep it simple!” In the team’s oscillations between 
optimistic dispositions, busy flurries of research and difficult periods of rejecting 
and re-evaluating ideas, one student doodled the ‘iGEM Circuit’ cartoon (Figure 
3.9). 
 
Figure 3.9: ‘iGEM circuit’ 
 
This cartoon plays on the style of synthetic biology genetic circuitry. Highlighting the “Student” 
circuit, it reads “ideas” get started (or inhibited by “criticism”), which get fed into by “papers” (or 
inhibited by “advisors”), which turns on “doodles”, leading to the production of “salsa” (referring 
to how some students go salsa dancing together to let out their iGEM frustrations). The “Wiki 
updates” segment stands alone, as a separate functional unit, with stop codons on either end. 
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Conclusion 
Conceptually, this chapter has been oriented around two borrowed notions: 
Bachelard’s (1984) phenomenotechnique and Miller and Rose’s (1990) 
intellectual technologies. To participate at iGEM, ideas for constructing new sorts 
of genetically engineered machines must first be conjured up in the mind before 
they are turned into real experimental processes – and this is done with technology 
and application in mind. I have described what is more an exercise in creative 
thought than in hypothesizing, deducing, or practicing on already existent 
biological phenomena. iGEM students are challenged to find their materials from 
a vast pool of genetic functions and think about how to put them together in novel, 
functional and exciting ways. This activity of dreaming up ideas is not abstract – 
there is materiality and ontological status to the envisioned projects. I’ve 
illustrated how ideas originated and were developed using tools for thinking: 
drawing mind maps, making lists, sketching pictures, using online forums and 
conducting presentations. These various media gave imaginative thoughts points 
of attachment, so they could be understood, extended and re-evaluated in multi-
disciplinary teams that also had advisory oversight (in differing degrees at 
Cambridge and Imperial College).  
 
An important condition on the possibilities for dreaming up iGEM ideas was how 
students were taught to think about synthetic biology and the competition. At 
Cambridge, the crash course was crafted in an attempt to evenly equip students 
with introductory knowledge, but even more, to inspire and excite. The 
involvement of designers and myself in the course, along with diverse practical 
sessions and some rather unconventional lectures all sparked the Cambridge 
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team’s initial creative brainstorming stage. That team’s week one output saw them 
arrive at an idea for a colour generator and ready to start laboratory work.  
 
With the Imperial College group, try outs shaped a particular way of coming up 
with potential projects. Students were taught that their pitches ought to 
demonstrate rather grand scale, problem-solution thinking, yet still with 
competitive deliverables. Coming up with a project – under high standards set by 
advisors, without the entire team having a thorough grasp on synthetic biology – 
was challenging. Overcoming their first wave of major difficulty, this team 
arrived at their sticking point idea, to engineer a self-encapsulating drug 
production system, in week three.  
 
Understanding how these groups were taught and how they developed project 
ideas was embedded in human characteristics, institutional cultures and social 
dynamics (further elucidated in the coming chapters). I have introduced how 
different ways of approaching the project at hand were especially apparent in 
comparing engineering to life science views. Another interesting point of 
comparison was in students’ self-identification as ‘creatives’ (who enjoyed 
dreaming up ideas) or more so ‘doers’ (who were eager to execute a plan of 
action); this was particularly evident at Cambridge. Students began to get to know 
each other too – they discovered each other’s strengths and weaknesses and found 
how different skills and knowledge bases could compliment or collide. Many 
were challenged by the amount of free rein thinking that is given to iGEMers, 
something rarely found in conventional undergraduate engineering and science 
courses. The diversity of talents and perspectives enhanced the imaginative nature 
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of ideas that arose. There also had to be a certain taming of imaginations in this 
process. Leadership within teams was needed, as were habituated ways to 
organise thoughts and tasks; advisors also provided reality checking of ideas for 
feasibility, and sometimes very direct steering.   
  
Leading into the next two chapters, Hacking’s (1983) position as a realist about 
entities and an anti-realist about theories is noteworthy. The brainstorming and 
arrival at ideas that has thus far been illustrated is theoretical. Though I have 
argued that thoughts can, in some ways, be materialised in mind maps, online 
postings, presentations, etc., at the dreaming up stage, they still do not amount to 
real existing, causally powerful entities. No strategically engineered, pigment 
producing bacteria existed, nor did a self-encapsulating drug production system – 
even though teams developed theories about how such biological machines might 
work and with what components. In the next chapter, I shift from the theoretical 
into experimental realms; then, in Chapter 5, the reader finds that some real 
entities are made. In that domain, another kind of reflection about new living 
synthetic biological forms is possible. 
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4.   EVOLVING IDEAS INTO DESIGN AND EXPERIMENT 
  
This chapter enters the territory of purposeful design, experiment and computer 
modelling; the iGEM groups’ evolution of ideas, team dynamics, individuals’ 
skills development and laboratory practices are examined. Interestingly, a 
conflicting understanding of biology as both discretely engineerable as well as 
impenetrably complex emerges. This stage of practice also reveals divergent 
views about how to understand and perform synthetic biology across the two 
institutions.  
 
4.1   Evolving ideas at Cambridge 
The project develops 
Right now we’re just looking at output; this isn’t yet a full machine 
and this is the genetically engineered machine competition! 
– Chelsea  
Following the idea to make bacteria produce pigments, the team knew they would 
have to start experimental work, while enlarging their project vision, attaching it 
to an application – even if it were only hypothetical (as most iGEM work turns 
out). The evolution toward ever-more practical ideas also targeted the 
competition’s general ethos. The process started with a suggestion to “paint a 
bacterial wall”; this was followed by a proposal for a “bacterial colour printer”; 
another student reminded everyone that the aim was to do something that ‘takes 
inputs 1, 2 and 3 and hooks it up to outputs x, y, z, making a machine that is 
modular and interchangeable so that you can have several possibilities and other 
people can build on the work’. Finally, despite a brief flurry of anxiety, the group 
had their first project overview on their Wiki by the end of week two: 
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Previous iGEM teams have focused on genetically engineering 
bacteria to respond to novel inputs – for example light, or biologically 
significant compounds. There is an unmistakable need, therefore, to 
also develop clear, user-friendly outputs, especially for use in 
biosensors. The most popular output is the expression of a fluorescent 
protein, detectable using fluorescence microscopy. However, how 
much easier would it be if we could simply see the output with our 
own eyes? The Cambridge 2009 iGEM team is engineering E. coli to 
produce a range of pigments in order to equip future projects with 
better, more reliable, discrete outputs under logic control. Further, our 
bacteria utilize a shutter mechanism that guarantees pigment 
production after just a brief exposure to the desired input.91 
 
This was an idealized project idea that continued to change. Shortly after this 
Wiki posting, one student remained dissatisfied with the extent to which the 
project looked exciting and innovative: “Isn’t it too basic? We’ve got engineers 
here – shouldn’t we be able to get a more complex pathway, with more than one 
arrow?” The desire to ‘go bigger and better’ led to a number of days when a few 
team members worked tirelessly with add-on proposals. Although the advisors all 
believed this extra work was unnecessary and ‘de-railing’ the team, they did not 
stop the students from making their own mistakes.  
It seemed like every day they were considering something new for a 
while and not necessarily for any reason… a step back. But, at the 
same time, these set-backs are part of the iGEM process – students 
consider a bunch more information, read a whole bunch of papers and 
they have to carefully weigh the excitement and feasibility balance of 
their project. – Andy  
After researching the addition of a “shutter mechanism”, various switches (a 
toggle-switch, a bi-stable switch, a latch), a kind of “engineered memory” and a 
“population control device”, all these potential add-ons were rejected as being 
too complex, especially given the limited project time and capacity of the team. 
However, one add-on would make the group’s pigment-producing E. coli just 
                                                
91 http://2009.igem.org/Team:Cambridge. Note that this quote is from an early posting on 22 July 
2009. It was later edited and so only the final version appears on this site. 
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that extra bit more sophisticated, and it was feasible: the students decided they 
would resurrect the Cambridge 2007 iGEM project and work on improving that 
team’s amplifier system. The basic idea was to develop the previous work and 
customize it as a ‘sensitivity tuner’ that would slot into the overall project design: 
[sensor] – [sensitivity tuner] – [colour], as [input] – [processor] – [output]. 
Students suggested potential mechanics for this tuner; their initial vision was that 
it could be functionally programmed to detect meaningful concentrations of a 
given input. The overall project – in its goals and deliverables – is discussed in 
the next chapter; for now, it suffices to understand that the project conception by 
the fourth week was a pigment production system that would have a set of tuning 
devices, making the students’ work especially relevant to biosensor 
applications.92  
 
While the team settled on their “big idea” (Figure 4.1), at least three students 
already had biological laboratory experiments underway. Early entry into both 
‘dry’ and ‘wet’ laboratory practices and processes (discussed in an upcoming 
section) meant that the team’s project evolved in parallel with successes and 
failures in experiments. A final important point about the idea evolution is that 
the team continued to draw mind maps, use the white-board, make lists and 
generally plaster their workspace with reminder notes.  
 
 
 
 
 
                                                
92 http://2009.igem.org/Team:Cambridge/Project. 
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Figure 4.1: The Big Idea 
  
 
The team evolves 
As ideas developed over the summer months, so too did group dynamics and 
individuals’ skills. One of the most significant team challenges was in learning to 
work productively between various disciplinary views – dealing with technical 
“language barriers”. Figure 4.2’s interview excerpts (taken from the project’s mid-
point) illustrates differences in disciplinary perspectives: 
 
Figure 4.2: Comments reflecting disciplinary perspectives 
Students of biology Students of engineering 
“[The challenge] has mainly been the 
vocabulary. They all have words for how 
devices work and synthetic biology is all 
about how to put devices together. So, 
suddenly, you are throwing words around 
like ‘adaptor’… It is funny because, in the 
lab, I’ll be pipetting and doing my thing 
really quickly and Alex is really only just 
learning how to do that. Then, Alex will start 
drawing electrical diagrams – bang, bang, 
bang... and I’ll just be sitting there, 
struggling to understand.”  
“The biggest challenge was probably the 
learning curve at the start – for me. All these 
big biology words that you just have to 
learn!”  
“Making everyone with a different 
background understand the project – that is 
something that we’re still struggling with, 
but that was also what was so interesting… 
Alex will look at the data and, where I’m 
interested in only if it works, he is interested 
in the slope and the thresholds. The different 
“Not one person knows everything that’s 
going on – we all work in our own little 
areas more. So I found myself not needing to 
learn some of the biology and then others 
don’t need to learn MatLab [a computer 
modelling program].” 
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perspectives really enriched the project but it 
was also very challenging to get everyone 
onto the same page...” 
“Biologists are very insular – we like to play 
with the bacteria and get our results and that 
is it. But, those guys [the engineers and the 
physicist] know how to program and they 
have new ideas. You were there when Tobey 
set up the idea for the whole new software 
programming thing. I don’t think a biologist 
would ever devote the time or even know 
how to begin doing that kind of thing. It is 
just great that people with other areas of 
expertise are getting involved with biology 
and improving it in ways that biologists 
themselves would never be able to do.” 
“It took me a long time to explain to some of 
the biologists what I was doing and still 
sometimes, no matter how well a biologist 
explains what they’re doing, I sometimes 
don’t get it. Sometimes I just decide not to 
bother. Otherwise, everyone has a vague 
idea and that is all that matters… At the 
beginning, without the knowledge of the 
biologists we would have gotten nowhere 
because you need someone to say what 
won’t work for whatever reason.” 
“Programming is my ultimate weakness – I 
really can’t wrap my head around it… It’s 
really interesting to see what programming 
can really do for biology. As far as 
modelling goes, that happened on the side – 
I am still not entirely sure what they do. But, 
they seemed to produce some nice graphs, 
which show what we want. I seem to have 
forgotten all the maths I was ever taught 
somewhere in the last three years…” 
“Both the diagrams and the differential 
equations that we use have simplicity at the 
heart of it. I mean we are talking about 
different genes and their relations to each 
other and so the obvious thing is to draw out 
that network onto a sheet of paper. And that 
is similar to electronics, apart from the fact 
that we don’t have wires in synthetic 
biology.”  
 
 
 
These quotes reflect the partial understanding about work that went on in the 
‘other’ discipline; there was a disjunction between biologists and those with 
engineering or physics backgrounds. Biologists were reluctant to do computer 
modelling – all the maths, circuit diagrams and graphs involved – and yet, they 
were fascinated and supportive of the fresh ideas and outputs that engineers and 
physicists were bringing. The engineers, on the other hand, found the amount of 
biology language far too onerous to learn in a short period; they wanted their 
colleagues to give them data that they could use, in a familiar fashion, to represent 
the systems, and, at best, make some predictions. During a memorable tea break 
with Alex and Chelsea, they described these caricatures: 
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• Alex is the “token engineer” – he likes to simplify and streamline 
problems and to number crunch; he wants to make models that can be 
used to build stuff; he’s inclined to work by rules of thumb. 
• Chelsea is the “token physicist” – she likes to make models too but 
she likes to actually represent the reality of a complex system; she 
doesn’t like to make everything as simple as the engineers. 
• The biologists of the team like to remind everyone how complicated 
biology is and how simple models won’t work – they are always 
saying how this or that might be toxic to the cells, or that there is 
complexity in a pathway that models don’t capture. 
 
Although one can acquire a basic language of synthetic biology (the Cambridge 
crash course afforded this opportunity), it is quite a leap to call someone a 
synthetic biologist, in the sense that he / she might have all the knowledge 
necessary to design and carry out this line of work. Involving oneself in iGEM 
(and in the field more broadly) means learning how to utilize one’s skills in a 
team effort, willing to be involved in an artful combination of individual 
knowledge and talents that are working towards a collective vision. The 
Cambridge team quickly recognized major talents and efficiently delegated – 
Emma, Derek, Eleonore and Senni were wet lab practitioners; Chelsea, Alex and 
Tobey were masterminds behind computer modelling and making the Wiki. In 
what could have been a much more difficult group dynamic, I was struck by how 
these characters made it work. 
There haven’t been any major fights or disagreements at all. It has 
been a nice little group. I mean, we’ve all been stressed at different 
points, but there has never been an argument. – Eleonore  
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The advisors were impressed by how well this group worked together; although 
they lent support and helped when asked, as the summer progressed, students were 
increasingly able to get on with the tasks at hand and required less supervision. 
Still, Andy remained almost a constant presence as he worked on his PhD just 
down the hall from the team’s lab; his attentiveness was invaluable as one of the 
rare practitioners who are versed in both engineering and biological aspects of 
synthetic biology (having worked in the field for over four years at that point). 
Douglas was also extremely helpful as he acquired tools and materials for the team 
and, like the other advisors, was a fount of knowledge on everything to do with 
microbiology. Samuel, Geoffrey and Frederick – the most senior and 
knowledgeable figures of the group – were around less often than Andy and 
Douglas, but nonetheless were always ready to provide additional advice. As the 
project developed, the team benefited from weekly meetings with at least a couple 
of the advisors to discuss general progress and troubleshoot problems.    
 
Even though there was plenty of support and all the best equipment iGEMers 
could hope for,93 the amount of freedom in this project remained greater than any 
individual on the team had experienced previously. As Andy said:  
The freedom that the group gets is really what can make or break them 
as researchers – they have a bunch of new skills to learn and nobody is 
spoon-feeding them. Students have to find out their own protocols and 
experiment with how to make things work! Plain and simple – there is 
a lot of doing your homework and a lot of trial and error. 
                                                
93 Cambridge University’s excellent alumni relations in biotech companies, in part, helped 
Douglas secure team sponsorship and donations of equipment and biological materials 
(http://2009.igem.org/Team:Cambridge/Sponsors).  
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Several students echoed similar sentiments; Emma explained that her previous lab 
experience had always been “like following a recipe – you do these things, in this 
time frame, and if you don’t get results, you’ll be given some”. She described 
iGEM work as “a huge trial by fire” – where making sure the lab was clean, 
ordering materials, setting up controls and refining or making new experimental 
protocols was all the responsibility of students. However, this curious, clever and 
dedicated group were equipped for the challenges at hand. Delegating tasks has 
already been mentioned, as has the group’s tendency to surround their workspace 
with To Do lists and mind maps – these were certainly important organizing 
mechanisms.  
 
Another essential aspect to the team’s effectiveness relied on Emma’s graceful 
leadership – noted in my observations and through comments from advisors and 
students. It was no surprise that Emma proved to be a brilliant conductor of this 
peer group – a top-student; an outgoing member of the rowing team; humble, yet 
vibrant (notorious for her ‘happy dance’ when good results were achieved in the 
laboratory). She was a fastidiously organized task master, yet sensitive and 
appreciative of the stresses and frustrations that all team members experienced. 
Emma was also efficient at getting to grips with new ideas and techniques. She 
remarked:  
Douglas would be speaking [about a modified technique or protocol] 
and I’d say to myself, ‘OK, those are important things – I should write 
them down’. So then I’ve got some massive list and he just talks about 
it so easily because he’s been doing it for years – and, for me, every 
step is new. I have to look at every one individually and figure out 
what is going on, but to him it is really quick. And now, I’ve gotten to 
the stage where – obviously not Douglas level – but, I can do a PCR 
without having to read books. 
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Samuel also commented, “Emma is just quick on the uptake every time”. It was 
required that all students get on with their work, write out protocols and devote a 
huge amount of time to learning new vocabulary, new materials and new skills; on 
top of that, Emma effortlessly took up the reins as a leader who drew over-arching 
maps (‘THE BIG IDEA’ diagrams), brought the group together to discuss what 
everyone was doing and managed to always know at least a little bit about every 
aspect of the project. Finally, Emma was also gracious to me, incredibly helpful in 
explaining laboratory work as I often ‘hung out’ alongside her.  
 
Before moving on to discuss the practices and processes of this design and 
experiment stage, I’ll highlight one more story of an individual’s development. At 
the beginning of the summer, Senni was a second-year biochemistry 
undergraduate who had very little laboratory experience; by the end of the project, 
he had done something in the realm of fifty gene assemblies (advisors told me that 
this number would be a rare achievement for most grad-students or post-docs in 
three years!) and he had earned the endearing nickname, The Professor. His 
personal success story, however, started with a rare moment of tension that 
occurred in this group. Andy recalled this specific irritation with Senni: 
It was that one morning, you remember… Senni started pulling plates 
out; I don’t know where he was getting them from, and he had no idea 
what was what, and what cloning came from which line, and which 
graph was which graph, and where was his control. And it was 
probably the tenth time in that two weeks that I’d said, ‘where’s the 
control?’ and he’s like, ‘ooohhh...’ 
Andy added that, at that point, Senni requested his help on an experiment that he 
felt was a waste of time. They had insufficient materials, which meant a low 
likelihood of getting results and there were further doubts about the genetic 
construct that Senni intended to work on. Senni agreed that there was good reason 
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to be sceptical of the chance of that experiment working, and yet his persistent 
attitude was, “why not just give it a try!” 
  
With stubborn determination and luck, Senni’s experiment worked the first time. 
He admitted to me, however, that at the project’s beginning, he didn’t have his 
controls organized. Lessons were learned: 
I got the hang of it… When something failed, we modified the 
protocol to make it better. It was much more encouraging. During the 
first few weeks, we were just very inexperienced – we hadn’t used the 
kits yet and we were just following the recipes and sometimes it 
doesn’t actually work... At first, we were quite cautious – you know, if 
the protocol says ‘1 minute’, we followed it for exactly 1 minute. But 
then, later, you realize what is more important and then you have the 
confidence to try out new things and explore new areas which will be 
able to bring the project forwards. 
 
Senni became an excellent scientist, as he evolved and refined in his skills over 
the summer. Advisor Samuel explained Senni’s transformation, where he went 
from being “completely all over the place – you were just hoping to God that he 
wouldn’t destroy something in the lab” to “someone that actually did the controls 
in experiments, knew where all the data were, put things together in a sensible 
order so he could explain the results to anybody that came by – it was all logical!” 
Figure 4.3 illustrates some of the impeccable organization in Senni’s mapping out 
his work on the carotenoid pigments.  
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Figure 4.3: Senni’s Carotenoid chart 
 
 
During his personal development, Senni also made a concerted effort to extend a 
positive attitude towards his colleagues, making him not only a valuable team 
member in terms of churning out results, but also in terms of helping to foster an 
encouraging atmosphere: 
I like to work in the lab – especially when things are working. I mean, 
it is tiring. But, when you see things work and you see the whole team 
progressing – especially when Eleonore was able to make the 
violacein work in the liquid culture – it really makes it all worth it. 
Eleonore was able to bring the violacein into large amounts in liquid 
and then, I measured it and I saw a very good colour. And her colour 
is very distinct so I think very useful. Also, the amplifier project now 
has all the all the things in the correct system – so now the next step is 
to just put the parts together and just test them. I see it all moving 
forwards now. It is all worth it! 
Positive attitudes in the team were essential in keeping the project moving. As 
Frederick reminded me, experiments are full of error and with high-achieving 
iGEMers, “there were definitely times of panic and unhappiness – tears on more 
than one occasion, and frustration, but then I think that’s all very much par for the 
course”.  
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Practices and processes  
This section is an examination of practices and processes involved in the team’s 
design and experiment phase: well-established wet laboratory protocols that often 
fail and require several repetitions are discussed; other work involves maths and 
computer modelling; the simple use of pen and paper to map ideas is illustrated 
further; finally, I describe the team’s ‘in silico’ designing and ordering of a 
bespoke gene construct, as well as the arrival of the synthetic DNA (via post) and 
its insertion into living cells.94 An important point about the setting is that all 
work was conducted in the same room – a simple laboratory space on the top floor 
of the Plant Sciences Department, overlooking a tidy green courtyard – separating 
two ‘wet benches’ from two ‘dry benches’ by posting signs at the end of the 
bench rows. 
 
Biologists were the main work force in Cambridge’s wet laboratory; only rarely 
did the engineers or physicist decide to conduct experiments, mostly preferring to 
keep to their computers. So what exactly did these biologists do? Despite the 
rhetoric associated with the field about modular, off-the-shelf components that fit 
together like Lego™, the vast majority of actually “doing synthetic biology is 
really about clear liquids and small volumes”, as an engineering student remarked. 
In molecular biology experiments, Frederick repeatedly reminded the team, “most 
of the time stuff doesn’t work – you just have to get used to that”. The following 
table illustrates some of these common molecular biology procedures (which, 
crudely, is just repeated transferring, cooling, heating, adding, shaking and 
waiting for clear liquids and small volumes to do something). What the reader 
                                                
94 It is a huge luxury for an iGEM team to use synthesis technology, as it is considerably 
expensive. Cambridge’s alumni connections at synthesis company, DNA 2.0, provided the team 
with £3000 worth of gene synthesis – for free. 
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should note in Figure 4.4 is not the technical detail, but rather, how these synthetic 
biology wet lab practices are rather mundane, tedious and, despite what is said to 
the contrary, these are not new biology protocols and they are executed much like 
following a recipe (over-and-over again). Figure 4.5’s photographs also show the 
discrete nature of this kind of labour, something that remains highly reliant on the 
experimenter’s excellent hand-eye coordination.  
 
Figure 4.4: Example wet laboratory protocols95 
Protocol Details 
Producing 
competent 
cells96 
Starting from a single colony on a plate: 
• Transfer colony into 50ml liquid LB media and leave in a 200rpm shaking 
incubator overnight 
• Take 10ml of culture and inoculate into one litre LB and grow in shaking 
incubator until OD600 of 0.2-0.3 (4 hours?) 
• Put culture on ice for 30 minutes 
• Centrifuge at 4000g for 6 minutes 
• Remove supernatant and resuspend cells in an equal volume of ice-cold 
0.1mM HEPES 
• Repeat centrifugation 
• Resuspend cells in 0.5 volume ice-cold 0.1mM HEPES 
• Repeat centrifugation 
• Resuspend cells in ice-cold 10% glycerol (20ml) 
• Combine to form two tubes of 40ml glycerol 
• Repeat centrifugation 
• Resuspend in ice-cold glycerol (3ml) 
• Divide cells into 100ul aliquots and store at -80 
(Cells should be at a final volume of ~3 x 10^10 cells.ml^-1) 
Competen
t cells 
transform
ation 
• Electrocompetent cells thawed on ice 
• Prepare vector DNA on ice 
• BioBricks 
o With pipette tip, punch hole through foil cover into designated well 
o Add 20uL DIW 
o We will be removing about 5uL; the rest needs to go in an eppendorf, 
labelled with biobrick number, and stored at -20°C 
• Violacein and melanin need to be thawed 
• Vector DNA pipetted into chilled 1mm separation electrocuvette = 4 total 
• 5uL of BioBricks 
• 0.5uL of melanin and violacein plasmid 
• Add 45 uL competent cells 
• Tap electrocuvette gently to evenly spread mixture in the electrocuvette gap 
with no air bubbles 
• Thoroughly dry cuvette 
                                                
95 http://2009.igem.org/Team:Cambridge/Protocols. 
96 Making cells competent in the laboratory means preparing them so they are more permeable, 
ready to take up DNA that will be introduced into the environment later in experiment. 
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• 1.68 kV passed across cuvette, 5.1-5.4 time constant at 200 ohms and 25 uF 
• Add 0.25 mL SOC liquid medium to electrocuvette 
• Incubate electrocuvettes at 37 degrees C for 60 minutes 
• Pipette 150uL onto a (warmed) selective LB agar plate, spread with blue 
spreader 
• Orange genes BioBrick: ampicillin 
• Promoter for orange genes BioBrick: ampicillin 
• Melanin: ampicillin, copper, and tyrosine 
• Violacein: trimethoprim 
• Do 1:10 dilution with SDW into a new eppendorf 
Pipette 150uL onto a selective LB agar plate, spread with blue spreader, 4 
separate inoculums 
PCR 
procedure
s 
For high accuracy sequence PCR 
• Use the Phusion set from Finnzymes 
• 50ul solution 
• Can alter conditions for optimisation 
For verification of plasmid presence/length 
• Use TAQ polymerase and buffer from stores 
• 20ul solution 
• Run with standard procedure as follows for Colony PCR 
Reaction Mixture 
• Template: 1 uL from O/N culture (1-2 uL if colony picked straight from 
plate into water) 
• VF2: 1uL 
• VR: 1uL 
• Eco-Taq: 0.2 uL 
• 10X buffer: 5 uL 
• dNTPs: 0.4 uL (stock is 10 mM) 
• make up to 20 uL volume with H20 
Reaction procedure 
• 95 degrees C for 2 minutes 
• 33 cycles of: 
• 95 degrees C for 30 seconds (denaturation) 
• 65 degrees C for 30 seconds (annealing) 
• 72 degrees C, 1000bp/min (elongation) 
• 72 degrees C for 5 minutes 
• hold at 4 degrees C 
Gels 
• Run on EtBr for good quality viewing (make agarose gel). This is viewed in 
the red-room downstairs. 
• Run on SYBR-safe gel if the DNA is required. This can be viewed under 
blue light in the covered dark-area. 
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Figure 4.5: Wet work 
 
 
Another essential protocol in iGEM is ‘BioBricking’ – that is, ‘snapping together 
of DNA components’, as the Lego™ parallel implies. A standard BioBrick is 
pictured in Figure 4.6 and consists of the following components: (i) a gene97 (or 
small set of genes), that encodes a function and is given a standard name (this part 
is bracketed in blue, named BBa_B0015); (ii) a plasmid98 (represented by the red 
bracket); (iii) prefix and suffix sections that contain restriction sites (the circles on 
either side of the gene), which are short flanking sequences around a gene that 
allow them to stick into a plasmid or to another gene; (iv) an origin of replication 
(the purple square) that allows the plasmid to be copied in a bacterial cell; and (v) 
an antibiotic resistance marker (in green) that allows the researcher a way to only 
work with the right bacteria that have taken up this whole plasmid + BioBrick 
format.99 Using a process called standard assembly and a series of other well-
established laboratory techniques (e.g. cloning and gel electrophoresis), BioBricks 
can be cut and pasted together and taken out or placed inside living bacterial 
                                                
97Acquired from The Registry in standard BioBrick form, or removed from bacteria (and 
occasionally other kinds of organisms), or designed and ordered online. 
98 See Key terms, p. 10. 
99 Plasmids are put into bacteria in a process called transformation; then, bacteria are plated onto 
antibiotic plates so that only those with the antibiotic resistance (containing the plasmid + 
BioBrick construct) survive.   
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cells.100 BioBricking is one of the most fundamental accomplishments for iGEM 
teams – to do well in the competition, teams must demonstrate a mastery of this 
protocol and, the most significant players, will have constructed a number of new 
BioBricks to give back to The Registry.  
 
Figure 4.6: Standard BioBrick 
 
  
To illustrate some of the team’s dry work, I must ask the reader to forgive the 
broad-stroke nature of the descriptions I offer about computer modelling as I’ve 
found this element of synthetic biology most challenging to comprehend and 
describe (given my limited mathematical and computational knowledge). The 
general aim of modelling in synthetic biology is to provide ‘simple’ mathematical 
frameworks that describe (and, at best, predict) the behaviour of engineered 
biological systems. The modeller’s task, therefore, is to construct the ‘Ordinary 
Differential Equations’ (ODE’s) and many sets of graphs that accord to their 
project’s various system operations. Modelling can, for instance, say something 
about rates of change in reactions; it can utilize production-degradation equations; 
it can show how gene expression dynamics and signal transduction is operating; it 
                                                
100 See http://partsregistry.org/Assembly:Standard_assembly and ‘Creating Biobricks’ post (23 
July 2009) on http://labrat.fieldofscience.com/. 
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can say something about concentrations of a chemical input that might be 
necessary to trigger a set of reactions or output. Modelling tries to find simplicity 
in a complex soup of noisy biological networks and does so by searching out 
defined structures, reusability or recurring patterns (network motifs), modularity 
([input]-[processing]-[output]) and feedback loops that operate on regular 
timescales. There is also a necessary back-and-forth that involves using real data 
generated from wet laboratory experiments and feeding it into the mathematical 
models – the wet and dry protocols then continuously shape each other. For 
example, experimental samples are measured using a piece of laboratory 
equipment, a plate reader, which generates data about biological, chemical and 
physical characteristics of specimens under examination; this information is then 
fed into the mathematical and computer simulation models and fine tuning of both 
wet and dry work can proceed. Leaving this modelling overview, in the next 
chapter the reader will find illustrations that show selected final outputs of this 
work. Until there was actual wet lab data to work with, modellers typically 
continued to map out ideas of how models might work, with theoretical data 
(Figure 4.7).  
 
Figure 4.7: Mind mapping from modellers 
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Finally, the most cutting edge practice that the team employed was in Eleonore’s 
work on a bespoke design to make violacein, a purple pigment found in marine 
bacteria. Through research, Eleonore found that there exists five genes in this 
system (labelled in Figure 4.8b as vioA-E) that, when working together inside a 
bacterial cell, could produce a violet pigment. She also found that there exists at 
least one (if not two) intermediate(s) in the genetic pathway that might allow the 
production of a blue or green pigment, if certain genetic components were 
knocked out or rendered inactive. The exciting prospect of a two (possibly three)-
in-one system, producing multiple colours convinced the team and advisors that 
this would be an area of the project worth spending extra time and resources on. It 
was decided that Eleonore could use the free DNA synthesis that the team had 
been given by DNA 2.0 in order to create the ideal violacein genetic system. 
 
To begin this process of designing, ordering and experimenting with synthetic 
DNA, Eleonore worked on DNA 2.0’s free software, Gene Designer 2.0101, that 
allows users to input and manipulate genetic code in silico in order to optimize a 
desired sequence before ordering it (Figure 4.8a).  
 
 
 
 
 
 
 
 
                                                
101 https://www.dna20.com/genedesigner2/. 
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Figure 4.8a: Design and order your gene online!  
 
The program shows DNA that is broken down into modular, functional pieces and 
represented as arrows (4.8b), though it can also be looked at in sequence form, 
showing, for instance, what proteins are made from a given component and where 
cuts in the DNA can be made (at restriction sites). Four iterations of Eleonore’s 
design are shown below, though she had saved “about a hundred incarnations” on 
her computer. She started simply, with just the vio operon (the five genes, one 
after the other), surrounded by the BioBrick prefix and suffix. After examining the 
operon in greater detail, Eleonore realized that some bits of the genetic sequence 
were out of sync, and producing undesirable (or, apparently non-functional) 
amino acids. She then carefully planned removal of non-functional DNA and 
mapped out all the useful nucleotides so they were lined up to optimally make the 
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desired proteins (which would ideally produce the desired pigments). Eleonore 
also added standard parts to her designs that were meant to improve protein 
yields. Designing this kind of construct in silico necessitates a thorough 
understanding of the biology (in broad terms as well as specifically in the genetic 
system that is being engineered) in order to judge what might make the system 
work better, be it through the addition or removal of segments of DNA.     
 
Figure 4.8b: Evolution of a gene design 
Design 1 
 
 
Design 2 
 
 
Design 3 
 
 
Design 4 
 
 
Modified from ‘Stages of Design’ post (12 August 2009): http://labrat.fieldofscience.com/. 
 
Upon completing the design online (a process which involved a great deal more 
thought than I describe here), it was as easy as sending the code attached in an 
email and waiting for DNA 2.0 to synthesize. The team’s bespoke violacein 
sequence arrived by courier a few weeks later. Then, the experiments with this 
novel construct commenced. After one unsuccessful attempt, this specially 
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tailored sequence was transformed into live E. coli cells. A few rounds of 
microbiology experiments later – chopping and changing parts of this construct – 
Eleonore had this synthetic system producing violet and green pigments. Further 
results details are found in the next chapter. Understanding the evolution of the 
project ideas, the team dynamics, as well as the experimental practices in the 
Cambridge team, I turn to discuss the Imperial College group’s mid-project 
developments. 
 
4.2   Evolving ideas at Imperial College 
The project develops 
After the team decided to attempt creating drug-producing, self-encapsulating 
bacteria, there remained several steps to fully formulating the project before 
experiments could begin. One major (somewhat stalling) point was deciding 
which application the group would gear their project toward. Several possibilities 
were researched, including providing treatments to lactose intolerance, Gaucher’s 
disease, cancer, cystic fibrosis and glycogen storage disease (Andersen’s disease). 
With each potential application for a given ailment, students worked out a basic 
understanding of biochemical deficiencies; they considered ‘compelling’ 
messages that could be coupled to the project; they worked out a hypothetical 
drug intervention; and they examined feasibility. I should emphasize that the 
project was recognized as having rather lofty ambitions; students knew they 
would only be able to construct a fraction of the overall project and there was no 
realistic possibility of them actually constructing a drug-producing E. coli for 
human consumption. As the team chose to focus more on an exciting project 
vision, they sometimes made quite creative. For example, one student found a 
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study showing that anthocyanin prevents oesophageal tumours in rats, as well as 
colon cancer; the grand hypothesis that followed this finding was that if the team 
could synthesize this compound, they might be able to pitch their project as a 
cancer treatment.  
 
Deciding how to narrow down the project’s applications and refine the 
engineering approach was largely driven by early comments from head professors. 
At one point, Bernard suggested that “children and disease is good… working to 
solve AIDS in Africa or curing cancer – this is the stuff that appeals to a Western 
consciousness… the stuff that wins”; he also commented that students shouldn’t 
hesitate to put pictures of suffering children in their presentation, if applicable. 
Joking aspect of this comment aside, it was odd to encourage this kind of 
fantasising to a team of aspiring practitioners of biotechnology. There were a few 
cringing expressions during that meeting. Beyond advising the students to focus 
on one or two captivating applications, the professors also stressed showing 
modularity in the work so it looked like a manufacturing platform where many 
possible drugs could be made. They had to seek out something prize worthy. 
Furthermore, it was advised that each module should be represented in 
engineering terms – with plenty of computer models, data and maths. Roger also 
emphasized that students ought to show “quality control before consumption”, as 
people might dislike the idea of consuming their medications with a genetically 
engineered bacteria – the obvious fear being that the bacteria could interact 
harmfully inside the human body, or multiply out of control.  
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With each day spent researching and debating the project in theory, pressure to get 
started on something in reality mounted. After three weeks of tireless work (days, 
evenings and weekends), the team outlined their (hypothetical) emotive and 
engineering-driven project, paraphrased here (and visualized in Figure 4.9):  
• The project: Auto-encapsulation of protein drugs for release in the 
small intestine. 
• Applications of focus:  
o Treatment for Phenylketonuria (PKU) disease: PKU is a genetic 
metabolic disorder, characterised by a deficiency in phenylalanine 
hydroxylase (PAH), the enzyme needed to metabolise 
phenylalanine. When phenylalanine is not properly metabolised, its 
build up causes problems with brain development, leading to 
mental impairment and seizures. There is no cure for PKU; its 
negative effects are reduced by special diet alone (low in proteins 
and starch). The diet, however, is unpleasant and decreases quality 
of life for PKU sufferers, particularly children and teenagers. The 
team aims to develop an application that would allow PKU 
sufferers to eat a normal diet by delivering PAH enzyme to the gut 
(in the form of an encapsulated, microbiologically produced drug) 
to break down phenylalanine before absorption. 
o Engineering cellulase to “help end world hunger”: Humans lack 
endogenous enzymes to digest cellulose. However, if we were able 
to metabolise plant cellulose, it could be nutritionally beneficial to 
a human diet – not only providing dietary fibre, but also nutrients 
and calories. The team aims to develop an application that would 
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deliver the cellulase enzyme to the gut, which would allow higher 
calorific and nutritional output from plant consumption. Arguably, 
students remarked, this project could “help end world hunger”. 
(“Just imagine if you could eat wood!” exclaimed one student.) 
• Demonstrating modularity (an interchangeable, multi-purpose drug- 
manufacturing platform) through defined stages: 
i. Cell growth: Cells grow to a critical density before the system 
starts.  
o Chemoinduction: The addition of IPTG (a common molecular 
biology reagent) kick starts the system once cell culture has 
reached sufficient density. 
ii. Module 1 – Protein production: Produce a protein of interest. 
o Autoinduction: The cell culture has two carbon sources for 
consumption. Once the primary source (glucose) has been 
exhausted, the system switches to metabolise the secondary carbon 
source; this switch triggers commencement of the next module, 
encapsulation. Furthermore, adjusting initial concentrations of each 
carbon source affords a programmable time delay between 
Modules 1 and 2. 
iii. Module 2 – Encapsulation: After producing the protein of interest, 
the cell is triggered to produce colonic acid, which coats the 
bacterium and protects it from acid degradation in the stomach.102  
o Thermoinduction: The system is initially grown at 28 degrees C, at 
which point Module 3 is repressed. Upon increasing temperature to 
                                                
102 Note that during the first few weeks, while researching various applications, the group 
considered another kind of coating, alginate. However, this route was found to be far too complex, 
as it would necessitate building at least a six-gene construct. 
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42 degrees C, repression is blocked and Module 3 is activated.  
iv. Module 3 – Genome deletion: Once the cell contains the protein 
and is encapsulated, this module triggers over-expression of 
restriction enzymes that cut up DNA, thereby killing the bacterium. 
o Secondary encapsulation:  Hypothetically, the generated material 
would be encapsulated again and manufactured into tablet form, 
ready for consumption. (For obvious reasons – cost, lack of time 
and equipment, health and safety, etc. – the team did not plan to do 
this for iGEM.) 
 
Figure 4.9: Mapping out the project vision 
 
 
Within this clearly outlined project, there were logical sections to be drilled down 
in specific detail. Two engineers and a biochemistry student proceeded to work on 
several models for a timer and the switches (chemoinduction, autoinduction and 
thermoinduction), while biologists mapped out which genes would be required to 
produce compounds of interest, allow for the bacterial encapsulation and initiate 
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“cell suicide”.103 The biologists also had plenty of background research to do in 
terms of understanding quality control variables: they needed to know information 
about pH and other conditions of the human GI tract; they needed to explore 
unintended effects that this drug-production method might lead to; they needed a 
good idea of how the genetic components they would use function, so that they 
could attempt to build a hypothesis about safely designing this system’s 
interaction with complex human bodies. Obviously, students could not look into 
all possible considerations of their project, virtually an endless task when 
considering a human intervention; however, as advised, the team was 
demonstrating a concerted effort to investigate and integrate finer details into their 
project that they hoped would look impressive at the competition.  
 
The Imperial College team didn’t go into the wet laboratory until a comprehensive 
vision of their system had been constructed (unlike the Cambridge team where 
experiments were underway early, while the project ideas evolved). They were 
also waiting on certain components for the project, such as genes requested from 
other academics or ordered through a DNA synthesis company. This postponing 
of hands-on experimental work meant the team did a great deal of planning out 
protocols along with further developing ideas in the dry lab, such as making a 
timer. However, making the designs more intricate turned out to be time wasted 
when, in week five, the senior advisors rejected the complex plans in favour of a 
simpler approach. 
Go for simple design. Do not go for complicated – it won’t add 
anything to the project… What will improve our position in the 
competition are data and some functioning parts. It is not about over-
                                                
103 I won’t go into more technical detail. Note that, as with the Cambridge team, genes were taken 
from The Registry, ordered from a DNA synthesis company and requested from other academic 
laboratories. For further, see: http://2009.igem.org/Team:Imperial_College_London/Wetlab.  
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complicating and tweaking at the moment; it is about the basics.          
– Roger  
Even though dry work proceeded to some extent (with theoretical models and 
data), and wet laboratory prep was done (e.g. competent cell strains were prepared 
for future experiments), not gathering data from real experiments until after week 
six was a significant hold-up. Looking back at that stage, Matt commented: 
We had a meeting with the professors and it was basically the end of 
week six and they just asked what we were realistically going to be 
able to do. So, we looked at all our assays… and we said, ‘OK, we’re 
going to look at one gene from Module one; we are going to look at 
encapsulation because that is the most important part of or project; 
trehelose is not really going to – well, it was a bit of an extra, it would 
be nice if we got it but probably we probably weren’t; and Module 
three we can sort of get what we can’. So that was quite important 
because, in our minds, it put us all on track in terms of what we were 
going to be able to achieve in the short time we had left. This 
signalled going from theoretical to practical. 
 
From the project’s start, I mentioned my willingness to help the team with a 
human practices side project, as the competition’s website clearly stated that this 
would be considered in judging the projects. It was encouraged that iGEM 
students address synthetic biology’s broader issues in public engagement, 
intellectual property, safety and security, as applicable to their projects. Given my 
familiarity with such topics, I was well placed to help the students do something 
meaningful in this regard. Moreover, I felt that this is could be a valuable 
component to the iGEM learning experience and I wanted to offer a gesture of 
thanks for all that I had been taught by the team. There was mixed support for 
taking on this work and despite there having been ample time to start building a 
human practices project early on, it was set aside as something the team would get 
around to later. As later in the project approached, support for doing a human 
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practices section seemed to wane – students and advisors alike were stressed 
about getting the “real work” done, with Zach, for instance, remarking that “any 
moment not spent in the lab is a moment wasted”. A few students also filled me in 
on what was said in meetings that I could not attend. Second-hand, I’d heard that 
Bernard said he didn’t understand the point of doing an ethics project; John, 
however, was more encouraging and thought it was a good thing to do if it didn’t 
take much time. The human practices project was also competing for time that 
some thought would be better spent not only in the lab, but also on improving the 
Wiki, building the presentation, getting the poster started and designing team T-
shirts. 
 
Still, there was enough enthusiasm with a couple of students (especially Andrew) 
and a couple of advisors that we were able to go ahead with an “ethics side 
project” in week eight. Before explaining how the ideas for this section of the 
project evolved, it should be noted that the group also had a one-day workshop 
with a designer that occurred earlier in the project. On that day, students were 
encouraged to engage with broader implications of synthetic biology by imagining 
possible futures for the field, once applications hit the mainstream. Although this 
one-off exercise was creative and fun for the team – as they clipped through 
newspapers and magazines and made artful poster presentations that constructed 
hypothetical timelines for synthetic biology’s future – the idea of actually 
incorporating critical design in the project to think about social and ethical issues 
did not significantly materialize.104   
 
                                                
104 The reader will see in the next chapter that, at Cambridge, the inclusion of critical design 
perspectives became integral to their project.  
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When Andrew and I finally found time to think about the human practices project, 
we brainstormed (as the rest of the group continued with other tasks at hand), 
talked through goals and set out a specific plan for how to achieve them in a 
timely manner. Andrew expressed that he really believed that having a human 
practices project would help the team win a prize at the competition, and, more 
profoundly, he wanted to “provoke a change in how people view the project”. He 
had been reading through an old philosophy text he studied during his 
International Baccalaureate – Andrew pointed out quotes from Pascal, Sartre, 
Hobbes and Nietzsche, describing to me his interests in questions such as ‘what is 
the meaning of existence?’; ‘is scientific knowledge factual?’; and ‘what is the 
universal value in humanity?’; as well as his curiosity in Kuhn’s theory of 
scientific revolutions or Popper’s concept of falsification. Andrew also explained 
that he had a friend who studied philosophy, with whom he enjoyed regularly 
talking about bioethics. The friends had co-written a couple of articles, including 
one that described the potential of biotechnology to “sow the seeds of our own 
destruction”.105 Andrew clearly had a deep curiosity in philosophy and sociology 
of science, and a desire to do “something more than just throw around the 
buzzwords” (i.e. biosafety, IP and biosecurity with respect to synthetic biology). 
However, we both recognized the team’s pragmatic priorities and were mindful 
not to add much more to the already lengthy To Do list. After two general 
discussions and one meeting with the whole group,106 we outlined a plan: I would 
                                                
105 Andrew gave me a copy of this article, evocatively entitled, ‘I have a gene, that one day…’. 
The article considered issues of human enhancement as well as social and political conflicts that 
may arise across developed and under-developed countries as a result of ‘the biological 
revolution’. It concluded: “the key to safely undergo this major turn is scientific and social critical 
debate… [to] permit society to sow the seeds of responsible change as opposed to those of human 
destruction”. 
106 This meeting generated a couple of interesting, if not bizarre comments. One student suggested 
we get an anti-GM activist to debate with the team on film; another student suggested the team go 
Speaker’s Corner to try to generate a public discussion. This latter idea was quickly snapped back 
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run a morning workshop to stimulate discussion on various commonly depicted 
social and ethical issues in synthetic biology; I would then interview each student, 
loosely talking around three themes (described below) and this would be video-
recorded. The video footage would then be cut down and used in the team’s Wiki 
and at the Jamboree; finally, Andrew and I would produce some written work to 
describe what had been learnt in this team’s human practices exercise. The three 
areas explored in interview were: 
(i) Describing the project in lay terms – Andrew and I decided that an 
important challenge for iGEMers to meet was to be able to present 
their work in a publicly accessible fashion. 
(ii) Reflecting on the nature of materials used – Discussing this 
subject was meant to provoke students to think about and articulate 
how they felt about being the creators of new biological forms. Did 
students believe that there was any special nature to these materials of 
‘life itself’ or were they just another laboratory reagent?   
(iii) Risks – This topic was meant to get students thinking about the 
risks particular to their project and how they might be mitigated.  
The human practices work is further discussed in later chapters. Now that the 
reader understands how the project vision had developed as the group proceeded 
into the design and experiment, I turn to explore the evolution of team dynamics.  
 
The team evolves 
As an ambitious group, there were a few minor interpersonal struggles as students 
competed to have their individual visions achieved. Still, on the whole, the team 
                                                                                                                                 
at by Pierre: ‘don’t expect to go to Speaker’s Corner unless you want to deal with some Hamas 
group of fundamentalists or other religious fanatics!’ 
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got along well, appreciated that every person was crucial to the group’s overall 
success and an increasingly friendly atmosphere developed. That’s not to say that 
they did not experience a collective elevation of stress as time ticked on. Five 
weeks into the project, the team had only just started wet laboratory work and an 
anxious depression descended on the group – amongst students, mid-level 
advisors and professors alike. At the beginning of a team meeting around this 
mid-way point, Roger remarked disappointedly, “Is it Friday the 13th?” and 
Andrew admitted, “The project just isn’t going fast enough”. That meeting 
became one of a few sessions that addressed built up emotions and attempted to 
get the team back into gear; here, a few excerpts illustrate this session’s tone: 
We’re at least a week behind on the wet lab and on the BioBricks!  
– Max  
It is very hard to balance what quality the team wants to achieve with 
moving forward with the ideas and the lab work… – Kajan  
You [students] are not listening to our [advisors’] points! – Olivia 
Sometimes people are hiding a bit when they don’t know what is 
going on in the biology. But people need to learn from each other and 
voice when they need help. – Andrew   
If we continue like this, we just aren’t going to do anything. What are 
the reasons behind us not getting where we should be? … We are a 
team – we sink or win together! This is really starting to get 
annoying… – Roger  
If you go into the final, you will be presenting in front of a thousand 
people. You need to have personal pride in this project. A half-assed 
job is not good enough, not for what we’re after. – John  
The mid-way phase of iGEM is very hard. It is difficult to see your 
way through the number of difficulties coming up. But, the key thing 
is to keep it moving and do so as a team. This is a competition – this is 
not just research! … You need to pull yourselves together and dig 
deep! … Do you really want to win this competition? Do you want to 
make an impact? How important is that? Because if not, you might as 
well bugger off. – Roger 
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At this same meeting, advisors declared that they would need to know who would 
commit to working beyond the initial obligation of ten weeks – it was expected 
that this would be everyone. In order to get the project to a competitive level, it 
was decided that students would have to accept that they’d be working right up 
until the Jamboree in the last weekend of October (this meant no holidays and 
working in any spare time once the academic term commenced in late September). 
Some students were whole-heartedly committed to making the best possible 
project and wanted to push ahead full steam, while others felt a little annoyed that 
they would have “no summer”, spending the best part of four months fully 
devoted to iGEM. Advisors wanted the students to show more determination and 
respect for their advice, while students felt frustrated by the lofty and critical 
comments that Bernard and Roger tended to make when they were quite removed 
from the team’s day-to-day actions. The stakes got higher as the competition 
finale drew nearer and I was very aware of being sensitive to the team’s stress, 
often taking up more of an observer role, rather than a participatory one.  
 
The group reasoned, similarly to the Cambridge team, that delegation of specific 
tasks to individuals (or pairs) on a weekly and daily basis was the best strategy to 
propel the work forward. After a slow start in nailing the project down, at week 
six, the team began to separate into the dry and wet laboratory bases – 
inconveniently on opposite sides of campus. Although students at Imperial 
College expressed the same kind of technical language barrier difficulty that 
Cambridge students struggled with, there was more mixing of disciplinary 
backgrounds over the iGEM months for this group. There were typically two to 
four students who worked on modelling: Nisha, with her bioengineering 
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background; Soo, with her engineering background; Kajan also did some 
modelling work, though he was new to it (coming from biochemistry); Andrew 
did some dry work too (he too comes from a biological sciences background). 
Zach and Felicity (both with biological sciences backgrounds) led the wet 
laboratory and were also joined by Matt and Sita (both from bioengineering and 
new to wet work); Kajan and Andrew also worked periodically in the wet lab, 
especially towards the project’s end. On the challenge of working in a new 
discipline and the importance of perseverance and collaboration, Sita remarked: 
From an engineering point of view, it was quite hard to firstly get into 
reading these biology papers and understand them to the point where 
we could say, ‘OK, we could modify this or that…’ But then once 
you’ve looked at different journals and stuff online, you’ve kind of 
trained yourself up to learn the kind of things you’re looking for. Also, 
input from others is critical. It was key to bounce ideas off everyone. 
 
My relationship with certain team members also developed. I spent a good deal of 
time with Nisha and Soo, who made an effort to help me understand some of the 
computer modelling. I was impressed by Nisha’s leadership and teaching skill, as 
she was incredibly patient with my slow learning process. Nisha and I had a 
friendly connection, talking outside the context of iGEM too about her interests in 
neuroscience, her travels and future ambitions. I also bonded with Andrew more 
than some of the other students, owing to his involvement with the human 
practices project and interest in my work. My relationship with other students was 
friendly and relaxed; I was grateful that, despite the obvious stresses, everyone 
made an effort to explain to me their work when it was convenient (something I 
judged carefully). Luckily, in biology, there are always waiting periods – waiting 
for the results of one step of an experiment before proceeding to the next – so, 
when in the wet laboratory, I tended to interject especially at these moments.  
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Gradually, my working rapport with Max and Pierre improved and they were 
usually generous with their time spent talking with me. Max was accommodating 
about what was going on in the wet laboratory, explaining experimental workings 
in understandable terms and periodically discussing synthetic biology’s broader 
field gossip. With Pierre, his initial distaste for my social sciences work 
occasionally broke down, for instance, when we discussed parallels between 
economic and biological modelling. As time went on, I was also developing a 
certain robustness as a researcher – even when Pierre continued to roll his eyes at 
the social scientist’s opinions (for instance, during the human practices 
workshop), it troubled me less and less. Besides, Pierre had shown a tendency to 
roll his eyes at most people, at one time or another. The other, more senior 
advisors – John, Bernard and Roger – were not involved in much day-to-day work 
of the team and when everyone did get together for meetings, the focus was on 
exactly what progress the students had made and setting out expectations for what 
was to come. Aside from the very early stages of my work at Imperial College, it 
wasn’t until during and after the Jamboree that I had much chance at casual 
conversations with these participants. Overall, I had a more distanced set of 
relationships at Imperial College than I did at Cambridge. Nevertheless, good 
working connections were achieved and now, with hindsight, having a 
comparison of field locations affords a deep appreciation of how specific 
individuals and institutional cultures really shape ethnographic research findings. 
With the background of how ideas and team dynamic evolved, I finally turn to 
detail some of this team’s design and experimental practices and processes.  
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Practices and processes  
Figure 4.10: Separate dry and wet laboratories 
  
 
In the wet laboratory, much of the work involved routine activities that are 
described earlier in this chapter (with respect to Cambridge’s practices and 
processes), so I won’t belabour another explanation (Figure 4.4, the BioBricking 
process and online ordering of synthetic DNA107). Most notably, the team’s middle 
weeks involved a progressive scaling back of expectations about what could be 
achieved in each project module, as biological complexities were confronted at 
seemingly every intended step. Olivia and Max assisted students in the wet lab, 
and their commitment was crucial in keeping the team going, despite a long haul 
of unsuccessful experiments. Olivia explained that typically, she or Max would go 
through experiments with students two to three times, patiently trying to work 
through possible problems; however, she also noted that “at a certain point, it can 
just be a huge waste of time and money” and so occasionally her or Max did 
procedures themselves.  
 
Max commented that students were “pretty good” at building procedures (e.g. 
BioBricking) where they were “applying the rules and carrying on”; however, 
                                                
107 The Imperial College team’s online-ordered synthetic DNA was significantly smaller scale than 
the Cambridge team. 
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testing procedures were more challenging, where there are many additional 
variables and “it can take a lot of de-bugging”. The reality of several experiments 
was that it had been “tricky to try to get the bacteria to behave how we’d expect”. 
Only one week prior to the competition, Max still felt that the team was at a key 
stage, without much data at all, striving to show proof of principle in each module:  
They’ve got it all laid out but they just need time now to test it. So, 
we’ve got the next week before the Jamboree. It is almost the most 
exciting part of the project – right before the Jamboree… to get the 
results is the most important part of the project. I mean last year, the 
most key result was got the day before we flew. So today could be a 
very important day – this RCSB, the encapsulation part, is the most 
important part of all of it. So fingers crossed, hopefully it will work. 
The team was late in acquiring results – constantly faced with a biology that 
resisted their engineering attempts – and the majority of wet lab time was spent 
setting up, and re-setting experiments. Still, in the next chapter, the reader finds 
details of the team’s results, acquired just in the nick of time. The photos below 
illustrate some typical laboratory practices.  
 
Figure 4.11: Scenes from the wet laboratory 
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The team’s neatly labelled DNA; plates on the bench; mixing and pipetting. 
 
Moving to the dry lab, note again that the following chapter details models in their 
final form, with completed mathematical equations and graphs describing rates of 
change (even if only hypothetical proofs of concept). Throughout August, 
modellers focused on developing the mathematics that might simulate the 
transition stages of their overall project vision – the auto-induction, chemical 
induction and thermo-induction – and they also did a bit of theoretical work on 
enzyme kinetics. Figure 4.12 illustrates how this process began, similarly to the 
Cambridge team, by roughly sketching out equations and corresponding graphs 
that they might expect biological experiments to yield. Because of a long delay in 
acquiring any results from the wet laboratory, the students often did “plug and 
play” – inputting hypothetical values into their equations, yielding hypothetical 
graphs and computer simulations, rather than using real data.  
In a way, the modelling was trying to compliment some of the things 
that we didn’t really get to do in the wet lab. But, then again, it is 
always better to kind of refine things later on so it didn’t quite get 
there because there were sides of the project that were still missing...  
– Nisha  
Everyone felt a bit in limbo until quite late in the project when, literally just days 
before the competition, there were some wet lab results to work with.  
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Table 4.12: From modellers’ notebooks 
   
 
For the human practices project, I began the workshop with a few provocative 
video clips from an interesting, if not hyperbolic and biased, BBC documentary 
which dramatically claimed that with synthetic biology, “scientists are close to 
repeating what has happened only once in four billion years – the creation of a 
new life form”.108 The students and Pierre attended the workshop and, though I 
was disappointed that the advisors showed little support for this event, the small 
group led to a relaxed and conversational workshop, with students leading 
discussion, while I periodically interjected to raise questions: 
• What might broader publics think of synthetic biology? Should 
scientists be responsible for doing public engagement? Who is 
accountable for explaining this field to lay audiences – scientists, 
policy makers, social scientists, private companies hired to do public 
opinion surveys? Are there any foreseeable problems with engaging in 
a public debate about synthetic biology? 
                                                
108 ‘The Spark of Life’, an episode in a series entitled The Cell was aired on BBC Four (26 August 
2009): http://www.bbc.co.uk/programmes/b00mbvfh. 
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• Is it at all unsettling that synthetic biology seeks to engineer life anew, 
for human purposes? Does this field’s development really imply a 
“second genesis”, as the documentary suggested? 
• What are the risks in synthetic biology, broadly and specifically in the 
team’s project? Who is responsible for governing the field?  
Though I understood that having this group talk would influence students’ 
responses in interviews that I conducted later that afternoon, Andrew felt that 
some team members wouldn’t know what to say without having had a collective 
discussion about the human practices themes. Although I disagreed in some sense, 
as this was intended to be an exercise of the students’ design, I followed 
Andrew’s suggestion. All eight interviews were completed, back-to-back, taking 
no more than 30 minutes of most of the students’ time (and ending in my 
exhaustion). A few days later, I enrolled in a workshop and learned to edit video. I 
then spent time turning over four hours of footage into a 30-minute cut of 
thematic interview clips for the students to reflect upon and use. The next chapter 
describes some interview highlights, as well as two documents that Andrew and I 
put together; further interesting plot twists with this aspect of the project are 
detailed in later chapters.  
 
Conclusion 
This chapter has captured some of the many challenges, practices, protocols, team 
dynamics and idea evolutions that both groups experienced during their design 
and experiment phase. There is, of course, overlap between this phase and the 
earlier stage of dreaming up ideas, as there is also overlap with moments of 
experimental success that yielded material results (next chapter). Previously, I 
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have shown the ways in which students utilized intellectual technologies (from 
mind mapping to computer forums) in order to dream up ideas, as well as 
described certain personalities and a different set of institutional cultures; these 
themes continued to be important in this chapter. Yet, in observing ideas turn into 
wet and dry laboratory practices, a number of additional conclusions arise: 
• Synthetic biology, as taught and practiced through iGEM, entails a 
conflicting understanding of biology as both discretely engineerable 
and impenetrably complex. Nowhere is this tension more apparent 
than in the transition between synthetic biology as a way of thinking to 
synthetic biology as a way of doing.  
• Synthetic biology, in practice, is far from a merging of biology and 
engineering; rather, it is about finding an effective way for biologists 
and engineers to work together, through different language barrier 
issues and visions of what might be possible. 
• A successful iGEM project requires a team dynamic that supports 
getting through the many challenges facing iGEMers.  
• Even in two seemingly similar institutions there are significantly 
different views on how synthetic biology ought to be practiced and 
performed in this competitive context.  
 
In its ideal conception, synthetic biology is described as the creative coming 
together of synthesis, sequencing and computational technologies, under a true 
engineering109 framework applied to biology; it is a field that brings modularity 
and physical standards to genes and microbiology so that, with grand functional 
                                                
109 This claim is often made and opposed to earlier decades of “genetic engineering” that saw ad 
hoc methodology and a limited scope (“just chopping and changing one or two genes”). 
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visions, biological machines can be designed and built, only restricted by the 
imaginative capacities of its practitioners. However, this chapter has demonstrated 
that when it comes to actually getting ideas of a synthetic biological system off 
the ground, a process of simplifying the goals to what is achievable is of utmost 
importance. Most ideas that students are encouraged to dream up when armed 
with synthetic biology ideals are not even remotely possible experimentally 
because of a vast array of (known and unknown) biological complexities that 
resist being (re-)engineered. Specific to iGEMers, Pierre commented:   
They’ve got very little experience… They can’t criticize what’s on 
paper and they think that everything is reproducible – which is 
definitely not true in the case of biology. So they start building up 
grand ideas about, ‘we can put this together and that together and if 
you put two and two together, you’ll get four, five and six…’ But the 
bottom line is you are not even sure you’ve got the two, let alone that 
two and two put together will give you six – three, at best! When you 
are very lucky. And that is probably what they discover over the 
summer, which is that you probably cannot trust what is printed. 
Experiments are incredibly difficult, unreliable and full of surprises. 
Basically, what you’ve started with – your grand idea – after a month, 
you realise that, well, it might not work that well... iGEM is a very 
ambitious project, but it is also very short. 
Note something interesting here – the initial messages in iGEM teaching and 
promotion of synthetic biology ideals are misleading, and experienced advisors 
clearly acknowledge this. Frederick of Cambridge added that iGEM advisors 
always have a good deal of comforting to do, when students inevitably realize that 
synthetic biology is not yet what it wishes to be – every year, he claimed to tell 
students, “it’s OK, it’s not necessarily you; it may just be that the molecules don’t 
want to do that and that’s the way it goes”. Yet, for a lucky few, successful 
experiments – such as Cambridge’s design, engineering and implementation of 
the violacein construct in living cells – keep the iGEM competition celebrating 
synthetic biology’s grand potential.  
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Another popular statement – that synthetic biology is a “merging of engineering 
and biology” – is worth deflating a little. In practice, this field really involves 
different disciplinary perspectives finding a way to their appropriate tasks for a 
given project. Although there were a couple brave students attempting true 
interdisciplinarity at Imperial College, my dominant observation was that 
engineers and biologists tended to prefer sticking to their own backgrounds – to 
either be fascinated with biological systems, or to programme and develop maths 
for systems dynamics in order to optimize engineering. They don’t understand 
each other’s languages: biologists may have a resourceful explanation for a given 
system’s functional complexities; engineers want good data that they can 
“crunch” in order to produce models, graphs and predictions.  
 
Interestingly, I might add that when Eleonore – the committed, self-identifying 
biologist, not synthetic biologist – was working on the violacein construct, she 
expressed considerable distress about a kind of disrespect for the natural order of 
things in this outsourcing, re-designing and re-engineering process of making 
synthetic DNA:  
I was a bit worried because I’ve always had this kind of non-synthetic 
biological view that the gene must not be messed with… If there are 
bits in there that don’t seem to be doing anything, they probably are 
doing something, and we were just cutting those bits out, choosing to 
have only the protein coding regions, one after the other… Then we 
codon optimized it, and I did a bit of that myself but a lot was done on 
DNA 2.0’s programme… And that felt wrong – actually going around 
and changing bases… I was thinking, ‘what the hell am I doing to this 
genetic code – this is not going to work?!’ … It felt weird, I’d be 
thinking, ‘this gene should know what it’s doing by now’110… But it 
makes sense, because when a bacteria makes colour, it doesn’t want to 
do it optimally, because that would probably kill it – it would take 
                                                
110 Alluding to evolution’s natural work. 
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away too many metabolic resources to create too much pigment… so 
it is beneficial for the bacteria to use worse codons [in nature]. 
How biologists and engineers differently qualify and appreciate synthetic biology 
will arise again in later chapters. 
 
I have also begun to demonstrate the importance of positive team dynamics and 
leadership. iGEMers face a long haul of re-evaluating and scaling-back initial “Big 
[dreamy] Ideas”, an extremely steep learning curve and months of committed 
intensive work – not to mention lessons in dealing with criticism from themselves, 
peers and superiors. Pierre, with his usual cynicism, remarked, “iGEM is basically 
about projects that are born to fail” and “as a general rule, iGEM students have 
never really failed before – they are bright students who have always done well in 
their studies”. To a large extent, this experience becomes about personal growth 
and developing group work skills. I’ve highlighted some examples in this vein –
Emma and Senni’s evolving roles on the Cambridge team, as well as Andrew and 
Nisha’s roles at Imperial College as particularly strong leaders with open minded 
attitudes. Note Geoffrey’s comment here on the necessity of leadership in iGEM: 
I was very impressed by the way some team members helped to bring 
people in, bring them back into the group, continually… It was done 
very seamlessly, very unobtrusively, but I certainly noticed, we all as 
a faculty noticed who was doing it, and how they were doing it, and it 
was great. You don’t always see that, I have to say… There were key 
people. They’ve got the momentum – and I think we know the people 
we’re talking about there – and they were driving things forward, and 
again done in a very nice way, a very enthusiastic way. Because 
within a team you always find a degree of fragility at times… It can be 
depressing not getting things to work when you’ve got high hopes, 
and I think as a team they worked really well together. That’s nothing 
to do with us; I think that’s to do with the personalities and the 
abilities of the people in the group. 
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There was a very different feel to Roger’s view of the Imperial College team: 
I felt frustrated by the team actually. The team didn’t communicate to 
their advisors as much as they should have. They weren’t 
communicating well across the team and they were a bit lethargic. 
And this is something we’ve never had before. We’ve always had very 
responsive teams – and we couldn’t quite put the finger on it this year. 
We didn’t know whether it was personalities or whether the team just 
didn’t gel. 
Certainly, this group seemed to face more challenges and communication 
difficulties than I witnessed at Cambridge – and yet, this was undoubtedly a very 
dedicated, highly intelligent and friendly group of students. Perhaps the different 
dynamics across these teams – at least, as judged by senior advisors – is partly also 
a result of different paces and degrees of successful outcomes (discussed in 
Chapter 5). I would also venture that different institutional cultures, values and 
approaches – one that has a tendency to follow creative ideas with a less 
competitive edge (Cambridge) and another that generally pursues applications with 
a highly competitive rigour (Imperial College) – influenced how the teams and 
ideas evolved over the course of these projects. 
 
Adding to that point, these different institutional cultures are indicative of the 
currently multiple – and sometimes divergent – ways in which to understand and 
perform synthetic biology more generally. Speaking on the approaches to this 
emerging field, and again separating biologists and engineers, Roger pointed out:  
It depends on the university but I suppose that certainly at Imperial, 
we’re more applied in our thinking… We’re using synthetic biology to 
solve problems, so it is very much an engineering approach. That is 
what engineers do – they solve problems. Biologists, you know, 
explore and try to find out how things work – they don’t necessarily 
solve problems. Biologists solve hypotheses not problems – 
hypotheses and problems, as you probably know, are slightly 
different. Synthetic biology is not a hypothesis driven science – it 
probably wouldn’t be very successful if it were… At Imperial 
College, we’ve got a bunch of engineers and students who want to do 
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something. I think that’s the power of this field. Now, other 
universities don’t necessarily do that – most do. Cambridge wants to 
develop technologies that could be useful ultimately, but perhaps 
they’re not as hard-core applied as we are. 
 
At Cambridge, Samuel contended: 
There are those great fans of the engineering approach… and, there’s 
actually nothing wrong with that if you’ve got a mature technology to 
underpin it. If for example, you have digital electronics, you want to 
make some kind of device and it’s simply a matter of finding the best 
way of assembling the underpinning logic to do that, then cool, no 
worries. But in biology, it’s a little less tangible than that because the 
rate-limiting step is actually finding the function and you don’t have, 
at this point, modular, universal tools to put things together. What you 
have is the biosphere and you need to pull out the various pieces that 
you need from the biological literature… And these are all naturally 
evolved systems and actually you have this huge diversity of function. 
It’s a bit like mining… 
Synthetic biology aspires to a mature technology state of having off-the-shelf 
components – and has gone some way with BioBricks (albeit a limited number that 
function reliably across different experiments) and bespoke online services to 
design and synthesize DNA. However, the technology remains immature, very 
flawed in practice and in need of a great deal of mining for suitable materials. 
Samuel added that, the Cambridge view is driven by the richness and “untapped 
nature” of biological resources. He continued:  
Real innovators in biology’s history… didn’t set out to make some 
kind of astounding discovery – they were curious people who were 
out looking to make lateral connections. And if you have a top-down 
approach you miss lateral connections by definition, because you’ve 
defined the project already. But if you have a degree of freedom to 
investigate, to think, so that the brainstorming process doesn’t end 
with the definition of the project but rather continues with 
investigation of the parts – as it should, as any kind of scientific 
endeavour should maintain that degree of flexibility. I know to my 
core that that’s how innovative biologists work…111  
                                                
111 When Samuel explained this view to me, he told stories of famous biological discoveries that 
were the result of serendipitous explorative-style research – for instance, the group who 
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These passages point out intriguing differences in approaches to synthetic 
biology. Recall that one aspect of the Imperial College project was certainly that 
once they had their modules and project overview, they stuck with that top-down 
design and drilled down into each module, trying to attain enough results to build 
a proof of concept argument for each section. The Cambridge group had an 
overview in which the project evolved but, as the reader will see in Chapter 5, 
there was a good deal of lateral thinking when, later in the summer, they were 
challenged by designers to really think about how their work might fit into a 
broader context of applications and implications. Thus far, it should be clear how 
different frameworks for thinking about, and doing, synthetic biology are in-the-
making and contested at this field’s presently early stage.  
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                                                 
accidentally discovered Green Fluorescent Protein (GFP), a luminescent protein found in jellyfish 
that has turned into one of the most revolutionary tools of contemporary bioscience.  
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5.   MAKING REAL 
 
This chapter describes the tangible new biological entities that the teams 
constructed. An overview of each group’s final results is given and some missed 
goals as well as potential futures for E. Chromi and the E.Ncapsulator (the 
playfully titled final projects of the Cambridge and Imperial College teams 
respectively). I also revisit Hacking’s (1983) position as a ‘realist about entities 
and an anti-realist about theories’, claiming that, although the projects do not fulfil 
their hoped for forms, there remains good reason to pay attention to the fact that 
undergraduates, working in a limited time frame, are capable of engineering new 
biological machines that operate according to bespoke design. Ideas on ‘machine’ 
and ‘organism’ are also highlighted, provoking consideration of how humans may 
interact with potential future breeds of living machines.  
 
5.1   Making real at Cambridge 
E. Chromi: final results 
Impressively, the Cambridge team brought in initial tangible results as early as 
week three when they effectively introduced genes encoding MelA (brown 
pigment production), violacein (purple) and carotenoids (orange/yellow) into E. 
coli cells (Figure 5.2). However, there was a great deal more to be achieved in 
terms of successfully designing, operating and testing the constructs to fit the 
BioBrick format. Over eight more weeks were spent looping around a design and 
experiment cycle, doing a great deal of troubleshooting, even after the team’s 
early success. Notably, this group’s three major colour generators were made by 
different means, demonstrating a range of BioBricking techniques (Figure 5.1).  
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Figure 5.1: Colour generator achievements  
Colour 
Generator 
Achievement 
MelA MelA is mutant gene from a Rhibozobium etli bacterium. This gene encodes 
for a macromolecular compound that produces a characteristic brown colour. 
Lucky for the team, Douglas had a stock of plasmids that carried MelA. The 
team was able to extract this gene, amplify it to generate thousands of copies 
(using PCR, as described in Figure 4.4) and put these into E. coli hosts – this 
was all done using basic microbiology tools and protocols. The group further 
designed MelA by adding the appropriate features of a BioBrick (detailed in 
Chapter 4). Testing this construct’s compatibility – proving that it ‘clicks 
together’ with other BioBricks, as the Lego™ analogy implies – was the final, 
and successful, step. 
Violacein With violacein (originating from Chromobacterium violacein), the first round 
of experiments was again swiftly accomplished because Douglas had a 
working construct that students could use. Indeed, they were able to put this 
construct into E. coli and have the cells produce purple. However, when it 
came to turning this genetic unit into BioBrick form, as already discussed, the 
group realized that synthesizing the gene from scratch with a nuanced design 
would achieve much more exciting results as it could be engineered to produce 
multiple colours.112 The group succeeded at producing two shades of green 
and violet; with additional time, it was likely that this construct could yield at 
least one further colour, though the team could not do so before the Jamboree. 
Carotenoid Experiments on the carotenoid system (originating from Pantoea ananatis) 
began by using existing BioBricks from The Registry (constructs made by 
previous iGEM teams). However, upon experimenting with these BioBricks, 
the Cambridge team realized that there were ways in which these constructs 
could be improved. Senni made new carotenoid devices under enhanced 
regulatory control and achieved better output when he used a different strain of 
E. coli.113 Figure 5.3 is the data sheet that Senni made to characterize the 
Lycopene-producing device – this thorough characterization of BioBricks that 
are given back to The Registry is an important goal for iGEM teams, though 
few groups manage to get this far. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
112 Also notable, the initial Vio operon from Douglas had “many forbidden restriction sites” and so 
could not be submitted to The Registry without a good deal of bespoke alteration. 
113 http://2009.igem.org/Team:Cambridge/Project/CA02; 
http://2009.igem.org/Team:Cambridge/Project/CA03. 
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Figure 5.2: Colour producing bacteria 
   
  
 
Figure 5.3: Lycopene Data Sheet 
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Sourced from: http://2009.igem.org/Team:Cambridge/Project/CA05. 
 
In addition to the success of the colour generators, the Cambridge 2009 team built 
on the work of their 2007 predecessors and constructed a series of sensitivity 
tuners. The detail of this section of the project is too technical for non-specialists 
so I refer those interested to the team’s Wiki.114 In essence, this section of the 
project addressed how some biosensor devices necessitate extreme sensitivity to a 
given input (e.g. to low concentrations of a toxin in water or the atmosphere) 
while also having an appropriate output indicator (e.g. a strong and sustained 
signal). The team therefore made a collection of tuner devices with a range of 
sensitivity levels that could be parts of future biosensors. Also notable, the team 
focused on good characterization of their tuner BioBricks, demonstrating an 
incremental step forward in building on previous synthetic biology work. 
Interestingly, there is something at odds in terms of how the iGEM competition 
tries to promote development of the field: on the one hand, blue sky ideas are 
                                                
114 http://2009.igem.org/Team:Cambridge/Project/Amplification; 
http://2009.igem.org/Team:Cambridge/Project/Amplification/Characterisation. 
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encouraged and celebrated as inspiring for students, but such projects mostly 
cannot be realized in functioning new synthetic biological systems; on the other 
hand, it is perhaps a more productive approach to make smaller, incremental 
improvements on existing work as this is far more likely to yield reliable, usable 
material forms. With flashy colours and a clever set of improved sensitivity 
tuners, this team captured the best of both kinds of desirable iGEM results. 
 
Before moving on to describe how the team envisioned the future implications of 
their project, the following two figures show other representations of real results. 
In Figure 5.4, note that “things built” were still identified in cartoonish 
illustrations, posted up around the lab, checking off accomplishments as the team 
neared the competition. Figure 5.5 illustrates different forms of modelling. The 
first part shows ordinary differential equations that were used to mathematically 
trace rates of reaction (e.g. the rate at which genetic material is transcribed in 
experiment), concentrations of reactants or the relative activity of a promoter115. 
Note too that the team included a written explanation of their mathematics. 
Experimental data was entered into various differential equations, sometimes run 
through simulation software and graphed. Graphs enabled better description of 
what was going on in a given part of the biological system and sometimes helped 
in forming predictive hypotheses. 
 
 
 
 
 
                                                
115 See Key terms, p. 11. 
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Figure 5.4: “Things Built” 
  
 
Figure 5.5: Basic modelling mathematics; example graph; example data analysis 
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Sourced from: http://2009.igem.org/Team:Cambridge/Modelling; 
http://2009.igem.org/Team:Cambridge/Notebook/Week5. 
 
 
 
 192 
Potential futures 
Mid-way into the summer work was really under way, and students had a 
tendency to focus on ticking off the long list of important experimental and 
modelling tasks at hand. Sometimes the wider implications were lost sight of. 
Luckily, the revisiting of interaction designers116 Daisy Ginsberg and James 
King117 was well timed – the team had a good idea of their project’s goals, but 
they had not yet begun thinking about presenting and contextualizing their work. 
Daisy and James had taken the synthetic biology crash course (Chapter 3) earlier 
that summer to begin informing their design work; however, they remained 
intrigued about where the iGEMers’ project was leading and agreed to return to 
Cambridge to run a design workshop for the students to help them think about 
their project’s future implications. This workshop was also the start of what was 
eventually a highly celebrated design project that Daisy and James created and 
presented, not only at the Jamboree, but also in several other shows around the 
world.  
      
Knowing that the team was working on a pigment-producing E. coli, Daisy and 
James began their workshop by proposing seven hypothetical scenarios, from the 
present to one hundred years into the future, that focused on groups, services, laws 
and products that might be oriented around this project idea. Through illustrative 
storytelling (Figure 5.6), these designers led students, advisors and myself through 
an imagined future in which engineered colourful bacteria allowed the production 
of an easy-to-use, colour indicator arsenic biosensor (ambitiously proposed for 
2010); later, a world in which “colour-hunters” unlawfully scavenge the living 
                                                
116 See Key terms, p. 11.  
117 http://www.daisyginsberg.com/; http://www.james-king.net/. 
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world in search of colours for printing inks and food dyes (2015); then, a world in 
which hypochondriacs could have their very own “scatalog” by consuming a 
colour-producing, bacteria-infused yogurt drink that would be specially designed 
to reveal one’s state of health through colourful faeces that could be mapped 
according to a disease chart (2049); finally, in 2099, the proposal entailed a world 
in which colour is everywhere, acting as a permanent reporter of ambient mood 
sensing, with surfaces in homes and on everyday materials being composed of 
living, colour-generating machines.118   
 
Figure 5.6: Synthetic colour design futures workshop 
 
 
 
                                                
118 http://www.echromi.com/. 
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… 
Such elaborate scenarios provoked the group to reflect upon both positive and 
negative possible future implications of synthetic biology, and we (students, 
advisors and myself) were then split into groups of three or four and asked to 
come up with our own provocative stories to fill in the timeline. Armed with a 
suitcase of props (with everything from face paint to rubber balls, pipe cleaners 
and Petri dishes), we were encouraged to spend a couple hours thinking 
creatively, talking to strangers in the street, getting into character, crafting a skit – 
in short, to go wherever our imaginations could take us. It was quite amazing 
when the team reconvened to present and discuss what was learned in stepping 
away from the molecular-scale work, turning to an exploration of macro-scale 
social, cultural and ethical implications projected into a possible futures realm.  
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Figure 5.7: Brainstorming potential futures 
  
   
 
The team returned to the workshop room with renewed energy and excitement 
(which had been slightly deflated through weeks of monotonous laboratory work), 
thrilled to tell the rest of the group what they had imagined for a future world 
dominated by colour-producing synthetic organisms. One group explored how 
synthetic biology might be used in a range of products – from children’s toys to 
food dyes – and they went out into the streets of Cambridge, asking members of 
the public about their feelings on such products. They posed questions such as: 
• ‘In the future, would you want to buy your children a genetic 
engineering kit that allowed them to build their own microorganism – 
something they could dress up with fancy colours and designs, while 
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learning about science?’ (Responses to this question were generally 
positive, though so was the framing.) 
• ‘How would you feel about consuming food that had been genetically 
engineered to incorporate colourings from the living kingdom? For 
instance, would you find it suitable (or even more appetizing) to eat 
vegetables that were flamingo pink?’ (People tended to think this was 
a bit absurd and were generally not keen on this idea. Still, some 
agreed that this seemed possible and even commented that they could 
see it as a future trend of haute cuisine.) 
A debate was brought up about whether or not it would be right for colour-coding 
genes to be patented. One group took this issue to extreme in a skit where they 
envisioned a world in which the colour orange was patented and under strict 
control – much to the anger of a popular mobile phone provider as well as 
countries whose national flags were meant to contain orange. This skit led to the 
enactment of a scene in which a rebellious group – “the orange liberation front” – 
sought to terrorize the orange patent-holders (see the bomb prop that students 
constructed in Figure 5.7). Another group discussed the role of “colour hunters” in 
a world in which several industries were trying to produce new trends in colourful 
products and services. Almost every story that was dreamed up during that 
workshop seemed to be an outlandish and unlikely future scenario; yet, this 
exercise effectively prompted students to think about their work’s potential future 
applications and ramifications – good and bad.   
 
The team eventually scaled back the creative design exercise and settled that, for 
the competition, they would present the realistic near(-ish) future of their work that 
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it might provide an improved, easy-to-read colour output for an existing biosensor 
(specifically, the arsenic biosensor device that the 2006 Edinburgh iGEM team had 
constructed119). Though the Cambridge team did not do an expanded human 
practices project120, in light of these design workshops, students were clearly 
inspired with a greater awareness of how synthetic biology might generate future 
tools, products and abilities that could change how we see ourselves in relation to 
the biological world. Furthermore, it was through a creative engagement – and one 
that was somewhat in line with the imaginative brainstorming that started the 
students’ iGEM process – that genuine curiosity in human practices subjects was 
sparked across the team. I felt fortunate to be involved in these interactive 
workshops as a participant, rather than talking to the students in a quasi-instructor 
way about how to develop a human practices side project. Furthermore, I noticed 
that after the design workshop, more students asked about my research and several 
additional conversations about social and philosophical implications of synthetic 
biology were had as time moved closer to the Jamboree. 
 
It was ideal to mix my everyday, casual conversation, along with the imaginative 
design workshops that inspired bigger picture thinking among this team over the 
course of the summer. Geoffrey commented on the effectiveness of an 
unconventional approach:  
People should be taking more on board that traditional ways of 
learning, if you want to call it that, probably don’t work in these kinds 
of contexts. You can go and give a lecture on all of these bigger 
implications things and you can have somebody listen to ethics, but 
                                                
119 Edinburgh 2006 project: http://parts.mit.edu/wiki/index.php/University_of_Edinburgh_2006. 
Note too that despite whispers of collaboration, the connection of E. Chromi to the Edinburgh 
biosensor has yet to be realized. 
120 I did offer to help the students with a human practices project, but given that they had the 
designer input and plenty to do, they decided to simply write a brief synopsis of their thoughts 
from the design workshop: http://2009.igem.org/Team:Cambridge/Future.  
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basically the kids are just going to… yawn, OK, and they won’t learn 
anything. But when you talk about it in the context of what they’re 
doing and you’re asking – it’s insidious in a certain way – but actually 
that’s the best way to learn. And the best way to understand how the 
process works is by participating in it, not being lectured at.  
He went on to rave about how iGEM is particularly important to the advisors as a 
unique, enjoyable teaching opportunity that fully embraces lateral thinking and 
interdisciplinarity – that is why they make this summer experience not only 
include science and engineering, but also business minds, designers and social 
scientists. Geoffrey said of doing iGEM properly, “you can’t do it without 
engaging all of it… all of it in parallel and seriously”. In later chapters, I continue 
to highlight the influence of design interactions on the Cambridge team and in 
synthetic biology more broadly.  
      
Before moving on, it is important to recall one other matter on the potential futures 
of iGEM projects: because teams give their created BioBricks back to The 
Registry, the colours and tuners that the Cambridge team made will undoubtedly 
live on in a number of future iGEM incarnations, yet to be imagined. Of course, 
the same applies for all useful BioBricks made in iGEM. 
 
5.2   Making real at Imperial College 
The E.Ncapsulator: final results 
As a versatile drug-manufacturing platform for targeted delivery of therapeutics to 
the intestine, The E.Ncapsulator set its project aims very high; it was not 
surprising that the Imperial College team achieved a fraction (about 30%, 
according to Olivia) of their overall vision. Additionally, the most impressive and 
substantial results were obtained almost at the last minute, as the team worked 
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tirelessly in the wet laboratory right up to the day before departing for Boston. 
Recalling the heavily structured and modular project that was outlined in the last 
chapter, notably, the team developed a strategy that progressively filled in as 
much data (real and hypothetical) into each section as their design and experiment 
work progressed. Still, a good number of results (or, at least proofs of concept) 
were achieved and described on the team’s Wiki and in their presentation at the 
Jamboree. The next chapter explores how this team was coached in expertly 
selling their project but, for now, I shall describe what was actually made real. 
 
In module one (protein production), the team was unable to construct cellulose. 
This section was intended to be simple as students ordered the necessary DNA 
from a synthesis company and would only have to effectively put this construct 
into cells; however, it was hypothesized that the fatal flaw came in the form of a 
typo in their order (all it would take is an error in the typing of a sequence of 
ATCG nucleotides that they ordered from a DNA synthesis). Figure 5.8 (top row) 
includes a photo of the cellulase sequence as well a receipt sent back to the team 
for their ordered synthetic DNA – which was non-functional. Still, the team did 
produce the PAH enzyme, allowing them to tick a box in module one.  
 
In the next step of the project, the team showed their auto-induction switch from 
module one to module two (whereby a change in the bacteria from consuming a 
primary metabolite to a secondary one triggers another genetic change) could 
work; this achievement also generated nice data for the modellers. The whole 
team agreed enthusiastically that their biggest achievement was to get E. coli to 
secrete and coat itself in colanic acid; for this, they had visual evidence (see the 
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EM photograph in Figure 5.8 and note how the RcsB+ result shows an 
encapsulated E. coli and the RcsB- control shows a bacterium that was naked of 
the colanic acid shell).  
 
Figure 5.8: Making some of the E.Ncapsulator real 
  
 
   
 
The thermoinduction switch to module three was minimally successful in reality, 
though to gain some data there, the team used the ever-popular ‘proof’ of genetic 
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activity by showing different degrees of fluorescence in their construct at different 
temperatures (Figure 5.8, bottom row).121 Module three – genome deletion – did 
not work in E. coli. The team was able to show in vitro (in a test tube) that DNA 
was chewed up by restriction enzymes but they could not show this working in a 
living organism. Stretching this result, the group tried to sell this in vitro result as 
a proof of concept though not being able to operate in vivo essentially meant that 
this aspect of the project failed. Another visual appeal – showing the result of a 
restriction digest in an agarose gel electrophoresis experiment – was used (the last 
photo of Figure 5.8 illustrates how DNA has been chewed up into different 
fragments, the relative length of which can be seen according to the positions of 
bands on the resulting photograph).122   
 
As the competition’s climax moved nearer and it became clear that some aspects 
of the project wouldn’t work, the team continued to design experiments that 
would further prove – or at least sell – their project vision. A series of testing 
experiments were designed, most of which were unsuccessful. An example of one 
which worked partially was that the team made a test for acid resistance of their 
coated bacterium – in doing so, they proved some degree of higher resistance to 
acid (than a non-coated bacterium), helping support their hypothesis that coated 
bacteria would be resistant to degradation in the stomach and so could travel to 
the gut to deliver medication. 
 
                                                
121 Green fluorescence protein (GFP) is a common reporter gene used in microbiology 
experiments. When GFP is coupled to the functioning of another gene, it is used as a visual 
demonstration of the system working. However, as one advisor noted, “saying that something 
glows green doesn’t necessarily mean it works!” For further on GFP, see: 
http://en.wikipedia.org/wiki/Green_fluorescent_protein. 
122 For further technical information, see: http://en.wikipedia.org/wiki/Restriction_digest; 
http://en.wikipedia.org/wiki/Agarose_gel_electrophoresis.   
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The modelling of autoinduction is illustrated in Figure 5.9 and though I will not 
examine the technical detail, I note the amount of work that was put into this part 
of the project. Such attention is unsurprising as, in the next section, I explain how 
much of the modelling was hypothetical, owing to late or failed experimental 
results. 
 
Figure 5.9: Modelling example: autoinduction 
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Sourced from Imperial College Wiki, Autoinduction sections: 
http://2009.igem.org/Team:Imperial_College_London/Drylab/Autoinduction; 
http://2009.igem.org/Team:Imperial_College_London/Drylab/Autoinduction/Model1; 
http://2009.igem.org/Wiki/Team:Imperial_College_London/Drylab/Autoinduction/Analysis/Komp
ala;   
http://2009.igem.org/Team:Imperial_College_London/Drylab/Autoinduction/Simulations.  
 
Finally, I’d like to detail what was achieved in the human practices section in 
which students participated in the workshop and interviews that I led. Despite 
little help from other team members (who were under pressure to ‘get the real 
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work done’), Andrew and I synthesized the human practices exercise into two 
written documents (as well as an additional brochure that was brought to the 
Jamboree) and a brief video of selected interview clips.123 I’ll highlight a few 
segments from the documents and interviews to give the reader an idea of this 
section’s output.124 
 
In Andrew’s summary document, the introduction attempted to justify the 
importance of iGEMers looking into human practices: 
As young iGEMers, a good number of us are likely to comprise the 
next generation of practicing synthetic biologists. It is therefore 
crucial that we enlarge our view to include an appreciation of this 
field’s potential societal impacts. That is why we believe that iGEM 
students should think carefully about how we can help to develop this 
area of biotechnology in a safe and productive way, acknowledging 
and participating in discussions that address wider socio-political and 
ethical concerns. Such dialogue is already taking place at multiple 
levels – a number of scientists and engineers practicing synthetic 
biology are participating in debate and discussion with public spheres, 
policy makers and social scientists in order to support development 
that aims at maximizing benefits and minimizing potential negative 
impacts of the field. 
The document continued to describe the workshop, group discussion and 
interviews that made up the team’s human practices exercise. Divided into three 
chapters of video clips, Figure 5.10 details some interesting interview quotes. 
 
 
 
                                                
123 The video can be seen at: http://2009.igem.org/Team:Imperial_College_London/Ethics. Links 
to the two documents are on this site as well. However, as the documents were uploaded last 
minute (the midnight EST deadline for all teams’ Wiki lock-downs, which was in the middle of the 
night GMT), I did not have time to check them online. As a result, there is glitch with the links to 
the documents online that cannot be changed – perhaps another reflection of how human practices 
was not really paid attention by the group who were much more occupied with uploading every 
last bit of ‘real data’ that they could as the Wiki closure deadline approached.  
124 Appendix III has copies of the two documents; the brochure is not included as it reveals 
students’ identity. 
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Figure 5.10: Interview highlights from Imperial College iGEM team human practices 
1: Explain your syn bio! 
In this section, students 
reflected on the importance of 
making science accessible to 
lay audiences. Students were 
challenged to explain their 
project in simple terms, in less 
than one minute. 
2: What are you engineering? 
In this section, students talked 
about the materials of synthetic 
biology, reflecting on what it 
means to redesign elements of 
life. Is there something special 
about this kind of work? Is this 
stuff like other engineering 
materials? 
3: How risky? 
In this section, students 
talked about their efforts 
to address and minimize 
risks in their project. 
They also discussed their 
views on risks and fears 
circulating around this 
field generally. 
“The problem we are trying to 
overcome is to bypass the 
stomach and to release this 
protein of interest into the 
small intestine. So, we hope to 
accomplish this by getting the 
bacteria to produce the 
compound of interest, then 
encapsulate itself with a 
polysaccharide sort of coating 
– which is basically like a 
slime layer. And, once it has 
encapsulated itself with this 
coating, it destroys its genetic 
material – it kills itself really. 
This means it is no longer a 
viable cell. Then, you 
swallow the cell and, the 
slime capsule – we hope – 
will be sufficient to allow the 
bacteria to bypass the 
stomach.” (Matt) 
“What we are doing is coming 
up with a new idea for a 
biofabrication platform. So, 
we are using synthetic biology 
and the bacterial machinery to 
produce drugs. The whole 
point of the design in our 
project is that we want to 
make a generic platform for 
drug production and delivery. 
The main emphasis is to 
actually be able to get these 
drugs through the stomach, 
but also to be able to have the 
freedom to choose what you 
want to manufacture.” (Nisha) 
“I think there is huge potential – 
it is only sort of bounded by your 
imagination. So there is a huge 
level of creativity that you are 
able to experiment with. 
Everyone has creative urges, 
right? But, I mean, I am no good 
at art, I cannot paint, I cannot 
draw. And this [in synthetic 
biology] is something where I 
feel you always can have some 
human nature artistic input, a 
kind of creative force – it is 
really cool… In synthetic 
biology, we have available more 
colours than maybe a traditional 
artist’s pallet anyway. When you 
try to say to someone, ‘try to 
picture a new colour in your 
mind’ – and, of course, you 
cannot do it because your 
reference point is what you know 
already. But, you are not 
bounded by that in synthetic 
biology because so many genes 
have yet to be discovered. And, 
with every gene that is 
discovered, there is functionality 
that maybe you can employ in 
some kind of a nifty way.” 
(Zach) 
“I’m just amazed by the idea that 
you’ve got a tiny tube and you’re 
working with tiny volumes and 
you’ve got this clear liquid in 
your epindorf tube and in there is 
DNA – and that DNA is all 
assembling into something that 
you’ve designed! I think that is 
quite amazing – it is awesome… 
You don’t always think about the 
bigger picture – it is a difficult 
one. I mean I try to consider the 
implications of what I’m doing 
when I’m in the lab and the 
effect that it will have in the 
bigger picture, but you do kind of 
“So I can understand that 
it is a weird idea that you 
kind of pop these pills of 
bacteria into your body 
but at the same time, I 
think it is about getting 
past a certain kind of 
notion: getting past the 
fear of it and getting 
used to the idea. I think 
that will come as there 
are more safety tests and 
things like that so people 
are assured, ‘OK, this is 
a safe thing to do’…” 
(Kajan) 
“I believe the technology 
has the potential to 
disseminate so fast and 
sort of untraceably in 
terms of DIY 
communities. So, I don’t 
think it is as much about 
being able to control 
activity. But possibly 
being able to understand 
it and grow a community 
that is able to think 
responsibly. So, I guess 
it is a bottom-up 
approach to risk and 
that’s what needs to be 
fostered in the nascent 
field.” (Zach) 
“Scientists need to 
explain what the real 
risks are – not dim them 
down. The scientists 
need to be able to 
understand the fears… 
And sometimes fears are 
irrational – it is a 
completely different 
level and so they have to 
understand their science 
but also be human 
beings, and understand 
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take it for granted that, OK, what 
I’m doing here is working with 
DNA, manipulating it and 
changing it – I’m changing the 
existing systems and how they 
are naturally.” (Felicity) 
why people fear. 
Whether they’re right or 
not – that’s a very valid 
question, whether they’re 
right to be in fear or not. 
The dialogue is very key 
to the field.” (Andrew) 
 
Andrew ended the summary document with a few short paragraphs on what was 
learned during this session as well as some suggestions for future iGEM teams. 
He talked about how the team found it interesting and stimulating to be pushed in 
interview to articulate views on broader socio-ethical issues when often students 
forget to think about such matters, feeling too bogged down, doing the science 
and engineering. He wrote about how some people may disapprove of black 
boxing analogies that attempt to understand biology like computing systems and 
noted that the synthetic biology community ought to “create a framework within 
which all these different points of view can come together, discuss and shape the 
future of the field.” 
 
The human practices document also addressed and justified work specifically in 
The E.Ncapsulator, explaining that the team was conscious of their work being 
“perceived as somewhat ‘risky’” in its implication that humans should ingest 
medications that have been made by a genetically engineered E. coli. Mindful of 
the risks, Andrew explained that the team “built in strong safety measures… right 
from the beginning”. Though I won’t go into much further detail, this document 
shows the beginnings of what turned a simple human practices exercise (that was 
largely neglected by students and advisors) into a real selling point for this team’s 
overall project. The following chapter goes into detail about the selling of human 
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practices at the Jamboree. And yet, imperfect as it was, I believe there was a good 
deal of value in the students’ participation in the workshop and interviews – I 
think they had a chance to engage with a broader set of questions that made them 
think about their work differently, if only briefly. In this chapter, I shall shortly 
leave the human practices results topic, just mentioning a few more things about 
the other document that was added to the Wiki.  
 
The other document, ‘Synthetic biology and bioethics’, was written by Andrew 
and his friend who studied philosophy (Appendix III). Though I did not oversee 
this document at all and believe it shows a puzzling use of medical ethics as it 
evaluates elements of the iGEM project according to principles of the Belmont 
Report125, it did show Andrew’s further interest in these broader questions. This 
document included a section titled ‘The scientist and the layman’ that covered how 
the promise of synthetic biology both inspires hope for a better future through 
biotech innovations but also fear of scientists ‘playing God’ or doing something 
destructive. The writers also commented on biosafety measures taken in the 
E.Ncapsulator such as using laboratory strain E. coli that could not survive in 
nature as well as in implementing the genome deletion module. Finally, in a 
confusing section on moral and philosophical implications the writers discussed 
the open matter of whether synthetic biology constitutes an affront to “the sacred 
nature of life”. They wrote: 
One cannot deny the fact that synthetic biology will change the way 
people see life. For decades now, everyone has linked the vague 
concept of “life” to DNA and genes. Now, however, the limit between 
life and objects becomes blurred, and we no longer have a scientific 
theory on which we can build our representation of what life is. Life is 
                                                
125 The Belmont Report detailed ethical principles and guidelines to protect human research 
subjects in the US (Office of the Secretary 1979).  
 210 
no longer in the genes, because the genes have become just another 
object we use in engineering. It is up to philosophers to redefine / 
recreate the concept of “life” – or at least to ease the acceptance of the 
fact that such a thing as life simply might not exist. 
While I quarrel with this document, I also find it interesting that Andrew’s friend – 
a philosophy undergraduate studying in France – probably spent more time 
thinking about and writing up this piece than some iGEMers did in participating in 
the workshop and interview.  
 
Potential futures 
I’ve already mentioned that key sections of the overall project vision were not 
achieved – cellulase wasn’t made; the thermoinduction switch was relatively 
unsuccessful; the genome deletion module didn’t really work; and several tests 
failed to yield meaningful results. In this section, I shall say a bit more about 
missed goals before examining elements of The E.Ncapsulator that were deemed 
as having further potential. Obviously, the first missed goal was attributed to a 
small human error of sorts – not writing in the correct code of nucleic acids could 
have been the mistake of a simple one letter typo. In the thermoinduction part of 
the project, it was relatively unclear as to what went wrong. With respect to 
genome deletion, John told me that this was unsurprisingly such a “challenging 
proposition… because you are dealing with something that is lethal” – it was 
incredibly difficult to time the engineering of a ‘cell suicide’ because “if you have 
any leaky expression, everything just dies”.  
 
Yet, it is essential to remember that this team set themselves an almost impossible 
task: 
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It was quite an ambitious project – you know, it was looking at a 
manufacturing process from beginning to end. The design was 
conceptually quite sophisticated, which always makes delivering 
something that works essentially way beyond the limit of what you 
can do in iGEM. – John 
 
In several cases, success proved elusive in the wet lab, and consequently the 
engineering cycle as practiced at Imperial College was not fully realized. That is, 
real experimental data – that would ideally be fed into modelling and simulations 
to, in turn, improve further rounds of experimentation and superior data collection 
(as in the engineering cycle ideal) – was not gathered.  
The difficulty is having meaningful integration of the modelling into 
this design process. I think there is an engineering framework to the 
whole design process in the way that the team abstracted it and had 
linking modules. But, in terms of actually modelling that, and the 
modelling being able to influence the design – that is really difficult 
because that is really a second cycle kind of process. And, in iGEM, 
you never really get to that second cycle. You are lucky if you get 
close to the end of the first. So, that is always quite difficult. Because 
then you just do modelling in abstract – you don’t get the data to 
feedback into model to then feedback into the design. – John  
 
The above quote suggests that modellers, in the end, were encouraged to ‘plug and 
play’ with hypothetical data input into their preconceived mathematical equations 
so that the team could reference possible scenarios in selling the project. In spite 
of experimental setbacks, the students never rested and kept experimenting at 
every chance they could (for many, this was between classes and during evenings 
and weekends as the next school year began). A couple students came up with an 
idea for “the triple hack” and attempted to build additional layers of coating 
protection on top of the colanic acid; unfortunately, the genetic materials weren’t 
received quick enough to complete the experiments before the Jamboree. In times 
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of waiting during routine protocols, students devoted themselves to playfully 
creating capsule-like forms that they thought they might be able to mock-up as the 
pill-like forms for E.Ncapsulated drugs (Figure 5.11).  
 
Figure 5.11: Playing around in the lab 
	   	  
 
Finally, I’ll briefly note what the advisors believed were elements of this team’s 
work that merited future research. Roger was particularly keen on encapsulation: 
I think the bit that we are interested in is the encapsulation program – 
it is quite an interesting concept for all sorts of reasons. For 
manufacturing of products really… Where you could use this to 
trigger the encapsulation and protection of products or something. I 
don’t know yet. But, it just sounds intriguing, interesting enough to 
take forward and explore more. 
John was slightly more reluctant about encapsulation’s feasibility, unless there 
were significant additions in further investigation: 
It’s a nice idea, a nice project – but it is very difficult at this stage to 
make a realistic assessment as to how achievable it would really be. 
You know, would the colanic acid really provide enough resistance to 
deliver active proteins to the intestine? I don’t know. I like the system 
they’ve come up with but I think just the colanic acid on its own is 
probably a no. But if the colanic acid can be fixed on other layers as 
they’ve proposed,126 then I think that would help significantly and it 
may be possible to some extent. But, you’re never going to deliver 
100% active product to the intestine through the stomach – you’re 
always going to have a pretty big drop off. So I think you’d have to 
                                                
126 This is alluding to the idea of “the triple hack” which was proposed too late in the summer to be 
completed for the Jamboree. 
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pick your target quite carefully – what you actually want to treat. 
Issues in terms of dosage and control are quite tricky too... And also 
taking something like that through to market is probably pretty 
difficult – you know, the regulatory controls would probably be a 
minefield. 
 
Other elements of the project perked the interests of advisors to varying degrees: 
I would quite like to get one of the master’s students looking at that 
cell death module. Because it is obviously a very important 
component in terms of synthetic biology – being able to program cell 
death is actually really important – but it has to be really robust. 
You’ve obviously got really high selective pressure against activating 
it. So it is quite tricky. – John 
The trigger programming, where you monitor metabolites and move 
from one metabolite to another and trigger a kind of control through 
that. Trying to model that properly – I think that is an interesting idea, 
where you use growth media to trigger signals, which allow different 
functions to be turned on in a bacteria. I thought that was good. People 
have used that before but not in synthetic biology. – Roger   
I would say the auto-inducible medium should be taken forward. 
There should be a further characterization of the thermoinducible 
promoter. I’m still not sure we’ll have a good idea of what colanic 
acid does. This year, we’ll have 12 MRes students and I think that 
some of them are going to be assigned various aspects of the 
characterization. Likewise, the IPTG induced promoter – the 
conversion of LacI – should be another project. These should be given 
out as MRes projects… Because we have interesting data but they are 
not conclusive. For iGEM, you can do an experiment once or twice 
but for somebody who looks at data – like I do – there’s no proof in 
that. It is good enough for the Jamboree but it is not good enough for 
science. – Pierre 
 
The reader should note this instance where iGEM ideas are used as a starting point 
for further research; this will come up again more generally in Chapter 7. There 
are other ways for projects to live on – I’ve mentioned already how BioBricks get 
submitted to The Registry and used by future teams in any number of unknown 
ways; papers are written too, leaving iGEM legacy in prestigious scientific 
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journals.127 For Max, publication seemed like the best possible future pursuit for 
the E.Ncapsulator: 
I think encapsulation is an interesting idea. But, in terms of protein 
drug production – I am not sure. I mean it is very early days – we are 
years and years off that. I don’t think it would really be a viable PhD 
or anything like that. I think there will be at least MRes projects from 
this iGEM project. I guess the end game for us would be to get a 
research paper out, rather than any kind of product. A lot of research 
papers can come off the backs of iGEM projects. For example, there is 
the cancer sensing stuff, an early paper by Chris Voigt. So this kind of 
thing can get published. 
 
To foreshadow the argument of Chapter 7 – that iGEM is a key tool for assisting 
the development of synthetic biology – note Pierre’s comment: 
As very often with iGEM projects, they just scrape the surface – and 
someone has to do it properly and more rigorously… As a policy in 
our department, we take iGEM projects forward. Two years ago we 
had the cell-free systems and bacterial sensors and now Max is doing 
it as a PhD. Last year, the B. subtilis project got split into two MRes 
projects. The project from three years ago unfortunately was not 
pushed forward but that was because there was no real synthetic 
biology activity here. 
 
Conclusion      
This chapter has shown what elements of E. Chromi and The E.Ncapsulator were 
actualized in some functioning material form, what elements remained 
hypothetical and where sections of the projects perhaps showed potential for 
future development. In Chapter 4, one appreciates how much of synthetic 
biology’s core engineering principles – e.g. that discrete parts, devices and 
systems can be black boxed, each level separable, modular and connectable as 
Lego™ – fail at the level of experiment. In the wet laboratory, practitioners face 
                                                
127 For example, some reputable publications highlighting iGEM projects are Check 2005b; 
Levskaya et al. 2005; Brown 2007; Peccoud et al. 2008; Smolke 2009.  
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natural complexity that resists this engineering ideal. So, when iGEM teams are 
faced with limited time, skill and resources to complete their projects, they are 
forced to think creatively about how to prove the theory of the project when 
evidence of real results is not delivered. This theme continues to be relevant in the 
next chapter when I show how teams must spin and sell their (rather incomplete) 
projects. Yet, these two teams both constructed some functioning parts of 
synthetic biological systems128 – among several accomplishments, just consider 
the success of Eleonore’s violacein construct that clearly yielded purple- and 
green-producing E. coli (Figure 5.2) or the Imperial College team’s colanic acid-
coated bacterium (Figure 5.8) that was not only viewed convincingly under EM 
photography but also tested with respect to having a higher acid resistance and 
protective effect on the cell than the non-coated control specimen.  
 
In conclusion, I’d like to bring these accomplishments into a philosophical debate 
about the status of scientific thought and phenomena – that is, to ask what kinds of 
hypotheses and entities are real, or true. And, how can we judge them to be so? 
Following Hacking’s (1983) position, I claim that although we cannot, at this 
stage, take synthetic biology’s theoretical postulates to be true, we can think of 
some (albeit limited) of its entities as real forms of living material with causal 
powers. Hacking (1983) writes:  
Experimental work provides the strongest evidence for scientific 
realism. This is not because we test hypotheses about entities. It is 
because entities that in principle cannot be ‘observed’ are regularly 
manipulated to produce new phenomena and to investigate other 
                                                
128 One might note that Knorr-Cetina (1983) highlights a similar point that is found in several 
laboratory ethnographies: the everyday, mundane preoccupation of lab scientists is that of ‘making 
things work’, that is, getting machinery, laboratory specimens, etc. to perform successfully and 
trying to avoid yet another experimental ‘failure’ (120). For the students and advisors involved in 
iGEM, they are not really concerned with ‘making things real’ or claiming the discovery of new 
scientific ‘facts’, rather, they are focused on the pragmatic problem of ‘making things work’. 
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aspects of nature. They are tools, instruments not for thinking but for 
doing. (262) 
 
Over the last three chapters, I have shown how iGEMers transition from using 
tools for thinking (mind maps, online forums, etc.) in dreaming up ideas to using 
tools for doing (synthesized DNA segments, BioBricks, PCR machines, etc.) in 
actually making new biological phenomena. In the former, we have good reason to 
doubt the truth of imagined project ideas (or believe that they will work); still, 
from this doubtful stage of thought, eventually real materials, with causal and 
measurable properties, were born. Further, the ways in which materials such as the 
violacein-carrying E. coli might live on in experimenting, connecting and 
interfering with other parts of biology are extensive – a major objective behind 
BioBricks being openly shared. Perhaps in the future these colour-producing 
constructs will not only connect to biosensors, but also other yet imagined 
biomechanical devices.  
 
Hacking (1983) believes that experimenting is about ‘creating, producing, refining 
and stabilizing phenomena’ (230). In his example, he argues that we ought to 
believe in the reality of electrons because of experiments in which electrons are 
used to interfere and cause other things to happen – for instance, in spraying 
nobium balls. He declares, “so far as I’m concerned, if you can spray them then 
they are real” (ibid, 23). Similarly, when Eleonore took the freeze-dried violacein 
DNA sequence (synthesized from scratch) from its FedEx package, worked it up in 
a series of experiments and then introduced it into live E. coli cells in three 
different forms (one was the full construct, the others had part of the sequence 
excised) to finally generate violet- and green-producing bacteria – we have good 
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reason to trust the reality of this construct. There is something created, produced, 
refined, used with intentional cause and effect behind the entities named 
BBA_K274002, BBA_K274003 and BBA_K274004129. Finally, I would add that 
my position strengthens if, in future, we see these BioBricks functioning inside 
other biological machines. 
Reality is bigger than us. The best kind of evidence for the reality of a 
postulated or inferred entity is that we can begin to measure it or 
otherwise understand its causal powers. The best evidence, in turn, 
that we have this kind of understanding is that we can set out, from 
scratch, to build machines that will work fairly reliably, taking 
advantage of this or that nexus. Hence, engineering, not theorizing, is 
the best proof of scientific realism about entities. (Hacking 1983, 274-
5) 
 
In Chapter 1, I noted the social constructionist position:  
Facts and artefacts in science, as well as what we think we know about 
them, are, according to some social constructionists, actually ‘social 
constructions’ tied into a matrix of people, ideas, institutions, 
practices, hierarchies, politics, etc. – without inherent truth. Therefore, 
a social constructionist might say, there is nothing ‘special’ about 
scientific knowledge and practice that should separate it from ‘the 
social’, nor other forms of knowledge production. 
Of course, in Chapters 3 through 5, I have shown how team dynamics, hierarchies, 
role-playing, competitive motivations and several other social constructions were 
at work as these iGEMers pursued their projects. However, just because social 
constructions are operating (as they do everywhere), it need not conflict with a 
position that believes real, functioning synthetic biological forms can, and have 
been, created. When parts of biological machines succeed in fulfilling designed 
functions (albeit rarely), we also have reason to believe that additional products 
and applications might arise from synthetic biology. These potential future living 
machines will undoubtedly interact with people and the environment in currently 
                                                
129 These are the violacein BioBricks (http://2009.igem.org/Team:Cambridge/Project/VI02). 
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unknowable ways. It seems sensible, however, that we deem these synthetic 
biological entities as having a status other than social construction so that we 
(especially those investigating this field from a humanities perspective) continue to 
interrogate their constitution and causal powers with technical rigour. 
 
How might we think of, name and categorize synthetic biological machines? Are 
they machines, organisms or a hybrid of both? Shall we even consider these 
completely new forms of life?  
The problem of the relations between machine and organism has 
generally been studied only in one direction: almost always, the 
attempt has been to explain the structure and function of the organism 
on the basis of the structure and function of an already-constructed 
machine. Only rarely has anyone sought to understand the very 
construction of the machine on the basis of the structure and function 
of the organism. (Canguilhem 2009, 75-6) 
Interestingly, the experience of many synthetic biologists contradicts 
Canguilhem.130 I’ve heard a great number of synthetic biologists explain that the 
living kingdom is an inspirational source of the most magnificent machines – DNA 
in a given organism encodes instructions for the functioning of vast numbers of 
proteins, reactions and phenotypes. Hence, synthetic biologists seek out patterns 
and regularities in biology that afford various forms of production in repeatable 
and robust ways. They want to not only replicate those patterns, but to make them 
better, more refined in their own re-designing, re-sequencing, re-synthesizing of 
DNA for specific mechanical functions. Many synthetic biologists construct their 
machines today on the basis of the structure and function of organisms. 
 
                                                
130 Note that the quoted passage was originally published in 1952 in La connaissance de la vie. 
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According to Canguilhem (2009), a machine is “an artificial construct, a work of 
man, whose essential function depends on mechanisms” (76). He continues:  
A mechanism is a configuration of solids in motion such that the 
motion does not abolish the configuration. The mechanism is thus an 
assemblage of deformable parts, with periodic restoration of the 
relations between them. The assemblage consists in a system of 
connections with a determined degree of freedom… The material 
realization of these degrees of freedom consists in guides – that is, in 
limitations on the movements of solids in contact. In any machine, 
movement is thus a function of the assemblage, and mechanism is a 
function of configuration. (76-7)  
Consider how synthetic biological machines do and do not fit this thinking: 
• They are man-made, artificial constructs – but they are also 
constituted, and inspired by, natural biological phenomena. 
• Their function depends on mechanism – but also on the materials and 
processes of living organisms (e.g. gene transcription allows a given 
biological machine to fulfil its purpose). 
• The mechanism depends on an assemblage of deformable parts: 
BioBricks. 
• Practitioners of synthetic biology would ideally like BioBricks in their 
systems to connect with a determined degree of freedom – but this is 
rare, as numerous biological complexities are constantly at play.  
• Movement in a synthetic biological machine will be a function of the 
assemblage – but there will also be a number of unknown and 
uncontrollable movements happening due to the noisy, stochastic 
nature of biology.   
 
Using Canguilhem’s (2009) sense of the differences between machine and 
organism, we can continue reflecting on the ambiguity of classifying synthetic 
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biological organisms as machines. For instance, he goes on to discuss how 
machines have “geometrical, measurable displacements” (ibid, 77); how they are 
“strictly the sum of the parts… [displaying] functional rigidity, a rigidity made 
increasingly pronounced by the practice of standardization” (ibid, 88); he talks 
about the uniformity of metric and qualitative characteristics that allows 
interchangeability and equivalence of parts of the same kind (ibid, 88). By now, it 
goes without saying that these mechanical qualities are clearly elements that 
synthetic biology theoretically strives for; however, experimental realities are 
mostly far from this mark. Though possible, it is very difficult to turn organisms 
into machines.  
 
In an organism, by contrast, Canguilhem (2009) writes that “one observes 
phenomena of self-construction, self-conservation, self-regulation, and self-repair” 
(88) and such sophisticated functioning means that organisms must possess “a 
plurality of functions” (90). Organisms, for Canguilhem, have “greater latitude of 
action than a machine… less purpose and more potentialities” (ibid, 90).  
The machine, which is the product of calculation, verifies the norms 
of calculation, that is the rational norms of identity, consistency, and 
predictability. Life, by contrast, is experience… improvisation, the 
utilization of occurrences; it is an attempt in all directions. (ibid, 90) 
Furthermore, the living world creates monstrosities and, in Canguilhem’s view, 
“there is no machine monster” (ibid, 99). But will this be true of future synthetic 
biological machines? Will synthetic biology generate systems that may be 
perceived as mechanical monsters? Though colour-producing bacteria are unlikely 
to offend most people’s moral conscience, perhaps ingesting drugs that are 
produced by a genetically engineered E. coli starts to be unsettling.   
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Design interactions work around synthetic biology provokes viewers’ reflection on 
the acceptability of imagined potentials in a future world of synthetic living 
machines. In Daisy Ginsberg’s video, A Natural History of the Synthetic Future, 
she asks the currently unanswerable question of how synthetic biology 
practitioners might control unknowns as biological machines endeavour to get 
increasingly sophisticated. She also asks how we will classify what is natural or 
unnatural when life is built from scratch and wonders whether the simplification of 
life to its molecular mechanics might “accidentally degrade our sense of self”.131  
 
In my view, it is not yet time to jump to categorical conclusions, not least because 
synthetic biology is at such a formative, uncertain stage in defining and delivering 
on its proposed theory. Rather, it is time to open out an informed space for 
questioning. This thesis has come to a critical stage, having shown several aspects 
of day-to-day workings of synthetic biology practitioners, giving insights with 
which to start reflecting on matters in the debate around engineering life. What are 
the promises of synthetic biology and, crucially, do we see evidence for believing 
them? What is actually possible in engineering living systems? Is this safe, sound 
and morally acceptable – and to whom? Who should judge and regulate how 
synthetic biology continues to develop its tools, techniques, products and 
applications such that the field is responsible and accountable with respect to 
social, ethical, legal and political concerns? Those interested in how this debate 
continues must inform themselves, raise questions and act in the present if they are 
to help shape the future of synthetic biology’s interaction with broader societal 
contexts.  
                                                
131 http://www.daisyginsberg.com/projects/synthetickingdom.html.  
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The next chapter moves into a new section of empirical data taken during the 
iGEM Jamboree, where I explore not only the Cambridge and Imperial College 
teams’ experiences, but also sociological aspects of the international synthetic 
biology community. Thus far, I have presented a picture of two microsocial 
circles in which iGEM teams conjured up intriguing ideas, faced challenges of 
turning thought experiments into real experiments and found some triumph in 
making new and interesting parts for biological machines. I have also shown how 
the teams went some length in reflecting on synthetic biology’s implications (in 
design workshops at Cambridge and in the human practices exercise at Imperial 
College). The kind of close ethnographic examination that I’ve offered is 
currently lacking in other synthetic biology commentary and it is my hope that 
this grounding in an actual narrative – with real characters who were authentically 
attempting to follow and define ways for constructing biological machines – is 
helpfully adding to a more informed position to take as debates around 
engineering life continue to unfold. 
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6.   SELLING IDEAS 
 
From late August until the Jamboree (30 October - 2 November, 2009), both 
teams slogged through long hours constructing presentations and posters, knowing 
that their efforts would soon culminate in highly competitive stakes. Both teams 
had the reputations of their universities to uphold on the international stage, in 
addition to pressures to excel for their advisors. Such pressure would be natural 
after months of intense learning and assistance from advisors, who would act as 
referees for students in their later educational and career choices; moreover, many 
students simply wanted to do well out of gratitude and respect for their teachers. 
Pressure to succeed for advisors (and the institution) was implicit at Cambridge 
where instructors often voiced their pride in the team, regardless of outcome at the 
Jamboree, as they neared the finale. At Imperial College, however, the pressure to 
deliver for the whole team (including advisors) – and also the reputation of the 
newly formed Centre for Synthetic Biology and Innovation (CSynBI) – was much 
more explicit. Advisors insisted that the team up their game for the competition: 
Imperial College has status as a winning institution.  
 
Exhausted yet still driven to succeed – especially since they had come this far – 
both groups realized that after all their dreaming up ideas, struggles in experiment 
and attempts to make new functional biological systems, their next big task was to 
sell their projects. I won’t belabour the lead-up to the Jamboree much further, but 
it is important to point out that the Cambridge team’s presentation was perfected 
over the course of several gently critiqued practice sessions, as well as at another 
design workshop with James King. Given the Cambridge advisors’ experience in 
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previous competitions (where some of them were judges), they were very useful 
in nudging students towards refined presentation that ticked the right iGEM 
boxes. James’ eye for sleek yet playful design, his probing questions about 
possible futures for the project’s colour-producing bacteria as well as lending the 
team the E. Chromi logo132 (designed by James and Daisy) further helped students 
craft their presentation. The Imperial College team also practiced and refined their 
presentation, as they persisted through several critiques to perfect their selling 
tactics right up until the moment they took stage.  
 
This chapter takes the reader into a new setting, mostly at MIT (Cambridge, MA, 
US), where members of various synthetic biology communities, from all corners 
of the globe, met for three days of what some refer to as the Olympics of amateur 
genetic engineering: the iGEM Jamboree. The first section sets necessary context. 
I then discuss how ideas were sold: this concerns not only how students sold their 
projects, but also how highly recognized figures of synthetic biology pushed 
enticing philosophies and future visions. Ideologies of sub-communities such as 
DIYbio were on display as well. Views on good and evil biological practice from 
Federal Bureau of Investigation (FBI) agents were presented. And, a new role for 
art and design in synthetic biology was being sold too.  
 
6.1   Setting the scene at the iGEM Jamboree  
Arriving in Boston on Thursday, October 29, 2009 (a day earlier than the iGEM 
teams I was following, so I could do some initial solo scoping), I was extremely 
                                                
132  (http://www.echromi.com/).  
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excited for this pinnacle event in my research that would inevitably expose me to 
a bigger and more complex picture of synthetic biology’s social world. Armed 
with recorder, notebooks, several back-up pens, batteries and camera, I was 
determined to absorb as much as I possibly could in four days. I had no idea how 
intense this weekend would turn out.  
 
Getting settled in my hotel, I found that Randy Rettburg (Director of the 
competition) had emailed me asking if I’d be willing to help with the judging 
process.133 I immediately called him and though I was not asked to be an official 
judge, Randy wondered if I would help judge the judging; this “meta-judging”, he 
explained, aimed to examine issues of fairness and think about ways to improve 
the competition’s judging standards. I agreed to keep watch for such issues and 
report back to Christina Smolke134 (in charge of meta-judging) with any 
interesting findings. This was an excellent start: I’d been included as a working 
member of the iGEM community; I’d be able to speak with several key players in 
the judging circle; and, I’d try to uncover issues of unfairness, which was a 
problem in the competition’s politics. All the while, I would be informally 
speaking with iGEM teams and stakeholders, just as I had hoped. 
 
I decided to spend Thursday evening strolling around MIT and Harvard, getting a 
feel for the setting and thinking about how to strategize for the weekend. The MIT 
campus is a hub of innovative engineering, with the outstanding Ghery-designed 
Stata Center being the heart of much of the weekend’s action (Figure 6.1). Inside 
                                                
133 I emailed iGEM Head Quarters prior to the competition, explaining my research and asking if 
there would be opportunities to get further involved ‘behind the scenes’ at the competition. 
134 Christna Smolke is one of very few female elite synthetic biology professionals, holding one of 
the most impressive CV’s in the field: http://openwetware.org/images/1/1a/CDS_CV.pdf.  
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the Stata Centre’s bold and bright architecture, plenty of light and chalkboards 
line the hallways. I wrote in my field-notes that this space seemed “like a cross 
between a playground and a spaceship”, certainly inspiring a sense of wondrous 
curiosity on its own, let alone with the addition of hundreds of keen, aspiring 
bioengineers, showing off their biological machines. A few subway stops away, I 
found myself gazing at Harvard Yard’s pristine red brick buildings and perfectly 
symmetrical walking paths in the main square, watching students shuffle in and 
out of evening classes and the library. This was land of the Ivy League. I’d also 
comment that the Jamboree’s timing added to the incredible atmosphere: it was 
Halloween weekend; jack-o-lantern pumpkins and monsters decorated the well-
groomed streets; brilliant red and orange foliage littered the landscape, the air was 
crisp, seasons were changing. After a few solo hours of wandering, I sat in my 
hotel lobby, watching iGEM teams from all over the world check-in – some noisy 
and animated, others reserved or simply exhausted from long-haul flights. It 
would all begin tomorrow, I told myself.  
 
Figure 6.1: The Stata Center 
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The Jamboree package pick-up and schedule didn’t start until Friday evening, so I 
packed the day with meetings and investigating. Firstly, I set out to Pamela 
Silver’s laboratory in the Department of Systems Biology at Harvard Medical 
School135. There, I met a PhD student in synthetic biology, Claire (pseudonym), 
who was involved in iGEM as an advisor and judge and whose interests ran 
through bioenergy, social studies of science and bioart. Claire and I had arranged 
to meet after she responded to a posting that I placed about my research on the 
DIYbio online forum136 and we exchanged a few emails. When I arrived at the 
Medical School, despite the building’s sterile exterior, the actual laboratory had a 
very warm feel to it, with pale wooden shelves and desks, cluttered benches that 
were decorated with people’s photos and some quiet background music. Claire 
was immediately likeable. After a bubbly and enthusiastic welcome, we decided 
the first order of business was a lab tour. I was shown the heavy machinery room 
with its massive centrifuges and other equipment that resembled industrial-sized 
washing machines; there were also several large gas tanks and elaborate tubing 
systems (as this laboratory specializes in bioenergy). I was then introduced to a 
few PhD’s and post-docs, given brief introductions to their work, and was struck 
by the much higher proportion of women in this lab than I experienced at 
Cambridge and Imperial College. To my delight, I also met Pamela Silver, who 
was rushing off to a meeting, but still took time to tell me about her laboratory’s 
over-arching bioenergy theme that emphasized understanding the underlying 
                                                
135 Pamela Silver is another notable female leader in synthetic biology (along with Christina 
Smolke): http://silver.med.harvard.edu/; http://openwetware.org/wiki/User:PamSilver.  
136 A link to my posting: 
http://groups.google.com/group/diybio/browse_thread/thread/3068730dc7c7ca57/c8686c7a8d3b86
c1?lnk=gst&q=Caitlin#c8686c7a8d3b86c1. 
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biology. Pamela reminded Claire, “make sure you show Caitlin the fish”137, then 
she was off.   
 
I return to my discussion with Claire in the following chapter, and now briefly 
describe the interesting meeting I had later that afternoon with Sam Gaty and 
George Costakis, documentary film-makers from Portland, Oregon. Again, Sam 
and George contacted me after I made the posting on the DIYbio forum; they 
wanted to discuss our mutual research interests in telling “an honest story of 
what’s going on in synthetic biology”. Sam and George were at the 2009 
Jamboree to do some initial research, before they set out to film in 2010. In an 
email, they described their work’s aims and wanting to meet with me: 
We are not interested in making a sensationalized or hysterical film 
about the terrors of genetic engineering or synthetic life. The goal is to 
simply explore where these technologies are and what they are 
capable of doing. The film should be educational and engaging, 
intended for a general audience... 
We read your posting on the DIYbio Google group which included a 
summary of your research and interests, all of which seem to be very 
in line with the goals of our proposed project. Your research sounds 
both interesting, and useful in informing how our project develops. If 
you have time while in Boston, it would be great to sit down with you 
and talk about our project and your research…  
The meeting with Sam and George was enjoyably casual, as I highlighted some of 
my experiences in being embedded with synthetic biologists and they asked 
questions. It was slightly odd too to be more an interviewee, as opposed to my 
usual interviewer position. In Chapter 7, I’ll point out where Sam and George’s 
work has progressed. 
                                                
137 I later saw the fish. Claire explained, “we have this strain of cyanobacteria that we are injecting 
into fish embryos in order to engineer photosynthetic fish. It is sort of more early stages! But, it 
works – they don’t die! And that’s the goal, sort of”. There were several points of interest at this 
laboratory but one I’d like to highlight is that although these practitioners include themselves in 
synthetic biology’s ‘engineering approach’, at that point, their focus remained on understanding 
the complex cell biology that underpins the engineering work of the more distant future.  
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The countdown to absolute Friday night frenzy at the Stata Center was nearing as 
masses of iGEMers gathered to pick up their team’s weekend Jamboree packages, 
eat pizza, drink soda and practice their presentations138. I received a text message 
from Andy, telling me that the Cambridge team had arrived and were heading for a 
tour of the Stata Center. I met the team – who were clearly exhausted, excited and 
nervous – and we set out for a guided march around MIT, led by Andy, who had 
attended three previous competitions and worked at The Registry one summer.  
 
The Registry of Standard Biological Parts is housed in the shared office of Tom 
Knight139, Randy Rettberg140 and Meagan Lizarrazo141 (among others), within 
MIT’s Computer Science and Artificial Intelligence Laboratory (CSAIL). Tom 
Knight and Randy Rettberg are well-regarded figures of the AI and computer 
science worlds, having developed several important tools and technologies in that 
field since the 1960s, as well as having been integral in developing the Internet. 
These guys are a big deal. Given that Andy, Samuel, Geoffrey and Frederick are 
friendly colleagues of Tom and Randy, we simply walked straight into their office 
– only a couple hours before the Jamboree, so one can appreciate how busy these 
people might have been. The tour was quick but seeing the setting and actual 
Registry of BioBricks was fantastic (another perk of being with a VIP team). The 
Knight Lab was messy and completely bizarre: papers piled high on most desks; 
an interesting mix of computer, physics, biology, maths, engineering and science 
                                                
138 Some teams registered beforehand for a limited number of practice slots on Friday evening that 
allowed access to the actual big auditoriums they would present in ‘for real’ later that weekend. 
Neither the Imperial College nor Cambridge teams decided this was necessary.  
139 Tom Knight is the creator of the BioBrick concept and a Senior Research Scientist at CSAIL. 
140 Randy Rettberg is Director of iGEM and a Principal Research Scientist at CSAIL. 
141 Meagan Lizarrazo is the assistant Director of iGEM. 
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fiction books lined wooden shelves; on top of old filing cabinets were relics of 
computer engineering, such as massive motherboards and floppy disks larger than 
the size of a full modern-day laptop. Oddly, it looked as though this office was 
caught in the 1970s, despite housing what is talked about as a ‘cutting edge’ 
repository of standard, interchangeable BioBricks that are meant to be the starting 
materials of a future generation of biological machines.142 Our tour highlight was 
also strangely anticlimactic: the real freezer (as opposed to the online repository) 
that now holds almost 15,000 BioBricks143 that have been contributed to The 
Registry through iGEM (and, to a lesser extent, other laboratories) was really just 
a large and extra cold freezer – no bells and whistles – and it was oddly situated in 
a cramped corner, tucked behind some bookshelves and the otherwise dry lab 
office space. Figure 6.2 shows Tom Knight opening up The Registry freezer for 
Daisy Ginsberg. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
142 Meagan’s work area was the exceptional space – tidy and organized. 
143 This number was cited by a key speaker (13 April 2011) at The Royal Society and The Royal 
Academy of Engineering meeting on ‘The economic and social life of synthetic biology’ 
(http://www.raeng.org.uk/events/pdf/syn_bio_programme.pdf). 
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Figure 6.2: The Registry Freezer  
 
Credited to James King. 
 
We cleared out of the Knight lab and Andy continued touring us around interesting 
nooks of the Stata Center – the rooftop view, the bar, the synthetic biology hang 
out areas, the place where he occasionally slept while he was working for The 
Registry. It was then time for everyone to head to the designated room to pick up 
registration packs. The second photo in Figure 6.3 illustrates the Jamboree packs, 
stacked like bricks, for over a thousand participants. I stood with the team in a 
lengthy, cramped queue and discussed the days ahead as we all soaked up the 
energy of loud, eager teams. I still hadn’t heard from the Imperial College team 
and the Cambridge clan were about to head out for dinner after grabbing 
registration packages, so I decided to stay for the Friday evening session of pizza, 
pop and practice in the Stata Center, hoping to meet other teams.  
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Figure 6.3: iGEM Jamboree 2009 begins 
    
Photos attributed to iGEM and David Appleyard.144 
 
As I wandered about the Stata Center’s corridors on the eve of the Jamboree, the 
spectacle really began to take shape. Teams found their own little corners – 
alcoves with benches and desks are a convenient feature of Gehry’s asymmetrical 
architecture – in which to eat, sleep, practice presentations and invite others to 
chat. The chalkboards began to get filled with artfully drawn team logos, cartoons 
and selling slogans. Students lifted their smallest team member onto the shoulders 
of the tallest in order to get every bit of blackboard space filled in. These 
blackboards, in fact, became (and have remained) one of the symbolic images of 
the Jamboree – in Figure 6.3 note that the first photo (left, by David Appleyard) 
became the cover of Nature Biotechnology’s December 2009 special issue on 
synthetic biology (right).145 That evening, I talked to at least a dozen different 
teams about their projects and iGEM journeys – notably, I recall student-led Osaka 
team’s enthusiasm.146 I was drawn to this team when I saw their poster, propped up 
on the table as they ate and slept in an alcove of the main atrium. The poster had 
                                                
144 These and other photos in chapters to come that are attributed to iGEM and David Appleyard 
are sourced from: http://www.flickr.com/photos/igemhq/sets/72157622736773466/. 
145 Cover credited to Kim Caesar, based on David Appleyard’s photo. Nature Biotechnology, 
December 2009, Vol. 27 No. 12: http://www.nature.com/nbt/journal/v27/n12/covers/index.html.  
146 http://2009.igem.org/Team:Osaka.  
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incredible photos of colourful plates and, talking to the students, I discovered that 
their project was based around creating new tools for bioart by integrating cell-to-
cell communication, colour and motility. All of their artworks (including the titles 
GFP Paper Bunny, Cocktail, Tomb and Mandala) were made using genetically 
engineered bacteria, and through this work the team explored biomedia and 
bioethics in synthetic biology. Interestingly, this group began as a completely 
student-led team, who then had to recruit an advisor to meet the iGEM 
requirements; they also told me that not a lot worked out in the lab as they hoped, 
but that they were still able to create some very pretty pictures (I encourage the 
reader to visit the team’s Wiki). I continued to network that evening, introducing 
myself to several interesting iGEM and synthetic biology affiliates – including 
members of the UN and FBI, members of the DIYbio community and members of 
biotech and pharmaceutical companies (seen, to some extent, as rivals the iGEM 
ethos in its private, corporate and heavily IP-protected research endeavours). 
Having set the scene, let us now dive into the fascinating story of who had ideas to 
sell at the Jamboree and how they did so. 
 
6.2   Selling ideas  
In exploring content and method behind selling ideas, I shall begin with examples 
of how iGEM teams presented their projects to judges, hundreds of peers and 
interested outsiders – with only twenty minutes to shine. On the first morning, I 
attended a presentation from UC Davis147 – clearly an underdog team. Yet, their 
performance was nonetheless exemplary of several trends in Jamboree talks. 
Firstly, the presenter explained that their project was personally motivated – a 
                                                
147 http://2009.igem.org/Team:UC_Davis. 
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team member described how his roommate had Celiac disease and how “this 
sucks because he can hardly eat anything”. Accompanied by a PowerPoint 
projection, team members stood in a row, passed the microphone along and 
described the disease, its negative effects on sufferers’ lives, the current treatment 
(a pill taken before every meal) and its drawbacks. Then came the team’s 
proposed genetically engineered solution: a microbe that would reside in the 
stomach for at least a month and secrete the necessary enzyme that Celiac-
afflicted people do not naturally produce, subsequently ending the need for pill 
consumption. With the ambitious problem-solution vision described, the team 
went on to humbly explain that they didn’t get very far in the lab. They said, “we 
kept on getting two mystery bands when we were running our gel. We think 
something – we’re not sure what – was getting in the media”. Experimental 
failures were mentioned in a number of presentations – though one can appreciate 
that it was also something not to say for teams that felt particularly competitive. 
For certain, after several informal conversations with iGEMers about their 
project’s details, it is reasonable to conclude that almost every team faced 
significant displacement between their original project vision and what was 
actually achieved. The UC Davis presentation also spoke about safety concerns – 
a minimum standard that needs to be met by every team (an additional brief safety 
report submission is also required). Finally, the UC Davis team also experienced a 
very negative comment following their presentation – another (occasionally even 
fierce) element of the competition. After this team’s rather endearing presentation, 
an audience member remarked that the group’s conception of the Celiac disease 
mechanism was fundamentally incorrect, essentially shutting down the entire 
project idea. Though this criticism may have been true, as I was sat next to 
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Geoffrey, he leaned over and said, “now that is just uncalled for” – implying that 
such comments are too harsh for, what should be (but sometimes is not), a 
friendly iGEM spirit. 
 
Moving to another of Saturday’s presentation highlights, the Imperial College 
team was up (Figure 6.4’s top row shows the team awaiting their session). The 
two chosen speakers (the most confident salespeople of the team) conducted the 
performance and their articulate, strong delivery was apparent – their audience 
listened attentively. The talk was a compelling initial problem-solution pitch that 
then took the audience through each module of the engineering approach in their 
encapsulated, drug-manufacturing system. An unfortunate point, however, was 
that the presenters were, at the last-minute, specially coached by Bernard to ‘ramp 
up the selling points’. A bit of an ‘old-school’ character, Bernard advised that the 
students address the audience as “ladies and gentlemen” and really emphasize the 
emotive messages – saying things like “these are children we are talking about 
here!” when talking about possibly curing PKU. Though uncomfortable with such 
a cheesy sales pitch style, the students respected their advisor’s advice and 
presented with this added spin. I heard several whispers following this 
presentation and witnessed a few eyes rolling, reflecting feelings that the sell was 
a bit excessive.  
 
Interestingly, the Imperial College team faced scrutiny from a leading human 
practices stream judge in the Q&A period. The judge urged a further explanation 
of the impact of the team’s human practices work, to which one student answered: 
“the genome deletion module was a direct consequence of doing the human 
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practices project”. This was actually not true (as the genome deletion module had 
been thought of prior to the human practices exercise), though it did seem to work 
as a selling line. The same judge also noted that he was unable to access one of 
the links on the human practices page of the team’s Wiki. At that point, I recalled, 
only weeks earlier, experiencing frustration in finishing the film editing, 
producing a summary document and making a brochure with little help from 
anyone except Andrew (and he too was experiencing mounting pressure from 
above to work on the more important tasks). I had been disappointed when the 
gesture of getting the human practices work online was not completed properly – 
and now the team was being called on this error by a judge in their presentation. 
Despite these hiccups in the team’s presentation, it remained clear that they had a 
rigorous engineering approach in conceiving, constructing and testing (or, at least 
attempting those last two stages) their biological machine and their work stood out 
as an obvious top-level contender.  
 
For brevity, and to appreciate the diversity of projects represented in iGEM, I 
summarize a few other presentation highlights: 
• The astounding and trail-blazing ArtScience Bangalore team148 was 
composed of art and design students, in association with staff at the 
Centre for Experimental Media Arts (CEMA) and the National Centre 
for Biological Sciences (NCBS). Describing their project to “engineer 
the smell of rain” (a scent of special cultural significance in India), the 
team endeavoured to learn about synthetic biology’s tools and 
techniques while developing a piece of life that reflected their 
                                                
148 This was the first team and work of this kind in iGEM 
(http://2009.igem.org/Team:ArtScienceBangalore).  After 2009, art and design continued to play a 
part in iGEM and in synthetic biology more broadly.  
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concerns with cultural, ethical and aesthetic implications. The team 
used a DIY approach to genetically engineer the synthesis of 
Geosmin, an enzyme responsible for the “earthy rain smell” that is 
produced by cyanobacteria and actinobacteria. This team also engaged 
the urban poor and students of design, explaining their artistic 
involvement with synthetic biology.  
• The BioBrick-A-Bot was a liquid handling robotic system made of 
actual Lego™ pieces (with hardware and software components), 
designed and amazingly built by an 11-year-old from the University of 
Washington. Unfortunately, this prodigy was unable to attend the 
Jamboree due to illness but he sent in a video of his incredible 
presentation, watched by a completely astounded audience.149   
• Team Valencia engineered yeast to sense and respond to electrical 
signals, producing light and showing movement on the first LED 
bioscreen. They had also done a lengthy literature review, interviews 
and a comparative analysis of previous iGEM human practices 
projects, in order to produce a ‘Sins, ethics and biology’ report.150  
• The Tokyo Tech team explained their vision to produce bacteria that 
Terraform Mars. A project to “open new doors for recent space 
programs” and “stimulate intellectual curiosity about space 
technologies”, this team worked on four approaches to making 
bacteria that could adapt to, and modify, a Martian environment.151  
                                                
149 http://2009.igem.org/Team:Washington-Software; for the highly recommended presentation 
video, see http://2009.igem.org/files/video/Washington-Software.mp4.  
150 http://2009.igem.org/Team:Valencia/home. 
151 http://2009.igem.org/Team:Tokyo_Tech.  
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• The Berkeley Wetlab team developed an automated approach to large-
scale parts assembly that was to be ‘accurate, high-throughput, 
reduced in labour, and decreased in cost’, as part of their foundational 
research project that characterized E. coli cell surface display 
systems.152 
• Gaston Day (High) School’s team of young teenagers worked on a 
farming issue in their rural community, as they attempted to engineer 
a microorganism to detect nitrate pollution in water. Incredibly, this 
team worked with extremely limited knowledge (the most relevant 
qualification any team member had was a high school course in 
biology and/or chemistry) and very little laboratory equipment and 
space. They explained, “We had to think creatively”. For instance, this 
team built a homemade UV light box for $15. Though little was 
achieved by way of bioengineering, this group certainly learned a lot; 
they were proud of their homemade equipment; and they embodied 
great enthusiasm for iGEM, remarking that the team would like to 
speak at conferences and further pursue synthetic biology.153 
• Then two-time overall iGEM competition winners (who won again in 
2010), team Slovenia presented highly technical work that 
manufactured nanomaterials by combining modular peptide elements 
and protein domains, which self-assemble into larger complex 
structures with designed macroscopic properties. The intriguing point 
of this team’s talk was their announcement that they filed three patents 
                                                
152 http://2009.igem.org/Team:Berkeley_Wetlab.  
153 http://2009.igem.org/Team:Gaston_Day_School.  
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on parts of their iGEM project. This was met with several huffs from 
an audience that mostly supports the iGEM’s open source spirit.154   
 
Finally, I’d like to discuss Cambridge’s selling presentation. Like the Imperial 
College team’s session, the full auditorium sprinkled with synthetic biology 
celebrities signalled that this might be one of the competition’s most exciting, 
prize-contending presentations. Four students shared the presentation’s twenty-
minute slot that Sunday morning – and though a couple of them began with 
shakiness in their voices, that quickly settled into clear, calm and well-rehearsed 
deliveries. The team had the elegant feature of the designed E. Chromi logo but, 
otherwise, it was real tangible results – vivid colours with data to match – that 
were the real selling points. This team wasn’t encouraged to speak hyperbolically 
and their modesty made for an even more believable presentation. At the end of 
their talk and after a full Q&A period, the team decided to sweetly sing happy 
birthday to one of their embarrassed teammates.  
 
Figure 6.4: Team spirit 
 
                                                
154 http://2009.igem.org/Team:Slovenia.  
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Photos attributed to iGEM and David Appleyard. 
 
Selling projects was of course, not only about that twenty-minute presentation; 
displaying team spirit and promotional messages was non-stop throughout the 
competition. Mascots, colourful team T-shirts, matching wigs and give-aways 
(stickers, toys, business cards, pamphlets, etc.) were all illustrative of how teams 
further marketed themselves (Figure 6.4). Of course, Wiki’s155 (freely available 
online to anyone, anytime) and posters (e.g. Figure 6.5) were another space in 
which to sell ideas, with dazzling images, hysterical video clips and overstated 
achievements. At every break from the parallel sessions (early morning, lunch and 
                                                
155 Access to all 2009 iGEM Wiki’s: http://ung.igem.org/Team_Wikis?year=2009. 
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evenings), there were usually a few students at hand alongside team posters (hung 
in delegated atrium spaces), ready to explain their work to anyone passing by, 
particularly to judges. At these times, I visited several team posters to hear many 
more pitches and I had the chance to conduct about ten informal team interviews. 
I was interested to hear how students described their work and responded to my 
questioning about an (inevitable) gap between their first ideal vision and what was 
actually accomplished; I also spent some time asking about students’ experiences 
of judging as part of my input into the meta-judging concern.  
 
Figure 6.5156: (i) Cambridge E. Chromi Poster and  
(ii) Imperial College E.Ncapsulator Poster 
 
                                                
156 Both posters have been cropped, so as not to identify real names of team members. 
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Turning to another form of performance, it is important to appreciate that iGEM’s 
creators, judges and orchestrators also have ideals, which were sold back to 
students and other players (e.g. the media). There was a sense of preaching the 
spirit of the competition and the virtues of jumping on the synthetic biology 
bandwagon throughout the weekend. For instance, iGEM leaders raved about the 
competition in the opening and concluding ceremonies, but it was also not 
unusual to see the well-known names of synthetic biology floating around the 
poster sessions, talking to students, as they welcomed in that year’s intake and 
made them feel part of the community. A list of synthetic biology’s idyllic 
philosophies were pushed, by convincing characters, to Jamboree attendees:  
• This community embraces creativity and out-of-the-box thinking in a 
way unparalleled in other fields of science and engineering today;  
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• This community is revolutionary in its open source ethos that supports 
collaboration as well as work from amateurs and lesser-funded 
laboratories; 
• This community believes biotechnology will make the world a better, 
cleaner, healthier place in the coming decades – we are now in The 
Century of Biology as Technology;  
• This community consists in friendly and outgoing contributors whose 
expertise cross several disciplinary fields – from all walks of science 
and engineering, to humanities, art and design. This community is not 
represented by stereotypical images of reclusive scientists; rather, it is 
represented by a mix of clever, vibrant and playful characters;  
• Finally, dedicated researchers who enter this up-and-coming field will 
prosper financially for their incredible work to come. Most notably, 
this point came through in the closing speech of iGEM Director 
Randy Rettburg when he announced, “I think that over the next 40 
years synthetic biology will grow in a similar way [as the computer 
revolution] and become at least as important as the Internet is now and 
that you will be the leaders, that you will form companies, that you 
will own the private jets and that you will invite me for rides”.  
 
Figure 6.6 helps tell the story of iGEM’s community spirit. Pictured first is a 
scene from Sunday night’s Jamboree party, held at Jillian’s Boston, self-described 
as “A 70,000 Square Foot Food Entertainment Universe”157; this place was a 
massive, four-floor, all-American, diner / sports bar / bowling alley / dancehall 
                                                
157 http://www.jilliansboston.com/.  
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combined venue. The iGEMers enjoyed hot dogs, burgers and soft drinks 
(alcoholic beverages for the strictly carded over-21’s), played pool, showed off 
their bowling arms or danced the night away (well, until that party ended at 
midnight, as everyone would have to be up for Monday morning’s exciting results 
announcements). Hilariously, the iGEM videotapes that had been rolling all 
weekend were played on the large screens that plastered the venue’s walls – see 
the scene of happy, jumping dancers with their not-so-distant competition tense 
expressions in the photo. Figure 6.6’s second photo (with the audience being 
conducted to cheer and do a synchronized wave) was taken on Monday morning 
as the audience anxiously awaited the finalists to be displayed on the big screen. 
Finally, the third image was taken at the pinnacle of build up: after all six finalists 
presented, the judges went into a closed room to make their final decisions as 
iGEMers were led outside for the symbolic ‘iGEM from above’ photo158. These 
photos only go a small way to illustrating the exhilarating iGEM energy that was 
effectively sold and taken up at the Jamboree. There was never a dull moment. 
 
Figure 6.6: An easy sell: membership into the iGEM community 
 
                                                
158 These symbolic iGEM photos have been taken every year to show the growth of competition 
and display colourful team spirit: http://ung.igem.org/Previous_iGEM_Competitions.  
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Photos attributed to iGEM and David Appleyard. 
 
I’ll now illustrate how associated individuals and groups also had impressions to 
give, ideals to push and provocations to illicit whilst at the Jamboree. For 
instance, members of the DIYbio community159 were found wandering about 
MIT’s hallways that weekend; this is unsurprising as key founders of DIYbio 
were originally inspired through their experiences in early iGEM years. DIY 
biohackers were visible with their T-shirts, sticker give-aways (Figure 6.7, top 
row) and because some members of this movement have celebrity status in 
                                                
159 http://diybio.org/.  
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synthetic biology circles (owing to extensive media coverage160 and heavy online 
presence). In speaking with DIYbio enthusiasts, it was clear that not only did they 
attend the Jamboree to hear about new amateur projects, but they also had a few 
messages to deliver: 
• Firstly, the organization’s mission: DIYbio is a fun sub-culture of 
synthetic biology enthusiasts who support open and safe endeavours 
of citizen scientists, amateur biologists and biological engineers.  
• Secondly, the organization’s position about effectively and 
responsibly achieving its mission: DIYbio’s success requires 
education for amateurs, access to experts, a code of ethics and 
leadership that supports bioengineering outside traditional 
professional settings.  
• Thirdly, many wanted to express disappointment at iGEM’s closing 
the doors to DIYbio participants, when it was initially announced that 
the competition would include teams of amateur biologists.161 
• Finally, DIYbio wanted to encourage growth of their community and 
sought to help iGEMers who wanted to join existing DIYbio hubs, or 
create new ones (they now exist all over the world, with a select few 
being quite active – Boston, New York and San Francisco).162 
 
 
 
 
 
                                                
160 A small sample of media references to DIYbio: Boustead (2008); Bloom (2009); The 
Economist (2009); Specter (2009); http://www.youtube.com/watch?v=-IIWH6Hhcnc. 
161 On February 9, 2009, it was published in the DIYbio blog that amateurs would be included in 
the competition (http://diybio.org/blog/diyigem). On April 10, 2009, it was announced that the 
offer of DIYers competing was withdrawn (http://diybio.org/blog/igem-closes-doors-to-amateurs).  
162 http://diybio.org/local; http://genspace.org/; http://www.meetup.com/biocurious/. 
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Figure 6.7: Other affiliated selling points 
  
 
Top left attributed to iGEM and David Appleyard; top right attributed to DIYbio.org;  
bottom attributed to James King (James introducing FBI and UN members to ‘The Scatalog’). 
 
Another keynote group included members of the FBI and the UN, who were 
attending the Jamboree to relay messages concerning biosecurity. Notably, the 
FBI is a major iGEM sponsor; it is their belief that these young aspiring synthetic 
biologists are key people to get their message to. On Saturday evening an informal 
presentation and Q&A session on biosecurity was held in the same auditorium 
that only hours earlier played host to the Edinburgh team’s presentation on 
creating microbiological landmine detectors.163 This biosecurity session was 
orchestrated by Piers Millet from the Biological Weapons Convention 
                                                
163 http://2009.igem.org/Team:Edinburgh.  
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Implementation Support Unit, of the United Nations Office at Geneva, 
Switzerland. With Piers were four FBI agents. This session was not particularly 
structured, with audience participation being the focus after each panellist gave a 
brief autobiography and described how their work related to “securing synthetic 
biology”. Most panellists had a background in life science but had moved careers 
into government and national security work (from a couple speeches, it seemed as 
though the audience was given a story about the excitement of career moves into 
the FBI). The experts spent a good deal of time discussing with the audience, 
“Biosecurity: What is it?” After responses that ranged from “it’s about 
bioterrorists” to “it’s about creating laws and policies”, Piers said plainly, 
“biosecurity is about responsible research and controlling risks”. This positive 
angle was meant to show that there is a reasonable, responsible and exciting way 
to progress synthetic biology – which was (and is) obviously the desirable route 
for almost every audience member there. Still, just how risks could be controlled 
– or, to what extent they could be – beyond continuing to use familiar laboratory 
safety practices, was a matter of debate, and remains as such in the wider 
synthetic biology sphere.164  
 
Interestingly, these biosecurity experts seemed calculative in trying to portray 
themselves as supportive and friendly with the emerging synthetic biology 
community. Moreover, they were conscious of resistant feelings that their cause 
                                                
164 Notably, the US Presidential Commission for the Study of Bioethical Issues hosted a series of 
meetings in 2010 and 2011, and produced an extensive report on the ethics of synthetic biology. 
The report (US Presidential Commission for the Study of Bioethical Issues 2010) suggests that 
“safeguards” and continued “monitoring” of synthetic biology safety is necessary, but there is no 
indication of needing to use precautionary measures that go beyond the standards of 
microbiological and genetic engineering protocols that have been followed for several years (e.g. 
the use of “suicide genes” and specific nutritional dependence of microorganisms so they could 
not survive outside laboratory settings).  
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comes up against: (i) most lab practitioners feel that they are already heavily-
regulated and don’t like the idea of adding new hurdles to their research 
endeavours, and (ii) many make the point that biological engineering is actually 
really difficult, so believe that the worry about bioterrorists doing sophisticated 
genetic engineering is a bit misplaced (e.g. Wouldn’t terrorists prefer to just make 
a bomb that had a reasonable chance of working?). It was clear then, that these 
biosecurity experts exercised concerted effort in showing their stance as pro- 
synthetic biology progress. The additional take-home message was merely that 
everyone needs to work together to ensure that synthetic biology develops with 
good communication between security experts and practicing synthetic biologists 
(particularly those who participate in a DIYbio capacity).  
 
One final highlight of this session cannot go unmentioned – it concerns how one 
of these experts really wanted to sell himself as a friend to these young synthetic 
biologists. ‘Hi, I’m Dan and I’m the local FBI guy here in Boston’, he proclaimed. 
His message was that in order to make sure that the FBI didn’t get confused or 
unjustifiably worried about the biotechnology work that audience members may 
be carrying out (now, or in the future), it would be advisable that DIYbio 
enthusiast just ‘call [Dan] up’ and ‘let [him] know what you were working on, 
where and with what intention’. This kind of casual communication, he claimed, 
might be the key to preventing the FBI from storming into an innocent DIYbio 
geek’s garage laboratory. An amusing caricature was apparent in Dan’s short talk: 
the FBI knows that there are good guys and bad guys who do biotechnology. 
According to Dan, it seemed like everyone that he had met in iGEM fell into that 
good guy category, showing how synthetic biology can do some ‘neat stuff’; 
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however, everyone in this field is responsible for ensuring that they could easily 
be identified as good guys, so that the FBI wouldn’t mistake them for bad guys. 
This may seem overly simplistic, but the scene was truly that amusing.    
 
There were also the designers, Daisy and James, who went to the Jamboree, 
armed with a briefcase of mocked-up coloured poo, to tell a story about how 
design could help incite important questions around synthetic biology’s potential 
future with respect to matters of feasibility, safety and ethics. The Scatalog was 
designed to reflect an imagined future application for the Cambridge team’s 
project – a (hypothetical) cheap, personalized disease monitoring system, 
consumable in the form of an E. Chromi yoghurt drink that would render a 
person’s faeces different colours that could be charted according to various 
pathologies (Figure 6.8). Daisy and James explained to me their multiple 
intentions behind their guerilla style presentation of the Scatalog as they revealed 
the shocking contents of their suitcase to as many Jamboree attendees as possible: 
• Provocation: The Scatalog was intentionally designed to be a stark 
contrast to the mechanical, engineered, standardized and sterile ideals 
of synthetic biology. Synthetic biology is full of simplified imagery of 
BioBricks, circuits, bacteria with cog wheel graphics and, for now, its 
practice remains in laboratories, where it seems contained, visible and 
measurable as scientific objects and tools. The Scatalog, on the other 
hand, takes a view of synthetic biology arriving at the human scale in 
a biomedical application. Furthermore, Daisy and James wanted this 
application to reside in the parts of the body where E. coli bacteria 
would naturally be found – in the digestive tract. The resulting 
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indicator output – coloured poo – would be sticky, messy, dirty. 
Showing that a re-introduction of synthetic biology into human 
biology may not at all be so engineered, mechanical or sterile was key 
to this project’s message.  
• Asking a synthetic biology-literate audience about feasibility and 
safety: Daisy and James were keen to hear views from experts and 
aspiring synthetic biologists on the feasibility and safety of their 
Scatalog. They received mixed reviews; however, in a given synthetic 
biology audience, the majority tended to believe this application might 
be safely possible in the future.  
• Asking about acceptability: Trying to gauge a sense of the moral and 
social acceptability of their proposal, Daisy and James wanted to hear 
observers’ opinions on whether or not they would really want this 
level of self-diagnosis in the future? What kind of society would want 
such a personalized disease monitoring system? Would it be one with 
an even more ratcheted-up anxiety and sense of personal 
responsibility for one’s health and wellbeing than we are part of 
today? Interestingly, presented to a scientific audience, it was almost 
uniformly desirable to have such control in monitoring one’s health; 
however, at a wider societal scale, it would almost surely be the case 
that some people would prefer ‘not to know’. 
• Asking whether, and how, design and biotechnology may work 
together meaningfully: In working with synthetic biology 
practitioners, Daisy and James were struck by how often the term 
design was used by scientists and engineers dreaming up, and 
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attempting to build, biological machines. As such, they were keen to 
understand what a synthetic biology view of design might be, finding 
many parallels with their own training (particularly in industrial 
design). However, they also saw opportunities for expanding the 
synthetic biologists’ conception in forming a working relationship 
with professional designers who tend to ask additional, and different 
sorts of questions. Synthetic biologists and designers both use design 
in their work to solve problems, but Daisy and James believe that 
thinking diverges then into (i) an engineering approach (in synthetic 
biology) and (ii) a human-scale approach (in classical design). The 
first approach, Daisy explained, is about “efficiency, minimizing cost, 
finding a way to do something”; in a designer’s approach, solutions 
are catered around “who we are as people and what we need to live 
better lives”. So, Daisy and James wondered if bringing classical 
design thinking into synthetic biology may be a more efficient way of 
giving people what they want, in terms of the products and 
applications that the field eventually aims to make. The wider results 
of integrating design perspectives into this field remains to be seen.165   
• Help promote the Cambridge team’s work: Though careful to separate 
the real synthetic biology that the students did on E. Chromi from the 
design proposal, Daisy and James’ presence at the Jamboree with their 
special briefcase certainly received a great deal of attention. After 
only a couple of viewings, word of the Scatalog spread wildly at the 
                                                
165 The Synthetic Aesthetics project (http://www.syntheticaesthetics.org/) has brought together 
synthetic biologists, social scientists, artists and designers to explore the potential of these 
collaborations. We await publications and exhibitions to describe this work.  
 253 
Jamboree and everyone wanted to see what was in the case! This 
attention undoubtedly further promoted the Cambridge team’s work. 
 
Figure 6.8: Scatalog 
 
Image credited to Daisy Ginsberg and James King.  
 
Though I will not go into detail, a couple of other stakeholders at the Jamboree are 
worth mentioning. There was a strong media presence, which included followers 
from Discovery, Wired Magazine, The New York Times, National Public Radio 
(NPR) and others.166 In my view, reporters would have had little difficulty in 
turning this fascinating network of ideas, extroverted characters and possible 
                                                
166 Bland 2009; Ginsberg 2009; Mooalem 2010; 
http://www.sciencefriday.com/program/archives/200911063. 
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futures into stories for a public audience. Biotech and pharmaceutical companies 
were players on scene, there to sell their companies’ services, tools and 
technologies, but also to recruit interest from iGEMers in joining their workforce. 
These biotech representatives had the somewhat awkward position of being seen 
as ‘the dark side’ in the views of some extreme open source enthusiasts; still, there 
were plenty of iGEMers and advisors who were keen to explore potentially 
lucrative, private sector opportunities. It is key that the reader has gathered a 
picture of the iGEM Jamboree as a kind of showroom, brimming with excited 
community spirit, fascinating projects, story telling, recruitment and hyperbolic 
messages of various sorts – all on display and convincingly sold and resold, in the 
over-arching belief that synthetic biology is the exciting, new, sexy biotechnology 
that is full of potential. 
 
Conclusion  
This chapter has shown how the Jamboree context – with its dramatic location, 
exciting attendee list, impressive presentation schedule and larger-than-life parties 
– created an ideal atmosphere to entice appreciation for synthetic biology projects 
and broader philosophies. Students gave selling performances of their works, 
delivered to a keen audience. iGEM leaders presented back to attendees a set of 
community ideals (in speeches, as well as closer interactions with teams) about 
embracing creative curiosity, making a difference, openly sharing knowledge and 
materials, and enjoying the benefits of a new field with a prosperous and exciting 
future. Other groups too – such as DIYbio, the FBI and designers – took the 
Jamboree as a place to stage their positions about synthetic biology. The next 
chapter segues into judgements that were made following these sales pitches, and 
 255 
the subsequent decisions of iGEMers (as well as advisors and institutions) to join 
the synthetic biology club, or not. 
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7.   TO JOIN THE CLUB, OR NOT 
 
As the Jamboree weekend neared its close, involved participants were making a 
number of judgements. These evaluations change over time and are sometimes 
wavering; nonetheless, I argue that they significantly influence who joins the 
synthetic biology club, or not. More strongly, an investigation of these judgements 
shows how iGEM has been an effective tool through which to grow and socially 
and culturally engineer an international synthetic biology community.  
 
This chapter’s first section notes which projects were deemed of winning quality. 
More interestingly, I explore the politics of judging that reveal disparate views on 
what counts as good synthetic biology. How students evaluated themselves, their 
peers, the competition and the broader field during, or very shortly following, the 
Jamboree is examined. Other assessments on the DIYbio community’s work, the 
FBI’s presence, the introduction of art and design, and from media perspectives 
are highlighted too. In 7.2, I describe follow-up sentiments and stories that are 
more distant from the immediate excitement of the Jamboree experience. At this 
stage, one can gain a more accurate picture of iGEM’s influence in spreading and 
developing synthetic biology. I conclude by summarizing how I view iGEM as a 
tool of social engineering, and also by highlighting some recent arguments open 
to investigation. I suggest that there are significant breaking points that look to be 
changing the landscape of iGEM and synthetic biology from 2011 onwards; in 
order to keep pace with this field’s state of flux, I suggest that such avenues are 
worthy of future research. 
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7.1   Judging ideas 
I begin considering a network of judgments that are among the final outcomes of 
an iGEM cycle with the obvious: as this is a competition, there were winners (but 
no losers in iGEM) and ways of deciding who deserved such titles. With all 
Jamboree participants crammed into MIT’s largest auditorium, out of over a 
hundred teams, six finalists were announced on that final Monday morning: 
Cambridge, Freiburg bioware, Groningen, Heidelberg, Imperial College London 
and Valencia. These groups presented their works again in order to contend for 
the Grand Prize BioBrick trophy. For the Cambridge and Imperial College lot, 
walking into MIT’s largest auditorium and seeing their team on that final list 
marked the beginning of a very exciting end to their iGEM experience; for other 
hopeful teams that didn’t make the cut, that was a moment of sinking 
disappointment. I won’t detail presentations and their selling points again (though, 
thankfully, Imperial College presenters toned things down a notch in the second 
round) and shall skip to the awards results. In keeping with iGEM’s community 
spirit that (almost) everyone is prize-worthy, the competition grants virtual 
Bronze, Silver and Gold medals to teams that satisfy certain criteria167. These 
basic medals were announced first, projected on screen and loud cheering ensued. 
Then, the special prize announcements began: Best New BioBrick Part, Natural 
(ULB-Brussels); Best New BioBrick Part or Device, Engineered (EPF-Lausanne 
and Freiburg Bioware tied); Best Human Practices Advance (Imperial College 
London and Paris tied); Best Model (BCCS-Bristol); Best Experimental 
Measurement (Valencia); Best New Standard (Heidelberg); Best Wiki 
(Heidelberg); Best Poster (Freiburg bioware); Best Presentation 
                                                
167 http://2009.igem.org/Judging/Judging_Criteria.  
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(ArtScienceBangalore). Track winner announcements followed: Best Food or 
Energy Project (UNIPV-Pavia); Best Environmental Project (Cambridge); Best 
Health or Medicine Project (Stanford); Best Manufacturing Project (Imperial 
College London); Best New Application Area (Valencia); Best Foundational 
Advance (Alberta); Best Information Processing Project (TUDelft); Best Software 
Tool (Berkeley Software and Illinois-Tools tied). There was, of course, copious 
amounts of clapping, whooping, screaming and jumping around throughout the 
ceremony, with every winning team getting up on stage, receiving a trophy, 
shaking hands with synthetic biology celebrities and smiling brightly for the 
cameras. This lasted about an hour until the ascending order of prize-winning 
importance reached its climax and team Cambridge was declared overall 
competition winners. Images in Figure 7.1 (and the second photo in Figure 6.6) 
illustrate this ceremonial scene. 
 
Figure 7.1: And the winners are… 
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Photos attributed to iGEM and David Appleyard. 
More intriguing than who won what, are the politics behind judging iGEM. It 
turns out that there exist many differing opinions about what counts as important 
in this contest and in synthetic biology, technically and culturally. One prominent 
disagreement circulates around the value in rewarding big ideas that align with the 
‘how synthetic biology can save the world’ spirit; such projects, though exciting 
and inspiring, rarely amount to substantial, functional contributions. On the other 
hand, there is the possible choice to reward more modest projects that can, at their 
best, actually contribute valuable tools, parts and insights for synthetic biology 
practice. I have discussed this subject already, and have noted a clear difference in 
the Imperial College and Cambridge approaches, but some additional interview 
clips help flesh out this contention: 
What I’ve seen that’s interesting is to start with a blank slate challenge 
to students, but then take that a step further by reminding them that 
they live in a world that has problems, challenges, opportunities – and, 
has engineers.... One of their first responsibilities, in fact, their first 
responsibility – which is often skipped over in the engineering 
educational process – is to choose what to work on and a lot of 
engineers just sort of, ‘oh, somebody hired me to do this so I’ll do it’. 
But that’s not really what the world needs; the world needs engineers 
who can look outside of where they are and take some stock of the 
state of things and help. – Assistant Professor Drew Endy 
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I think the synthetic biology community is celebrating things that 
are… imaginative and new, right. I don’t think it’s the only aspect, 
because I think there’s also a celebration of things that are useful… If 
you look at the Heidelberg team this year (2009), some people were 
complaining that they didn’t think it was that creative or imaginative – 
you know, people have done promoter engineering before. I loved it. 
Because I saw it and was like, I can use that stuff! And we were just 
talking about how we needed that in the lab. And so to see someone 
go through and do what I thought was a really good job, I was totally 
jazzed because I just thought someone did a really great job of 
building a library that I feel comfortable using.  
– Professor Christina Smolke 
One of the points about iGEM is that it is a competition and it is very 
media driven so you have to go for the flashiest application you can 
think of. And that, in my opinion, leads to bad science and bad 
technology. And there is a lot at iGEM that, in my opinion, I wouldn’t 
trust – just pure waffle. But, it also means we have to go for an 
application that is high profile, otherwise we won’t be seriously 
considered. – Pierre, Imperial College iGEM advisor 
 
In speaking with judges and having observed a couple of their insider meetings, it 
was apparent that there were many further disagreements regarding what was 
significant to synthetic biology. Some were insistent about a strict following of 
the BioBricks-based approach, firmly believing that the best way forward is to 
have a library of standard, highly characterized components because this is the 
optimal way to utilize an engineering cycle. Others revealed their position that 
though they’d like to design and build functional biological systems, synthetic 
biology is not yet sufficiently advanced to exclude approaches that do not 
conform to the engineering and accumulation of BioBricks, as pushed in iGEM. 
Such advocates generally believe that this field should simply help researchers 
develop tools to do the work they’re pursuing; moreover, they take the position 
that it is currently not helpful to delimit, or even to really define, what is and is 
not synthetic biology. Taking that line of argument, some professionals believe 
that this ‘new’ area really just folds into and extends other fields, such as 
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metabolic engineering, or plant genetics, for example. Of course, it is important to 
point out that this sentiment is usually reserved for candid conversations, as most 
people in this community see the merits of claiming synthetic biology’s ‘newness’ 
in order to finance their research pursuits.  
 
Another interesting view from judges that arose several times was that iGEM 
projects are often blinded by their framework – they set out to solve a problem 
with biology when there is already a non-biological solution, or when there is 
obviously a better means and method to tackle the problem than with complex 
living material. According to Drew Endy, “an important thing that I think is 
missing from a lot of projects is to ask the team to consider alternative approaches 
that are not based on biology – so competitive analysis of other ways to solve a 
problem”. Spelling this out further, Frederick from Cambridge remarked,  
Many iGEM projects … either address solved problems or the wrong 
problems in the real world. So, for instance, Imperial’s protection of 
bugs from the stomach – there are a lot of drugs on the market today 
that have to be protected against the stomach and they have enteric 
coatings already. That’s a completely solved problem! 
 
Judging politics goes beyond disagreeing over the qualities of iGEM projects in 
terms of their approaches (BioBricks or not) and overall visions (grand or 
realistic; targeting an unsolved or solved problem). Roger felt, for instance, that 
the international nature of the competition was enormously important and “the 
fact that they had six European teams as finalists was a very poor decision – that 
was wrong”. He continued, 
If you want to have the whole world engaged in this, then you’ve got 
to have the United Nations. You know, it ain’t going to work if you 
don’t have an Asian team or an American team at the final… You 
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want to encourage these kids – there should be two teams from each 
continent...    
To me, this commentary exemplifies a wider sentiment that sees the competition 
as having an important role as the media friendly image of synthetic biology. 
Interestingly, at highly professional meetings, conferences and policy-related 
symposia – especially when audiences include social scientists, reporters and 
politicians – speakers often call attention to the exciting and educational nature of 
iGEM and how it has infectiously led to the field’s international spread. Some 
view this happy face of synthetic biology as an especially valuable contrast to the 
field’s serious challenges around biosecurity, economic and legal dilemmas. 
 
Also related to presenting a certain sense of this field as virtuous, I found different 
opinions as to the value of integrating human practices in the competition 
(discussed further in later sections). Christina Smolke, official meta-judge of 
2009, told me that human practices judges were disappointed by the superficial 
nature of students’ efforts in this area – most teams were just ticking another box. 
I saw this first-hand in my experience with the Imperial College team, throughout 
the competition and in conversations with human practices judges. Yet, there were 
a small number of genuinely impressive efforts in this area and it is clearly valued 
as representing the competition’s open and responsible ethos.  
 
Christina Smolke and Drew Endy both explained an experimental approach to 
iGEM pursuits (and synthetic biology): an idea exists, a group of people try to 
take it forward in some way, mistakes are made, lessons are learned and 
experimental cycles move forward, hopefully making improvements. This was 
how the competition developed as a whole since 2004, and it is how the 
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integration of human practices has been working (since it began in 2008). Endy 
believes that at the end of every iGEM year, it is the judging panel’s responsibility 
to “diagnose what’s been experienced so far… celebrate what’s surprisingly, 
unbelievably impressive… which means it’s probably worth doing again and 
again and again, and then figure out how to do it better”. That positive perspective 
is, however, actually mixed with several frustrations between scientists and 
engineers in one grouping and human practices people (generally coming from 
science and technology studies, sociology, philosophy and theology backgrounds) 
in another. 
 
Fairness in iGEM is certainly striven for – seen, for instance, in the added layer of 
meta-judging reflexivity – but it will always remain, to an extent, problematic. I 
have already shown that there are biases in judging what qualifies as good 
synthetic biology; there are views about keeping up iGEM’s international, media-
friendly nature in a way that must be crafted beyond the merits of students’ work; 
there are hierarchies that operate across differing kinds of judges (those with 
technical expertise being prioritized over human practices); and, it is simply 
impossible to educate and provide fair resources for over a thousand students, all 
coming from very different educational institutions, with diverse expertise, levels 
of help, funding, talent, equipment, sponsorship, etc.   
 
I shift now to how students judged themselves, their peers and, most of all, the 
merits of synthetic biology’s community and philosophies. While at the Jamboree, 
among synthetic biology stars offering personal congratulations, prizes, media 
attention and a general frenzied atmosphere, many students (particularly on 
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successful teams) were sold on synthetic biology, wanting nothing more than to 
join the club and continue on with a prosperous and morally motivated career in 
this field (e.g. as suggested by Randy Rettburg in the closing ceremony, p. 225). 
A great number of students were of course, on the other side of that coin, as they 
left the competition without prizes or attention, feeling defeated and depleted, 
after all their weeks of hard work. There were also students who, despite not 
taking home prizes and glory, remained inspired. The Jamboree’s uplifting quality 
and the chance for students to interact with so many interesting projects and 
people served as enough reward for many to want to continue synthetic biology 
pursuits.  
 
This comment from Senni reflects a delighted surprise (uniform among the 
Cambridge team’s students) about winning the competition; it also shows how his 
previously hesitant views around the hype of synthetic biology were altered by the 
Jamboree experience.   
The fact that we won – I can’t believe it! The fact that we can win is a 
good sign for the field – you can do simple but good projects and do 
well. I think that is more important than, like some teams, where their 
entire university is helping them! I see a bigger world of synthetic 
biology now – there are actually people out there who believe in this 
thing. I think there are things going on. It does have a future. 
Previously, I thought not really – maybe after fifty years… But now I 
think it will come sooner.  
Teammate Derek expressed similar surprise: he thought iGEM and synthetic 
biology were about celebrating really ambitious projects, ones with “800-odd 
BioBricks” or “the fact that another team had two patent applications” (not that 
this was celebrated in iGEM but that it reflects high ambition), and so he was 
quite amazed that their project was so well received. In the immediate aftermath 
of the Jamboree, the fact that the Cambridge team’s work – self-reflexively 
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considered as exciting yet modest, simple and realistic – championed iGEM 2009 
gave the students considerable hope in the future of synthetic biology. 
 
Some of the Imperial College students’ reflections, shortly after the Jamboree, are 
captured in the following excerpts. They are further evidence that, as Zach so 
poignantly remarked, “iGEM is the process by which this school of thought is 
indoctrinated into you, from the ground up”168: 
The experience at MIT was amazing, firstly. When you’re working in 
a field that’s more developed, you wouldn’t actually get to meet the 
leaders in one summer. And to go to MIT and to have Randy 
Rettburg, Drew Endy, Tom Knight, … everyone there! That just goes 
to show how tight this field is… It is this neat little community. That 
hit home, going there. And everyone is interested in everyone’s work. 
Even though we’re iGEM students, the leaders of the field are there 
and they want to come to our talks and talk to us about the kind of 
stuff that we’re doing. And that just shows that we’re learning from 
them but they are also learning from us – there is a lot of bouncing 
ideas around. That was really cool. – Sita  
I think iGEM is one of the big facilitators of synthetic biology as 
opposed to genetic engineering in as much as genetic engineering was 
kind of stalled by campaigners against genetically modified 
organisms. But in synthetic biology, if we could redesign the whole 
system in the most efficient and most controlled manner – this 
modular way. It’s kind of like the most efficient language that was 
ever invented… What was it called? Esperanto. – Zach  
                                                
168 In additional team interviews, I found similar expressions of being sold on synthetic biology: 
• UCSF student A: “I think iGEM is awesome. It is my first time here. We have a few 
veterans who are coming back for the second time but for our first time, we came 
here and thought, ‘we don’t know what to expect’. Then, our first day here, we 
checked out some presentations and a lot of us were surprised with the new ideas, 
new applications coming in and just putting it out there for everyone to view. And, 
it’s also good because it is in different areas – not only focused in one area.” 
• UCSF student B: “For me, I feel a lot of pride in being part of this pioneering new, 
young field. There are lots of people in my college who don’t even know what 
synthetic biology is. But, in ten or twenty years from now, synthetic biology is 
probably going to be the first thing they’d think about when they think about biology 
or some scientific field that they’d want to get into.” 
• UCSF student C: “A lot of the ideas here, if you are working in a real lab, they 
wouldn’t let you do all these crazy ideas that might actually turn out to be good 
ideas. So this is the place to test those ideas” 
• Valencia student A: “I knew synthetic biology through iGEM; I didn’t know it 
before. I recommend it to everyone – it is fun, it is instructive, and you meet a lot of 
people.” 
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I think iGEM is really great in that it shows how exciting this field 
really is. I never knew before what this was all about. And so it is just 
a really great route into the field. And with some of the projects, you 
get just some really great ideas coming out of it. The creativity there is 
really quite amazing. Some of the ideas are quite, I dunno, headline 
grabbing, I guess. Which is good for the field if you get people 
interested. – Matt  
However, not everyone was sold on synthetic biology’s popular narrative. Kajan 
departs from the views above:  
I think iGEM is a good springboard for this kind of thing but I don’t 
think it is a very sustainable way for the field to develop… So, after 
iGEM, centres have to develop and go forward… I think, after a 
period of time, when the field gets sufficiently developed, I think 
iGEM can stop and the research centres themselves can go on to do 
more substantial research. 
This point will be discussed again later in this chapter when I explore breakages 
from iGEM. 
 
Following their human practices award win, I asked some Imperial College 
students to turn this judgment back on themselves, to reflect about the process in 
this aspect of their project. Candidly, there were admissions of surprise and 
expressions of gratitude, as it was recognized as mainly the work of Charles and 
myself. The team was nonetheless happy to have the prize. When I spoke with the 
students over coffee after having arrived back in London, Sita recalled speaking to 
a human practices judge who told her that they were tired of the same old leaflets 
and questionnaires; what struck the judges about Imperial College’s work was that 
the team implemented their considerations of human fears in their actual design 
by including the genome deletion module. However, Zach jumped in correctively:  
I would agree that that was the reason we won but I don’t think we 
deserved it for that reason because the idea of genome deletion came 
up very early for different reasons. It was originally that we were 
trying to delete the plasmid because people don’t want to have that 
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inside them… It wasn’t like there was a big debate. It was just 
obvious. Nobody needs some kind of extra intuition to understand 
that. And the other thing, of course, was dosage control. Those were 
the two big things that factored into doing genome deletion. It wasn’t 
that we’d re-designed it – but that was the line that we sought because 
it is a competition. 
The students’ comprehension of their own spin on the human practices process 
was evident. 
 
Further in this conversation on human practices at iGEM, some students 
expressed that the emphasis on doing this kind of work alongside the already 
demanding science labour creates another unfair bias in the competition, working 
against teams that do less controversial projects. Students who are new to the 
social sciences intersections with biotechnology often don’t know what this kind 
of work could involve and, lacking help and support, many teams resort to doing 
surveys and outreach, asking others’ views on synthetic biology’s social and 
ethical consequences as they don’t yet feel they’ve got their own opinions on such 
matters. Now that human practices has become increasingly important (albeit 
lesser to the technical evaluation of projects) in the iGEM judging circle, asking 
teams to go beyond surveys in order to be recognized in this category is unfair, 
claimed a couple of students. Yet, another student’s opinion resounded positively: 
I thought the human practices exercise was really quite interesting and 
it opened up my eyes to different issues that are sort of more 
important in the field. And I think as far as synthetic biology goes, it is 
really quite relevant to talk about these things – it is important for how 
the development goes… And, as a lot of us are planning to go into the 
field, I think it is useful – quite important that, at this stage, we 
explore these things. 
 
 268 
This group discussion with Imperial College students may have revealed a mixed 
view of the importance of human practices; however, the conversation’s 
conclusion was particularly interesting: 
Matt: I think also having won the Human Practice prize must have 
been great for you [directed at me] and it must have done a lot of good 
for the relationship between Imperial and the BIOS Centre. You’ve 
changed people’s minds about this. 
Zach: Bernard has come around… 
Matt: Yeah, he was really closed minded about this stuff before… 
And I think, from that perspective, it is really great what you’ve done. 
Caitlin: Well, I hope that it has sparked some lessons learned… 
Sita: Yeah, I think that’s a good thing.   
I will highlight the theme of how a social science intersection in synthetic biology 
is viewed and to what extent it is valued later in this chapter and in the next. It is 
indeed fascinating to have witnessed (in retrospect) what assisting with a human 
practices project revealed over time: it began with resistance and side-lining until 
the project was contained and mainly worked on by myself and one other student; 
to my surprise, the team won a prize through spinning sales tactics; and, further to 
my amazement, there seemed to be some partial redemption in a few people’s 
reformed beliefs that this kind of collaboration between social sciences and 
practicing synthetic biologists really deserves more attention and credit.  
 
Let us move away from how students judged the merits of synthetic biology as 
well as their team’s own Jamboree performance to another set of ideologies on sale 
at the Jamboree, those of the DIYbio community. In several informal discussions, I 
gathered a mixed body of feeling, support for and clear attitudes against DIYbio. 
On the one hand, many expressed great positivity about making biotechnology 
popular and accessible, and certainly the DIYbio spokespeople do a good job in 
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getting attention and drawing interest. On the other hand, even resounding 
cheerleaders of iGEM and an open source ethos could be sceptical, feeling that this 
fringe group of garage biohackers go one step too far and risk giving synthetic 
biology a bad reputation. That is, some believe DIYbio is a potential threat-by-
association to the well-intentioned practice of synthetic biology in proper, 
established laboratories that abide to tedious but necessary systems of health, 
safety and security regulations.  
 
A few additional (and dramatic) sentiments against the DIYbio community, 
voiced by Claire (a synthetic biology PhD student at Harvard), are noteworthy: 
[A prominent DIYbio advocate] was trying to tell me that he was 
going to be more innovative than I could ever be because he has to 
work around the constraint of not being funded. But, you know 
innovation means different things. I am sure he is going to make a 
fabulous gel box, but…. If you can talk those outspoken, self-
righteous DIYbio people down a little and actually get them to talk 
about the biology – like what are they doing that is not just hype?! I 
mean, they’re not doing synthetic biology – it is outrageous for them 
to even suggest that they are. I mean, it is hard to do! There is a lot of 
stuff that you need first of all! It is good in terms of getting people 
into biology, but really – what is extracting DNA from a strawberry 
going to do? 
Claire continued to inform me about how basic the work was from DIYbio 
practitioners and though she supports their popularization of science whole-
heartedly, she finds the rhetoric of their mission rather difficult to bear. In spite of 
the length of the following excerpts, I hope the reader appreciates the frank 
expressions of opinion: 
The language that they use is about ‘we are going to make a biotech 
company in our garage…’ And the idea that DIYers are going to 
develop synbio in a way that mirrors electronics! That is just not 
realistic – biology is not computers! 
And they also use a lot of language of oppression – as if we have 
some sort of natural right to do science and that there is some sort of 
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institution that is ‘repressing them by not letting them do science’! 
These are white guys with college degrees – no one is stopping them 
from doing science! They could get a job, in a lab, doing science – 
tomorrow! I mean on the DIY website, there have been recent 
discussions about, you know, ‘if there are laws against you, you have 
to fight against them – like Rosa Parks and Ghandi!’ This is 
ridiculous, this notion that there are ‘unjust laws that are preventing 
DIYers from doing science’! I find it offensive to bring up the Civil 
Rights movement to talk about a bunch of 20-something white guys 
doing science! It is actually offensive! And, they could do so much 
good because it is kind of hip and they are cool guys who love science 
– they could do so much good with that.  
You know, DIYers criticize scientists for being so isolated and that 
academic scientists are pushing DIYers away. But, part of what I want 
to do is explain my science and try and reach out. And then the DIY 
attitude towards other scientists is sometimes aggressive. I mean, yes, 
I work at Harvard but I am not trying to be mean or oppress DIY 
scientists. It is also interesting from a labour point of view – I mean, I 
do this to make a living. I get paid to do my science. I understand 
hobbies and investing money in those hobbies – but, to do science and 
put money into it, as a hobby?! That is a bit crazy!  
Clearly, there are numerous points of divergence between Claire’s academic 
perspective and her view of the DIYbio culture – on everything from what is 
possible or innovative in biological engineering (given that it is hard to do!) to the 
moral authority of citizen scientists resisting established institutional norms. 
Though much further discussion on this topic is warranted, it is beyond the scope 
of this work; the important point is that this kind of judgement exists in a sea of 
evaluations, and that the Jamboree creates a perfect storm for several positions on 
various aspects of synthetic biology to come together.  
 
Another point of consideration is whether or not Jamboree participants were 
interested in, or taking seriously, messages about securing synthetic biology. In 
the last chapter, there was something quite odd about a local FBI agent taking 
stage to convince iGEMers about the importance of open communication so that 
security experts could have a clear picture of good guys and potential bad guys in 
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synthetic biology. There was awkwardness about the FBI presence at iGEM – 
although every suggestion was made that the organisation supports having fun and 
learning by engineering biology and the representatives concertedly displayed an 
up-beat attitude, it was nonetheless strange to have official government agents 
walking around an undergraduate science competition with guns in their belts.  
 
A number of people I spoke with expressed appreciation that a connection to 
biosecurity experts is necessary and they take seriously the idea of a community 
responsibility to develop a code of ethics that ensures safe and secure practice of 
genetic engineering. Certainly American practitioners of synthetic biology and 
members of the DIYbio community see links to the FBI as compulsory. Others – 
especially those from countries that are less acutely concerned with terrorism than 
in the US – are sceptical of the need to get so excited about bioterrorists when it is 
actually extremely difficult to execute synthetic biology reliably. They might 
typically raise the question of why anyone would want to use this technology to 
make weapons when there are many easier technologies to utilise in order to 
achieve those ends. Such views often think the biosecurity concern is rather 
misplaced in synthetic biology at this time. Other participants had very little idea 
about biosecurity or international politics and seemed uninterested in this 
subject’s tie to their practice. These are often people who express a desire to just 
get on with their work and though they will obey the rules, they dislike the idea of 
further restrictions in their scientific endeavours. As biosecurity authorities have 
declared that they do not intend to restrict good bioengineering that aims to make 
the world better, some synthetic biology practitioners just hope to stay out of 
complexities in developing connections with FBI agents.  
 272 
 
Despite a range of judgements about the biosecurity presence within synthetic 
biology communities – marked mostly by a certain ambivalence among Jamboree 
attendees (as one can easily imagine it is bizarre to know that your work, as an 
undergraduate student, is tracked by a top national intelligence service) – this 
relationship will remain and biosecurity experts show signs of deepening their 
connection and infiltration. In 2010, a security presence at the Jamboree was 
apparently stronger, and a thorough website has been included among the iGEM 
pages as an awareness-building and educational tool for students.169  
 
The integration of art and design perspectives has been embraced and become 
influential in the community since its beginnings in 2009. At a local level, 
involving design viewpoints from Daisy and James in the Cambridge team’s 
project was regarded as an absolute success by all participants in its inspiring new 
and fun ways of thinking about both this particular work and the wider field. 
When Daisy and James brought their Scatalog of coloured poo to the Jamboree 
and displayed it guerrilla-style, a great deal of intrigue was generated – seemingly 
every attendee wanted to peek inside the case to see the shocking contents that 
made visible an imagined future application for personalised medicine via 
synthetic biology. The reactions that this interactive design work received were 
mixed that weekend, ranging from disgusted faces to giggles, to a good number of 
people expressing genuine curiosity about how to make such an idea a reality. 
Other artistic explorations of synthetic biology – such as ArtScience Bangalore’s 
                                                
169 http://2010.igem.org/Security. 
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smell of rain project (winner of Best Presentation) and team Osaka’s beautiful 
fluorescent E. coli – were highly celebrated at the Jamboree too.  
 
What is most remarkable, however, is the ricochet effect that ensued after the 
2009 Jamboree when art and design ventured into several collaborative 
explorations of synthetic biology – and received a great deal of attention in the 
process. The following shortlist briefly describes some of the projects, exhibitions 
and keynote publications in this vein since 2009:  
• E. Chromi continued to live on in Daisy and James’ design 
imaginations. They made a short film, several material objects 
(illustrating other imagined futures), developed the E. Chromi story on 
the project’s own website as well as through a Twitter feed and 
exhibited their work around the world.170 
• Synthetic Aesthetics (Stanford University and University of 
Edinburgh collaboration, 2009 - 2011) – An Engineering and Physical 
Sciences Research Council (EPSRC) and US National Science 
Foundation (NSF) jointly-funded project171 that brings together 
synthetic biologists, artists, designers and social scientists to explore 
the value of such collaborations.172 
• Wellcome Trust windows display What if…? (London, UK, 
February 1 - July 20, 2010) – Huge window displays at Wellcome 
                                                
170 http://www.echromi.com/. 
171 One of five successfully funded projects that were part of a ‘sandpit’ meeting in 2009 that 
awarded £6 million to various competing ideas in the area of synthetic biology 
(http://www.epsrc.ac.uk/newsevents/news/2009/Pages/syntheticbiologysandpit.aspx). 
172 http://www.syntheticaesthetics.org/. 
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Trust headquarters showed speculative future design projects related 
to biotechnology, including The Synthetic Kingdom and E. Chromi.173 
• Guerilla Science exhibits E. Chromi at Secret Garden Party, 
(Cambridgeshire, UK, July 22 - 25, 2010).  
• Impact! (Royal College of Art (RCA), London, UK, 2010) – UK 
designers and scientific research groups fused in this EPSRC and 
RCA collaboration. James King’s Cellularity was exhibited among 
sixteen other works.174 
• Alter Nature (House for contemporary art, Brussels, Belgium, 
November 21, 2010 - March 13, 2011) – A show of twenty 
international artists and designers whose works focus on the ways in 
which human beings change and design nature. James King’s 
Cellularity was included in this exhibit.175 
• Nano Supermarket by Next Nature (Dutch Design Week, Einhoven, 
Netherlands, October 2010) – Speculative design projects around 
nanotechnology exhibited; E. Chromi was included.176 
• Becoming Trans-Natural (Trouw, Amsterdam, Netherlands, March 4 
- April 1, 2011) – Daisy Ginsberg and Sascha Pohflepp’s Growth 
Assembly work was displayed at this speculative design exhibit.177 
• Brit Insurance Designs of the Year (Design Museum, London, UK 
February 16 - August 2011) – E. Chromi was nominated for this 
prestigious award and an expanded exhibition was displayed.178 
                                                
173 http://www.wellcome.ac.uk/News/Media-office/Press-releases/2010/WTX058379.htm. 
174 http://www.epsrc.ac.uk/SiteCollectionDocuments/events/impact-exhibition.pdf.  
175 http://www.z33.be/en/projects/alter-nature-we-can.  
176 http://www.nextnature.net/events/nano-supermarket/.  
177 http://multiplexart.ning.com/page/expositie-tn-02.  
178 http://www.londondesignfestival.com/blog/e-chromi-embedding-design-scientific-research.  
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• Life 2.0 (Science Exchange, Royal Institute Australia, April 25 - July 
8, 2011) – This exhibit considers changing ideas about nature and 
technology, given synthetic biology’s proposal to rebuild life from 
bottom-up; E. Chromi is included.179 
• Talk To Me (MoMA, NYC, US, July 24 - November 7, 2011) – An 
upcoming exhibit on communication between people and objects; E. 
Chromi will be included.180 
• Ginsberg, A.D. (November 9, 2009) ‘Building New Life Forms at the 
iGEM Jamboree’, Wired.co.uk, UK. 
• Bleicher, A. (December 11, 2009) ‘Technicolor doo-doo’, The 
Scientist, US. 
• Antonelli, P. (October 2010) ‘Fresh as a Daisy’, Feature on 
Biomedical Art, Nature Medicine, 16:942. 
• Neuhaus, L. (January 28, 2011) ‘How to humanize technology – from 
the scatological to the sublime’, Scientific American, US. 
• Nakajima, K. (May 2011) ‘Design in Synthetic Biology’, Axis Design 
Magazine, Japan. 
• In the Italian edition of Rolling Stone, a special feature on the world’s 
hot list of design talent includes Daisy Ginsberg in the top twenty 
(Rawsthorn 2010). 
This list’s impressive length, notable exhibition locations and media appearances 
speak volumes of how art and design have effectively staked a place as part of the 
emerging global synthetic biology community.  
                                                
179 http://www.riaus.org.au/events/2011/04/07/life_20_artifice_to_synthesis.jsp.  
180 Talk To Me show yet to go up at MoMA (http://wp.moma.org/talk_to_me/). An interview with 
James King has already featured on the MoMA blog (May 17 2010): 
http://wp.moma.org/talk_to_me/2010/05/meeting-with-designer-james-king/.  
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Following documentary film-makers Sam and George and what they did after 
their impressions of the 2009 Jamboree was interesting. These two spent over a 
year driving around the US, interviewing keynote figures in the field, iGEM teams 
and DIYbiologists so they could tell a real story about synthetic biology – what 
today’s reality is and what tomorrow’s possibilities may bring. In the process, 
they’ve documented several interesting people and narratives and gathered 
financial support of over $31,000 (USD) that is currently enabling them to 
produce their film. Sam and George are hoping to enter their ‘Synthetic Bio 
Documentary’ into the Sundance Film Festival. From the beautiful work that I’ve 
seen so far, I can imagine this will turn out to be quite an interesting independent 
film.181 I will not go into detail about all media presences; reports from the New 
York Times Magazine, Science Friday (on National Public Radio), Discovery, 
Wired and many more followed tales of the 2009 Jamboree.   
 
It is certainly remarkable how the endeavours of iGEM students, DIYbio 
enthusiasts and synthetic biology pioneers have attracted a flurry of additional 
creative interest – from artists and designers, documentary film-makers, 
journalists and social scientists – all coming to judge that there are several 
narratives within this diverse community worth telling. During the colourful 
excitement of the Jamboree – the Olympics of amateur genetic engineering – 
evaluating ideas and philosophies was on the minds of all participants, both within 
the sphere of practicing synthetic biologists, or those aspiring to be, and among 
interested parties on the fringes. In the rather overwhelming three days, almost 
                                                
181 http://www.fieldtest.us/bio/about/; http://www.fieldtest.us/bio/videos/. 
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everyone found an attraction to interesting facets of synthetic biology – people 
wanted to join the club. However, with reflection and distance from the Jamboree, 
decisions about further pursuits in the field can change and many realise that 
several notions in synthetic biology’s technical and socio-cultural missions are 
easier discussed than accomplished.  
 
7.2   Follow-up after the dust settled 
Before considering some student follow-up from the Cambridge and Imperial 
College 2009 teams, I will go back in iGEM history to the 2006 MIT team who 
engineered E. coli to produce wintergreen and banana scents during different 
growth phases.182 To date, that remains one of the most talked about iGEM 
projects, notable not only for being a fun, imaginative and successful idea, but 
also for representing a kind of dream team. It was a dream team because it had 
four highly ambitious graduate student advisors (along with five undergraduates 
and an additional graduate advisor) and Tom Knight and Drew Endy as faculty 
advisors (founders of iGEM) – all of whom went on to become synthetic biology 
superstars. 
 
The four graduate advisors teamed up with Tom Knight after finishing their PhD’s 
and co-founded Gingko Bioworks183, a Boston-based company whose mission is 
to “make biology easy to engineer”. Further to this mission, Gingko’s website 
claims “Only when biological engineering is fast and predictable will we fulfil the 
potential of biological technologies to revolutionize the provision of food, 
medicine, energy, and materials”. Under that umbrella, the company has been 
                                                
182 http://parts.mit.edu/wiki/index.php/MIT_2006. 
183 http://ginkgobioworks.com/about.html.  
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developing a range of projects, from heavily funded work (sharing $6.7 million 
from the US Department of Energy with collaborators) on electrofuels to 
developing IP for DNA assembly technology; from a user-friendly BioBrick 
assembly kit to biomanufacturing protein therapeutics; from strategic consulting 
to helping the MIT Registry of Standard Biological Parts improve its catalogue 
design. The Gingko group has even continued to work on their banana-scented 
bacteria from the 2006 iGEM project, looking to manufacture flavours and 
fragrances. This company’s formation, its slow but steady growth and its 
recruitment of iGEM student interns184 (an example to be discussed shortly) is 
emblematic of how the competition fuels synthetic biology’s development. 
 
Moving back to the particular groups of this work’s focus, Cambridge 
University’s first iGEM experience (and for the UK) was in 2005. One notable 
trend that followed was simply an increase in UK academic laboratories paying 
attention to iGEM and synthetic biology: by 2006, University of Edinburgh and 
Imperial College joined the competition and by 2010, the UK was represented by 
nine teams. Another important point about Cambridge’s history of iGEM 
participation is that it began with a team that included Andy as an undergraduate, 
who went on to pursue a PhD in the field, advise several iGEM teams, orchestrate 
conferences, recruit more UK interest in this area (from Microsoft Research, for 
instance) and work for The Registry at MIT. The faculty involved in Cambridge’s 
synthetic biology circle have also constructed a recognized, credited 
undergraduate course in synthetic biology that has been operating since 2009. 
This was the crash course that I took (Chapter 3) and it is not only required for the 
                                                
184 I recommend viewing the video that encourages prospective Ginkgo employees to be among 
the “engineers of the future”: http://ginkgobioworks.com/careers.html. 
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University’s iGEM students but is also open to other science and engineering 
undergraduates at Cambridge who do not participate in the competition. Samuel, 
Geoffrey and Frederick have all explained to me the great challenges in opening 
up academic disciplines and divisions at such a traditional university, but they 
have made some strides (in getting funding and PhD students) and continue to 
fight institutional battles in order to increase synthetic biology’s research 
presence.  
 
As for the 2009 Cambridge team, about a month after the Jamboree, when I 
conducted follow-up interviews, the excitement remained palpable as students 
recalled their iGEM experience. Indeed, everyone continued to express their 
surprise and delight in winning the competition; the additional congratulations 
received upon returning to Cambridge kept a certain buzz going and the media 
features of their work were another thing to smile about. Yet, interestingly, even 
this champion group demonstrated a cautious uptake of synthetic biology’s 
promises. When we discussed casually the possibility of students carrying on in 
the field, responses were tepid, at best: 
• Derek claimed, “I wouldn’t want to be involved in synthetic biology 
for at least another five years. It is just not practical yet… Synthetic 
biology’s parts system will be old news once DNA synthesis becomes 
automated – that little printer on the desk idea…” 
• Alex felt that, intellectually, what interested him in mathematics and 
modelling was to look at complexity, not the simple two or three gene 
systems of synthetic biology. He expressed that, “things don’t seem to 
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be improving at a drastic rate” and, at his most supportive, he said “I 
am keeping it [synthetic biology] as an option, if it gets better”.  
• Eleonore claimed to “see synthetic biology failing” and that the field 
as a whole neglected her main curiosity – “It is not interested in what 
the bacteria are actually doing”. To Eleonore, synthetic biology wants 
to build with biology, without actually capturing what is most 
fascinating about the microbial world. 
• Chelsea said, “There isn’t enough of what I’m interested in. I do 
physics. I mean I might be interested in biophysics.” 
• Emma, the most supportive of synthetic biology, claimed that iGEM 
made her “a lot more open minded about jumping into something that 
is a lot more unstructured, with an uncertain future… Even if synthetic 
biology doesn’t work, the people are still fun and they’re having a 
great time – and you really need people like that to build up a science 
because it is a really difficult thing… I have a lot of respect for the 
people in this field who are just really going for it. The idea of 
jumping into that is exciting but it is also really scary because it means 
taking a lot of responsibility from the very beginning.” Emma 
continued with a modest, but certainly what seemed to be the most 
excited view on possibly joining the synthetic biology club: “Right 
now I am just doing biochem and if I get inspired by my biochem 
project, then that’s great. But I already know that I have been 
massively inspired by iGEM. So it is definitely an open door, which is 
really exciting…. The fact that I know the people now and that I’m 
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only going to gain lab experience and lab skills, which will make me a 
better synthetic biologist, that’s pretty exciting.”  
 
By February 2011, sentiments and paths of many Cambridge students had shifted:  
• Derek was finishing off his biological sciences degree and applying 
for biotech positions in San Diego, US;  
• Tobey was enjoying his third year of engineering, with another year to 
go, specializing in Information and Computer Engineering, and 
though he said he was uncertain about where he may end up, he was 
taking some biology modules and remarked that synthetic biology still 
appeals;  
• After working for several months in Geoffrey’s laboratory, continuing 
to optimize her violacein sequence, Eleonore was applying for PhDs 
(and, despite her earlier reservations about the field, her top choices 
were in synthetic biology);  
• Chelsea was interviewing for PhDs in physics;  
• Senni had taken up a position as a researcher at the Genome Institute 
of Singapore, but intends to undertake a PhD position in a yet 
unknown area of biological science;  
• Emma was getting excited to embark on a PhD in metabolic and 
cardiovascular disease research, based at the Institute of Metabolic 
Science in Cambridge.  
So it seemed that after a year and half of distance from the iGEM experience, the 
Cambridge 2009 team had recruited maybe two (of seven) students into the wider 
synthetic biology club.  
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In the Imperial College story, it is again noteworthy that synthetic biology started 
at this institution with an iGEM team in 2006. After 2007, one of the team 
members that year (Max, a 2009 advisor) became the institution’s first synthetic 
biology PhD student, continuing with an infector detector system that they had 
constructed for the competition.185 In 2008, the trend continued as two iGEM 
members followed through with Master’s degrees and subsequent PhD work in 
this subject. In terms of setting up other structures to support synthetic biology 
development at Imperial College, by 2007, there was an undergraduate course. In 
2008, an MRes course was added; by 2009, the successful EPSRC grant allowed 
the formal set up of the Centre for Synthetic Biology and Innovation (CSynBI)186, 
which now offers a comprehensive education program in synthetic biology and 
has a number of new staff leading various research projects.  
      
For the 2009 iGEM team, the follow-up involves three of eight students carrying 
on in synthetic biology PhD’s (Zach, Andrew and Nisha) and, directly following 
iGEM, there were four students who completed CSynBI’s MRes course in 
Systems and Synthetic Biology (Zach, Felicity, Nisha and Matt). A couple of 
students diverged to completely different career paths, such as banking; while Soo 
and Kajan have been contracted to work for a year in Singapore in biotechnology 
industry jobs, before they plan to pick up again with graduate studies sometime in 
2011 or 2012.  
      
                                                
185 http://parts.mit.edu/igem07/index.php/Imperial.  
186 http://www3.imperial.ac.uk/syntheticbiology.  
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After pursuing an MSc in Bioinformatics and Theoretical Systems Biology at 
Imperial College, Nisha has ended up in Samuel’s lab at the University of 
Cambridge, focusing her PhD on computer modelling in synthetic biology. Zach 
completed his MRes in Systems and Synthetic Biology and is now doing a PhD at 
CSynBI, proudly stating that he hopes to be a biotech leader one day.  
      
Andrew’s story begins directly after the 2009 Jamboree as he remained in Boston 
to embark on a one-year hiatus from his undergraduate degree, getting industry 
experience at Ginkgo Bioworks. Andrew worked on developing an automated 
solution for the purification and building of engineered plasmids as well as the 
subsequent transfection into bacteria. Additionally, he gained competency in using 
the latest software that seeks to integrate a complex network of a given 
laboratory’s users, equipment, standards, functions, sample management and 
workflow automation; and, he carried out experiments using a cutting-edge liquid 
handling robot187. Andrew gained highly valuable practice in using some of the 
best equipment of synthetic biology – moreover, he was responsible for trying to 
improve the implementation of this software and technology, given the 
complexity still inherent in any experimental reality, in this relatively new biotech 
start-up company. Andrew was the first intern at Ginkgo and not only did this 
work turn out to be hugely valuable exposure to a higher level of synthetic 
biology practice, his time in Boston and traveling the US allowed him to meet a 
list of major players in this field, spanning academic and industry laboratories as 
well as the DIYbio community. When I caught up with Andrew a couple of times 
following his year in America, he was more motivated than ever as he worked 
                                                
187 Such robots in action: http://www.youtube.com/watch?v=tTicZnyvPlA&feature=related. 
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tirelessly in applying to the most prestigious synthetic biology PhD programmes. 
Unfortunately, he has not received funding and is unable to commence his next 
step in this field at this time; nonetheless, Andrew will continue to pursue this 
dream. 
 
The Imperial College 2009 iGEM team effectively recruited at least three (of 
eight) students, moving towards a professional career in synthetic biology – this 
rate is fairly high. Even if, at a global scale, the rate of iGEM alumni pursuing the 
field further is much lower, it remains reasonable to hypothesize that there is a 
trend of some significance that demonstrates the competition’s recruitment of a 
sub-section of participants to help grow and evolve this nascent biotechnology.   
      
Thus far, it has been a mixed group of aspiring synthetic biologists and the pursuit 
of other directions in the iGEM alumni that this work has closely followed. For all 
the students, the iGEM experience was nonetheless one of tremendous learning 
and personal development. Previous chapters have explored how some students 
felt that they’d acquired skills at a whole different level than would have been 
possible to achieve in undergraduate courses or other ready-designed research 
projects. In the teams’ own building of their ideas, designs, experiments and ways 
of presenting, biological engineering turned into more of an art form than a simple 
following of recipes. I have also discussed earlier how this intensive collaborative 
work engaged students to be self-reflexive about their best role in these particular 
teams – development as leaders, better listeners, efficient deliverers of results, and 
becoming more able to receive criticism constructively was evident across the 
board. After the Jamboree, students also reached new levels of presentation skill 
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in delivering their project sales pitch several times (not only on stage, but also 
alongside their poster and during other conversational opportunities). The 
Jamboree’s showcasing of several ideas and philosophies across a wide range of 
stakeholders also helped to open the minds of iGEMers. Undoubtedly, this 
competition excels in its ability to train, inspire and indoctrinate a huge number of 
students, a proportion of whom will go on to later synthetic biology pursuits.                                       
      
Following up with advisors’ views, a perfect passage to begin with is this remark 
by Andy: 
How else are we going to educate the next generation? For me, as an 
iGEM student turned ambassador turned advisor, I remember coming 
back from the Jamboree in 2005 and wanting to tell the world – my 
mother, my best friend, everyone at Cambridge – about synthetic 
biology...  
The point is clear from yet another angle: iGEM is a unique and effective 
educational tool for students and advisors involved, and it has also successfully 
enrolled institutional (and with that, financial) support, as well as the next 
generation of players for synthetic biology. There is uniform agreement among 
the Cambridge advisors that their teaching in iGEM is one of the most interesting, 
fun and effective ways to ignite the curiosity of undergraduates about synthetic 
biology.  
Part of the appeal of iGEM and synthetic biology, is that you can take 
students out of the world of lectures and codified information and a 
view that’s hemmed into getting down to an atomic description of 
some living process… But, what’s that for? And, in iGEM, you take 
students out of that kind of environment and put them into something 
which uses their existing skills, in a better way in fact, and points 
them outwards so that they can go explore.  
– Samuel, Cambridge advisor, 2009  
 286 
Having extensively described, over the course of this thesis, alternative forms of 
brainstorming, group work, creativity and high levels of independence that 
iGEMers experienced, I shall not go into further detail.  
      
Another important point for the Cambridge advocates of synthetic biology is that 
“it’s a technology for the young”, as Geoffrey put it. Moreover, it’s a technology 
that, at Cambridge, has faced considerable resistance from senior, established 
positions and disciplines, given the highly traditional institutional structures of the 
university. Andy explained his experience: “No one wanted to listen, senior 
scientists would tell me that it had all been done before, and when I tried to 
explain, get them to understand why synthetic biology was different, they just 
either laughed or turned away”. In that conversation, Geoffrey added “They’re too 
wired into doing things in a particular way and they’re not open to ideas, and part 
of that’s arrogance too, because they think they know everything, they think they 
know the way it works”. The resistance that Samuel, Frederick, Geoffrey and 
Andy faced seemed to only strengthen their resolve to continue building synthetic 
biology at Cambridge. Frederick pointed out, after the 2009 Jamboree, that there 
was more hope. The Wellcome Trust announced it would provide student stipends 
for UK iGEM teams188 and the BBSRC named synthetic biology as a priority 
funding area189. Subsequently, the synthetic biology clan at Cambridge carried on 
with new grant applications. 
      
                                                
188 http://www.wellcome.ac.uk/Funding/Biomedical-science/Funding-schemes/PhD-funding-and-
undergraduate-opportunities/WTX056624.htm; http://www.wellcome.ac.uk/News/Media-
office/Press-releases/2010/WTX059006.htm.  
189 http://www.bbsrc.ac.uk/publications/planning/strategy/priority-bioenergy.aspx.  
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In one meeting, Andy – perhaps overly enthusiastic about the group’s success and 
still deeply moved by the Jamboree spirit – claimed that the flourishing of 
synthetic biology was inevitable: 
Synthetic biology has gained momentum and turned from a snowflake 
into a snowfall into potentially an avalanche. It really is now showing 
off science and technology and engineering that is not just cutting 
edge but like, bleeding edge – it’s better than anything else that the 
current techniques, or established traditional techniques can offer, and 
senior scientists have no choice but to listen now. It’s not like they can 
say, ‘Oh we’ve been doing this for thirty years’. They haven’t, 
because if they had, then where are their data sheets, where are their 
characterized parts, where are their off-the-shelf components that snap 
together from lab to lab? They aren’t there, and they’re not engineers 
– they’re scientists. 
This almost outrageous statement indicates a kind of wild hope that being 
involved in the synthetic biology community can inspire; however, it is crucial to 
remind the reader that, at another moment – perhaps after a common experience 
involving weeks of tedious failing experiments – one would find a completely 
different tone. In its currently early stage, this field is highly characterized by an 
oscillation between easily talked about grand ideas and difficult realities of 
practice. In this chapter’s conclusion though, I suggest that there are some 
ideological bubbles being burst and, as a result, many synthetic biologists are 
trying to find a more constructive middle ground for thought and experiment.  
 
At Imperial College, iGEM leaders similarly echoed that iGEM is mainly about 
training, thinking and education, along with “getting kids excited about synthetic 
biology” (Roger). Specific to this institution, for a few years, their synthetic 
biology capacity was mainly in iGEM but since 2009, iGEM is only one 
component of the greater synthetic biology network of CSynBI. As mentioned, 
iGEM feeds into the MRes program, which in turn feeds into PhD research and 
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helps to fill out the laboratories of new researchers who started at the Centre in 
2010. Max told me “iGEM projects sell well” and this, in no small way, was what 
generated publicity and institutional attention to encourage funding bigger 
synthetic biology endeavours at Imperial College. Not only has iGEM helped to 
seed CSynBI, it has also brought people to the Centre from all corners of the 
globe as many current collaborators began as iGEM-mediated contacts.   
      
Outside the UK, coming from laboratories and universities with greater synthetic 
biology status and funding than either Cambridge or Imperial College, it is 
interesting to consider the views of Drew Endy and Christina Smolke, whose 
work has collectively influenced this subject’s pursuit at MIT, CalTech, Stanford 
University and further a field. Of course, Endy says “you can’t do anything 
without people”, so iGEM is a place where lots of people come together to try to 
use biology as technology; moreover, he claims that iGEM is a vehicle for 
figuring out what synthetic biology is. 
iGEM is a harvest of opportunity to figure out how you get better at 
designing a system; how you get better at building it; how you get 
better at testing it; how you get better at debugging it; how you get 
better at evaluating whether it’s good, bad or ugly; how you get better 
at sharing all of this stuff; how you get better at talking about it; how 
you get better at repeating all of that. And that, for me, is hidden often 
times when people look at iGEM, but it’s where it came from as a 
whole exercise, and it’s at the heart and soul of it.  
– Drew Endy, a co-founder of iGEM 
 
Christina notably added, “iGEM’s goals have evolved over time”. When it started 
at MIT with Drew Endy, Tom Knight, Gerald Sussman and Randy Rettberg, it was 
“built around them developing their foundational ideas that they were testing at the 
time – sort of abstraction hierarchy and common signal carriers and these sorts of 
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things”. What started as getting students to help in figuring out these guys’ 
biological engineering foundations, progressed into something that revolved 
around designing living systems. Then, upon getting funding from the National 
Science Foundation (NSF), a multi-school competition began, influenced by the 
success of robotics competitions. It followed that the integration of more rules 
about conforming to standards became important in order for the competition to 
build an open platform for sharing these biological parts, tools and techniques. 
Now, Christina noted, iGEM’s primary goals are about education and community 
development; to a lesser extent, it remains “partly sort of about building out the 
foundational technologies”. Further supporting my claim, Christina added: 
iGEM is a lot of students’ first interaction with synthetic biology and 
how they get interested in it, and as you saw, not everybody loves it 
but there’s a good number of people that get very inspired and 
motivated and interested in synthetic biology from this experience. So 
it builds out a number of people at the younger level that are going to 
go on and at least try to do something within synthetic biology. It 
pushes the boundaries there, whether going on to graduate school and 
research or industry etc. So I think it plays a very important role in at 
least filling out the numbers at the young level, which are then going 
to grow up and become part of the older community. 
 
Conclusion 
This chapter began by considering judgements that were made during, and shortly 
after the Jamboree, where projects and broader philosophies were being sold and 
evaluated. I have shown how everyone is deemed a winner of sorts in iGEM as 
the competition concluded with an extensive prize-giving ceremony, celebrating 
several categories and a broad range of accomplishments. Still, deciding on 
finalists – the very elite teams of the competition who are held up as innovative 
synthetic biology thinkers and exemplary of the iGEM spirit – involved a great 
deal of interesting judging politics which, in turn, influence both student and 
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advisor decisions on joining this community further. Questions around what 
qualities ought to mark a good iGEM project, making it particularly award 
worthy, were hotly debated: 
• Must projects have a grand vision, a significant and emotionally 
appealing real-world problem that they propose to solve? Or, are 
mundane, but useful small accomplishments just as, or more important 
than (sometimes impossible) ‘save the world’ ideas? Must teams 
adhere to BioBricks standards, or will other tools, techniques and 
stand-alone innovations be celebrated? What qualities of human 
practices projects might prove them to be more than just a box-ticking 
exercise? 
Additionally, many pioneers of the field feel that this competition serves a 
particular media-friendly function, believing that its results ought to reflect that – 
for instance, in having a finalist from each continent to demonstrate synthetic 
biology’s international uptake. Fairness, meritocratic evaluation, practical 
advances and several other issues were further debated in the iGEM judging 
circle; the important point remains that leaders are far from agreeing on what 
counts as good (and, with what priority ranking) for this competition, or for the 
field. When an international community of synthetic biology minds meet (and 
when there is an opportunity to find out what is contested behind closed doors and 
in smaller circles) the early, undefined and evolving qualities of this research area 
are apparent.  
 
I have also shown how, at the Jamboree, students are significantly, actively 
judging themselves, their peers and broader messages. The Cambridge group 
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deemed that their modest work’s winning result spoke volumes about iGEM, 
disproving some earlier concerns that the competition tended to support more blue 
sky dreaming at the expense of real science. The Imperial College team was 
mindful of how their selling tactics set them apart and earned them a prize for 
human factors; yet, after the competition, I was struck by how a number of these 
students seemed to reconsider, and take more seriously, an integration of 
humanities thinking into synthetic biology. Within those two teams and among 
several other iGEMers I spoke with, I found that (at least, in the short-term), there 
was an irresistible allure to synthetic biology as the Jamboree delivered countless 
exciting presentations, parties, motivational speeches and personal interactions 
with the field’s celebrities. Most participants couldn’t help but be absorbed by the 
experience of that weekend and subsequently, they took on board idyllic 
philosophies about synthetic biology’s potential to revolutionize the world in 
coming decades and often remarked that they wanted to remain part of that 
community spirit and mission. Additional ideas to attend to from groups such as 
DIYbio, the FBI, artists and designers, as well as a strong media interest, further 
heightened the Jamboree’s stimulating effects. iGEM organisers have effectively 
crafted the competition’s climax to ensure that students leave feeling deeply 
inspired in this way – that is why I claim that the Jamboree is a show, not only of 
genetic engineering, but also social engineering.  
 
Though a majority expressed eagerness in wanting to join the synthetic biology 
club whilst at the Jamboree (and shortly thereafter), I have also shown that, over 
time, iGEM alumni enthusiasm about venturing into this emerging area waned. As 
I’ve followed-up in this community (and particularly with iGEMers from 
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Cambridge and Imperial College) in 2010 and 2011, informally and through 
interviews, I’ve found that most former competition participants look very fondly 
upon their experience (having learned and developed personally a great deal 
through it), but chose to proceed within more established fields.  
 
Yet, there remains a significant group of believers who are still chasing a 
synthetic biology career. Having found that five students from two teams are now 
pursuing synthetic biology in a more involved sense (through master’s 
programmes, PhDs and work placements) two years following their iGEM 
experience, it is reasonable to postulate that the competition has enjoyed some 
effectiveness in its broader recruitment aims. Recall too that the competition has 
thus far exponentially grown since its beginnings (though it has probably now 
reached a plateau) and a calculation of 430 teams, having participated in the 
competition between 2004 and 2010, would entail over 2,500 iGEM alumni 
students alone190 – probably a few hundred more participants including advisors 
and other interested parties. Even if it is only a small fraction of competition 
alumni who continue in the field, it remains a significant contribution to synthetic 
biology’s development. Additionally, stories such as the 2006 MIT iGEM 
advisors that have gone on to form Ginkgo Bioworks, which continues to feed 
iGEM student interns into the company, support an argument for the 
competition’s importance in attempting to help synthetic biology flourish in 
future. Whether or not the field actually does flourish in years to come is, of 
course, another unknown matter.  
 
                                                
190 This is assuming teams of about 6 students; generally, the range is from 5 to 12 students, plus 1 
to 4 advisors. For iGEM history statistics, see: http://ung.igem.org/Previous_iGEM_Competitions. 
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iGEM has also been the first seed for several academics around the world to begin 
growing synthetic biology endeavours in their institutions and countries. With 
respect to Cambridge and Imperial College, I’ve explained how the competition 
sparked these universities’ progressive generation of courses, research 
programmes, funding applications and even the development of CSynBI (the 
UK’s largest synthetic biology facility of this kind). After these leading 
institutions set this example, many other universities in the UK and across the EU 
have taken notice and started pursuing the field. Drew Endy and other prominent 
pioneering figures claim that this phenomenon of synthetic biology spreading 
from university to neighbouring university, as well as growing in importance 
within institutions, is traceable globally. 
 
Over the last five or so years, iGEM has helped drive and configure the BioBricks 
or engineering school-of-thought in this field by producing a wealth of ideas, 
material realities and followers of this methodology. In this process, a social 
community has formed – or, more accurately, several factions within this 
community have formed and co-exist under the same umbrella – and there is a 
coming together on occasions such as the iGEM Jamboree. This community has a 
number of compelling founding values191 that have to do with embracing 
creativity; fostering a culture for sharing that affords quicker progress; being 
open-minded and adventurous with ideas across several disciplines; making the 
world better; and, in being part of this cutting edge biotechnology, prospering 
financially. However wonderful such philosophies are, they are also not stable and 
are easily doubted: 
                                                
191 Note that sub-groups such as DIYbio have their own more particular missions (described in the 
previous chapter). 
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• How far can creative, blue sky ideas really go? Most of the time, the 
answer is not far at all. Projects in synthetic biology that make 
small, incremental steps forward are the ones that are actually 
useful. 
• Is open source really sustainable when researchers need buy-in to 
support and protect their ideas in order to take them into 
development stages? Many believe the open source pot of synthetic 
biology tools, techniques and materials will have to yield to patent 
measures as the field develops.192 
• To what extent are the cross-disciplinary collaborations really 
working? Many biologists and engineers in this field disagree on 
their approaches and speak different languages. Many technical 
practitioners don’t want to get involved with social scientists, artists 
or members of the public – they’d like to simply get on with their 
work. 
• Is synthetic biology delivering on world-saving promises? We await 
the token anti-malarial treatment out of Jay Keasling’s laboratory to 
be given en mass and, further along the line, we don’t know much 
concrete information about how biofuels research is progressing. 
There simply aren’t many real synthetic biology applications out 
there, or even in the pipeline, that are discussed in convincing detail 
or formally publicised.  
                                                
192 Desires to increase patenting practices in synthetic biology, even within this BioBricks 
approach, are evident among some members of this community. For instance, note that the 
Slovenia 2009 iGEM team patented and did not share two parts.  
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• It is far from clear whether synthetic biology will continue to 
receive funding and, in particular, the kind of large-scale corporate 
and venture capital support that it would take for there to be many 
people making serious money in this field – the kind that goes 
beyond good academic salaries and might eventually afford private 
jets (as Randy Rettburg alluded, p. 225).  
 
Across the broad spectrum of those interested in synthetic biology – from its 
pioneers to iGEMers, from social scientists to artists, from members of the media 
to government officials – there is a great range in the extent to which people 
subscribe to the field’s ideals and decided to join the club, or not. Ideas and ideals 
about synthetic biology are distant from practical realities of both the technical 
(dis-)order of biology and the social (dis-)order of human beings who naturally 
have different visions for everything they do.  
 
As this work’s conclusion approaches, I am still compelled to point out recent 
findings (from the early months of 2011) of a few breaking points that are worthy 
of further study, but beyond the scope of this work. iGEM’s present position is 
important context: as of 2011, the competition has become too large to be housed 
at MIT in one final Jamboree, and so has split into regional sub-competitions 
(Americas, Asia and Europe) that will have separate Jamborees in October; the 
final Jamboree is to be held at MIT November 5 - 7, 2011, with the top percentage 
of each region presenting their work to compete for the Grand Prize.193 Although 
iGEM has continued to grow, there are several whispers in the community about 
                                                
193 http://2011.igem.org/Main_Page; http://2011.igem.org/Regions. 
 296 
what negative effects this splitting into regionals may have on synthetic biology. 
Some question whether teams will be motivated to invest the same amount of 
money, energy and thought to the projects when there is no guarantee of the truly 
international experience at MIT; some believe that staff will not continue to get as 
involved and the competition will have to be more student-driven and organised to 
survive; some are disheartened by the additional organisation pressures and 
politics in having to adhere to new regional, as well as Head Quarter, rules and 
preferences. There are several other points of speculation that I won’t go into. 
Overall, I believe one of the most interesting things to track in this change in the 
competition will be its effects on the already multiple (and often divergent) 
opinions about what iGEM and synthetic biology ought to value most – something 
that is suspected to get more complicated with additional levels of regional 
orchestration194. 
 
An important division that is increasingly remarked separates iGEM synthetic 
biology from professional synthetic biology (and with that, The Registry of 
Standard Biological Parts versus professional registries such as The BIOFAB195). 
Several iGEM advisors claim that although the competition has been hugely 
influential for the early years of this field (in educating, recruiting, inspiring, 
figuring out technical possibilities in this area and establishing a synthetic biology 
presence in institutions), many laboratories are at a turning point and now want to 
be considered more “professional” – that is, they have PhD’s, post-docs and more 
                                                
194 I make this statement with knowledge that there are several different ‘traditions’ of synthetic 
biology that are being developed around the world. For instance, in doing research in Japan for a 
project on international synthetic biology governance, I found that leaders of the field there are 
much more interested in foundational research (e.g. understanding components of living systems) 
than they are in building tools and applications (as the ideal focus is in many American 
laboratories and at CSynBI). 
195 http://www.biofab.org/about.  
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skilled researchers applying for grants and starting up larger-scale projects to 
build functional parts, devices and systems. A few thousand parts have 
accumulated in The Registry since 2003, but there are nonetheless several 
problems with iGEM BioBricks in that they are poorly described and often not 
functionally used beyond the initial makers. Most people attribute these 
significant weaknesses of The Registry to the fact that BioBricks are made by 
inexperienced students over a short period of time. Despite measures being taken 
to improve iGEM repository standards, it is widely agreed that professional 
researchers in the field must separate their work from the amateurs and develop 
technically sophisticated libraries of parts, devices and systems – whether that is 
kept in a given institution, or shared among several laboratories. As of early 2011, 
institutions participating in The BIOFAB collaboration are beginning to indicate 
that their professional registry is starting to grow; there is, however, still only very 
limited information on the kinds of biological parts that have been made and used 
effectively from this source.196 If indeed synthetic biology is maturing and 
outgrowing the iGEM level, it is just beginning to do so. As such, there is 
opportunity to take ethnographic research forward in an investigation of a next 
phase that synthetic biologists are eager to demark – from iGEM to professional 
ranking synthetic biology. 
 
This maturation, however, is not directed in a uniform fashion given that the 
community consists in such different disciplines and interests. Several researchers 
calling their work synthetic biology do not have their hearts set on the BioBricks 
paradigm:  
                                                
196 http://www.biofab.org/projects; http://biofab.jbei.org/services/data/client/.    
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Whether BioBricks themselves will develop the field, I think that’s 
more of an open question. I think the standardisation in mechanical 
parts is a much more straightforward and obvious proposition than 
standardisation of biological parts. And part of the problem is that 
biological parts operate in parallel – by that I mean there’s a soup and 
lots of stuff’s in the soup and you can’t predict what all the 
interactions are. And specifically it prevents you from really treating 
things as black boxes because we already know for many of the 
BioBrick black boxes, they actually re-use the same components 
inside so you automatically have interaction between them and 
therefore they’re not black boxes and you can’t use them as such. So I 
don’t actually know yet whether the BioBrick paradigm is the right 
one. – Frederick, Cambridge iGEM advisor 
When technical practitioners are more biology-focused (and realistic about its 
‘complex soup’) than engineering-focused, there are and will continue to be many 
departures from the project of tediously building and testing possible functional 
biological parts. A great number of researchers may prefer to take a myriad 
approach, using what is useful and branching off to find other, non-BioBrick 
methods that can usefully be employed in their work. I would suggest that an 
important avenue of investigation going forward would be to note the various 
adherences to and departures from the engineering approach that has led the early 
years of this field. 
 
Finally, I’d like to point out finding that there is unrest in the social dynamics in 
synthetic biology’s complex sub-divided community. I’ve briefly considered 
tensions that exist between academic versus garage biologists who share attention 
around safety and security issues, albeit in different ways; other points of 
disagreement among these camps in terms of what counts as innovation, or the 
legitimacy of a claim that DIYbiologists must resist the tyranny of established 
institutions, have also been mentioned. Another relationship worth watching in 
further research is between artists, designers, synthetic biology professionals and 
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other interested parties. I am curious whether the intertwining of different design 
perspectives can help illuminate what might be useful and acceptable in a possible 
future where humans consume synthetic biology products. A continued 
examination of media portrayals of synthetic biology197, as well as government 
interventions, would be of interest insofar as these players may significantly shape 
the field’s future, potentially posing dramatic challenges and changes in the 
development trajectory (e.g. in voicing a distaste for synthetic biology, or 
changing regulations).  
 
There is also opportunity to intervene as social scientists involved with synthetic 
biologists as these relationships continue to be forged. Social scientists in the US, 
UK and other parts of Europe have joined the synthetic biology club (in various 
collaborative networks and initiatives) and have been working with scientists and 
engineers for a few years now (Calvert and Martin 2009); there have indeed been 
tensions, not least because the humanities research is almost always a distant 
second-place to the technical matters at hand, or tokenised in some form, but 
lessons are being learned and incorporated. For one thing, I believe that a very 
constructive site for this kind of collaboration is at the level of engaging students 
who are particularly open minded and primed to think among several 
perspectives; but this must go further, effectively into the professional ranks, 
especially if the amateur versus professional divide deepens. It is now crucial that 
given this opportunity for several interested parties to co-construct synthetic 
biology’s path forward, current and future collaborators must strive to build a 
more positive, affirmative relationship that will develop this field in a way that is 
                                                
197 Media coverage of synthetic biology has started to be examined by researchers at The 
Woodrow Wilson Center for Scholars (Pawels and Ifrim 2008). 
 300 
responsive to the realities of technical, social, political, ethical and legal 
challenges.  
 
The choice now to join the synthetic biology club or not is not a simple question. 
In understanding the kinds of everyday feelings and realities in synthetic biology, 
there are evidently more people sitting on the fence about diving into this field 
than is comforting for the evangelists of this subject. There remain several 
fundamental points of instability in synthetic biology – from what is technically 
achievable to what will be the dominant socio-cultural messages. This may be too 
risky for many to bet their careers on; however, for those who do take the risk and 
join the synthetic biology club, there is still much in formation and as such, plenty 
of opportunity to help direct this field. That is an exciting prospect for several 
hundred iGEM alumni and current students of this subject around the world. 
Beyond filling the wet and dry laboratory positions that will shape this 
biotechnology, there will also continue to be input from DIY biologists, artists, 
designers, social scientists, members of governing bodies and journalists that 
significantly influence the trajectory. If indeed this field does present an 
opportunity to engineer life for a variety of human ends in the coming decades, 
how thrilling will be the prospect of involvement.  
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8.   CONCLUSION: 
EMERGING WAVES IN SYNTHETIC BIOLOGY AND BEYOND? 
 
This work was originally inspired by an enticing vision of synthetic biology and 
the opportunity to engage in collaborative conversations that helped to lay 
technical, social and cultural foundations in this field’s early stages of 
development. After decades of incremental advances in molecular biology, 
microbiology and genetics, along with the advent of tools such as PCR, DNA 
sequencing and synthesis and the use of computer modelling in life sciences, we 
might just possibly be on the brink of witnessing a revolution that could see 
several elements of the living world engineered anew, aiming to solve pressing 
world problems with respect to energy, pollution, food and biomedicine. The idea 
that a true engineering perspective (as opposed to the ad hoc and small scale 
genetic engineering of previous decades) can be applied to biology, such that a 
vast array of vital operations can be categorized according to standard parts, 
devices and systems that obey mechanical rules is captivating to some (although 
terrifying to others). Of course, this concept of humans mastering and redesigning 
nature for our own ends is certainly not new (one only has to consider centuries of 
agricultural practices), but many people are working hard to argue that synthetic 
biology may present a different paradigm.  
 
However, the story of synthetic biology has yet to be realized by many tangible 
innovations that convince us of the truth of its promises. I was curious therefore to 
get behind the popular narrative and into laboratories, observing, participating and 
talking amongst pioneering practitioners, in order to gauge how synthetic biology 
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is being taught; how new ideas are dreamed up; what the actual practices and 
processes are like; and what the social dynamics consist in. Having had previous 
experience researching synthetic biology (2007-2008), I knew that, especially at 
the field’s relatively immature stage (with very few laboratories having 
established substantial professional endeavours when I started fieldwork in 2008-
2009), one of the most interesting facets was the International Genetically 
Engineered Machine competition (iGEM). Within iGEM teams, I found not only a 
site to examine knowledge and material production, but also a place to witness 
how synthetic biology is a unique feat of both genetic and social engineering. In 
the early days of this biotechnology’s conception and development, a few clever 
pioneers enrolled their undergraduate students to help them engineer a biological 
system; seven years later, this has turned into a competition that educates, inspires 
and indoctrinates hundreds of students so that they help build, and take forward, 
synthetic biology’s technical and socio-cultural foundations. It is a kind of 
evangelism that converts students to the cause. 
 
Returning to this work’s core research questions as they were initially posed: 
• How do teams of scientists and engineers imagine, design and build 
new living systems? What tools for thinking and doing do they 
employ in this process? 
• In this process of knowledge and material production in synthetic 
biology, how do young researchers transition and rationalise the gaps 
between the imagined, the designed and the real microbiological 
machines that they craft? 
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• How does an undergraduate competition at the heart of synthetic 
biology seek to ensure the future flourishing of this emerging 
biotechnology? 
This thesis, a work broadly situated in the field of sociology of scientific 
knowledge, thus concerned the process of idea generation and its evolution into 
design and experiment that eventually generated new knowledge and material 
forms. The incubation of this trajectory was situated in layers of socio-cultural 
dynamics. In Chapter 2, I presented the case why, methodologically speaking, it 
was necessary for me to be observing and participating directly in the field in 
order to unravel the processes of interest. From Chapters 3 through 7, this work 
has gradually built that story of knowledge and material production, observing 
two core teams and adding the layers of social complexity that accrued as there 
was the addition of advisors and affiliates, an institutional culture and a global 
community of players with a variety of goals and visions for synthetic biology. 
 
Summarizing this thesis’ major arguments, I begin with ‘Dreaming up ideas’, in 
which the story of how Cambridge and Imperial College iGEM students were 
taught, and how they came to conjure up project ideas, presented a convincing 
case that the early stages of a synthetic biology endeavour are highly creative. I 
made use of the Bachelardian (1984) notion of phenomenotechnique to describe 
an act of the scientific spirit that is not particularly hypothesis-, discovery- or 
deduction-driven (as the pursuit of scientific knowledge can often be described); 
rather, dreaming up ideas in synthetic biology is first an imaginative exercise in 
the mind, before rational processing of design and execution possibilities can go 
on. This creative exercise also had a technology- and application-driven bend, 
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right from the beginning. Furthermore, dreaming up ideas is not abstract insofar as 
students extensively used tools for thinking such as drawing mind maps, making 
lists, sketching pictures, using online forums and conducting presentations. Such 
media gave a materiality and ontological status to thought – they served as a point 
of attachment upon which ideas could be understood, extended and re-worked by 
teammates and advisors.198  
 
Dreaming up ideas is not only about phenomeno-techniques in operation, making 
use of intellectual technologies (Miller and Rose 1990) that materialize ideas so 
they can evolve; the way in which students thought of possible projects was also 
highly influenced by how they were taught to understand synthetic biology and 
iGEM. At Cambridge, the crash course was crafted to introduce all students to the 
basics of this biotechnology, but it did so in a particularly inspiring way – lectures 
were animated and filled with appealing analogies (Lego™, electronics industry 
development, etc.); workshops from designers as well as guest appearances from 
entrepreneurs and a computer scientist at Microsoft kept things interesting; and 
laboratory practicals were playful, showcasing the best of synthetic biology ideas 
(e.g. the banana and wintergreen smelling bacteria experiment, working with 
Arduino kits, etc.). This group’s initial two weeks of sparking creative interest 
meant that they were somewhat primed to the difficult task of facing a blank page, 
considering a massive biological library and thinking about how to apply 
                                                
198 Other laboratory ethnographies, notably that of Latour and Woolgar (1986 [1979]), have also 
brought to light an obsession that scientists’ have with various writing practices (on black-boards, 
drawing pictures, creating graphs and charts, etc.). Latour and Woolgar’s (ibid) concept of literary 
inscriptions shares some interesting similarities with what I’ve described about the mind maps, 
experimental protocols, etc. of iGEMers; however, as noted in the literature review, Latour’s 
(1986; 1987) specialized inscription, the immutable mobile doesn’t fit well with the especially 
mutable nature of synthetic biology’s inscriptions and descriptions of existing entities and 
practices, new hypotheses or new entities. 
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synthetic biology rules in order to craft a microbiological machine. The Imperial 
College team members did not all partake in an introductory course to synthetic 
biology; rather, a series of try out meetings shaped and unified a particular pattern 
for the group’s thinking. Students learned early that, in their institution’s tradition, 
iGEM project pitches ought to demonstrate grand-scale, problem-solution 
oriented thinking; they ought to show a clear adherence to a modular, engineering 
approach; yet, they still had to offer competitive deliverables. The bar was set 
very high from the beginning and the team focused their formation of ideas 
around the advice of their supervisors.  
 
In the iGEM experience, the initial educational and inspirational framing that 
takes place is probably quite specific to a given team and their advisors’ and 
institution’s driving values. Still, there are significant features that unite over a 
hundred teams’ iGEM experiences in a given year – most importantly, each team 
receives the same standard BioBricks from the Registry and generally follows the 
parts-devices-systems school of thought. These standardization practices play an 
essential role in unifying synthetic biology (to some extent), giving the field’s 
practitioners a sense of collective creation of standard theories, tools, techniques 
and components for going about their work.199 Although there are such large-scale 
group efforts helping to coalesce what synthetic biology is about, I was somewhat 
more fascinated by the differences apparent in localised groups of iGEM teams 
and their advisors. At the introductory, microsocial scale, there are only a small 
collection of people at the heart of dreaming up an idea for a synthetic biology 
project. The specific knowledge, virtues and goals of individuals significantly 
                                                
199 Recall from the literature review echoes from Fujimura’s (1996) study that demonstrates how 
standardization of theory and methods played an essential role in the co-construction and growth 
of proto-oncogene research. 
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shape the possibilities of a team’s dreaming. I suspect that this feature is shared 
across several domains of innovative thinking. Whether a team is aspiring to 
design a new iPhone App, a medical device or a biosensor, the motivations of the 
characters involved, their curiosities, beliefs, talents and broadness of outlook, are 
all crucial in determining the boundaries of thought. 
 
In Chapter 4, I described the teams’ transitioning from thinking about synthetic 
biology (a world of ideas) to doing synthetic biology (a world of practical design, 
experiment and computer modelling). The evidence points to this transition not 
being a smooth one partly because there are conflicting understandings of 
synthetic biology as a field of effective, discrete engineering (in theory) but also 
one that frequently faces impenetrable complexity in living systems (in practice). 
Nonetheless, teams forged ahead, and after arriving at an idea that stuck – to build 
a colour-producing microbiological machine (Cambridge) and a self-
encapsulating drug manufacturing system (Imperial College) – they dived into a 
set of wet and dry laboratory practices. In doing so, both teams found that many 
protocols were not streamlined as descriptions of synthetic biology often present. 
There was a great deal of tedious work, which involved small volumes of clear 
liquid and lots of waiting time. Many cycles of failed experiments had to be 
repeated and there was lots of returning to the mind map-style drawing board.200 
The major work of the dry lab was to model various aspects of the biological 
systems under construction (rates of reaction, changes in the system over time, 
etc.), which gave the teams some nice data for presentation; additionally, 
                                                
200 Recalling the literature review’s descriptions of other laboratory ethnographies, I found the 
Cambridge and Imperial College laboratories in their experimental stages to be similarly full of 
failure, highly contingent and somewhat mundane. Knorr-Cetina’s (1981; 1983) concept of making 
thing work as well as Fujimura’s (1996) concept of scientists constructing “doable” problems both 
resonate with my findings in observing the iGEM teams processes. 
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modelling was sometimes used to input hypothetical data when experiments 
didn’t go as planned so that students could at least build a proof of concept case 
for missing components of their project. Perhaps the most exciting venture in the 
mid-phase for both teams was to design and order gene constructs online, which 
were synthesized by an outside company and sent back to their laboratories in the 
post. The Cambridge team’s violacein construct that year remains one of the most 
ambitious synthesis endeavours that the iGEM competition has seen. So it is true 
that, mixed with old methods and failed experiments, there was some very 
exciting synthetic biology technology used. The ability to cut and paste a desired 
gene sequence into a computer programme, make some artful (and well-
researched) changes to that sequence so it would function better for a given 
purpose; being able to then click send and receive synthetic DNA in a FedEx 
package a couple of weeks later, ready to be incorporated into an experimental 
living system – an impressive feat.   
 
What is important to highlight in conclusion about this design and experiment 
phase is that it was where I found the most candid discourse about, and display of, 
synthetic biology’s present reality. Practitioners in this field may all believe that 
there are numerous exciting ideas to be imagined and tried; they might also hold 
that an engineering framework is the key to taking this strand of biotechnology to 
an industrial scale (though there are many variations on this view). However, the 
reality of everyday design-experiment-fail-redesign (and so on…) cycles serves as 
a sobering reminder that the foundations of synthetic biology were not then (when 
I was in the field in 2009), and are not yet (2011), stable. Many experiments don’t 
work out as planned because many BioBricks from the Registry don’t function 
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reliably. Presently, engineering that is accomplished with BioBricks in one lab 
and described in a standard fashion, certainly does not guarantee that the same 
result is reproducible in another lab. In the iGEM context, projects required a 
great deal of scaling down from their initial visions in order for any tangible 
results to be achieved. Because students were often disheartened by experiments 
not working, I frequently witnessed advisors comforting them and telling a more 
grounded story of what is achievable in iGEM and, more broadly in synthetic 
biology, given the field’s immature state. Recall this poignant consolation to the 
iGEMers, from Cambridge advisor Frederick: “It’s OK, it’s not necessarily you; it 
may just be that the molecules don’t want to do that and that’s the way it goes”.  
 
Molecules not wanting to line up a certain way; a strand of DNA that is rendered 
non-functional due to one very small change in code; bacteria that die with the 
introduction of a gene that produces a compound not native to that species; a vial 
that is shaken too much, or not shaken enough; an experimental specimen left at a 
slightly less than ideal temperature for one minute too long – such seemingly 
small things separate operative elements of life from inert or useless material. 
Vitality persists only in a delicate balance. Yet, synthetic biology pushes the very 
boundaries of vitality, wondering what new designs and combinations of nature’s 
mechanics might yield (fuel, medicine, sensors and remediators, art…). It is at this 
boundary, and when ideas turn into experimental practice, that Canguilhem’s 
(2009) reference to the ‘vitality of vitalism’, the ‘fecundity of vitalism’ and the 
‘character of honesty in vitalism’ has an important place. Canguilhem’s work 
articulates changes in biological theory throughout history and takes special notice 
of repeated returns to vitalism. For him, the rebirths of vitalism translate “life’s 
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permanent distrust of the mechanization of life”, where one finds “life seeking to 
put mechanism back into its place within life” (ibid, 73).  Canguilhem’s (2009) 
vitalism is a philosophy rather than a mode of scientific thinking, something of an 
ethical cue rather than a working theory. Bringing vitalism into a discussion 
around synthetic biology is not about the persistence of a mysterious vital force; 
given that today there is undeniably a great deal of knowledge and control at 
biology’s molecular scale, support for a reductionist and mechanistic view of the 
living world seems to defeat rather archaic-sounding theories of vitalism. 
Nonetheless, as a philosophy, vitalism has its place today, reminding us to not 
only recognize the limits of our understanding and engineering ambitions with 
respect to the living world, but also to undertake a broader reflection on how 
biotechnology practices shape a society’s philosophy of life.  
 
Rose (2011) recently argued that, in light of Canguilhem’s work, we must 
remember that, “every mode of biological reason is also, in a certain way, a 
philosophy of life”. For Rose, “our way of living, our sense of how we should live 
as humans, why we should live as humans, of what we owe to ourselves and 
others, of what we can know, of what we can do, what we can hope for – all of 
these have become tangled up in what we think we are as living creatures and 
what we think about our relation to other living creatures in the world in which we 
inhabit” (ibid). With respect to synthetic biology, vitalism not only brings in the 
obvious concepts of life’s complex, dynamic, evolving, reproducing, sensitive 
qualities that entail a resistance to being re-engineered, but it also prompts a 
reflection on what might be humble limits as practitioners continue to develop 
technologies that remake life (slow as that process may be). These limits ought to 
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be responsible to social morality – a broader philosophy of life – and considering 
them can be a key impact of the cross-disciplinary engagement that is occurring 
between synthetic biologists, social scientists, artists and designers.   
 
Returning to the narrative, recall that another activity that did not transition 
smoothly from the idea stage to the doing stage was in getting the Imperial 
College human practices project off the ground. Although there was initial support 
from a couple of advisors when I first proposed to help the team with this idea, as 
time went on, the side-lining of such an exercise was evident when compared to 
the need to get real experimental results churned out as the team felt behind, with 
pressure mounting. Yet, with the help of an inspired student (Andrew), I was able 
to accomplish, in one day, the orchestration of a workshop and interviews with 
every team member; together, Andrew and I proceeded to make the human 
practices video and write a summary document about this side project.  
 
Collaborations between synthetic biology practitioners and humanities scholars – 
though desirable, celebrated and funded – remain in uneasy territory. Some 
synthetic biologists are weary of being the subjects of a study; others show their 
belief in science and technology’s moral authority over different forms of 
knowledge; and still others are just not interested or don’t see the advantage in 
really engaging with ideas from the humanities or artistic fields. Such feelings 
certainly present challenges for the involved social scientists, yet, for the time 
being, there remains a window for this type of collaboration. Having witnessed a 
number of meetings and been involved directly in this community over three 
years, I have hope that practices and values inherent in synthetic biology have 
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been, and can continue to be, mutually shaped by perspectives from life sciences, 
engineering, humanities, government, publics, art and design. I believe the kind of 
multifaceted and integrated making of this biotechnology is most fruitful among 
those still in education – those participating in iGEM (including in an advisory 
capacity) or in university courses – as there are often open, inspired and excited 
frames of mind in such spheres. Interestingly, there is also a good deal of 
collaborative outreach from the DIYbio community, particularly with public 
audiences (though I have not been able to examine it in detail). On an inevitably 
bumpy road, synthetic biology stakeholders in every discipline are learning from 
experiences as they go along, hopefully building some relationships that will take 
this field forward in a manner that is especially mindful of a broad range of 
societal, regulatory and ethical concerns. 
 
Another important gap between synthetic biology theory and synthetic biology 
practice that was illuminated is that there is no seamless merging of biology and 
engineering perspectives (as is sometimes presented). In reality, different 
disciplinary perspectives (loosely categorised in camps of biologists and 
engineers) struggled with technical language barrier issues. More broadly, we can 
analyse these boundaries as distinctions in styles of thought. Biologists tended to 
have, or sought out, explanations of biological complexities; though this activity 
could lend insight into why some experiments did not work, it tended to confuse 
and frustrate engineers who wanted some good data crunching material so they 
could build the models, graphs and predictions that they enjoy. Only a couple of 
exceptional students at Imperial College sought to really learn more about (and 
practice) the other disciplines that were not in their previous training. Most 
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biologists did more of the wet lab work and most engineers stuck with their 
computers and differential equations. Rather than a merging of disciplines, 
synthetic biology practice here was more about each individual finding a way to 
contribute their knowledge and skill-set to the tasks at hand. The different views 
about synthetic biology ideas, ideals and practices that were divided between 
biology-leaning minds and engineering-leaning minds was a highly significant 
observation that came up again in the selling and judging stages at the Jamboree.   
 
In Chapter 5, the narrative shifted and examined what kinds of entities were 
actually made real in E. Chromi and the E.Ncapsulator. I found that, given the 
limited time frame and various set-backs, although the teams developed an idea 
for something that would qualify as a whole biological machine – an arsenic 
biosensor that would have programmable sensitivity tuners as well as easy-to-read 
colour outputs (in the E. Chromi story) and a drug manufacturing and delivery 
platform that would allow a chemical synthesis of choice, targeted delivery of that 
compound to the gut, plus a guarantee that the bacteria had ‘committed suicide’ 
before consumption (in the E.Ncapsulator story) – they could actually only build 
parts of these overall systems and make some additional proof of concept cases 
with hypothetical models. It is important to emphasize that the chance of 
constructing a fully functioning, synthetic biology-driven machine remains slim in 
the scope of iGEM. Still, both teams’ accomplishments were remarkable, 
including colour generators that vividly produced brown, purple, green, orange 
and yellow outputs as well as an engineered E. coli that evidently coated itself in a 
protective colonic acid layer, increasing the cell’s resistance to acid degradation 
and therefore protecting its contents.  
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Understanding the kinds of material entities that were actually produced, I made 
use of two areas of discussion in order to question how we might think of, name 
and categorize synthetic biological machines. Firstly, I invoked Hacking’s (1983) 
position as a ‘realist about entities and an anti-realist about theories’ that considers 
experimental entities real when they have been created, produced, refined and 
used with respect to other experimental materials with known cause and effects. I 
claimed that although there is good reason to doubt the truth of synthetic 
biology’s theory or project ideas, once the move to experiment takes place and 
some new material forms clearly display intentionally engineered causal 
properties – such as the purple producing bacteria, or an E. coli that coats itself in 
acid upon a particular trigger switch – then we have good reason to believe in the 
realness of such entities. With this argument, I highlighted that despite having 
unpacked a number of social dynamics (e.g. about character roles, tensions 
between disciplines and institutional cultures) throughout the narrative, has not 
been my intention to build a case for the social construction of scientific 
knowledge and artefacts.  
 
I aimed to present an accurate picture of the practices and processes that generate 
ideas and entities in synthetic biology; and, once we do see materials being made, 
and we witness their causal potentialities, I think taking a position and labelling 
such things as social constructions is not terribly illuminating. Like Latour and 
Woolgar’s (1986) move in removing the word “social” from the subtitle in the 
second edition of Laboratory Life: The Construction of Scientific Facts, I too 
rather avoid confusion, and leave aside the words “social construction” in 
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describing the resulting entities of genetic engineering. All truth claims and 
human engineered entities have social factors that shape their possible existence; 
as such, they can be described in terms of a social constructionist line of 
argument. There are of course several social constructions operating in synthetic 
biology laboratories. However, in my argument, I have intended to step outside 
the social constructionist debate, and attend to lessons specifically inherent in 
synthetic biology. Biologically engineered entities that have causal properties, that 
are capable of being affected by and interacting with other entities in a milieu, 
ought to be treated according to their real material potentialities. In the case of a 
biosensor made with synthetic biology parts, this consideration entails attending 
to important matters such as the safety and functionality of a machine. Just 
because the construction of the entities in synthetic biology involves a social 
process and many contingent ways of interpretation and ascribing meaning, it is 
not reason to cry ‘social construction’ and stop there. The point that real things are 
constructed in complex, risky and specific ways – and that such things could 
continue to be complex, risky and involve other yet unknown specifics when they 
are pieced together with additional biological parts or situated in different 
environments – needs to be taken seriously. Social scientists must be careful to 
attend to the biology itself, just as we ask that synthetic biologists attend to our 
presence and our research concerns in a serious and rigorous fashion.201  
 
Thinking about the materiality of synthetic biology systems, I also raised some of 
Canguilhem’s (2009) ideas about machine and organism. Might these ideas help 
individuals formulate a view on the categorisation of present and possible future 
                                                
201 This attending to the materiality of synthetic biological entities that I am calling for is, in some 
ways, along the same lines of argument developed by the new materialists (for instance, Bennett 
and Connolly 2002; Bennett 2004; Barad 2008).   
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synthetic biology’s outputs? If, according to Canguilhem, machines obey 
calculations, are rationally designed and function predictably, and organisms have 
endless latitude, behaving as “an attempt in all directions” (ibid, 90), then what 
are we to make of a new, intentionally engineered, mechanical organism? In the 
end, I raised these questions but do not believe we need to precisely define a novel 
breed of synthetic, mechanical organisms at this time. Synthetic biology remains a 
young field, and though its ambitions for creating synthetic life can sound like 
lofty, scary Frankenstein science, I think its current outputs of discrete biological 
parts and systems is, for the most part, not terribly dramatic or worrying.  
Nonetheless, the subject of engineering life in the 21st Century has profound 
social and ethical implications that we should attend to and debate. Moreover, I 
have argued that a continuing conversation among many interested parties ought 
to seriously consider present realities of everyday laboratory practice. Real stories, 
with real people, showing the sorts of things that this field is actually doing are 
critical – not only to avoid indulging overly fantastical narratives (good and bad) 
but also to provide valuable insights about entry points for those who want to get 
involved in shaping synthetic biology’s future.  
 
This study moved from the UK to the international Jamboree stage in Chapter 6 
and presented two sections of empirical data that helped answer how this 
competition has sought to support a flourishing future for synthetic biology. The 
Jamboree context was the first important layer: with its dramatic location (the 
spaceship of the Frank Ghery building at MIT), spirited Halloween timing, the 
high profile attendee list of synthetic biology V.I.Ps, interested groups on the 
fringes, American-themed parties and colourful displays of team pride, it is no 
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wonder that the event is coined the Olympics of amateur genetic engineering. The 
backdrop of the finale created an ideal atmosphere that served to excite, inspire 
and sell synthetic biology projects and philosophies to hundreds of 
undergraduates, many of whom aspire to be future leaders in this field.  
 
The second section of Chapter 6 detailed the sorts of projects and ideologies that 
were vibrantly on display at the Jamboree. Teams had their twenty-minutes to 
shine in front of a peer audience and several judges: they explained their 
aspirations to solve a given problem, showed off their most impressive results, 
likely exaggerated a few points, admitted to some setbacks and orchestrated their 
best version of a competitive and engaging presentation. Highlights such as 
ArtScience Bangalore’s intriguing ‘smell of rain’ project, or the 11-year-old’s 
BioBrick-A-Bot and a high school team’s building of their own lab kit reflected 
the open-minded and adventurous spirit of iGEM. Teams were also busy selling 
their projects through poster presentations, cartoons on blackboards, mascots, 
give-aways, team T-shirts and the like. The active pitching that competitive teams 
were doing was matched by more established leaders’ roles in selling back to 
students a number of synthetic biology’s idyllic philosophies (worth repeating): 
• This community is revolutionary in its open source ethos that supports 
collaboration as well as work from amateurs and lesser-funded 
laboratories; 
• This community believes biotechnology will make the world a better, 
cleaner, healthier place in the coming decades – we are now in The 
Century of Biology as Technology;  
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• This community consists of friendly and outgoing contributors whose 
expertise cross several disciplines – from all walks of science and 
engineering, to humanities, art and design. This community is not 
represented by stereotypical images of reclusive scientists; rather, it is 
represented by a mix of clever, vibrant and playful characters;  
• Finally, dedicated researchers who enter this up-and-coming field will 
prosper financially for their incredible work to come. Most notably, 
this point came through in the closing speech of iGEM Director 
Randy Rettburg when he announced, “I think that over the next 40 
years synthetic biology will grow in a similar way [as the computer 
revolution] and become at least as important as the Internet is now and 
that you will be the leaders, that you will form companies, that you 
will own the private jets and that you will invite me for rides”. 
The fact that the Jamboree was also host to non-competitive, but nonetheless 
interested parties, who had their own messages or stories to seek out – I’m 
referring to groups such as DIYbio, biotech representatives, government officials, 
designers, journalists, film-makers and social scientists – served to increase this 
sense of synthetic biology’s general significance as a key, budding 21st Century 
technology. All of this information serves my argument that the competition is 
designed to help inspire (and in some senses, socially engineer) its participants to 
want to jump on the synthetic biology bandwagon, in order to develop this field in 
years to come.202     
                                                
202 Note that Fujimura (1996) similarly discusses the creation of an oncogene research bandwagon, 
which, in her study, is a configuration held together primarily by the standardization of 
experimental systems, tools and packages that enabled practices and theories to be shared and 
passed between participants across several social and disciplinary spheres. Similarly, the synthetic 
biology bandwagon is, in part, held together by shared practices, standards and an over-aching 
theory for the field (parts, devices, systems, etc.); however, what I’ve shown to be equally 
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It is important too to mention another gap that becomes apparent as teams move 
from working at their own institution’s laboratories to the competition stage. 
Although the vast majority of projects would not have turned out as teams 
hopefully envisioned, they eventually land at the finale and find themselves 
presenting in front of hundreds of peers and an impressive list of judges. In this 
transition, the grounded conversations that may have easily been had in home 
laboratories weeks earlier (about synthetic biology’s pitfalls) were abandoned; 
students and leaders find the Jamboree an occasion to sell, spin and hype ideas 
and ideals. This again serves the purpose of generating an alluring ambiance over 
that weekend, but it does not reflect an accurate picture of what synthetic biology 
entails in the day-to-day.  
 
Chapter 7 continues to support my argument that iGEM is a tool to educate, 
inspire and indoctrinate a next generation of researchers who can help take this 
field forward; however, the follow-up data presents a mixed picture and it is 
important that the nuances come through. All participants of the Jamboree 
evaluated team projects and broader ideals in some way and these judgments 
shaped decisions to join the synthetic biology club or not. During and shortly after 
the Jamboree, most students inhaled an air of inspired buzz – they sounded keen 
to join. After some time and distance, reflections about pursuing synthetic biology 
seemed to become more tempered for most students and many decided against 
going into further studies of the field. This point is worthy of a little elaboration in 
conclusion. 
                                                                                                                                 
important, or perhaps more important, in the synthetic biology bandwagon, is a kind of social and 
political rallying that in the processes of ‘selling ideas’ and choosing to ‘join the club, or not’. 
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Forging a new interdisciplinary field is easier said than done. In practice, the 
extent to which people want to themselves become true cross-disciplinary experts, 
as well as their comfort levels in leaping into the unknown203, have their limits. 
There is a riskiness involved, with uncertainty about whether a new discipline 
may blossom or fade out – understandably, individuals may feel hesitant 
identifying themselves with a field that will inevitably make many mistakes in 
trying to define its scope. When a synthetic biology team is mainly composed of 
members trained in established fields of engineering and life sciences, there is a 
sense in which people like the idea of being part of this emerging, exciting field 
(especially at events like the Jamboree); however, they also tend to want to keep 
one foot firmly rooted in their original discipline. It is exceedingly difficult to 
satisfy, or settle, a broad range of views on what synthetic biology is. The 
frustration involved, I suspect, has some people turning back to their original 
discipline, where there are perhaps more stable jobs, research and funding 
trajectories – or, at least where the territory is more familiar. It takes courage and 
a leap of faith to dive whole-heartedly into a new area. The case studies I have 
presented show that some participants who have appeared to dive in, have actually 
later chosen to step back into engineering or biology comfort zones a couple of 
years following their iGEM experience. 
 
                                                
203 I refer to a sense (explained by many participants) in which, in the case of synthetic biology, its 
so-called ‘merging of biology and engineering’ (two independently established fields) leaves it in 
unsettled territory. Is it more biology, or more engineering? Does bringing the disciplines together 
entail something entirely new? Or, is it merely an awkward mixing of established practices and 
philosophies? What exactly this field is about can be difficult to articulate, especially when it is 
held in comparison to one of its more strongly defined composite disciplines.   
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Still, there are a few specific stories and a notable trend of uptake of iGEM alumni 
deciding to join the synthetic biology club that remains impressive. I have 
described how previous MIT iGEM advisors went on to found Ginkgo Bioworks 
and illustrated how the progressive growth of the competition over the past seven 
years has led to several universities starting synthetic biology endeavours (in, for 
example, developing courses and even full-fledged research centres). iGEM has 
undoubtedly been a very significant influence in spreading the word of this 
emerging biotechnology to all corners of the globe. In the groups that I’ve 
followed, there are at least five students currently striving to be part of a next 
generation of synthetic biologists. Overall, the competition has now educated and 
inspired well over two thousand students, advisors and faculty, a portion of whom 
will still be actively participating in the broader field, hoping that its future 
delivers something substantial of its present (mostly not realised) promises. 
Undoubtedly, iGEM has been a remarkable site for amateur genetic engineering 
that has worked out many early-stage ideas about what synthetic biology ought to 
be about; moreover, it has been a unique phenomenon in the landscape of today’s 
emerging biotechnologies204 with respect to its ability to socially and culturally 
influence a number of people, committing them, in some sense, to be promoters of 
this new field.  
 
This summary of arguments has detailed major points from Chapters 3 through 7 
that specifically work to answer the core research questions outlined above. I have 
                                                
204 There is no analogous competition to point to other recent developments in the neurosciences, 
nanotechnology, stem cell research, etc. Although the iGEM competition was, in part, modelled on 
the success of various robotics competitions (look, for instance, at http://robots.net/rcfaq.html) – 
something I do not know much about and will not comment on – its effect in recruiting 
involvement to synthetic biology’s cause is, to my knowledge, intriguingly unique. What 
combination of characters, timing, powerful rhetoric, larger social phenomena in open source 
collaborations, etc. made this happen is an interesting matter of conversation. 
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also explored other interesting, sometimes slightly tangential, findings from the 
field. Throughout the empirical chapters, I developed a flavour of many characters 
behind the story that was developed. Early on, I wrote about the striking 
leadership found in Emma (Cambridge), the development of Senni’s great 
scientific skill (Cambridge), Andrew’s curiosity in philosophical discussions 
(Imperial College) and Nisha’s tremendous teaching talents (Imperial College). I 
developed a sense of who the advisors to these teams are, and what they valued 
about iGEM and synthetic biology: the hugely devoted Andy; the patient 
fountains of knowledge found in Samuel, Geoffrey and Frederick; the tough love 
spirit of Roger’s advising; Bernard’s bizarre ideas about the importance of 
emotional appeals that ought to be attached to competitive projects; Max’s and 
Olivia’s devotion to helping students in their most trying of moments in the wet 
lab. These characters and their relations to one another all evolved over the course 
of the summer, as did my relations with participants (detailed in Chapter 2). I also 
explored institutional cultures, various values and mission statements of numerous 
sub-groups – from the traditions at Cambridge and Imperial College to the 
perspectives of DIYbiologists, biosecurity officials and designers attempting to 
provoke reflections about this field’s future implications. iGEM 2009 proved to be 
a hugely important experience of personal development for the great majority of 
individuals I interacted with, and for myself as a researcher.  
 
Before moving to a few broader conceptual thoughts, I’d like to emphasize that a 
large part of what this thesis has done is to capture a detailed narrative of 
knowledge and material production as well as the surrounding sociality, that took 
place in a relatively short window of time, among pioneering synthetic biology 
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practitioners. I have only been able to illustrate a small part of the life cycle of 
iGEM, and synthetic biology’s development. This field is actively changing – in 
its technicality, tangible outputs, social structures and ideologies, size, relations to 
governments and publics – and with that, some of this narrative is set in historical 
bounds. In that sentiment, I present a final figure below, picturing the two teams 
and I at the conclusion of the 2009 iGEM Jamboree.  
 
Figure 8.1: An ethnographer embedded in winning teams 
 
  
Photos attributed to iGEM and David Appleyard.  
 
Yet, there remains a broader set of conclusions and open questions that this work 
speaks to. I would like to now, in closing, share a few reflections on the nature of 
innovative knowledge production and an understanding of life.  
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The notion that developing a new area of technology must first come from a set of 
imagined possibilities in an exercise of ‘dreaming up ideas’ has been an important 
theme in this thesis. It is an interesting finding that even in today’s highly 
scientific and engineering-driven fields – associated somehow with sterility, high-
level molecular control, concrete facts, robotic practices, computerised precision, 
black-box descriptors and the like – people are creatively imagining, mind 
mapping, sketching out loose ideas and reaching into virtual communities; they 
are grappling with a mix of languages in often conflicting frames of thinking and 
doing; they stumble along and try to find a way to bridge several gaps. Innovative 
knowledge production can, it seems, arise from a rather messy landscape of 
thoughts and social interaction. I now wonder: might an iGEM-style of imagining 
ideas be indicative of some broader characteristics of contemporary innovative 
science? 
 
David Edwards, founder of Le Laboratoire in Paris205, believes that there is 
gathering momentum behind a process of ideation and product generation that is 
driven in a creative, highly interdisciplinary fashion – something, he says, 
happens best when conventions and boundaries between science, art, design and 
culture are broken down (Edwards 2010). (Apparently, Edwards’ teams of 
scientists, artists, designers and entrepreneurs can be found dreaming up their 
ideas in a circular room, encapsulated with white boards, equipped with several 
colours of marker for complex drawing, as well as bean bags and a log for quiet 
moments of contemplation.) In reading Edwards’ (ibid) book, it strikes me that 
                                                
205 Le Laboratoire is an experimental science, technology, art and design laboratory, shop and 
exhibition space in central Paris “where creators and society meet through cultural exhibition, a 
new platform for innovation” (Edwards 2010, 3-4). Also note http://www.lelaboratoire.org/en/.  
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there is a notable collection of sites for idea incubation where doors are being 
opened to incorporate a wide variety of views – sites such as iGEM, Le 
Laboratoire, École des Arts Politiques206, SymbioticA207 and even much larger 
companies such as IDEO208. Though I cannot claim to understand the workings of 
all such organisations, perhaps they show parallel opportunities in which many 
interdisciplinary perspectives are included, not only to ideate and create real 
things but also to assess critically what should and should not make a transition 
from idea to reality. In some spheres of innovation – right at that early stage of 
furious idea generation, extraction of the pursuable project and transitioning to a 
process of design, experiment and making real – one can find life scientists, 
engineers, artists, designers, entrepreneurs and social scientists. 
 
Whether or not ideas in synthetic biology (and under the broader umbrella of 
bioengineering) get made real is, of course, also a matter of the extent to which 
biology is amenable to our designer wishes and technical ability. The stuff of life 
mostly shows its recalcitrance at the point of physical intervention. Biology, more 
than any other material one can attempt to shape and re-make, defies being tamed, 
black-boxed, engineered. What an empirical story of knowledge and material 
production in synthetic biology currently highlights are limits to what we can 
create. Those many views involved in shaping what ideas are dreamed up and 
                                                
206 Founded by Bruno Latour in 2009, École des Arts Politiques, is an innovative educational 
institution that connects the arts with a broad range of social and natural sciences 
(http://speap.sciences-po.fr/en.php?item.8).  
207 Founded in 2000 by a cell biologist, a neuroscientist and an artist at the University of Western 
Australia, “SymbioticA is an artistic laboratory dedicated to the research, learning, critique and 
hands-on engagement with the life sciences” (http://www.symbiotica.uwa.edu.au/).  
208 IDEO is a design consultancy firm, renowned for its human-centred approach that develops a 
wide range of products, services, processes and strategy (http://www.ideo.com/about/).  
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attempted, I’ve suggested, can voice this limit; however, ultimately, biology 
decides.  
 
Living entities are situated in layer-upon-layer of milieu: DNA (in BioBrick form 
or otherwise) operates only with a host of cellular machinery, in a complex 
chemical soup; multiple cells clumping together (whether from the same organism 
or many independent unicellular organisms) take on a whole new set of functional 
properties; and so on, to the complexity of human beings and our interactions with 
each other and the rest of the living world. With every additional environmental 
layer, living entities exist under a set of conditions that become harder to 
comprehend. Biology is inherently difficult to define and characterize; it is 
unpredictable, unwieldy, reproducing and struggling to persist through evolution. 
Even if one believes that living entities are mere composites of purely physical 
and chemical properties, their vital organisations and mechanics, in many 
respects, remain mysterious, perhaps unknowable.  
 
Whether or not we will ever categorically add a branch of Synthetica on the Tree 
of Life, and what those organisms might consist in, remains to be seen. In the 
coming years and decades, as approaches and possibilities in engineering biology 
change, what we can do, as Rose (2007) suggests, is continue to map a “modest 
cartography of the present” that shows our living in “in the middle of multiple 
histories” with a conditional present and an open future (5). Moreover, one can 
seize the opportunity to intervene and act in collaboration to help dream and make 
up our living world. 
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APPENDIX I 
 
(i) PhD Research Information Sheet 
This sheet was given to research participants to keep. It was purposely 
designed to be user-friendly and cater to the mostly undergraduate 
student population that was involved in this ethnography. 
 
 
GOING SYNTHETIC: HOW SCIENTISTS AND ENGINEERS DREAM A NEW 
BIOLOGY INTO REALITY 
 
Who am I? The researcher: 
• Caitlin Cockerton: Current sociology PhD student exploring synthetic biology, supervised by Prof 
Nikolas Rose and Dr. Filippa Lentzos, BIOS Centre, LSE 
• 2008: MSc Biomedicine, Bioscience and Society, LSE, distinction and top of class 
• 2003-2007: BASc, McGill University (with study abroad at University of Edinburgh), double 
major in microbiology and immunology as well as philosophy  
What am I researching? Why is this research important? 
• In 2009-2010, I will conduct fieldwork to examine how iGEM teams design and build a biological 
‘machine’. I want to explore how iGEM inspires interest in synthetic biology and gives space for 
students to dream, model and fabricate new biological entities.  
• What is at stake as synthetic biology tries to take its place as the latest productive stream of 
biotechnology? Is the application of engineering to biology really analogous to engineering as 
applied to nuts and bolts, electronics and computers or the construction of bridges? 
• Might synthetic biology evoke a change in how human beings and social practices understand 
biology (and what it is to be a ‘living organism’)? How might human interactions with the 
‘biological world’ be altered (if at all) when dealing with biological forms that are ‘synthetic’ 
and constructed from scratch?  
• What might a social scientist learn from paying close attention to the way in which synthetic 
biology requires its innovators to imagine, design and then construct new biological (even 
‘living’) units? Investigating how the dreams of scientists and engineers evolve into reality is 
profoundly interesting at a sociological level. 
• I am also interested in the extent to which the new ways of thinking about biology in synthetic 
biology might percolate into social life and culture more generally. For example, Darwin’s 
theory of natural selection and the ‘gene for’ idea both had consequences far beyond 
biological research.  
What will this involve? 
• I will focus on two elite UK teams and trace the groups’ project development from the 
beginning stages to the aftermath, following the iGEM Jamboree at MIT.  
• I will primarily use ethnographic methodology, observing and participating amongst iGEM 
participants (03/09-12/09). Notes and selective recordings will serve as data. 
• Ethnography will be supplemented with semi-structured interviews, both in groups and in 
one-to-one formats. Interviews will generally be recorded. 
How will the data be used? 
• Research data will be used in writing my PhD thesis; however, it may also may be blogged 
online, discussed at conferences, published in a book and in academic journals. 
Will your input be anonymous? 
• Interviewees will complete a consent form; a choice is available to remain anonymous or to 
have one’s name and/or occupation written in my work. 
• Interviewees have the right to stop participation in an interview at any time or ask the 
researcher to have segments taken ‘off-record’. 
• I will be holder and interpreter of the research data; however, upon request, data can be 
accessed by participants.  
Further questions? Please do not hesitate to contact me: 
Caitlin Cockerton: c.cockerton@lse.ac.uk 
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(ii) Consent form 
This was the consent form I gave to participants and received signatures 
for.  
 
 
HUMAN SUBJECTS CONSENT FORM 2009-2010 
Going synthetic: how scientists and engineers dream a new biology into reality  
Caitlin Cockerton,  
PhD Candidate, BIOS Centre 
London School of Economics and Political Science 
http://www.lse.ac.uk/collections/BIOS/ 
c.cockerton@lse.ac.uk   
 
You have been asked to participate in research conducted by Caitlin Cockerton, PhD candidate at 
the BIOS Centre, The London School of Economics and Political Science. The purpose of the 
research is to explore the process in which iGEM teams formulate their summer project and work 
towards building a synthetic biology ‘machine’. The research will be taking place in 2009-2010. 
 
PARTICIPATION AND CONFIDENTIALITY 
Your participation in the research will involve informal participant/observation interaction with 
Caitlin Cockerton and potentially being involved in interviews (group or one-to-one). Caitlin will 
be taking notes and making selected recordings. You may choose to remain anonymous, but 
Caitlin will ask permission to use your name and/or occupation in her work (below).  
Results of this research will be used for Caitlin’s PhD thesis at The London School of Economics 
and Political Science. In addition, results may be blogged online, published in a book, in academic 
journals and discussed at conferences. 
Caitlin Cockerton will be the holder and interpreter of the research data; however, upon special 
request, data can be accessed by participants. You have the right to stop your participation in an 
interview at any time or ask the researcher not to record.  
 
PLEASE TICK ONE 
[    ]  My name, occupation and institutional affiliation can be written in Caitlin         
Cockerton’s work. 
[    ]  My occupation and institutional affiliation can be written in Caitlin                
Cockerton’s work; however, I would not like my name used. 
 [    ]  I would like to remain anonymous in any of Caitlin Cockerton’s work. 
 
CONSENT 
I understand the purpose of this research and my questions have been answered. I have indicated 
whether my name, occupation and institutional affiliation can be written or whether I prefer to 
remain anonymous. I understand that I have the right to stop an interview at any time during the 
interview, and to withdraw permission to use part or all of the interview material within reasonable 
time after the conclusion of the interview. 
 
I give my consent to participate in this research and be interviewed. 
 
_________________________  _______          _______________________  _______     
Participant’s Signature                     Date       Participant’s Printed Name         Date 
 
_________________________  _______           ______________________  _______` 
Interviewer’s Signature (witness)     Date                  Interviewer’s Printed Name       Date 
Contact details: Name:  ____________________     Email: _____________________ 
            Phone:  ____________________ 
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(iii) Further Agreement 
This further agreement was made for the Cambridge iGEM advisors to 
further protect the participants. The agreement was signed and kept in my 
records. A similar agreement was made and signed by the leaders of the 
Imperial College iGEM team as well. 
 
 
GOING SYNTHETIC: HOW SCIENTISTS AND ENGINEERS DREAM A NEW 
BIOLOGY INTO REALITY 
Further discretionary agreement for  
University of Cambridge participants 
May 2009 
 
In addition to the human subjects’ consent form that will need to be completed by all participants 
in Caitlin Cockerton’s research, this document provides a further discretionary agreement that 
aims to protect information of an individual personal nature of the involved iGEM participants. 
This document is to be signed by the researcher (Caitlin Cockerton) and co-ordinators of the 2009 
Cambridge iGEM team.     
 
Caitlin’s research focuses on styles of thought and practices involved in iGEM and how these 
change over the course of the team’s summer project. Broadly speaking, Caitlin seeks to 
understand how iGEMers imagine, design and construct a new synthetic biological entity. 
Although the research will involve exploring the thought processes and social dynamics that arise 
in a group of students from different disciplinary backgrounds, who are likely to have different 
approaches to their subject matter, Caitlin’s work will maintain respect for the personal privacy of 
participants. Furthermore, as far as possible, Caitlin will try to avoid identifying features in 
presenting the interview data, but her work will disclose institutional affiliation and disciplinary 
background of involved iGEM participants. No iGEM student will be named by his or her real 
name; however, co-ordinators and other advisors or guest speakers involved with the iGEM team 
may or may not be named, as agreed to in individual consent forms.  
 
Additional measures will be taken throughout the course of Caitlin’s research in order to ensure 
that a suitable level of personal protection exists for participants: 
• Caitlin has agreed NOT to blog her research in ‘real time’ and will seek approval of 
participants and the iGEM supervisors should she wish to make online postings related to this 
project. An exception may arise if it is deemed suitable that Caitlin contribute to the team’s 
wiki site as the summer project develops. 
• Interviewees have the right to stop participation in an interview or ask the researcher to have 
segments taken ‘off-record’(within reasonable time after the conclusion of the interview). 
• Caitlin will meet with iGEM supervisors periodically to discuss her research progress and 
come to an agreeable resolution to any potential conflicts of interest that may arise. Upon 
special request, coordinators of the iGEM team may access Caitlin’s written material that 
draws upon data gathered in this research in order to assist in discussing and resolving such 
potential conflicts of interest.  
 
It is taken in trust that, with the conditions stated, Caitlin can proceed with her research as a 
participant/observer with the Cambridge iGEM team of 2009. 
 
Signed by: 
• Caitlin Cockerton, Prof. X [Samuel], Prof. Y [Geoffrey] and Prof. Z [Frederick]  
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APPENDIX II 
 
Intellectual Property / Open Source: supplementary excerpts 
To provide the reader with a little further information from the BBF and 
the Registry, I have included the following excerpts from Endy and 
Grewal (2010). 
 
 
(4.i)  BBF is a not-for-profit organization that seeks to coordinate the creation of a repository of 
standardized synthetic biology elements and specifically meet the following goals: 
• to develop and implement legal strategies to ensure that BioBrick™ standard 
biological parts remain freely available to the public; 
• to support the development of open technical standards that define 
BioBrick™ standard biological parts, and; 
• to develop and provide educational and scientific materials to allow the public 
to use and improve existing BioBrick™ standard biological parts, and 
contribute new BioBrick™ standard biological parts. 
http://bbf.openwetware.org/; http://bbf.openwetware.org/Our_Goals.html. 
(4.ii) The BioBricks Legal Scheme (which shares obvious parallels to open software frameworks), 
proposed in January 2008, has the following three conditions: 
(1) You are free to modify, improve, and use all BioBrick™ parts, in systems 
with other BioBricks™ parts or non-BioBrick™ genetic material. 
(2) If you release a product, commercially or otherwise, that contains 
BioBrick™ parts or was produced using BioBrick™ parts, then you must 
make freely available the information about all BioBrick™ parts used in the 
product, or in producing the product, both for preexisting BioBrick™ parts 
and any new or improved BioBrick™ parts. You do not need to release 
information about any non-BioBrick™ material used in the system. 
(3) By using BioBrick™ parts, you agree to not encumber the use of 
BioBrick™ parts, individually or in combination, by others.209 
 (4.iii) There is currently a BioBrick™ Public Agreement (in Draft form, Version 1a) that is meant 
“[f]or public distribution and comment” (Endy and Grewal 2010). This working document 
shows how the BBF is working towards creating a mixed – open, yet also with patent 
provisions – IP framework for BioBrick™ parts (ibid). Currently, the document’s preface 
reads: 
“The BioBricks Foundation, Inc. (the “Foundation”) was established to foster 
and advance innovation, research, standardization, and education in synthetic 
biology through the open design, construction, distribution, understanding, 
and use of BioBrick™ compatible parts, namely standardized genetic 
materials and associated functional information, in ways that benefit the 
world. The Foundation believes that a free and easy-to-use legal framework 
for sharing and making use of engineered genetic materials underlies and 
serves these goals. Some such genetic materials may be subject to patents; 
some will not be. The patent-related provisions in this Contributor Agreement 
may or may not apply to the Materials” (ibid, 2).  
Endy, D. and Grewal, D. (2010) The BioBrick Public Agreement, DRAFT Version 1a, January 
2010: 
http://dspace.mit.edu/bitstream/handle/1721.1/50999/BPA_draft_v1a.pdf?sequence=1 
 
 
                                                
209 http://openwetware.org/wiki/The_BioBricks_Foundation:Legal 
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APPENDIX III 
 
(i) Imperial College 2009 iGEM team Human Practices project: 
supplementary document. This document was written by Andrew (and 
edited by me) to summarize the team’s human practices work. It was 
disseminated via the team’s Wiki and in hard-copy form at the Jamboree. 
 
 
Imperial College 2009 iGEM team Human Practices project: supplementary documents.. 
 
Imperial College London 2009 iGEM Team  
Human Practices Project 
 
1. Why do human practices in iGEM? 
     Synthetic biology is clearly an exciting and inspiring area for those participating in iGEM. For 
the most part, our enthusiasm arises because we have got the chance to learn how to use the tools 
and techniques of synthetic biology in order to work towards applications that benefit humanity – 
with teams working towards more effective ways to deliver medicines, make biofuels, or even 
make bacteria smell nicer, the iGEM competition opens up a space for students to imagine how to 
make the world better, one BioBrick at a time. Yet, we believe that iGEM participants ought to go 
beyond learning about what synthetic biology can do and how to accomplish positive goals in this 
field.  
     It has become apparent in recent years that a number of social, political, legal and ethical issues 
circulate around synthetic biology (i.e. see Lentzos 2009). For example, there are concerns about 
how a sceptical public may perceive this technology as well as worries about biosafety, biosecurity 
and the fair distribution of knowledge and applications that disseminate from this field with mixed 
open source and IP regimes – and saying that merely scratches the surface!  
     As young iGEMers, a good number of us are likely to comprise the next generation of 
practicing synthetic biologists. It is therefore crucial that we enlarge our view to include an 
appreciation of this field’s potential societal impacts. That is why we believe that iGEM students 
should think carefully about how we can help to develop this area of biotechnology in a safe and 
productive way, acknowledging and participating in discussions that address wider socio-political 
and ethical concerns. Such dialogue is already taking place at multiple levels – a number of 
scientists and engineers practising synthetic biology are participating in debate and discussion with 
public spheres, policy makers and social scientists in order to support development that aims at 
maximizing benefits and minimizing potential negative impacts of the field. 
 
2. About our human practices project 
     Keeping in mind that a number of synthetic biologists are participating in the kind of dialogue 
discussed above, we thought it would be a good idea for us to get some practice at talking through 
the ‘human practices’ side of this field. That is why, with the help of Caitlin Cockerton (a PhD 
student from the BIOS Centre at London School of Economics), we developed a human practices 
project.  
     We decided to focus on three themes: (1) describing our work in easily understandable terms; 
(2) reflecting on the biological (some might even think ‘life like’) nature of the materials used in 
synthetic biology; and (3) addressing risks in our project and in synthetic biology in general. 
Caitlin conducted interviews with each of us in the iGEM team and these were recorded on video. 
This was where we had the chance to talk through our personal views on the three themes. We also 
participated in a group workshop with Caitlin, where we discussed and debated our views 
collectively. We have included a short video (see wiki) of some of our favourite clips from the 
interviews.   
 
3. What we learned & suggestions for future iGEM human practices projects 
     From this enriching experience, we learned that such discussions are essential to the safe 
advancement of the field. Many of us expressed their desire to have a transparent scientific 
community where the scientists and society discuss freely about the expectations and risks that the 
field touches on. It was an interesting exercise to be pushed to articulate our views on topics that 
are indeed closely tied to our work in iGEM, but that sometimes we forget about when we are just 
‘doing the science and engineering’.  
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     We need to be able to explain our work in understandable terms – this ties into the matter that 
synthetic biology will have to discuss and debate about this biotechnology in public spheres as the 
field progresses and begins to impact society.  
     We also ought to think about how others may perceive the manipulation and engineering of the 
components of life – although we may think biology can be ‘black-boxed’ and thought of in 
analogous ways to computer systems, others may disagree. It is for example important to keep in 
mind that the materials that are manipulated in synthetic biology do not have the same moral 
implications as existing, non-living technology such as the computer. It is important for us to 
appreciate that there will be many different views on what synthetic biology is about and we will 
need to create a framework within which all these different points of view can come together, 
discuss and shape the future of the field. 
     Finally – and this was something we knew right from the beginning of our project – it was 
essential that we all knew about how our project may be perceived as somewhat ‘risky’, in that the 
application would imply human beings could ingest capsules that are filled with proteins that have 
been made by a genetically engineered E. coli. We have built in strong safety measures into our 
project right from the beginning and we need to be able to articulate what this is about to others. 
We strongly believe that the wider sociological issues and concerns need to be addressed in the 
design of synthetic biological systems. This will show the commitment of the synthetic biologist 
towards the aim of creating a field that will contribute to the betterment of society as a whole. 
 
     In conclusion, we would recommend that future iGEM teams take on a human practices project 
of some sort. Even the simple exercise of reading and talking through some of the wider socio-
political and ethical issues amongst fellow iGEM peers does a lot to benefit the field. If we begin 
now to work on developing ourselves as scientists and engineers who can relate our work to a 
bigger picture, it will only serve to benefit our research community and our society at later stages 
of synthetic biology’s development.  
     Of course, there are many avenues to go down to take human practices projects further – do 
some public outreach by visiting schools or community centres to talk about synthetic biology; 
make questionnaires for members of the synthetic biology community or wider circles in our 
universities, cities or countries; think carefully about how to build in safeguards into our projects 
and then make sure we are able to talk about it clearly to lay audiences as well as to peers in the 
field. This is another reason why we are excited about coming together at the jamboree, as it is an 
ideal opportunity for discussion and debate around the aforementioned issues. We believe that as 
the next generation of synthetic biologists – and hopefully as the generation who will really be 
transferring the products of synthetic biology into society – it is essential for us to consider human 
practices of synthetic biology as an inherent part of our work!  
 
Recommended reading… 
For those interested in exploring literature more in the social sciences realm of synthetic biology 
(or biotechnology in general), the following reading list has been provided as a starting point… 
Happy reading! 
(i) Some books and journals in the social sciences realm… 
 
BioSocieties Debate (2008) ‘Beyond the genome: The challenge of synthetic biology,’ 
BioSocieties Vol.3(1): 3-20 
 
Fox-Keller, E. (2009) ‘What Does Synthetic Biology Have to Do with Biology?’ BioSocieties 
Vol.4: 291-302 
 
Hope, J. (2008) Biobazaar: the Open Source Revolution and Biotechnology, Cambridge, MA: 
Harvard University Press 
 
Jasanoff, S. (2005) Designs on nature: Science and Democracy in Europe and the United States, 
Princeton, NJ: Princeton University Press 
 
Lentzos, F. (2009) ‘Synthetic Biology in the Social Context: The UK Debate to Date,’ BioSocieties 
Vol.4: 303-315 
 
Lentzos, F., Gaymon Bennett, Jeff Boeke, Drew Endy and Paul Rabinow (2008) ‘Visions and 
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Challenges in Redesigning Life,’ BioSocieties Vol.3(3):311-23 
 
Rai, A. & Boyle, J. (2007) ‘Synthetic Biology: Caught between Property Rights, the Public 
Domain, and the Commons,’ PLoS Biology Vol.5:389-393 
 
Rose, N. (2007) The Politics of Life Itself: Biomedicine, Power, and Subjectivity in the Twenty-
First Century, Princeton, NJ: Princeton University Press 
 
Sunder Rajan, K. (2006) Biocapital: The Constitution of Postgenomic Life, Durham: Duke 
University Press 
  
Wilmut, I., Campbell, K. & Tudge, C. (2000) The Second Creation: Dolly and the Age of 
Biological Control, Cambridge, MS: Harvard University Press 
 
 
(ii) Some links to interesting recent articles in popular intellectual media… 
 
http://www.newyorker.com/reporting/2009/09/28/090928fa_fact_specter 
http://www.economist.com/printedition/displaystory.cfm?story_id=14299634 
http://www.wired.co.uk/wired-magazine/archive/2009/09/features/at-home-with-the-dna-
hackers.aspx 
http://www.nybooks.com/articles/20370 
 
 
(iii) Articles in science journals address some of the wider social concerns surrounding 
synthetic biology too! See these for a start… 
 
Bhattacharjee, Y. (2007) ‘Gene-synthesis companies join forces to self-regulate,’ Science 
Vol.316(22June): 1682 
 
Bügl, H. et al. (2007) ‘DNA synthesis and biological security,’ Nature Biotechnology Vol.25(6): 
627-9 
 
Check, E. (2005) ‘Synthetic biologists face up to security issues,’ Nature Vol.436(18 Aug): 894-5 
 
Check, E. (2006) ‘Synthetic biologists try to calm fears,’ Nature Vol.441(25 May): 388-9 
 
Nature Editorial (2006) ‘Policing Ourselves,’ Nature Vol.441(25 May): 383 
 
Nature Editorial (2008) ‘Pathways to Security,’ Nature Vol.445(25 Sept): 432 
 
Parens, E. et al. (2008) ‘Do We Need “Synthetic Bioethics”?’ Science, Vol.321(12 Sept): 1449 
 
Service, R.F. (2006) ‘Synthetic biologists debate policing themselves,’ Science Vol.312(26 May): 
1116 
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(ii) Imperial College 2009 iGEM team Human Practices project: 
supplementary document. This document was co-written by Andrew and his 
friend and was given out in hard copy at the Jamboree. (Note that the entire 
document is credited to these two students, so I have not added the references or 
made any editorial changes.)   
 
 
  Imperial College London 
  The E.Ncapsulator 
iGEM 2009-10-21 
 
Synthetic biology and bioethics 
 
 The E.Ncapsulator project is a direct application of synthetic biology’s theories. For that 
matter, it is important to analyze it from an ethical perspective: first of all, to make sure that the 
project is done according to the main principles of bioethics announced in the Belmont Report210 
and especially the principles of autonomy and beneficence. Moreover, it should also respect the 
idea of biosafety: genetically engineered products should not interfere with the environment – and 
especially with human health - to the point where it degrades it.   
 
In addition of those basic ethical issues – that apply to other fields such as genetic engineering, 
synthetic biology raises moral and philosophical issues: does using DNA and genes, which are to 
some people the very core of life, as tools change the definition of life? Does it not blur our 
conceptions of what life is?     
     * 
 
I. The scientist and the layman 
 
Synthetic biology is a new field. As such, its productions have not yet arrived in everyday life, nor 
has it changed it…yet. But already, many scientists talk about its potential; synthetic biology is 
seen by many as something that would change the world we live in. A European Commission 
report has tried to sum up all the fields synthetic biology could be used in and according to the 
report, applications could change the fields of medicine, pharmaceutical products, chemical 
industry, energy…211  
 
Thus, it is fair to assume that synthetic biology will change our lives during the next decades, and 
that it will have an impact in reality itself. 
 
Such promises create hopes, but fears as well: the same reluctance that exist in some countries 
towards GMO – whether they are legitimate or not – will come towards synthetic biology as soon 
as its products will be available to everyday life. We can even say that this reluctance will be more 
important, since some people already see synthetic biologists as God-playing scientists. As the 
European Commission Report puts it, “to some, this is sure to seem like ‘playing God’”212. 
Therefore, it is important that scientists explain to the public what synthetic biology is, and explain 
both its risks and benefits. 
 
We believe that the importance of taking human practices into account in the iGEM is to create 
awareness of this among young scientists. Not only is it important to be capable of explaining their 
project in lay terms, but also it is crucial that they fully understand why ethics are an important 
part of scientific life especially with regard to the link between science and society. 
 
II. The E.Ncapsulator and biosafety 
 
                                                
210 The Belmont Report 
211 The report of a NEST High-Level Expert Group (European Commission) 
212 Cf. supra, page 21. 
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One of the major themes in bioethics is the issue of biosafety. Ever since Dr. Eckard Wimmer 
announced that he and his team had artificially created the polio virus213, fears were stirred among 
civil society. Incidentally, one of the main fears concerning synthetic biology is that a dangerous 
living organism could accidently – or even intentionally – escapes from a laboratory and cause a 
biological catastrophe. Perhaps it is that fear can be reduced to an over-reaction from people who 
don’t know synthetic biology. As a matter of fact, most scientists will argue that the organisms 
used in laboratories would not resist a normal environment. However, asking for precaution from 
the synthetic biologists is a legitimate request. Thus, it falls naturally to ask that the International 
Biosafety Protocol214 be applied in synthetic biology. 
 
Being aware of such matters, the people working on the E.Ncapsulator project have decided from 
the beginning to use cells that could not hurt the environment and human health. Although some 
strains of Escherichia coli (commonly known as E.coli) can affect human health (e.g. 
Enterotoxigenic E. Coli), the strain used for the E.Ncapsulator (TOP10) was consciously chosen to 
be harmless. Thus, even if it did escape, however unlikely that event is, there would be no risk for 
the environment whatsoever: the E.Ncapsulator is biosafe. 
 
Moreover, the E.Ncapsulator team is aware of what their project would look like to the eyes of 
people who do not know much about biology: eating an genetically engineered living pill can be 
repulsive for some people. In fact, not only can they fear a catastrophe, but they can also be 
reluctant to eating alive bacteria. For that reason, the E.Ncapsulator team added a module to their 
project. Module 3 is the genomic neutralisation of the bacteria – a phenomenon where the bacteria 
commit suicide by chopping up their DNA. That way, the team – assessing the public’s potential 
fears – makes sure that these are minimized and the public reassured. 
 
On a bioethical level, the E.Ncapsulator respects the notion of biosafety and also the principles of 
the Belmont Report. Indeed, its aim is to create genetically engineered pills aimed at curing or 
alleviating conditions such as Phenylketonuria. This project respects in full the principle of 
autonomy as it provides people with the choice of taking or not taking the pills. Furthermore, 
because those pills are meant to cure some malfunctions, it respects the principle of beneficence. 
 
III. Moral and philosophical implications 
 
Beyond those bioethical issues, synthetic biology raises moral and philosophical questions that do 
not seem to have been answered yet. For that matter, the E.Ncapsulator project is not an exception. 
Our goal here is not to give straight answers to all of these questions, but to raise awareness about 
some of them. 
 
First of all, most philosophers until now tended to define morality in terms of ends and means. 
Immanuel Kant, founder of the modern conception of morality, thought that we should consider 
other people not as means to our ends, but as ends. When stealing from someone, a thief considers 
this person as the possessor of money you need, not as a full person whom you should respect. A 
good way to sum up morality would be : “Always recognize that individuals are ends, and do not 
use them as means to your end.” 215 Some philosophers extended this principle to all living 
beings.216 Synthetic biology uses life as a material – and therefore are not always considering what 
we could call “the sacred nature of life” – could be considered as immoral. On the other hand, so 
would a 16th century peasant building a house out of trees he cuts. This debate concerning 
synthetic biology and morality is certainly not the most important one, but it leads to a second 
philosophical –perhaps more important- question: how do we define life? 
 
According to Edouard Machery, “a stable definition of ‘life’ is impossible and useless.”217 This 
might be true philosophically speaking, but one cannot deny the fact that synthetic biology will 
change the way people see life. For decades now, everyone has linked the vague concept of “life” 
                                                
213 BBC News article from June 11th 2002 
214 Biosafety Protocol homepage 
215 Karl Popper, The Open Society and Its Enemies (1945) 
216 Hansson M.G, Human Dignity and Animal Well-being: a Kantian Contribution to Biomedical 
Ethics (1991) 
217 Quoted on page 27 
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to DNA and genes. Now however, the limit between life and objects becomes blurred, and we no 
longer have a scientific theory on which we can build our representation of what life is. Life is no 
longer in the genes, because the genes have become just another object we use in engineering. It is 
up to philosophers to redefine/recreate the concept of “life” – or at least to ease the acceptance of 
the fact that such a thing as life simply might not exist. As Shakespeare said, “Life every man 
holds dear”218. This might very well mean that by blurring the concept of “life”, we are stealing 
“life” from ourselves –as human beings.  
 
These issues are due to the very principles of synthetic biology. The E.Ncapsulator raises yet 
another issue: among the possibilities that this product offers is the delivery of cellulase in the 
intestine, an enzyme that breaks down cellulose to glucose. In theory, a cellulase capsule would 
allow people to eat... grass. Although, no precise definition of the human being exists, it does not 
usually cover grass-eating. One of the issues of synthetic biology is therefore this possibility of 
changing the human being and its very definition. 
 
     * 
 
The E.Ncapsulator project is bioethical: it respects core principles such as the principles of 
autonomy, beneficence, and biosafety. However it raises a number of philosophical issues. Even 
though these issues do not interfere with the scientists’ every day work, the E.Ncapsulator team 
acknowledges them and believes scientists should participate in any future debates concerning the 
impact of synthetic biology on human conceptions of life or humanity. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                
218 William Shakespeare, Troilus and Cressida (1602) 
